Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-08-16
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| AC015660.1 | 2.664554 |
| AC092142.1 | -2.481810 |
| AK5 | 2.445086 |
| SNHG29 | -2.437354 |
| AKR1C3 | -2.378403 |
| DCAF15 | -2.368150 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10461 |
| num_genes_in_profile | 15152 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 11615 |
| num_profile_genes_not_in_sets | 3537 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets:| Gene sets metrics | |
|---|---|
| num_genesets | 10461 |
| num_genesets_excluded | 4463 |
| num_genesets_included | 5998 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP TRANS SYNAPTIC SIGNALING BY LIPID | 5 | 9.19e-04 | -0.856 | 0.065700 |
| GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY | 5 | 1.69e-03 | -0.811 | 0.091900 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 5.34e-04 | -0.756 | 0.043200 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 5 | 3.56e-03 | -0.753 | 0.144000 |
| GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 5 | 3.92e-03 | -0.745 | 0.151000 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 1.05e-03 | -0.715 | 0.072800 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION | 5 | 6.71e-03 | 0.700 | 0.194000 |
| GOCC LAMIN FILAMENT | 5 | 6.75e-03 | -0.699 | 0.194000 |
| GOCC WEIBEL PALADE BODY | 5 | 8.25e-03 | 0.682 | 0.214000 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 8.94e-03 | -0.675 | 0.220000 |
| GOBP POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS | 5 | 9.93e-03 | -0.666 | 0.233000 |
| GOBP SKELETAL MUSCLE TISSUE GROWTH | 5 | 1.02e-02 | 0.663 | 0.236000 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 2.72e-03 | 0.654 | 0.122000 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 7 | 2.95e-03 | -0.649 | 0.129000 |
| GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY | 5 | 1.23e-02 | 0.647 | 0.253000 |
| GOCC PROTEASOME CORE COMPLEX | 18 | 2.35e-06 | -0.643 | 0.000706 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 4.36e-04 | -0.642 | 0.038800 |
| GOBP PHOSPHATE ION HOMEOSTASIS | 6 | 6.58e-03 | 0.641 | 0.192000 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 1.34e-02 | -0.639 | 0.262000 |
| GOMF CASPASE BINDING | 8 | 2.06e-03 | -0.629 | 0.104000 |
| GOCC MEIOTIC COHESIN COMPLEX | 5 | 1.53e-02 | 0.626 | 0.277000 |
| GOBP PROTEIN UNFOLDING | 5 | 1.60e-02 | -0.622 | 0.282000 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 5 | 1.61e-02 | 0.621 | 0.282000 |
| GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY | 6 | 8.81e-03 | -0.618 | 0.219000 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 9.79e-03 | 0.609 | 0.232000 |
| GOBP URETER DEVELOPMENT | 5 | 1.86e-02 | 0.608 | 0.295000 |
| GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 1.94e-02 | -0.604 | 0.299000 |
| GOBP TYPE II HYPERSENSITIVITY | 5 | 1.95e-02 | -0.603 | 0.299000 |
| GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 2.08e-02 | 0.597 | 0.306000 |
| GOBP PLASMA CELL DIFFERENTIATION | 6 | 1.19e-02 | -0.593 | 0.252000 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 7 | 6.64e-03 | -0.592 | 0.193000 |
| GOCC GROWTH FACTOR COMPLEX | 5 | 2.20e-02 | 0.592 | 0.312000 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 2.28e-02 | 0.588 | 0.317000 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 6 | 1.26e-02 | 0.588 | 0.253000 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 7 | 7.09e-03 | 0.588 | 0.198000 |
| GOCC SPECTRIN ASSOCIATED CYTOSKELETON | 5 | 2.32e-02 | 0.586 | 0.318000 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 9 | 2.34e-03 | 0.586 | 0.114000 |
| GOCC PARANODE REGION OF AXON | 5 | 2.36e-02 | -0.585 | 0.319000 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 7.40e-03 | 0.585 | 0.204000 |
| GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY | 5 | 2.36e-02 | 0.584 | 0.319000 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 2.40e-02 | -0.583 | 0.320000 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 6 | 1.35e-02 | 0.582 | 0.264000 |
| GOBP SEQUESTERING OF IRON ION | 5 | 2.42e-02 | -0.582 | 0.322000 |
| GOBP IRON IMPORT INTO CELL | 5 | 2.43e-02 | 0.582 | 0.322000 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 6 | 1.39e-02 | 0.580 | 0.265000 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 5 | 2.50e-02 | 0.579 | 0.323000 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 2.51e-02 | 0.578 | 0.323000 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 7 | 8.43e-03 | 0.575 | 0.216000 |
| GOBP B 1 B CELL DIFFERENTIATION | 5 | 2.62e-02 | -0.574 | 0.329000 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 1.49e-02 | 0.574 | 0.274000 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP TRANS SYNAPTIC SIGNALING BY LIPID | 5 | 9.19e-04 | -8.56e-01 | 6.57e-02 |
| GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY | 5 | 1.69e-03 | -8.11e-01 | 9.19e-02 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 5.34e-04 | -7.56e-01 | 4.32e-02 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 5 | 3.56e-03 | -7.53e-01 | 1.44e-01 |
| GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 5 | 3.92e-03 | -7.45e-01 | 1.51e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 1.05e-03 | -7.15e-01 | 7.28e-02 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION | 5 | 6.71e-03 | 7.00e-01 | 1.94e-01 |
| GOCC LAMIN FILAMENT | 5 | 6.75e-03 | -6.99e-01 | 1.94e-01 |
| GOCC WEIBEL PALADE BODY | 5 | 8.25e-03 | 6.82e-01 | 2.14e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 8.94e-03 | -6.75e-01 | 2.20e-01 |
| GOBP POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS | 5 | 9.93e-03 | -6.66e-01 | 2.33e-01 |
| GOBP SKELETAL MUSCLE TISSUE GROWTH | 5 | 1.02e-02 | 6.63e-01 | 2.36e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 2.72e-03 | 6.54e-01 | 1.22e-01 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 7 | 2.95e-03 | -6.49e-01 | 1.29e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY | 5 | 1.23e-02 | 6.47e-01 | 2.53e-01 |
| GOCC PROTEASOME CORE COMPLEX | 18 | 2.35e-06 | -6.43e-01 | 7.06e-04 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 4.36e-04 | -6.42e-01 | 3.88e-02 |
| GOBP PHOSPHATE ION HOMEOSTASIS | 6 | 6.58e-03 | 6.41e-01 | 1.92e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 1.34e-02 | -6.39e-01 | 2.62e-01 |
| GOMF CASPASE BINDING | 8 | 2.06e-03 | -6.29e-01 | 1.04e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 5 | 1.53e-02 | 6.26e-01 | 2.77e-01 |
| GOBP PROTEIN UNFOLDING | 5 | 1.60e-02 | -6.22e-01 | 2.82e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 5 | 1.61e-02 | 6.21e-01 | 2.82e-01 |
| GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY | 6 | 8.81e-03 | -6.18e-01 | 2.19e-01 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 9.79e-03 | 6.09e-01 | 2.32e-01 |
| GOBP URETER DEVELOPMENT | 5 | 1.86e-02 | 6.08e-01 | 2.95e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 1.94e-02 | -6.04e-01 | 2.99e-01 |
| GOBP TYPE II HYPERSENSITIVITY | 5 | 1.95e-02 | -6.03e-01 | 2.99e-01 |
| GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 2.08e-02 | 5.97e-01 | 3.06e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 6 | 1.19e-02 | -5.93e-01 | 2.52e-01 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 7 | 6.64e-03 | -5.92e-01 | 1.93e-01 |
| GOCC GROWTH FACTOR COMPLEX | 5 | 2.20e-02 | 5.92e-01 | 3.12e-01 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 2.28e-02 | 5.88e-01 | 3.17e-01 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 6 | 1.26e-02 | 5.88e-01 | 2.53e-01 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 7 | 7.09e-03 | 5.88e-01 | 1.98e-01 |
| GOCC SPECTRIN ASSOCIATED CYTOSKELETON | 5 | 2.32e-02 | 5.86e-01 | 3.18e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 9 | 2.34e-03 | 5.86e-01 | 1.14e-01 |
| GOCC PARANODE REGION OF AXON | 5 | 2.36e-02 | -5.85e-01 | 3.19e-01 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 7.40e-03 | 5.85e-01 | 2.04e-01 |
| GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY | 5 | 2.36e-02 | 5.84e-01 | 3.19e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 2.40e-02 | -5.83e-01 | 3.20e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 6 | 1.35e-02 | 5.82e-01 | 2.64e-01 |
| GOBP SEQUESTERING OF IRON ION | 5 | 2.42e-02 | -5.82e-01 | 3.22e-01 |
| GOBP IRON IMPORT INTO CELL | 5 | 2.43e-02 | 5.82e-01 | 3.22e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 6 | 1.39e-02 | 5.80e-01 | 2.65e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 5 | 2.50e-02 | 5.79e-01 | 3.23e-01 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 2.51e-02 | 5.78e-01 | 3.23e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 7 | 8.43e-03 | 5.75e-01 | 2.16e-01 |
| GOBP B 1 B CELL DIFFERENTIATION | 5 | 2.62e-02 | -5.74e-01 | 3.29e-01 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 1.49e-02 | 5.74e-01 | 2.74e-01 |
| GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION | 5 | 2.70e-02 | 5.71e-01 | 3.34e-01 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 6 | 1.57e-02 | 5.70e-01 | 2.80e-01 |
| GOBP SPHINGOLIPID TRANSLOCATION | 5 | 2.88e-02 | 5.65e-01 | 3.43e-01 |
| GOBP ZYMOGEN INHIBITION | 7 | 9.93e-03 | -5.63e-01 | 2.33e-01 |
| GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT | 5 | 2.95e-02 | 5.62e-01 | 3.46e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 18 | 4.10e-05 | -5.58e-01 | 6.74e-03 |
| GOMF SUMO POLYMER BINDING | 6 | 1.79e-02 | 5.58e-01 | 2.95e-01 |
| GOBP LIPOXYGENASE PATHWAY | 5 | 3.14e-02 | -5.56e-01 | 3.52e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 8 | 6.54e-03 | -5.55e-01 | 1.92e-01 |
| GOBP CHONDROCYTE PROLIFERATION | 10 | 2.42e-03 | 5.54e-01 | 1.15e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 7 | 1.12e-02 | 5.54e-01 | 2.45e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 7 | 1.12e-02 | 5.54e-01 | 2.45e-01 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 5 | 3.22e-02 | -5.53e-01 | 3.56e-01 |
| GOBP HEPATOCYTE DIFFERENTIATION | 6 | 1.90e-02 | -5.53e-01 | 2.96e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 16 | 1.29e-04 | 5.53e-01 | 1.61e-02 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 5 | 3.28e-02 | -5.51e-01 | 3.57e-01 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 7 | 1.16e-02 | -5.51e-01 | 2.48e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 8 | 7.02e-03 | -5.50e-01 | 1.98e-01 |
| GOMF SODIUM ION BINDING | 5 | 3.39e-02 | -5.48e-01 | 3.63e-01 |
| GOBP OUTER EAR MORPHOGENESIS | 5 | 3.46e-02 | -5.46e-01 | 3.65e-01 |
| GOCC PREFOLDIN COMPLEX | 7 | 1.26e-02 | -5.44e-01 | 2.53e-01 |
| GOBP ASYMMETRIC NEUROBLAST DIVISION | 5 | 3.52e-02 | 5.44e-01 | 3.68e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 6 | 2.18e-02 | -5.41e-01 | 3.12e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 3.66e-02 | -5.40e-01 | 3.73e-01 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 8 | 8.22e-03 | -5.40e-01 | 2.14e-01 |
| GOBP OVULATION | 7 | 1.37e-02 | 5.38e-01 | 2.65e-01 |
| GOBP DETOXIFICATION OF COPPER ION | 10 | 3.24e-03 | 5.38e-01 | 1.36e-01 |
| GOBP PIRNA PROCESSING | 9 | 5.39e-03 | 5.36e-01 | 1.77e-01 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 6 | 2.31e-02 | -5.36e-01 | 3.18e-01 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 5 | 3.85e-02 | 5.34e-01 | 3.80e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 8 | 8.89e-03 | -5.34e-01 | 2.20e-01 |
| GOBP LEUCINE METABOLIC PROCESS | 7 | 1.45e-02 | 5.33e-01 | 2.71e-01 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 2.39e-02 | -5.33e-01 | 3.19e-01 |
| GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 6 | 2.39e-02 | -5.32e-01 | 3.19e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 9.34e-03 | -5.31e-01 | 2.25e-01 |
| GOCC PINOSOME | 6 | 2.44e-02 | 5.31e-01 | 3.22e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY | 6 | 2.45e-02 | -5.30e-01 | 3.22e-01 |
| GOBP CILIUM DISASSEMBLY | 5 | 4.02e-02 | -5.30e-01 | 3.86e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 7 | 1.55e-02 | 5.29e-01 | 2.79e-01 |
| GOBP PROTEIN REPAIR | 6 | 2.51e-02 | -5.28e-01 | 3.23e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 1.57e-02 | 5.27e-01 | 2.80e-01 |
| GOCC LAMININ COMPLEX | 6 | 2.53e-02 | 5.27e-01 | 3.23e-01 |
| GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY | 5 | 4.12e-02 | -5.27e-01 | 3.86e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 7 | 1.58e-02 | 5.27e-01 | 2.81e-01 |
| GOCC EMC COMPLEX | 10 | 3.94e-03 | -5.27e-01 | 1.51e-01 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 5 | 4.17e-02 | 5.26e-01 | 3.86e-01 |
| GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 9 | 6.36e-03 | 5.25e-01 | 1.89e-01 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 2.71e-02 | 5.21e-01 | 3.34e-01 |
| GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.40e-02 | 5.20e-01 | 3.93e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 7.04e-03 | 5.19e-01 | 1.98e-01 |
| GOBP MICROTUBULE SEVERING | 7 | 1.78e-02 | 5.17e-01 | 2.95e-01 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 6 | 2.84e-02 | -5.17e-01 | 3.41e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 4.56e-02 | 5.16e-01 | 3.99e-01 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 4.60e-02 | -5.15e-01 | 4.01e-01 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 6 | 2.92e-02 | -5.14e-01 | 3.45e-01 |
| GOBP RESPONSE TO LEUCINE | 13 | 1.34e-03 | 5.14e-01 | 8.28e-02 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 5 | 4.67e-02 | -5.14e-01 | 4.03e-01 |
| GOBP REGULATION OF FERTILIZATION | 5 | 4.68e-02 | -5.13e-01 | 4.03e-01 |
| GOMF GDP PHOSPHATASE ACTIVITY | 7 | 1.87e-02 | -5.13e-01 | 2.95e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 1.20e-02 | -5.13e-01 | 2.52e-01 |
| GOBP CELLULAR RESPONSE TO GLUCAGON STIMULUS | 5 | 4.76e-02 | 5.11e-01 | 4.06e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 1.92e-02 | -5.11e-01 | 2.97e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 6 | 3.03e-02 | 5.11e-01 | 3.50e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 6 | 3.03e-02 | 5.11e-01 | 3.50e-01 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 3.38e-03 | 5.10e-01 | 1.39e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 11 | 3.39e-03 | -5.10e-01 | 1.39e-01 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 8 | 1.26e-02 | -5.09e-01 | 2.53e-01 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 5 | 4.90e-02 | -5.08e-01 | 4.11e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 4.92e-02 | -5.08e-01 | 4.12e-01 |
| GOBP OLFACTORY BEHAVIOR | 6 | 3.13e-02 | 5.08e-01 | 3.52e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 11 | 3.56e-03 | -5.08e-01 | 1.44e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 7 | 2.01e-02 | 5.07e-01 | 3.02e-01 |
| GOMF INTRACILIARY TRANSPORT PARTICLE B BINDING | 5 | 5.02e-02 | 5.06e-01 | 4.15e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 5 | 5.14e-02 | 5.03e-01 | 4.18e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 7 | 2.12e-02 | -5.03e-01 | 3.08e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 6 | 3.36e-02 | 5.01e-01 | 3.62e-01 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 7 | 2.21e-02 | 4.99e-01 | 3.12e-01 |
| GOBP ECTODERMAL CELL DIFFERENTIATION | 5 | 5.33e-02 | 4.99e-01 | 4.27e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 1.63e-10 | -4.98e-01 | 1.58e-07 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 1.47e-02 | -4.98e-01 | 2.72e-01 |
| GOCC BORC COMPLEX | 8 | 1.47e-02 | -4.98e-01 | 2.72e-01 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 6 | 3.47e-02 | -4.98e-01 | 3.65e-01 |
| GOBP NEURON CELL CELL ADHESION | 7 | 2.33e-02 | 4.95e-01 | 3.18e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE | 5 | 5.62e-02 | 4.93e-01 | 4.36e-01 |
| GOBP PROTEIN DENEDDYLATION | 11 | 4.80e-03 | -4.91e-01 | 1.65e-01 |
| GOBP LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION | 5 | 5.73e-02 | 4.91e-01 | 4.42e-01 |
| GOMF SULFATIDE BINDING | 6 | 3.73e-02 | -4.91e-01 | 3.76e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 5 | 5.75e-02 | -4.91e-01 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 8 | 1.63e-02 | 4.90e-01 | 2.84e-01 |
| GOMF FOLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.76e-02 | 4.90e-01 | 4.43e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 7 | 2.48e-02 | 4.90e-01 | 3.23e-01 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 15 | 1.06e-03 | 4.88e-01 | 7.28e-02 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 1.12e-02 | -4.88e-01 | 2.45e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 2.32e-04 | -4.88e-01 | 2.67e-02 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 5.91e-02 | -4.88e-01 | 4.45e-01 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 3.88e-02 | -4.87e-01 | 3.81e-01 |
| GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB | 5 | 5.98e-02 | 4.86e-01 | 4.47e-01 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 2.61e-02 | -4.85e-01 | 3.28e-01 |
| GOMF ALKALI METAL ION BINDING | 11 | 5.36e-03 | -4.85e-01 | 1.77e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 6.04e-02 | -4.85e-01 | 4.48e-01 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 6 | 4.01e-02 | 4.84e-01 | 3.86e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 13 | 2.52e-03 | -4.84e-01 | 1.18e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 6 | 4.05e-02 | -4.83e-01 | 3.86e-01 |
| GOMF POLY ADP D RIBOSE BINDING | 6 | 4.05e-02 | -4.83e-01 | 3.86e-01 |
| GOBP MYOBLAST MIGRATION | 8 | 1.81e-02 | -4.82e-01 | 2.95e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 7 | 2.74e-02 | -4.82e-01 | 3.35e-01 |
| GOBP NEUROENDOCRINE CELL DIFFERENTIATION | 5 | 6.23e-02 | 4.81e-01 | 4.55e-01 |
| GOMF IGG BINDING | 6 | 4.12e-02 | -4.81e-01 | 3.86e-01 |
| GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 6.25e-02 | -4.81e-01 | 4.56e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 13 | 2.67e-03 | 4.81e-01 | 1.22e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 10 | 8.51e-03 | 4.80e-01 | 2.16e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 9 | 1.26e-02 | 4.80e-01 | 2.53e-01 |
| GOBP CGMP BIOSYNTHETIC PROCESS | 7 | 2.79e-02 | 4.80e-01 | 3.40e-01 |
| GOMF GUANYLATE CYCLASE ACTIVITY | 7 | 2.79e-02 | 4.80e-01 | 3.40e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 8 | 1.88e-02 | 4.80e-01 | 2.95e-01 |
| GOCC SUPER ELONGATION COMPLEX | 6 | 4.20e-02 | 4.79e-01 | 3.87e-01 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 4.25e-02 | -4.78e-01 | 3.89e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 11 | 6.07e-03 | 4.78e-01 | 1.83e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 2.87e-02 | -4.77e-01 | 3.43e-01 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 6.47e-02 | -4.77e-01 | 4.66e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 1.95e-02 | 4.77e-01 | 2.99e-01 |
| GOBP APOPTOTIC CHROMOSOME CONDENSATION | 5 | 6.54e-02 | 4.76e-01 | 4.66e-01 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 6.55e-02 | 4.76e-01 | 4.67e-01 |
| GOBP HISTONE H3 ACETYLATION | 6 | 4.39e-02 | -4.75e-01 | 3.93e-01 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 9 | 1.38e-02 | -4.74e-01 | 2.65e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 6.65e-02 | 4.74e-01 | 4.70e-01 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 7 | 3.01e-02 | -4.73e-01 | 3.50e-01 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 6 | 4.49e-02 | -4.73e-01 | 3.96e-01 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 6.82e-02 | -4.71e-01 | 4.74e-01 |
| GOMF MOLECULAR TAG ACTIVITY | 12 | 4.78e-03 | -4.70e-01 | 1.65e-01 |
| GOBP INOSITOL METABOLIC PROCESS | 7 | 3.13e-02 | -4.70e-01 | 3.52e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 5 | 6.90e-02 | -4.70e-01 | 4.75e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 5 | 6.91e-02 | 4.69e-01 | 4.75e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 23 | 9.79e-05 | -4.69e-01 | 1.38e-02 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 8 | 2.16e-02 | 4.69e-01 | 3.12e-01 |
| GOBP ADP BIOSYNTHETIC PROCESS | 5 | 6.95e-02 | 4.69e-01 | 4.77e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 5 | 7.00e-02 | -4.68e-01 | 4.77e-01 |
| GOCC COHESIN COMPLEX | 8 | 2.20e-02 | 4.68e-01 | 3.12e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT | 5 | 7.03e-02 | 4.67e-01 | 4.78e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 7 | 3.23e-02 | -4.67e-01 | 3.56e-01 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 7 | 3.23e-02 | -4.67e-01 | 3.56e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 4.79e-02 | -4.66e-01 | 4.06e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 6 | 4.80e-02 | 4.66e-01 | 4.06e-01 |
| GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 5 | 7.10e-02 | -4.66e-01 | 4.78e-01 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 4.80e-02 | -4.66e-01 | 4.06e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 2.25e-02 | -4.66e-01 | 3.15e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 7.45e-07 | -4.64e-01 | 2.71e-04 |
| GOBP LYMPHOCYTE ANERGY | 5 | 7.31e-02 | -4.63e-01 | 4.84e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 5.00e-02 | 4.62e-01 | 4.14e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 7 | 3.44e-02 | 4.62e-01 | 3.64e-01 |
| GOMF POTASSIUM ION BINDING | 7 | 3.44e-02 | -4.62e-01 | 3.64e-01 |
| GOBP TRNA 3 END PROCESSING | 7 | 3.46e-02 | -4.61e-01 | 3.65e-01 |
| GOCC AXONEMAL MICROTUBULE | 18 | 7.13e-04 | -4.61e-01 | 5.36e-02 |
| GOMF LIPASE INHIBITOR ACTIVITY | 10 | 1.17e-02 | -4.61e-01 | 2.49e-01 |
| GOBP OOCYTE CONSTRUCTION | 5 | 7.45e-02 | 4.61e-01 | 4.87e-01 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 7 | 3.53e-02 | -4.59e-01 | 3.68e-01 |
| GOMF PHOSPHATIDYLSERINE FLIPPASE ACTIVITY | 5 | 7.55e-02 | 4.59e-01 | 4.90e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 7 | 3.55e-02 | 4.59e-01 | 3.68e-01 |
| GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 7 | 3.55e-02 | -4.59e-01 | 3.68e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 10 | 1.20e-02 | 4.59e-01 | 2.52e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 14 | 3.02e-03 | 4.58e-01 | 1.30e-01 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 8 | 2.51e-02 | 4.57e-01 | 3.23e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 8 | 2.52e-02 | -4.57e-01 | 3.23e-01 |
| GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 12 | 6.29e-03 | -4.56e-01 | 1.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 7.80e-02 | 4.55e-01 | 4.96e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 11 | 8.95e-03 | 4.55e-01 | 2.20e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 4.52e-03 | 4.55e-01 | 1.58e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 19 | 6.05e-04 | -4.54e-01 | 4.75e-02 |
| GOCC DYNACTIN COMPLEX | 8 | 2.61e-02 | -4.54e-01 | 3.28e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION | 6 | 5.40e-02 | 4.54e-01 | 4.30e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 5.45e-02 | -4.53e-01 | 4.31e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 9 | 1.86e-02 | 4.53e-01 | 2.95e-01 |
| GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY | 5 | 7.97e-02 | 4.53e-01 | 4.98e-01 |
| GOMF U1 SNRNA BINDING | 8 | 2.69e-02 | -4.52e-01 | 3.33e-01 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 6 | 5.54e-02 | -4.52e-01 | 4.34e-01 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 5 | 8.04e-02 | 4.52e-01 | 4.98e-01 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 5.63e-02 | 4.50e-01 | 4.36e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 5.63e-02 | 4.50e-01 | 4.36e-01 |
| GOBP VAGINA DEVELOPMENT | 5 | 8.16e-02 | 4.50e-01 | 4.99e-01 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 8.23e-02 | -4.49e-01 | 4.99e-01 |
| GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 2.70e-03 | -4.47e-01 | 1.22e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE | 11 | 1.02e-02 | 4.47e-01 | 2.36e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 6 | 5.81e-02 | -4.47e-01 | 4.44e-01 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 5 | 8.37e-02 | 4.47e-01 | 5.03e-01 |
| GOCC B WICH COMPLEX | 7 | 4.08e-02 | 4.46e-01 | 3.86e-01 |
| GOMF PHOSPHOLIPASE D ACTIVITY | 5 | 8.41e-02 | -4.46e-01 | 5.04e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 11 | 1.04e-02 | 4.46e-01 | 2.40e-01 |
| GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT | 5 | 8.45e-02 | 4.46e-01 | 5.04e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 7 | 4.14e-02 | -4.45e-01 | 3.86e-01 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 11 | 1.07e-02 | 4.45e-01 | 2.41e-01 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 4.18e-02 | -4.44e-01 | 3.86e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 10 | 1.51e-02 | 4.44e-01 | 2.75e-01 |
| GOMF DENEDDYLASE ACTIVITY | 6 | 5.98e-02 | -4.44e-01 | 4.47e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 7.91e-03 | -4.43e-01 | 2.10e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 5 | 8.66e-02 | -4.43e-01 | 5.09e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 8 | 3.02e-02 | -4.43e-01 | 3.50e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 6 | 6.06e-02 | -4.42e-01 | 4.49e-01 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 6 | 6.10e-02 | -4.42e-01 | 4.50e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 14 | 4.23e-03 | -4.42e-01 | 1.55e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 2.18e-02 | 4.42e-01 | 3.12e-01 |
| GOBP REFLEX | 6 | 6.12e-02 | 4.41e-01 | 4.50e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 11 | 1.13e-02 | -4.41e-01 | 2.45e-01 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 5 | 8.78e-02 | 4.41e-01 | 5.10e-01 |
| GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS | 7 | 4.43e-02 | 4.39e-01 | 3.94e-01 |
| GOBP RENAL VESICLE DEVELOPMENT | 7 | 4.43e-02 | 4.39e-01 | 3.94e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 7 | 4.44e-02 | 4.39e-01 | 3.94e-01 |
| GOBP REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 5 | 9.02e-02 | -4.38e-01 | 5.13e-01 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 10 | 1.66e-02 | 4.37e-01 | 2.87e-01 |
| GOBP TOXIN TRANSPORT | 6 | 6.52e-02 | 4.35e-01 | 4.66e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 6 | 6.62e-02 | -4.33e-01 | 4.69e-01 |
| GOCC ESCRT I COMPLEX | 10 | 1.79e-02 | -4.32e-01 | 2.95e-01 |
| GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 5 | 9.43e-02 | -4.32e-01 | 5.22e-01 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 7 | 4.78e-02 | -4.32e-01 | 4.06e-01 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 5 | 9.47e-02 | 4.32e-01 | 5.22e-01 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 9 | 2.51e-02 | 4.31e-01 | 3.23e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.74e-02 | -4.31e-01 | 4.72e-01 |
| GOBP SEQUESTERING OF METAL ION | 8 | 3.50e-02 | -4.30e-01 | 3.67e-01 |
| GOCC STEREOCILIA COUPLING LINK | 5 | 9.66e-02 | 4.29e-01 | 5.26e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 5 | 9.71e-02 | 4.29e-01 | 5.26e-01 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 10 | 1.90e-02 | 4.28e-01 | 2.96e-01 |
| GOBP METANEPHRIC GLOMERULUS DEVELOPMENT | 6 | 6.94e-02 | 4.28e-01 | 4.77e-01 |
| GOCC NADPH OXIDASE COMPLEX | 10 | 1.91e-02 | -4.28e-01 | 2.97e-01 |
| GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING | 5 | 9.77e-02 | 4.28e-01 | 5.27e-01 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 8 | 3.63e-02 | -4.28e-01 | 3.71e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 5 | 9.82e-02 | 4.27e-01 | 5.28e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 8 | 3.67e-02 | 4.27e-01 | 3.73e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 11 | 1.44e-02 | 4.26e-01 | 2.69e-01 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 6 | 7.10e-02 | 4.26e-01 | 4.78e-01 |
| GOBP LIPID DIGESTION | 6 | 7.10e-02 | 4.26e-01 | 4.78e-01 |
| GOMF SNRNP BINDING | 9 | 2.72e-02 | -4.25e-01 | 3.34e-01 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 6 | 7.18e-02 | -4.25e-01 | 4.80e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 8 | 3.76e-02 | 4.24e-01 | 3.78e-01 |
| GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 1.01e-01 | -4.24e-01 | 5.34e-01 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 10 | 2.05e-02 | -4.23e-01 | 3.04e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 2.05e-02 | 4.23e-01 | 3.04e-01 |
| GOBP LEUCINE CATABOLIC PROCESS | 5 | 1.02e-01 | 4.22e-01 | 5.37e-01 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 23 | 4.57e-04 | -4.22e-01 | 4.00e-02 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 8 | 3.90e-02 | 4.22e-01 | 3.81e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 6 | 7.43e-02 | -4.21e-01 | 4.87e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 156 | 1.26e-19 | -4.21e-01 | 5.49e-16 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 6 | 7.45e-02 | 4.20e-01 | 4.87e-01 |
| GOBP THALAMUS DEVELOPMENT | 5 | 1.04e-01 | -4.20e-01 | 5.41e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL | 5 | 1.04e-01 | -4.20e-01 | 5.41e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 1.58e-02 | -4.20e-01 | 2.81e-01 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 7 | 5.43e-02 | -4.20e-01 | 4.31e-01 |
| GOCC LATERAL ELEMENT | 9 | 2.92e-02 | 4.20e-01 | 3.45e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 72 | 7.32e-10 | -4.20e-01 | 6.38e-07 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 5 | 1.04e-01 | -4.20e-01 | 5.41e-01 |
| GOMF TRAIL BINDING | 5 | 1.04e-01 | 4.20e-01 | 5.41e-01 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 2.18e-02 | 4.19e-01 | 3.12e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 8 | 4.06e-02 | -4.18e-01 | 3.86e-01 |
| GOCC MICROTUBULE MINUS END | 6 | 7.63e-02 | 4.18e-01 | 4.91e-01 |
| GOBP DEDIFFERENTIATION | 5 | 1.06e-01 | 4.18e-01 | 5.43e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 8 | 4.09e-02 | 4.17e-01 | 3.86e-01 |
| GOBP CUT CATABOLIC PROCESS | 5 | 1.06e-01 | -4.17e-01 | 5.43e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 7.68e-02 | -4.17e-01 | 4.93e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 9 | 3.04e-02 | -4.17e-01 | 3.50e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 8 | 4.13e-02 | 4.17e-01 | 3.86e-01 |
| GOCC CONDENSIN COMPLEX | 8 | 4.13e-02 | 4.17e-01 | 3.86e-01 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 3.05e-02 | -4.17e-01 | 3.50e-01 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 1.07e-01 | -4.16e-01 | 5.44e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 4.15e-02 | -4.16e-01 | 3.86e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 9 | 3.09e-02 | -4.15e-01 | 3.51e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 2.33e-02 | -4.14e-01 | 3.18e-01 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 7 | 5.80e-02 | 4.14e-01 | 4.44e-01 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 1.09e-01 | 4.14e-01 | 5.51e-01 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 5 | 1.10e-01 | 4.13e-01 | 5.52e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 12 | 1.33e-02 | -4.13e-01 | 2.61e-01 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 14 | 7.51e-03 | -4.13e-01 | 2.05e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 11 | 1.79e-02 | 4.12e-01 | 2.95e-01 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 1.10e-01 | 4.12e-01 | 5.54e-01 |
| GOBP DORSAL AORTA DEVELOPMENT | 6 | 8.04e-02 | 4.12e-01 | 4.98e-01 |
| GOBP DORSAL AORTA MORPHOGENESIS | 6 | 8.04e-02 | 4.12e-01 | 4.98e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 7 | 5.90e-02 | 4.12e-01 | 4.45e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 15 | 5.73e-03 | 4.12e-01 | 1.81e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 7 | 5.93e-02 | -4.12e-01 | 4.46e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 6 | 8.11e-02 | -4.11e-01 | 4.99e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 9 | 3.27e-02 | 4.11e-01 | 3.57e-01 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 6.44e-04 | -4.11e-01 | 4.98e-02 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 5 | 1.12e-01 | -4.11e-01 | 5.57e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 8 | 4.45e-02 | -4.10e-01 | 3.95e-01 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 12 | 1.40e-02 | -4.10e-01 | 2.66e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 3.34e-02 | -4.10e-01 | 3.62e-01 |
| GOCC RIBOSOMAL SUBUNIT | 180 | 3.05e-21 | -4.09e-01 | 2.66e-17 |
| GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 1.07e-02 | -4.09e-01 | 2.41e-01 |
| GOCC PHOSPHORYLASE KINASE COMPLEX | 5 | 1.13e-01 | 4.09e-01 | 5.61e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 3.38e-02 | -4.09e-01 | 3.63e-01 |
| GOCC POLE PLASM | 13 | 1.08e-02 | 4.08e-01 | 2.42e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 9 | 3.39e-02 | 4.08e-01 | 3.63e-01 |
| GOMF LRR DOMAIN BINDING | 13 | 1.10e-02 | -4.08e-01 | 2.44e-01 |
| GOBP SEX DETERMINATION | 5 | 1.15e-01 | -4.07e-01 | 5.64e-01 |
| GOCC POLYSOMAL RIBOSOME | 30 | 1.14e-04 | -4.07e-01 | 1.56e-02 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 8.43e-02 | 4.07e-01 | 5.04e-01 |
| GOMF BUBBLE DNA BINDING | 6 | 8.43e-02 | 4.07e-01 | 5.04e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 15 | 6.37e-03 | -4.07e-01 | 1.89e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 16 | 4.86e-03 | 4.07e-01 | 1.66e-01 |
| GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 8 | 4.68e-02 | -4.06e-01 | 4.03e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 8.51e-02 | 4.06e-01 | 5.05e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 9 | 3.52e-02 | -4.05e-01 | 3.68e-01 |
| GOCC ANNULATE LAMELLAE | 5 | 1.16e-01 | 4.05e-01 | 5.66e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 12 | 1.52e-02 | -4.05e-01 | 2.76e-01 |
| GOBP LIPID DROPLET DISASSEMBLY | 5 | 1.18e-01 | -4.04e-01 | 5.68e-01 |
| GOCC BRCA1 C COMPLEX | 6 | 8.67e-02 | 4.04e-01 | 5.09e-01 |
| GOBP NORADRENERGIC NEURON DIFFERENTIATION | 5 | 1.19e-01 | 4.03e-01 | 5.69e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 16 | 5.28e-03 | 4.03e-01 | 1.76e-01 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 11 | 2.08e-02 | 4.03e-01 | 3.06e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 6 | 8.79e-02 | 4.02e-01 | 5.10e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE | 5 | 1.19e-01 | -4.02e-01 | 5.69e-01 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 11 | 2.10e-02 | 4.02e-01 | 3.07e-01 |
| GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 5 | 1.20e-01 | 4.02e-01 | 5.69e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 21 | 1.44e-03 | 4.02e-01 | 8.63e-02 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 6.62e-02 | -4.01e-01 | 4.69e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 2.83e-02 | -4.00e-01 | 3.41e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 5 | 1.21e-01 | -4.00e-01 | 5.70e-01 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 7 | 6.68e-02 | -4.00e-01 | 4.70e-01 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 8 | 5.01e-02 | 4.00e-01 | 4.14e-01 |
| GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 9.01e-02 | 4.00e-01 | 5.13e-01 |
| GOMF PEROXIREDOXIN ACTIVITY | 8 | 5.08e-02 | -3.99e-01 | 4.17e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 27 | 3.37e-04 | 3.99e-01 | 3.41e-02 |
| GOBP REGULATION OF AXON GUIDANCE | 6 | 9.08e-02 | 3.99e-01 | 5.16e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 12 | 1.68e-02 | -3.99e-01 | 2.89e-01 |
| GOCC CYTOSOLIC RIBOSOME | 110 | 5.64e-13 | -3.98e-01 | 7.03e-10 |
| GOBP REGULATION OF DNA DUPLEX UNWINDING | 5 | 1.23e-01 | 3.98e-01 | 5.71e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 10 | 2.94e-02 | 3.98e-01 | 3.46e-01 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 3.88e-02 | 3.98e-01 | 3.81e-01 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 5.15e-02 | -3.98e-01 | 4.19e-01 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 8 | 5.15e-02 | 3.98e-01 | 4.19e-01 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.18e-02 | 3.97e-01 | 5.18e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 112 | 3.84e-13 | -3.97e-01 | 5.58e-10 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 6 | 9.21e-02 | 3.97e-01 | 5.18e-01 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 9.21e-02 | -3.97e-01 | 5.18e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 7 | 6.89e-02 | 3.97e-01 | 4.75e-01 |
| GOBP INTERLEUKIN 4 PRODUCTION | 22 | 1.26e-03 | -3.97e-01 | 8.05e-02 |
| GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES | 5 | 1.24e-01 | -3.97e-01 | 5.72e-01 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 9 | 3.95e-02 | -3.96e-01 | 3.84e-01 |
| GOBP RESPONSE TO REDOX STATE | 10 | 3.04e-02 | -3.95e-01 | 3.50e-01 |
| GOBP DELAMINATION | 5 | 1.26e-01 | -3.95e-01 | 5.75e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 6 | 9.40e-02 | 3.95e-01 | 5.21e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 10 | 3.07e-02 | -3.95e-01 | 3.50e-01 |
| GOBP UREA CYCLE | 7 | 7.07e-02 | 3.94e-01 | 4.78e-01 |
| GOBP UREA METABOLIC PROCESS | 7 | 7.07e-02 | 3.94e-01 | 4.78e-01 |
| GOBP REGULATION OF CELL PROJECTION SIZE | 5 | 1.27e-01 | -3.94e-01 | 5.77e-01 |
| GOMF LYSOPHOSPHATIDIC ACID BINDING | 5 | 1.28e-01 | -3.93e-01 | 5.80e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 1.28e-01 | -3.93e-01 | 5.80e-01 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 6.52e-03 | -3.93e-01 | 1.92e-01 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 5 | 1.29e-01 | 3.92e-01 | 5.82e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 26 | 5.52e-04 | 3.91e-01 | 4.42e-02 |
| GOBP REGULATION OF ODONTOGENESIS | 5 | 1.31e-01 | 3.90e-01 | 5.83e-01 |
| GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY | 6 | 9.82e-02 | -3.90e-01 | 5.28e-01 |
| GOBP ADP METABOLIC PROCESS | 7 | 7.41e-02 | 3.90e-01 | 4.87e-01 |
| GOMF COMPLEMENT BINDING | 10 | 3.29e-02 | -3.90e-01 | 3.59e-01 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 11 | 2.53e-02 | -3.89e-01 | 3.23e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 7.50e-02 | 3.89e-01 | 4.89e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 10 | 3.35e-02 | 3.88e-01 | 3.62e-01 |
| GOBP CARDIOBLAST PROLIFERATION | 5 | 1.33e-01 | 3.88e-01 | 5.86e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 3.37e-02 | -3.88e-01 | 3.63e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 7.57e-02 | -3.88e-01 | 4.90e-01 |
| GOMF BIOTIN BINDING | 5 | 1.34e-01 | 3.87e-01 | 5.86e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 17 | 5.80e-03 | -3.87e-01 | 1.81e-01 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 6 | 1.01e-01 | -3.86e-01 | 5.36e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 12 | 2.06e-02 | -3.86e-01 | 3.04e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 1.02e-01 | -3.86e-01 | 5.37e-01 |
| GOBP RESPONSE TO WATER | 8 | 5.88e-02 | 3.86e-01 | 4.45e-01 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 6 | 1.02e-01 | -3.86e-01 | 5.37e-01 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 5.89e-02 | -3.86e-01 | 4.45e-01 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 1.36e-01 | 3.85e-01 | 5.91e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 8 | 5.96e-02 | 3.85e-01 | 4.47e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 7 | 7.86e-02 | -3.84e-01 | 4.96e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 6 | 1.04e-01 | -3.84e-01 | 5.41e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 23 | 1.46e-03 | 3.84e-01 | 8.63e-02 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 9 | 4.65e-02 | 3.83e-01 | 4.03e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 146 | 1.50e-15 | -3.83e-01 | 2.62e-12 |
| GOBP PROTEIN UFMYLATION | 6 | 1.05e-01 | -3.83e-01 | 5.42e-01 |
| GOMF TPR DOMAIN BINDING | 7 | 7.98e-02 | -3.82e-01 | 4.98e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 1.39e-01 | 3.82e-01 | 5.96e-01 |
| GOBP CHEMOSENSORY BEHAVIOR | 8 | 6.12e-02 | 3.82e-01 | 4.50e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 5 | 1.39e-01 | 3.82e-01 | 5.96e-01 |
| GOBP NOTOCHORD DEVELOPMENT | 5 | 1.39e-01 | 3.82e-01 | 5.96e-01 |
| GOBP TRNA THIO MODIFICATION | 5 | 1.40e-01 | -3.81e-01 | 5.97e-01 |
| GOBP PHASIC SMOOTH MUSCLE CONTRACTION | 7 | 8.08e-02 | 3.81e-01 | 4.99e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 1.06e-01 | 3.81e-01 | 5.43e-01 |
| GOMF HEXOSAMINIDASE ACTIVITY | 12 | 2.24e-02 | -3.81e-01 | 3.15e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 15 | 1.07e-02 | -3.81e-01 | 2.41e-01 |
| GOBP REGULATION OF HISTONE ACETYLATION | 16 | 8.41e-03 | 3.81e-01 | 2.16e-01 |
| GOMF ADENYLATE CYCLASE BINDING | 6 | 1.07e-01 | -3.80e-01 | 5.44e-01 |
| GOMF AMIDINE LYASE ACTIVITY | 7 | 8.15e-02 | -3.80e-01 | 4.99e-01 |
| GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 5 | 1.41e-01 | -3.80e-01 | 5.99e-01 |
| GOBP SPERMINE METABOLIC PROCESS | 5 | 1.42e-01 | 3.80e-01 | 6.00e-01 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 6 | 1.08e-01 | -3.79e-01 | 5.47e-01 |
| GOMF BMP BINDING | 5 | 1.42e-01 | 3.79e-01 | 6.00e-01 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 1.08e-01 | 3.79e-01 | 5.47e-01 |
| GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT | 7 | 8.26e-02 | 3.79e-01 | 5.00e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 9 | 4.92e-02 | 3.79e-01 | 4.12e-01 |
| GOBP ATRIOVENTRICULAR VALVE FORMATION | 5 | 1.43e-01 | 3.78e-01 | 6.01e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 13 | 1.83e-02 | 3.78e-01 | 2.95e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 10 | 3.87e-02 | -3.78e-01 | 3.80e-01 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 1.09e-01 | 3.77e-01 | 5.51e-01 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 6 | 1.10e-01 | -3.77e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 6 | 1.10e-01 | 3.77e-01 | 5.53e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 3.07e-02 | 3.76e-01 | 3.50e-01 |
| GOBP RENAL TUBULAR SECRETION | 5 | 1.46e-01 | 3.75e-01 | 6.06e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 10 | 3.99e-02 | 3.75e-01 | 3.86e-01 |
| GOBP TRNA TRANSPORT | 5 | 1.46e-01 | -3.75e-01 | 6.06e-01 |
| GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 8 | 6.64e-02 | -3.75e-01 | 4.69e-01 |
| GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION | 5 | 1.47e-01 | 3.74e-01 | 6.07e-01 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 1.47e-01 | -3.74e-01 | 6.07e-01 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 5 | 1.48e-01 | -3.74e-01 | 6.07e-01 |
| GOBP INNER CELL MASS CELL DIFFERENTIATION | 5 | 1.48e-01 | 3.74e-01 | 6.07e-01 |
| GOCC U4 SNRNP | 10 | 4.08e-02 | -3.74e-01 | 3.86e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 10 | 4.08e-02 | 3.74e-01 | 3.86e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 8.70e-02 | 3.74e-01 | 5.09e-01 |
| GOBP MEMBRANE RAFT ASSEMBLY | 8 | 6.78e-02 | -3.73e-01 | 4.72e-01 |
| GOMF OPSONIN BINDING | 8 | 6.78e-02 | -3.73e-01 | 4.72e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 11 | 3.24e-02 | -3.73e-01 | 3.56e-01 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 7 | 8.79e-02 | -3.73e-01 | 5.10e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 7 | 8.79e-02 | 3.72e-01 | 5.10e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 8 | 6.84e-02 | 3.72e-01 | 4.74e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 16 | 1.00e-02 | 3.72e-01 | 2.33e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 9 | 5.35e-02 | -3.72e-01 | 4.28e-01 |
| GOBP PROTEIN IMPORT | 6 | 1.15e-01 | -3.72e-01 | 5.65e-01 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 6.89e-02 | -3.71e-01 | 4.75e-01 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 8 | 6.90e-02 | -3.71e-01 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR BINDING | 5 | 1.51e-01 | -3.71e-01 | 6.12e-01 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 7 | 8.90e-02 | 3.71e-01 | 5.12e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 12 | 2.60e-02 | -3.71e-01 | 3.28e-01 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 6 | 1.16e-01 | 3.71e-01 | 5.65e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 5.40e-02 | 3.71e-01 | 4.30e-01 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 9 | 5.41e-02 | -3.71e-01 | 4.30e-01 |
| GOBP PROSTATE GLAND GROWTH | 6 | 1.16e-01 | 3.71e-01 | 5.65e-01 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 1.51e-01 | -3.71e-01 | 6.13e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 11 | 3.34e-02 | 3.70e-01 | 3.62e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 21 | 3.32e-03 | 3.70e-01 | 1.39e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 6 | 1.16e-01 | -3.70e-01 | 5.66e-01 |
| GOMF ADENOSINE RECEPTOR BINDING | 5 | 1.53e-01 | 3.69e-01 | 6.13e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 8 | 7.05e-02 | 3.69e-01 | 4.78e-01 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 10 | 4.34e-02 | 3.69e-01 | 3.92e-01 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 11 | 3.43e-02 | -3.69e-01 | 3.64e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 6 | 1.18e-01 | 3.68e-01 | 5.69e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 6 | 1.18e-01 | 3.68e-01 | 5.69e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 6 | 1.18e-01 | 3.68e-01 | 5.69e-01 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 6 | 1.19e-01 | -3.68e-01 | 5.69e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 15 | 1.37e-02 | -3.68e-01 | 2.65e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 6 | 1.19e-01 | -3.67e-01 | 5.69e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 9.27e-02 | 3.67e-01 | 5.18e-01 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 5 | 1.55e-01 | 3.67e-01 | 6.19e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 11 | 3.55e-02 | 3.66e-01 | 3.68e-01 |
| GOBP CGMP METABOLIC PROCESS | 12 | 2.82e-02 | 3.66e-01 | 3.41e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 13 | 2.25e-02 | 3.65e-01 | 3.16e-01 |
| GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 5 | 1.57e-01 | 3.65e-01 | 6.19e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 6 | 1.21e-01 | -3.65e-01 | 5.71e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 5 | 1.58e-01 | -3.65e-01 | 6.19e-01 |
| GOMF LEUCINE BINDING | 6 | 1.22e-01 | 3.65e-01 | 5.71e-01 |
| GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 1.59e-01 | -3.64e-01 | 6.19e-01 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 1.23e-01 | 3.64e-01 | 5.71e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 7 | 9.59e-02 | -3.63e-01 | 5.26e-01 |
| GOBP HISTIDINE METABOLIC PROCESS | 6 | 1.23e-01 | 3.63e-01 | 5.71e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 13 | 2.33e-02 | 3.63e-01 | 3.18e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 7 | 9.61e-02 | -3.63e-01 | 5.26e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 9.64e-02 | -3.63e-01 | 5.26e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 9.66e-02 | -3.63e-01 | 5.26e-01 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 5 | 1.60e-01 | 3.62e-01 | 6.20e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 14 | 1.89e-02 | -3.62e-01 | 2.96e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 9.74e-02 | -3.62e-01 | 5.27e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 14 | 1.91e-02 | 3.62e-01 | 2.97e-01 |
| GOBP CD40 SIGNALING PATHWAY | 14 | 1.91e-02 | -3.62e-01 | 2.97e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 8 | 7.66e-02 | -3.62e-01 | 4.92e-01 |
| GOBP CAMP CATABOLIC PROCESS | 7 | 9.76e-02 | 3.62e-01 | 5.27e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 4.77e-02 | -3.62e-01 | 4.06e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 10 | 4.79e-02 | -3.61e-01 | 4.06e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 14 | 1.93e-02 | 3.61e-01 | 2.98e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 9 | 6.08e-02 | 3.61e-01 | 4.50e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 11 | 3.82e-02 | 3.61e-01 | 3.78e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 13 | 2.43e-02 | 3.61e-01 | 3.22e-01 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 4.19e-04 | -3.60e-01 | 3.84e-02 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 27 | 1.20e-03 | 3.60e-01 | 7.76e-02 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 9 | 6.15e-02 | -3.60e-01 | 4.51e-01 |
| GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 5 | 1.63e-01 | -3.60e-01 | 6.25e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 9 | 6.16e-02 | 3.60e-01 | 4.51e-01 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 7 | 9.96e-02 | 3.59e-01 | 5.31e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 6 | 1.28e-01 | 3.59e-01 | 5.79e-01 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 8 | 7.89e-02 | 3.59e-01 | 4.97e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 8 | 7.89e-02 | 3.59e-01 | 4.97e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 10 | 4.96e-02 | 3.59e-01 | 4.12e-01 |
| GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY | 6 | 1.28e-01 | 3.58e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 5 | 1.65e-01 | -3.58e-01 | 6.27e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 1.29e-01 | 3.58e-01 | 5.82e-01 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 7 | 1.01e-01 | -3.58e-01 | 5.36e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 5 | 1.67e-01 | -3.57e-01 | 6.28e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 1.02e-01 | 3.57e-01 | 5.37e-01 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 8 | 8.07e-02 | 3.57e-01 | 4.99e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 10 | 5.10e-02 | -3.56e-01 | 4.17e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDOGLYCAN | 5 | 1.68e-01 | -3.56e-01 | 6.30e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 1.67e-03 | -3.56e-01 | 9.13e-02 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE | 6 | 1.31e-01 | -3.56e-01 | 5.83e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 6 | 1.31e-01 | 3.56e-01 | 5.83e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 1.31e-01 | 3.56e-01 | 5.83e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 13 | 2.62e-02 | -3.56e-01 | 3.29e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 1.31e-01 | -3.56e-01 | 5.83e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 8 | 8.16e-02 | -3.56e-01 | 4.99e-01 |
| GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS | 5 | 1.69e-01 | -3.55e-01 | 6.33e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 8 | 8.24e-02 | 3.55e-01 | 4.99e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 16 | 1.43e-02 | 3.54e-01 | 2.69e-01 |
| GOCC SEC61 TRANSLOCON COMPLEX | 5 | 1.71e-01 | -3.53e-01 | 6.36e-01 |
| GOBP EPITHELIAL FLUID TRANSPORT | 5 | 1.71e-01 | 3.53e-01 | 6.36e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 10 | 5.32e-02 | -3.53e-01 | 4.27e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 6 | 1.35e-01 | -3.53e-01 | 5.89e-01 |
| GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.72e-01 | 3.53e-01 | 6.36e-01 |
| GOCC COP9 SIGNALOSOME | 15 | 1.81e-02 | -3.53e-01 | 2.95e-01 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 11 | 4.31e-02 | 3.52e-01 | 3.91e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 13 | 2.81e-02 | 3.52e-01 | 3.40e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 6 | 1.36e-01 | 3.52e-01 | 5.91e-01 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 5 | 1.74e-01 | -3.51e-01 | 6.38e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 14 | 2.29e-02 | 3.51e-01 | 3.18e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 17 | 1.22e-02 | 3.51e-01 | 2.53e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 1.74e-01 | 3.51e-01 | 6.38e-01 |
| GOMF GLYCOSPHINGOLIPID BINDING | 5 | 1.74e-01 | 3.51e-01 | 6.38e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 6 | 1.37e-01 | 3.50e-01 | 5.93e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 8 | 8.61e-02 | 3.50e-01 | 5.08e-01 |
| GOBP RNA SURVEILLANCE | 17 | 1.24e-02 | -3.50e-01 | 2.53e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 8.67e-02 | -3.50e-01 | 5.09e-01 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 8 | 8.69e-02 | -3.50e-01 | 5.09e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 1.76e-01 | -3.49e-01 | 6.40e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 9 | 7.00e-02 | -3.49e-01 | 4.77e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 2.39e-02 | 3.49e-01 | 3.19e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 10 | 5.64e-02 | 3.48e-01 | 4.36e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 29 | 1.19e-03 | 3.48e-01 | 7.76e-02 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 9 | 7.09e-02 | -3.48e-01 | 4.78e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 8 | 8.86e-02 | -3.48e-01 | 5.11e-01 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 7 | 1.11e-01 | -3.47e-01 | 5.57e-01 |
| GOMF NEUROPEPTIDE RECEPTOR ACTIVITY | 6 | 1.41e-01 | 3.47e-01 | 5.98e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 9 | 7.13e-02 | 3.47e-01 | 4.79e-01 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 8.96e-02 | -3.47e-01 | 5.12e-01 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 5.78e-02 | -3.47e-01 | 4.43e-01 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 5 | 1.80e-01 | -3.46e-01 | 6.47e-01 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 1.42e-01 | -3.46e-01 | 6.00e-01 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 10 | 5.82e-02 | -3.46e-01 | 4.45e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 1.14e-01 | 3.45e-01 | 5.61e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 25 | 2.80e-03 | 3.45e-01 | 1.24e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 11 | 4.74e-02 | 3.45e-01 | 4.06e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 12 | 3.84e-02 | -3.45e-01 | 3.80e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 13 | 3.12e-02 | 3.45e-01 | 3.52e-01 |
| GOCC DYNEIN AXONEMAL PARTICLE | 10 | 5.88e-02 | -3.45e-01 | 4.45e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 23 | 4.22e-03 | 3.45e-01 | 1.55e-01 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 1.44e-01 | 3.44e-01 | 6.03e-01 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 9.16e-02 | -3.44e-01 | 5.18e-01 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 9 | 7.37e-02 | -3.44e-01 | 4.85e-01 |
| GOBP KERATINOCYTE MIGRATION | 12 | 3.92e-02 | 3.44e-01 | 3.82e-01 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 1.41e-02 | -3.44e-01 | 2.67e-01 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 6 | 1.45e-01 | 3.44e-01 | 6.04e-01 |
| GOCC PROTEASE INHIBITOR COMPLEX | 5 | 1.83e-01 | -3.44e-01 | 6.51e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 13 | 3.19e-02 | 3.44e-01 | 3.54e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 8 | 9.24e-02 | -3.44e-01 | 5.18e-01 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 9 | 7.44e-02 | -3.43e-01 | 4.87e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 10 | 6.01e-02 | 3.43e-01 | 4.47e-01 |
| GOBP MEIOTIC CELL CYCLE PHASE TRANSITION | 7 | 1.16e-01 | 3.43e-01 | 5.65e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 17 | 1.43e-02 | -3.43e-01 | 2.69e-01 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 8 | 9.28e-02 | 3.43e-01 | 5.18e-01 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 9.28e-02 | 3.43e-01 | 5.18e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 12 | 3.97e-02 | 3.43e-01 | 3.85e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 13 | 3.24e-02 | -3.43e-01 | 3.56e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 5 | 1.85e-01 | -3.43e-01 | 6.53e-01 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 20 | 8.01e-03 | 3.43e-01 | 2.12e-01 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 1.46e-01 | 3.43e-01 | 6.06e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 9 | 7.53e-02 | -3.42e-01 | 4.89e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 1.17e-01 | 3.42e-01 | 5.67e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 4.01e-02 | 3.42e-01 | 3.86e-01 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 8 | 9.37e-02 | -3.42e-01 | 5.21e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 14 | 2.67e-02 | -3.42e-01 | 3.33e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 10 | 6.12e-02 | 3.42e-01 | 4.50e-01 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 1.47e-01 | -3.42e-01 | 6.07e-01 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 8 | 9.40e-02 | 3.42e-01 | 5.21e-01 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 20 | 8.14e-03 | -3.42e-01 | 2.14e-01 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 16 | 1.79e-02 | -3.42e-01 | 2.95e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 12 | 4.05e-02 | 3.42e-01 | 3.86e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 12 | 4.06e-02 | -3.41e-01 | 3.86e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 7 | 1.18e-01 | -3.41e-01 | 5.69e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 1.87e-01 | -3.41e-01 | 6.56e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 7 | 1.19e-01 | -3.41e-01 | 5.69e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 1.19e-01 | 3.41e-01 | 5.69e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 9 | 7.70e-02 | -3.40e-01 | 4.94e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 13 | 3.36e-02 | -3.40e-01 | 3.62e-01 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 5 | 1.88e-01 | -3.40e-01 | 6.57e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 21 | 6.96e-03 | -3.40e-01 | 1.97e-01 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 16 | 1.86e-02 | 3.40e-01 | 2.95e-01 |
| GOCC EKC KEOPS COMPLEX | 5 | 1.88e-01 | -3.40e-01 | 6.58e-01 |
| GOCC SMAD PROTEIN COMPLEX | 7 | 1.20e-01 | -3.39e-01 | 5.70e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 11 | 5.17e-02 | 3.39e-01 | 4.19e-01 |
| GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 7 | 1.21e-01 | -3.39e-01 | 5.70e-01 |
| GOBP CELL CYCLE DNA REPLICATION INITIATION | 5 | 1.90e-01 | 3.39e-01 | 6.61e-01 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 6 | 1.51e-01 | 3.39e-01 | 6.13e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 7 | 1.21e-01 | 3.38e-01 | 5.70e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 12 | 4.24e-02 | -3.38e-01 | 3.89e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 1.51e-01 | -3.38e-01 | 6.13e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 1.90e-01 | 3.38e-01 | 6.61e-01 |
| GOBP BLASTODERM SEGMENTATION | 12 | 4.29e-02 | 3.38e-01 | 3.91e-01 |
| GOMF GAMMA CATENIN BINDING | 5 | 1.91e-01 | 3.38e-01 | 6.62e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 24 | 4.30e-03 | -3.37e-01 | 1.57e-01 |
| GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 1.92e-01 | -3.37e-01 | 6.64e-01 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 7 | 1.23e-01 | -3.36e-01 | 5.71e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 14 | 2.96e-02 | 3.36e-01 | 3.47e-01 |
| GOCC PROTEASOME COMPLEX | 57 | 1.18e-05 | -3.36e-01 | 2.63e-03 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 1.55e-01 | 3.35e-01 | 6.18e-01 |
| GOBP POSITIVE REGULATION OF HYPERSENSITIVITY | 5 | 1.95e-01 | -3.35e-01 | 6.66e-01 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 6 | 1.56e-01 | -3.34e-01 | 6.19e-01 |
| GOBP TAURINE TRANSPORT | 6 | 1.56e-01 | 3.34e-01 | 6.19e-01 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 9 | 8.24e-02 | -3.34e-01 | 4.99e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 39 | 3.04e-04 | -3.34e-01 | 3.16e-02 |
| GOCC NUCLEAR LAMINA | 12 | 4.50e-02 | -3.34e-01 | 3.96e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 6 | 1.56e-01 | -3.34e-01 | 6.19e-01 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 6 | 1.56e-01 | 3.34e-01 | 6.19e-01 |
| GOCC GLYCOGEN GRANULE | 7 | 1.26e-01 | -3.34e-01 | 5.75e-01 |
| GOMF VIRION BINDING | 9 | 8.30e-02 | -3.34e-01 | 5.01e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 7 | 1.27e-01 | 3.34e-01 | 5.76e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 25 | 3.92e-03 | -3.33e-01 | 1.51e-01 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 6 | 1.58e-01 | -3.33e-01 | 6.19e-01 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 1.58e-01 | 3.33e-01 | 6.19e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 10 | 6.85e-02 | -3.33e-01 | 4.74e-01 |
| GOBP PODOCYTE CELL MIGRATION | 6 | 1.58e-01 | 3.33e-01 | 6.19e-01 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 8 | 1.03e-01 | -3.33e-01 | 5.41e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 25 | 4.01e-03 | 3.32e-01 | 1.52e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 1.98e-01 | -3.32e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 6 | 1.59e-01 | 3.32e-01 | 6.19e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 18 | 1.48e-02 | 3.32e-01 | 2.72e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 8 | 1.04e-01 | -3.32e-01 | 5.41e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 9 | 8.47e-02 | -3.32e-01 | 5.05e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 12 | 4.66e-02 | -3.32e-01 | 4.03e-01 |
| GOCC MITOTIC COHESIN COMPLEX | 6 | 1.60e-01 | 3.31e-01 | 6.20e-01 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 9 | 8.53e-02 | -3.31e-01 | 5.06e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 18 | 1.50e-02 | -3.31e-01 | 2.74e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 28 | 2.43e-03 | -3.31e-01 | 1.15e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 1.60e-01 | -3.31e-01 | 6.20e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 12 | 4.74e-02 | -3.31e-01 | 4.06e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 5 | 2.01e-01 | -3.30e-01 | 6.68e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 5 | 2.01e-01 | -3.30e-01 | 6.68e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 15 | 2.69e-02 | -3.30e-01 | 3.33e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 10 | 7.08e-02 | 3.30e-01 | 4.78e-01 |
| GOCC CCR4 NOT COMPLEX | 14 | 3.26e-02 | 3.30e-01 | 3.57e-01 |
| GOCC TRANSLOCON COMPLEX | 6 | 1.62e-01 | -3.30e-01 | 6.21e-01 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 8.69e-02 | -3.30e-01 | 5.09e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 29 | 2.14e-03 | -3.29e-01 | 1.07e-01 |
| GOBP LACTATE TRANSMEMBRANE TRANSPORT | 5 | 2.02e-01 | 3.29e-01 | 6.69e-01 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 5 | 2.02e-01 | -3.29e-01 | 6.69e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 17 | 1.89e-02 | -3.29e-01 | 2.96e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 9 | 8.77e-02 | -3.29e-01 | 5.10e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 7 | 1.32e-01 | -3.28e-01 | 5.85e-01 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 7 | 1.33e-01 | 3.28e-01 | 5.85e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 8 | 1.09e-01 | 3.28e-01 | 5.50e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 10 | 7.28e-02 | 3.28e-01 | 4.83e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 2.05e-01 | 3.27e-01 | 6.73e-01 |
| GOCC U2 SNRNP | 25 | 4.64e-03 | -3.27e-01 | 1.61e-01 |
| GOBP CHOLESTEROL CATABOLIC PROCESS | 5 | 2.05e-01 | -3.27e-01 | 6.73e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION | 5 | 2.06e-01 | 3.27e-01 | 6.73e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 12 | 5.00e-02 | 3.27e-01 | 4.14e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 5 | 2.06e-01 | 3.27e-01 | 6.73e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 2.06e-01 | -3.27e-01 | 6.73e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 1.66e-01 | 3.27e-01 | 6.28e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 15 | 2.89e-02 | -3.26e-01 | 3.43e-01 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 6 | 1.67e-01 | -3.26e-01 | 6.28e-01 |
| GOBP HIPPO SIGNALING | 29 | 2.39e-03 | 3.26e-01 | 1.15e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 42 | 2.60e-04 | 3.26e-01 | 2.95e-02 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 30 | 2.04e-03 | 3.25e-01 | 1.04e-01 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 10 | 7.50e-02 | 3.25e-01 | 4.89e-01 |
| GOBP REPLACEMENT OSSIFICATION | 13 | 4.25e-02 | 3.25e-01 | 3.89e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 9.14e-02 | -3.25e-01 | 5.18e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 8 | 1.12e-01 | 3.25e-01 | 5.57e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 7 | 1.37e-01 | -3.25e-01 | 5.93e-01 |
| GOCC MHC PROTEIN COMPLEX | 22 | 8.49e-03 | -3.24e-01 | 2.16e-01 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 9.23e-02 | 3.24e-01 | 5.18e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 21 | 1.02e-02 | 3.24e-01 | 2.36e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 10 | 7.60e-02 | 3.24e-01 | 4.91e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2 COMPLEX | 5 | 2.10e-01 | -3.24e-01 | 6.75e-01 |
| GOBP LEUCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 2.10e-01 | -3.23e-01 | 6.75e-01 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 7 | 1.39e-01 | -3.23e-01 | 5.96e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 6 | 1.71e-01 | 3.23e-01 | 6.35e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 30 | 2.20e-03 | -3.23e-01 | 1.09e-01 |
| GOCC UNIPLEX COMPLEX | 6 | 1.71e-01 | -3.23e-01 | 6.35e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 8 | 1.14e-01 | -3.23e-01 | 5.61e-01 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 12 | 5.31e-02 | 3.23e-01 | 4.27e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 2.12e-01 | -3.22e-01 | 6.77e-01 |
| GOCC KATANIN COMPLEX | 5 | 2.12e-01 | 3.22e-01 | 6.77e-01 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 7 | 1.40e-01 | 3.22e-01 | 5.98e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 2.13e-01 | 3.22e-01 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 6 | 1.73e-01 | 3.22e-01 | 6.37e-01 |
| GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY | 5 | 2.14e-01 | -3.21e-01 | 6.79e-01 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 8 | 1.16e-01 | -3.21e-01 | 5.65e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 13 | 4.52e-02 | -3.21e-01 | 3.97e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 19 | 1.56e-02 | 3.21e-01 | 2.79e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 5 | 2.15e-01 | -3.20e-01 | 6.79e-01 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 6 | 1.75e-01 | 3.20e-01 | 6.39e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 8 | 1.18e-01 | -3.20e-01 | 5.68e-01 |
| GOBP LYMPHANGIOGENESIS | 8 | 1.18e-01 | 3.19e-01 | 5.69e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 2.00e-07 | -3.19e-01 | 9.17e-05 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 19 | 1.61e-02 | -3.19e-01 | 2.82e-01 |
| GOBP FLOOR PLATE DEVELOPMENT | 5 | 2.17e-01 | 3.19e-01 | 6.81e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 34 | 1.30e-03 | 3.19e-01 | 8.23e-02 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 7 | 1.45e-01 | -3.18e-01 | 6.05e-01 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 21 | 1.17e-02 | -3.18e-01 | 2.49e-01 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 7 | 1.45e-01 | 3.18e-01 | 6.05e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 10 | 8.18e-02 | 3.18e-01 | 4.99e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 1.96e-02 | -3.18e-01 | 3.00e-01 |
| GOMF RRNA BINDING | 64 | 1.12e-05 | -3.18e-01 | 2.56e-03 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 6 | 1.78e-01 | 3.17e-01 | 6.43e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 9 | 9.93e-02 | -3.17e-01 | 5.31e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 5 | 2.19e-01 | 3.17e-01 | 6.82e-01 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 2.20e-01 | 3.17e-01 | 6.82e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 8 | 1.21e-01 | 3.17e-01 | 5.70e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 6 | 1.79e-01 | -3.16e-01 | 6.46e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 1.21e-01 | -3.16e-01 | 5.70e-01 |
| GOCC RNA POLYMERASE I COMPLEX | 10 | 8.32e-02 | -3.16e-01 | 5.01e-01 |
| GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION | 5 | 2.21e-01 | 3.16e-01 | 6.83e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY | 5 | 2.21e-01 | 3.16e-01 | 6.83e-01 |
| GOBP RESPONSE TO DISACCHARIDE | 5 | 2.21e-01 | -3.16e-01 | 6.83e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 16 | 2.86e-02 | 3.16e-01 | 3.42e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 13 | 4.84e-02 | -3.16e-01 | 4.08e-01 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 18 | 2.03e-02 | -3.16e-01 | 3.02e-01 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 1.48e-01 | 3.16e-01 | 6.07e-01 |
| GOCC RIPOPTOSOME | 6 | 1.80e-01 | -3.16e-01 | 6.48e-01 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS | 7 | 1.48e-01 | -3.16e-01 | 6.07e-01 |
| GOCC RIBOSOME | 224 | 4.34e-16 | -3.16e-01 | 9.46e-13 |
| GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 1.48e-01 | 3.16e-01 | 6.07e-01 |
| GOBP MALE MEIOSIS I | 15 | 3.45e-02 | 3.15e-01 | 3.65e-01 |
| GOBP AMP SALVAGE | 5 | 2.22e-01 | -3.15e-01 | 6.85e-01 |
| GOBP CGMP MEDIATED SIGNALING | 15 | 3.47e-02 | 3.15e-01 | 3.65e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 8 | 1.23e-01 | 3.15e-01 | 5.71e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 17 | 2.46e-02 | -3.15e-01 | 3.22e-01 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 7 | 1.49e-01 | 3.15e-01 | 6.09e-01 |
| GOMF CCR1 CHEMOKINE RECEPTOR BINDING | 5 | 2.23e-01 | 3.15e-01 | 6.86e-01 |
| GOMF FLOPPASE ACTIVITY | 14 | 4.16e-02 | 3.15e-01 | 3.86e-01 |
| GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.82e-01 | -3.14e-01 | 6.51e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 7 | 1.50e-01 | 3.14e-01 | 6.11e-01 |
| GOBP BICARBONATE TRANSPORT | 21 | 1.28e-02 | 3.14e-01 | 2.55e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 1.83e-01 | -3.14e-01 | 6.51e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 43 | 3.77e-04 | -3.13e-01 | 3.65e-02 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 1.84e-01 | -3.13e-01 | 6.52e-01 |
| GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 5 | 2.26e-01 | 3.13e-01 | 6.90e-01 |
| GOBP TRACHEA MORPHOGENESIS | 7 | 1.52e-01 | -3.13e-01 | 6.13e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 9 | 1.04e-01 | 3.13e-01 | 5.41e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE MATURATION | 6 | 1.85e-01 | 3.13e-01 | 6.53e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 6 | 1.85e-01 | 3.12e-01 | 6.53e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 8 | 1.26e-01 | -3.12e-01 | 5.75e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 9 | 1.05e-01 | -3.12e-01 | 5.42e-01 |
| GOBP GROOMING BEHAVIOR | 7 | 1.53e-01 | -3.12e-01 | 6.13e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 10 | 8.76e-02 | 3.12e-01 | 5.10e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 21 | 1.33e-02 | -3.12e-01 | 2.61e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 8 | 1.27e-01 | -3.12e-01 | 5.76e-01 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 4.34e-02 | 3.12e-01 | 3.92e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 9 | 1.05e-01 | 3.12e-01 | 5.43e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 14 | 4.34e-02 | -3.12e-01 | 3.92e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 27 | 5.07e-03 | 3.12e-01 | 1.71e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 9 | 1.07e-01 | -3.11e-01 | 5.44e-01 |
| GOBP REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 2.29e-01 | 3.10e-01 | 6.92e-01 |
| GOBP DNA PROTECTION | 5 | 2.29e-01 | -3.10e-01 | 6.92e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 9 | 1.07e-01 | 3.10e-01 | 5.47e-01 |
| GOBP RETINAL ROD CELL DEVELOPMENT | 5 | 2.31e-01 | -3.10e-01 | 6.94e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 10 | 9.04e-02 | 3.09e-01 | 5.14e-01 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 7 | 1.57e-01 | -3.09e-01 | 6.19e-01 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 7 | 1.57e-01 | -3.09e-01 | 6.19e-01 |
| GOBP VIRAL BUDDING | 24 | 8.78e-03 | -3.09e-01 | 2.19e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 7 | 1.58e-01 | 3.09e-01 | 6.19e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 13 | 5.43e-02 | -3.08e-01 | 4.31e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 25 | 7.67e-03 | -3.08e-01 | 2.07e-01 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 5 | 2.33e-01 | -3.08e-01 | 6.97e-01 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 8 | 1.32e-01 | 3.08e-01 | 5.84e-01 |
| GOCC U6 SNRNP | 8 | 1.32e-01 | -3.08e-01 | 5.84e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 3.31e-02 | -3.08e-01 | 3.60e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 11 | 7.72e-02 | -3.08e-01 | 4.94e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 2.34e-01 | -3.08e-01 | 6.97e-01 |
| GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 7 | 1.59e-01 | 3.08e-01 | 6.19e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 12 | 6.53e-02 | -3.07e-01 | 4.66e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 7 | 1.59e-01 | 3.07e-01 | 6.19e-01 |
| GOCC HAUS COMPLEX | 8 | 1.33e-01 | -3.07e-01 | 5.85e-01 |
| GOBP CELL AGGREGATION | 6 | 1.93e-01 | 3.07e-01 | 6.65e-01 |
| GOBP PARENTAL BEHAVIOR | 5 | 2.35e-01 | -3.07e-01 | 6.99e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 11 | 7.85e-02 | 3.06e-01 | 4.96e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 6 | 1.94e-01 | -3.06e-01 | 6.66e-01 |
| GOMF U3 SNORNA BINDING | 10 | 9.38e-02 | -3.06e-01 | 5.21e-01 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 6 | 1.94e-01 | -3.06e-01 | 6.66e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 2.10e-02 | 3.06e-01 | 3.07e-01 |
| GOMF U1 SNRNP BINDING | 6 | 1.94e-01 | -3.06e-01 | 6.66e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 18 | 2.47e-02 | 3.06e-01 | 3.23e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 10 | 9.40e-02 | -3.06e-01 | 5.21e-01 |
| GOMF NEUROTRANSMITTER BINDING | 6 | 1.95e-01 | 3.06e-01 | 6.66e-01 |
| GOBP GLYCINE TRANSPORT | 6 | 1.95e-01 | 3.06e-01 | 6.66e-01 |
| GOMF VINCULIN BINDING | 9 | 1.13e-01 | 3.06e-01 | 5.58e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 1.96e-01 | -3.05e-01 | 6.67e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 2.38e-01 | -3.05e-01 | 7.02e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 6 | 1.96e-01 | 3.05e-01 | 6.67e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 19 | 2.17e-02 | 3.04e-01 | 3.12e-01 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 9 | 1.14e-01 | 3.04e-01 | 5.62e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 12 | 6.82e-02 | 3.04e-01 | 4.74e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 11 | 8.08e-02 | 3.04e-01 | 4.99e-01 |
| GOBP ENDOCARDIUM DEVELOPMENT | 7 | 1.64e-01 | 3.04e-01 | 6.25e-01 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 4.16e-02 | 3.04e-01 | 3.86e-01 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 6 | 1.97e-01 | -3.04e-01 | 6.67e-01 |
| GOBP METANEPHRIC TUBULE MORPHOGENESIS | 5 | 2.40e-01 | 3.04e-01 | 7.04e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 7 | 1.65e-01 | -3.03e-01 | 6.26e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 1.65e-01 | -3.03e-01 | 6.26e-01 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 5 | 2.41e-01 | 3.03e-01 | 7.05e-01 |
| GOBP TRNA 5 END PROCESSING | 16 | 3.59e-02 | -3.03e-01 | 3.69e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 74 | 6.63e-06 | -3.03e-01 | 1.75e-03 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 7 | 1.65e-01 | 3.03e-01 | 6.26e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 5 | 2.41e-01 | 3.03e-01 | 7.06e-01 |
| GOBP ESTROUS CYCLE | 11 | 8.20e-02 | 3.03e-01 | 4.99e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 7 | 1.65e-01 | 3.03e-01 | 6.27e-01 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 5 | 2.41e-01 | 3.03e-01 | 7.06e-01 |
| GOCC RETROMER COMPLEX | 12 | 6.97e-02 | -3.02e-01 | 4.77e-01 |
| GOBP ISOCITRATE METABOLIC PROCESS | 6 | 2.00e-01 | -3.02e-01 | 6.68e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 10 | 9.80e-02 | 3.02e-01 | 5.28e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 12 | 6.99e-02 | 3.02e-01 | 4.77e-01 |
| GOCC U2AF COMPLEX | 5 | 2.42e-01 | -3.02e-01 | 7.07e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 6 | 2.00e-01 | -3.02e-01 | 6.68e-01 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 1.67e-01 | 3.02e-01 | 6.28e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 23 | 1.23e-02 | -3.02e-01 | 2.53e-01 |
| GOBP PML BODY ORGANIZATION | 6 | 2.01e-01 | -3.01e-01 | 6.69e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 13 | 6.00e-02 | 3.01e-01 | 4.47e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 16 | 3.70e-02 | 3.01e-01 | 3.75e-01 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 2.02e-01 | -3.01e-01 | 6.69e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 8 | 1.41e-01 | -3.01e-01 | 5.98e-01 |
| GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 5.13e-02 | 3.01e-01 | 4.18e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 28 | 5.89e-03 | -3.01e-01 | 1.81e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 6 | 2.02e-01 | 3.01e-01 | 6.69e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 6 | 2.02e-01 | 3.01e-01 | 6.69e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 10 | 9.98e-02 | 3.01e-01 | 5.32e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 14 | 5.16e-02 | -3.00e-01 | 4.19e-01 |
| GOCC RAGULATOR COMPLEX | 5 | 2.45e-01 | -3.00e-01 | 7.09e-01 |
| GOCC CIA COMPLEX | 5 | 2.46e-01 | -3.00e-01 | 7.10e-01 |
| GOBP GAP JUNCTION ASSEMBLY | 7 | 1.70e-01 | 2.99e-01 | 6.35e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 9 | 1.21e-01 | -2.99e-01 | 5.70e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 2.47e-01 | -2.99e-01 | 7.13e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 21 | 1.80e-02 | -2.98e-01 | 2.95e-01 |
| GOCC MALE PRONUCLEUS | 7 | 1.72e-01 | -2.98e-01 | 6.36e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 28 | 6.41e-03 | 2.98e-01 | 1.89e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 12 | 7.42e-02 | -2.98e-01 | 4.87e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 19 | 2.48e-02 | 2.97e-01 | 3.23e-01 |
| GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS | 6 | 2.07e-01 | 2.97e-01 | 6.74e-01 |
| GOBP B CELL LINEAGE COMMITMENT | 5 | 2.50e-01 | -2.97e-01 | 7.16e-01 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 7 | 1.73e-01 | 2.97e-01 | 6.38e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 8 | 1.46e-01 | -2.97e-01 | 6.06e-01 |
| GOMF DYNEIN COMPLEX BINDING | 20 | 2.15e-02 | 2.97e-01 | 3.12e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 7 | 1.74e-01 | 2.97e-01 | 6.38e-01 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 2.08e-01 | 2.97e-01 | 6.75e-01 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 19 | 2.53e-02 | 2.96e-01 | 3.23e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 5 | 2.52e-01 | -2.96e-01 | 7.18e-01 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 2.52e-01 | 2.96e-01 | 7.18e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 10 | 1.05e-01 | -2.96e-01 | 5.43e-01 |
| GOCC PARANODAL JUNCTION | 5 | 2.52e-01 | -2.96e-01 | 7.18e-01 |
| GOBP GLOMERULUS MORPHOGENESIS | 5 | 2.52e-01 | 2.96e-01 | 7.18e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 8.97e-02 | 2.96e-01 | 5.12e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 6.51e-02 | 2.96e-01 | 4.66e-01 |
| GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.10e-01 | -2.95e-01 | 6.75e-01 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 14 | 5.57e-02 | -2.95e-01 | 4.34e-01 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 2.53e-01 | 2.95e-01 | 7.18e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 8 | 1.48e-01 | -2.95e-01 | 6.07e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 13 | 6.54e-02 | -2.95e-01 | 4.66e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 11 | 9.02e-02 | 2.95e-01 | 5.13e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 1.77e-01 | -2.95e-01 | 6.40e-01 |
| GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY | 5 | 2.53e-01 | 2.95e-01 | 7.18e-01 |
| GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY | 5 | 2.53e-01 | 2.95e-01 | 7.18e-01 |
| GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY | 5 | 2.53e-01 | 2.95e-01 | 7.18e-01 |
| GOMF SEROTONIN RECEPTOR ACTIVITY | 5 | 2.53e-01 | 2.95e-01 | 7.18e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 18 | 3.05e-02 | 2.95e-01 | 3.50e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 2.54e-01 | -2.94e-01 | 7.18e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 23 | 1.46e-02 | 2.94e-01 | 2.71e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 8 | 1.50e-01 | 2.94e-01 | 6.11e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 5 | 2.55e-01 | -2.94e-01 | 7.18e-01 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 5 | 2.55e-01 | 2.94e-01 | 7.18e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 6 | 2.12e-01 | -2.94e-01 | 6.77e-01 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 7.82e-02 | -2.94e-01 | 4.96e-01 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 9 | 1.28e-01 | -2.93e-01 | 5.80e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 32 | 4.14e-03 | 2.93e-01 | 1.53e-01 |
| GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY | 5 | 2.57e-01 | -2.93e-01 | 7.20e-01 |
| GOBP FOLIC ACID TRANSPORT | 9 | 1.29e-01 | 2.93e-01 | 5.80e-01 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 9 | 1.29e-01 | 2.92e-01 | 5.81e-01 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 6 | 2.15e-01 | 2.92e-01 | 6.80e-01 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 7.98e-02 | 2.92e-01 | 4.98e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION | 5 | 2.58e-01 | 2.92e-01 | 7.21e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING | 5 | 2.58e-01 | 2.92e-01 | 7.21e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 12 | 8.02e-02 | -2.92e-01 | 4.98e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 13 | 6.88e-02 | -2.91e-01 | 4.75e-01 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.30e-01 | 2.91e-01 | 5.82e-01 |
| GOMF CD4 RECEPTOR BINDING | 6 | 2.16e-01 | -2.91e-01 | 6.80e-01 |
| GOBP CHROMOSOME CONDENSATION | 29 | 6.66e-03 | 2.91e-01 | 1.93e-01 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 1.66e-04 | -2.91e-01 | 2.01e-02 |
| GOBP ASTROCYTE CELL MIGRATION | 6 | 2.17e-01 | 2.91e-01 | 6.80e-01 |
| GOBP ACROSOMAL VESICLE EXOCYTOSIS | 5 | 2.60e-01 | -2.91e-01 | 7.22e-01 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 10 | 1.12e-01 | 2.91e-01 | 5.57e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 10 | 1.12e-01 | -2.90e-01 | 5.57e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 33 | 3.94e-03 | 2.90e-01 | 1.51e-01 |
| GOBP FATTY ACID ALPHA OXIDATION | 5 | 2.62e-01 | -2.90e-01 | 7.24e-01 |
| GOBP BIOLOGICAL PHASE | 5 | 2.62e-01 | -2.90e-01 | 7.24e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 12 | 8.22e-02 | 2.90e-01 | 4.99e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 11 | 9.63e-02 | 2.90e-01 | 5.26e-01 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 8 | 1.56e-01 | -2.90e-01 | 6.19e-01 |
| GOBP MICROGLIAL CELL MIGRATION | 5 | 2.62e-01 | -2.89e-01 | 7.24e-01 |
| GOMF INTERLEUKIN 1 BINDING | 6 | 2.20e-01 | 2.89e-01 | 6.82e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 8 | 1.57e-01 | 2.89e-01 | 6.19e-01 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 7 | 1.85e-01 | 2.89e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 6 | 2.20e-01 | -2.89e-01 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 8 | 1.57e-01 | -2.89e-01 | 6.19e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 16 | 4.54e-02 | 2.89e-01 | 3.98e-01 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 5 | 2.63e-01 | 2.89e-01 | 7.24e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 8 | 1.57e-01 | 2.89e-01 | 6.19e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 13 | 7.16e-02 | -2.89e-01 | 4.79e-01 |
| GOMF POLYSACCHARIDE BINDING | 12 | 8.37e-02 | -2.88e-01 | 5.03e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 21 | 2.22e-02 | 2.88e-01 | 3.12e-01 |
| GOBP CMP METABOLIC PROCESS | 7 | 1.87e-01 | -2.88e-01 | 6.56e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 16 | 4.60e-02 | 2.88e-01 | 4.01e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 13 | 7.21e-02 | -2.88e-01 | 4.81e-01 |
| GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE | 6 | 2.22e-01 | 2.88e-01 | 6.84e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 13 | 7.22e-02 | -2.88e-01 | 4.81e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 13 | 7.24e-02 | 2.88e-01 | 4.82e-01 |
| GOCC EXTRINSIC COMPONENT OF ENDOSOME MEMBRANE | 5 | 2.65e-01 | -2.88e-01 | 7.27e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 26 | 1.13e-02 | 2.87e-01 | 2.45e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 20 | 2.63e-02 | 2.87e-01 | 3.29e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 13 | 7.32e-02 | 2.87e-01 | 4.84e-01 |
| GOBP DNA STRAND ELONGATION | 36 | 2.89e-03 | 2.87e-01 | 1.27e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 13 | 7.33e-02 | 2.87e-01 | 4.84e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 11 | 9.95e-02 | -2.87e-01 | 5.31e-01 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 5 | 2.67e-01 | -2.87e-01 | 7.28e-01 |
| GOCC FEMALE PRONUCLEUS | 9 | 1.36e-01 | -2.87e-01 | 5.92e-01 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 6 | 2.24e-01 | -2.87e-01 | 6.87e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 5 | 2.67e-01 | 2.86e-01 | 7.29e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 5 | 2.68e-01 | 2.86e-01 | 7.29e-01 |
| GOBP REGULATION OF HISTONE METHYLATION | 17 | 4.12e-02 | 2.86e-01 | 3.86e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 18 | 3.57e-02 | -2.86e-01 | 3.68e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 8 | 1.62e-01 | 2.86e-01 | 6.21e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 7 | 1.91e-01 | -2.86e-01 | 6.61e-01 |
| GOBP NEUROBLAST DIVISION | 9 | 1.38e-01 | 2.86e-01 | 5.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 23 | 1.78e-02 | 2.85e-01 | 2.95e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 13 | 7.49e-02 | -2.85e-01 | 4.88e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 13 | 7.53e-02 | -2.85e-01 | 4.89e-01 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 2.27e-01 | -2.85e-01 | 6.91e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 6 | 2.27e-01 | -2.85e-01 | 6.91e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 2.27e-01 | 2.85e-01 | 6.91e-01 |
| GOBP TYROSINE METABOLIC PROCESS | 7 | 1.92e-01 | -2.84e-01 | 6.64e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 13 | 7.62e-02 | -2.84e-01 | 4.91e-01 |
| GOMF LIPID KINASE ACTIVITY | 35 | 3.69e-03 | 2.84e-01 | 1.46e-01 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 24 | 1.62e-02 | -2.84e-01 | 2.82e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 11 | 1.04e-01 | 2.83e-01 | 5.41e-01 |
| GOBP TRNA TRANSCRIPTION | 11 | 1.04e-01 | 2.83e-01 | 5.41e-01 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 6 | 2.30e-01 | -2.83e-01 | 6.93e-01 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 11 | 1.04e-01 | -2.83e-01 | 5.41e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 15 | 5.77e-02 | 2.83e-01 | 4.43e-01 |
| GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION | 5 | 2.73e-01 | 2.83e-01 | 7.36e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 13 | 7.74e-02 | 2.83e-01 | 4.95e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 18 | 3.77e-02 | -2.83e-01 | 3.78e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 20 | 2.85e-02 | 2.83e-01 | 3.42e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 2.74e-01 | 2.83e-01 | 7.36e-01 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 8 | 1.67e-01 | 2.82e-01 | 6.28e-01 |
| GOMF CARD DOMAIN BINDING | 14 | 6.73e-02 | -2.82e-01 | 4.72e-01 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 11 | 1.05e-01 | -2.82e-01 | 5.42e-01 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 10 | 1.22e-01 | -2.82e-01 | 5.71e-01 |
| GOBP CATECHOLAMINE UPTAKE | 6 | 2.32e-01 | -2.82e-01 | 6.96e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 7 | 1.97e-01 | 2.82e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 26 | 1.29e-02 | -2.82e-01 | 2.55e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 5 | 2.75e-01 | -2.82e-01 | 7.38e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 7 | 1.97e-01 | -2.82e-01 | 6.67e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 11 | 1.06e-01 | 2.82e-01 | 5.43e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 11 | 1.06e-01 | -2.81e-01 | 5.43e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 10 | 1.24e-01 | -2.81e-01 | 5.72e-01 |
| GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.44e-01 | 2.81e-01 | 6.04e-01 |
| GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 6 | 2.34e-01 | 2.81e-01 | 6.97e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 120 | 1.10e-07 | -2.81e-01 | 5.63e-05 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 7 | 1.98e-01 | -2.81e-01 | 6.68e-01 |
| GOMF I SMAD BINDING | 13 | 7.99e-02 | -2.81e-01 | 4.98e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 35 | 4.09e-03 | -2.80e-01 | 1.53e-01 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 8 | 1.70e-01 | 2.80e-01 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 15 | 6.03e-02 | -2.80e-01 | 4.48e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 14 | 6.97e-02 | 2.80e-01 | 4.77e-01 |
| GOMF U2 SNRNA BINDING | 6 | 2.35e-01 | -2.80e-01 | 6.99e-01 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 9 | 1.46e-01 | 2.80e-01 | 6.06e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 19 | 3.49e-02 | -2.80e-01 | 3.67e-01 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 2.79e-01 | 2.80e-01 | 7.39e-01 |
| GOBP ENDOSOMAL VESICLE FUSION | 12 | 9.38e-02 | 2.79e-01 | 5.21e-01 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 12 | 9.39e-02 | -2.79e-01 | 5.21e-01 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 6 | 2.36e-01 | 2.79e-01 | 7.00e-01 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 5 | 2.80e-01 | 2.79e-01 | 7.40e-01 |
| GOMF 5S RRNA BINDING | 9 | 1.47e-01 | -2.79e-01 | 6.07e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 14 | 7.09e-02 | -2.79e-01 | 4.78e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 6 | 2.37e-01 | -2.79e-01 | 7.01e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 5 | 2.81e-01 | -2.79e-01 | 7.42e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 20 | 3.11e-02 | 2.78e-01 | 3.52e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 6 | 2.38e-01 | -2.78e-01 | 7.03e-01 |
| GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.82e-01 | 2.78e-01 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 30 | 8.43e-03 | 2.78e-01 | 2.16e-01 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 6 | 2.39e-01 | -2.78e-01 | 7.03e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 11 | 1.11e-01 | 2.78e-01 | 5.54e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 35 | 4.46e-03 | -2.78e-01 | 1.58e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 33 | 5.76e-03 | 2.78e-01 | 1.81e-01 |
| GOBP RESPONSE TO IRON II ION | 5 | 2.82e-01 | -2.78e-01 | 7.42e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 11 | 1.11e-01 | 2.78e-01 | 5.56e-01 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 18 | 4.15e-02 | 2.78e-01 | 3.86e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 6 | 2.39e-01 | 2.77e-01 | 7.04e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 24 | 1.87e-02 | -2.77e-01 | 2.95e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 7 | 2.04e-01 | 2.77e-01 | 6.72e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT | 5 | 2.83e-01 | 2.77e-01 | 7.43e-01 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 13 | 8.40e-02 | 2.77e-01 | 5.04e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 12 | 9.70e-02 | -2.77e-01 | 5.26e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 10 | 1.30e-01 | -2.77e-01 | 5.82e-01 |
| GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 9 | 1.51e-01 | 2.76e-01 | 6.13e-01 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 25 | 1.68e-02 | 2.76e-01 | 2.89e-01 |
| GOBP NEURONAL ACTION POTENTIAL PROPAGATION | 5 | 2.85e-01 | 2.76e-01 | 7.44e-01 |
| GOCC SCHMIDT LANTERMAN INCISURE | 6 | 2.41e-01 | -2.76e-01 | 7.06e-01 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 2.06e-01 | -2.76e-01 | 6.73e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 12 | 9.82e-02 | 2.76e-01 | 5.28e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 1.70e-02 | -2.76e-01 | 2.92e-01 |
| GOBP MUSCLE ATROPHY | 6 | 2.42e-01 | 2.76e-01 | 7.08e-01 |
| GOBP RESPIRATORY BURST | 30 | 9.00e-03 | -2.76e-01 | 2.20e-01 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 2.86e-01 | -2.76e-01 | 7.46e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 17 | 4.92e-02 | 2.76e-01 | 4.12e-01 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 8 | 1.77e-01 | -2.75e-01 | 6.42e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 9 | 1.53e-01 | -2.75e-01 | 6.14e-01 |
| GOBP RRNA CATABOLIC PROCESS | 19 | 3.82e-02 | -2.75e-01 | 3.78e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 25 | 1.75e-02 | 2.75e-01 | 2.95e-01 |
| GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 6 | 2.44e-01 | -2.75e-01 | 7.08e-01 |
| GOBP INTERLEUKIN 23 PRODUCTION | 6 | 2.45e-01 | -2.74e-01 | 7.09e-01 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 16 | 5.76e-02 | 2.74e-01 | 4.43e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 14 | 7.57e-02 | -2.74e-01 | 4.90e-01 |
| GOBP TRANSLOCATION OF MOLECULES INTO HOST | 8 | 1.79e-01 | -2.74e-01 | 6.46e-01 |
| GOCC LEWY BODY | 7 | 2.09e-01 | 2.74e-01 | 6.75e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 6 | 2.45e-01 | -2.74e-01 | 7.09e-01 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 13 | 8.72e-02 | 2.74e-01 | 5.10e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 38 | 3.48e-03 | 2.74e-01 | 1.42e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 15 | 6.66e-02 | 2.74e-01 | 4.70e-01 |
| GOBP SEGMENT SPECIFICATION | 7 | 2.10e-01 | 2.74e-01 | 6.75e-01 |
| GOBP EOSINOPHIL MIGRATION | 15 | 6.68e-02 | 2.73e-01 | 4.70e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 12 | 1.01e-01 | -2.73e-01 | 5.35e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 5 | 2.91e-01 | 2.73e-01 | 7.50e-01 |
| GOCC SEX CHROMATIN | 5 | 2.92e-01 | -2.72e-01 | 7.51e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 8 | 1.83e-01 | -2.72e-01 | 6.51e-01 |
| GOBP REGULATION OF HYPERSENSITIVITY | 9 | 1.58e-01 | -2.72e-01 | 6.19e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 25 | 1.85e-02 | -2.72e-01 | 2.95e-01 |
| GOMF TELOMERASE INHIBITOR ACTIVITY | 5 | 2.92e-01 | 2.72e-01 | 7.52e-01 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 6 | 2.49e-01 | 2.72e-01 | 7.15e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 17 | 5.23e-02 | -2.72e-01 | 4.23e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 5 | 2.93e-01 | -2.72e-01 | 7.52e-01 |
| GOCC KINESIN COMPLEX | 33 | 6.96e-03 | 2.72e-01 | 1.97e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 7 | 2.14e-01 | 2.71e-01 | 6.79e-01 |
| GOCC TERTIARY GRANULE LUMEN | 42 | 2.36e-03 | -2.71e-01 | 1.14e-01 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 10 | 1.38e-01 | -2.71e-01 | 5.95e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 8 | 1.84e-01 | 2.71e-01 | 6.52e-01 |
| GOCC MCM COMPLEX | 8 | 1.85e-01 | 2.71e-01 | 6.53e-01 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 12 | 1.04e-01 | 2.71e-01 | 5.42e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 13 | 9.12e-02 | 2.71e-01 | 5.18e-01 |
| GOCC OUTER KINETOCHORE | 16 | 6.11e-02 | 2.71e-01 | 4.50e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 6 | 2.51e-01 | 2.70e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 2.95e-01 | 2.70e-01 | 7.54e-01 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.95e-01 | 2.70e-01 | 7.54e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 7.99e-02 | -2.70e-01 | 4.98e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 18 | 4.72e-02 | 2.70e-01 | 4.05e-01 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 6 | 2.52e-01 | -2.70e-01 | 7.18e-01 |
| GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING | 6 | 2.52e-01 | -2.70e-01 | 7.18e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 2.96e-01 | -2.70e-01 | 7.54e-01 |
| GOCC ESCRT COMPLEX | 26 | 1.73e-02 | -2.70e-01 | 2.94e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 16 | 6.19e-02 | -2.70e-01 | 4.52e-01 |
| GOBP ECTODERM DEVELOPMENT | 14 | 8.08e-02 | 2.70e-01 | 4.99e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 9.25e-02 | 2.70e-01 | 5.18e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 7.07e-02 | -2.70e-01 | 4.78e-01 |
| GOCC INHIBITORY SYNAPSE | 5 | 2.97e-01 | 2.70e-01 | 7.54e-01 |
| GOBP TOLERANCE INDUCTION | 18 | 4.78e-02 | -2.70e-01 | 4.06e-01 |
| GOCC LATERAL PART OF CELL | 5 | 2.97e-01 | 2.69e-01 | 7.54e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 11 | 1.22e-01 | -2.69e-01 | 5.71e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 40 | 3.21e-03 | 2.69e-01 | 1.36e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 28 | 1.37e-02 | 2.69e-01 | 2.65e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 48 | 1.25e-03 | 2.69e-01 | 8.02e-02 |
| GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 6 | 2.53e-01 | -2.69e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF HISTONE DEACETYLATION | 5 | 2.98e-01 | 2.69e-01 | 7.54e-01 |
| GOBP REGULATION OF HISTONE DEACETYLATION | 5 | 2.98e-01 | 2.69e-01 | 7.54e-01 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 2.98e-01 | 2.69e-01 | 7.54e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 7.15e-02 | 2.69e-01 | 4.79e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 18 | 4.85e-02 | 2.69e-01 | 4.08e-01 |
| GOCC RESPIRASOME | 90 | 1.07e-05 | -2.69e-01 | 2.53e-03 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 1.63e-01 | -2.68e-01 | 6.24e-01 |
| GOBP DUMP METABOLIC PROCESS | 6 | 2.55e-01 | -2.68e-01 | 7.18e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 14 | 8.24e-02 | 2.68e-01 | 4.99e-01 |
| GOBP CELL REDOX HOMEOSTASIS | 36 | 5.39e-03 | -2.68e-01 | 1.77e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 10 | 1.42e-01 | 2.68e-01 | 6.00e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 10 | 1.42e-01 | -2.68e-01 | 6.00e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 2.32e-02 | -2.68e-01 | 3.18e-01 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 7 | 2.20e-01 | -2.68e-01 | 6.83e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 26 | 1.83e-02 | 2.67e-01 | 2.95e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 2.57e-01 | 2.67e-01 | 7.19e-01 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 3.00e-01 | -2.67e-01 | 7.56e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 5 | 3.00e-01 | -2.67e-01 | 7.56e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 7 | 2.21e-01 | -2.67e-01 | 6.83e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 8 | 1.90e-01 | -2.67e-01 | 6.61e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 19 | 4.37e-02 | -2.67e-01 | 3.92e-01 |
| GOBP CHROMATIN LOOPING | 11 | 1.25e-01 | 2.67e-01 | 5.74e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 22 | 3.02e-02 | -2.67e-01 | 3.50e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 2.22e-01 | 2.67e-01 | 6.84e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 18 | 5.01e-02 | -2.67e-01 | 4.14e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 10 | 1.44e-01 | 2.67e-01 | 6.03e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 37 | 5.02e-03 | 2.67e-01 | 1.70e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 24 | 2.38e-02 | 2.67e-01 | 3.19e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 46 | 1.80e-03 | -2.66e-01 | 9.68e-02 |
| GOCC EXORIBONUCLEASE COMPLEX | 19 | 4.47e-02 | -2.66e-01 | 3.95e-01 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 3.03e-01 | 2.66e-01 | 7.59e-01 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 3.03e-01 | 2.66e-01 | 7.59e-01 |
| GOCC NADH DEHYDROGENASE COMPLEX | 47 | 1.61e-03 | -2.66e-01 | 9.00e-02 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 3.03e-01 | 2.66e-01 | 7.59e-01 |
| GOBP RESPONSE TO CORTICOSTERONE | 6 | 2.60e-01 | -2.66e-01 | 7.22e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 13 | 9.77e-02 | -2.65e-01 | 5.27e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 9 | 1.68e-01 | 2.65e-01 | 6.32e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 48 | 1.48e-03 | -2.65e-01 | 8.67e-02 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 10 | 1.47e-01 | 2.65e-01 | 6.07e-01 |
| GOCC AP 1 ADAPTOR COMPLEX | 10 | 1.47e-01 | 2.65e-01 | 6.07e-01 |
| GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS | 5 | 3.05e-01 | -2.65e-01 | 7.60e-01 |
| GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS | 7 | 2.25e-01 | 2.65e-01 | 6.88e-01 |
| GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY | 5 | 3.05e-01 | 2.65e-01 | 7.60e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 7 | 2.25e-01 | -2.65e-01 | 6.88e-01 |
| GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 5 | 3.05e-01 | 2.65e-01 | 7.60e-01 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 8 | 1.95e-01 | 2.65e-01 | 6.66e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS | 5 | 3.05e-01 | 2.65e-01 | 7.60e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 40 | 3.78e-03 | 2.65e-01 | 1.48e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 17 | 5.90e-02 | -2.65e-01 | 4.45e-01 |
| GOCC GTPASE COMPLEX | 26 | 2.00e-02 | -2.64e-01 | 3.02e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 3.07e-01 | -2.64e-01 | 7.62e-01 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 6 | 2.64e-01 | 2.63e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 14 | 8.81e-02 | -2.63e-01 | 5.10e-01 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 22 | 3.27e-02 | 2.63e-01 | 3.57e-01 |
| GOCC NURF COMPLEX | 7 | 2.28e-01 | 2.63e-01 | 6.91e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 11 | 1.31e-01 | 2.63e-01 | 5.83e-01 |
| GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 5 | 3.09e-01 | -2.63e-01 | 7.63e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 171 | 3.32e-09 | -2.63e-01 | 2.63e-06 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 3.10e-01 | 2.62e-01 | 7.63e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 27 | 1.83e-02 | 2.62e-01 | 2.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 49 | 1.50e-03 | -2.62e-01 | 8.73e-02 |
| GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY | 5 | 3.10e-01 | 2.62e-01 | 7.64e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 34 | 8.18e-03 | 2.62e-01 | 2.14e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 6 | 2.67e-01 | 2.62e-01 | 7.28e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 21 | 3.79e-02 | -2.62e-01 | 3.78e-01 |
| GOBP REGULATION OF CD40 SIGNALING PATHWAY | 6 | 2.67e-01 | -2.62e-01 | 7.29e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 13 | 1.03e-01 | 2.61e-01 | 5.39e-01 |
| GOCC MICROTUBULE END | 26 | 2.10e-02 | 2.61e-01 | 3.07e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 9 | 1.74e-01 | 2.61e-01 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 10 | 1.52e-01 | 2.61e-01 | 6.13e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 10 | 1.52e-01 | 2.61e-01 | 6.13e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 11 | 1.33e-01 | -2.61e-01 | 5.86e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 8 | 2.01e-01 | -2.61e-01 | 6.68e-01 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 6 | 2.68e-01 | 2.61e-01 | 7.29e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 10 | 1.53e-01 | 2.61e-01 | 6.13e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 7 | 2.32e-01 | -2.61e-01 | 6.96e-01 |
| GOMF ACTIVIN BINDING | 10 | 1.53e-01 | 2.61e-01 | 6.14e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 11 | 1.34e-01 | -2.61e-01 | 5.88e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 7 | 2.32e-01 | -2.61e-01 | 6.97e-01 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 20 | 4.37e-02 | 2.61e-01 | 3.92e-01 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 19 | 4.93e-02 | 2.61e-01 | 4.12e-01 |
| GOCC NSL COMPLEX | 11 | 1.35e-01 | 2.60e-01 | 5.90e-01 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 6 | 2.70e-01 | 2.60e-01 | 7.32e-01 |
| GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION | 5 | 3.14e-01 | -2.60e-01 | 7.66e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 36 | 6.95e-03 | -2.60e-01 | 1.97e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 14 | 9.21e-02 | 2.60e-01 | 5.18e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 8 | 2.03e-01 | -2.60e-01 | 6.71e-01 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 5 | 3.14e-01 | -2.60e-01 | 7.66e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 94 | 1.36e-05 | -2.60e-01 | 2.90e-03 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 2.71e-01 | -2.60e-01 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 3.15e-01 | 2.60e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 3.15e-01 | -2.60e-01 | 7.66e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 10 | 1.55e-01 | -2.60e-01 | 6.18e-01 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 36 | 7.05e-03 | -2.60e-01 | 1.98e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 14 | 9.27e-02 | -2.60e-01 | 5.18e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 24 | 2.80e-02 | 2.59e-01 | 3.40e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 8 | 2.05e-01 | -2.59e-01 | 6.72e-01 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 11 | 1.37e-01 | 2.59e-01 | 5.93e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 44 | 2.99e-03 | -2.59e-01 | 1.29e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 99 | 8.82e-06 | -2.59e-01 | 2.26e-03 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 13 | 1.07e-01 | -2.59e-01 | 5.44e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 1.57e-01 | -2.58e-01 | 6.19e-01 |
| GOBP COLLECTING DUCT DEVELOPMENT | 5 | 3.17e-01 | 2.58e-01 | 7.67e-01 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 11 | 1.38e-01 | -2.58e-01 | 5.95e-01 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 2.06e-01 | -2.58e-01 | 6.73e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 51 | 1.43e-03 | -2.58e-01 | 8.63e-02 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 9 | 1.80e-01 | -2.58e-01 | 6.47e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 8 | 2.06e-01 | 2.58e-01 | 6.74e-01 |
| GOCC MYOSIN FILAMENT | 10 | 1.58e-01 | 2.58e-01 | 6.19e-01 |
| GOMF PEPTIDE HORMONE BINDING | 16 | 7.43e-02 | 2.58e-01 | 4.87e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 12 | 1.22e-01 | 2.58e-01 | 5.71e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 50 | 1.64e-03 | -2.58e-01 | 9.03e-02 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 15 | 8.42e-02 | -2.58e-01 | 5.04e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 3.19e-01 | -2.57e-01 | 7.67e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 9 | 1.81e-01 | 2.57e-01 | 6.49e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 22 | 3.67e-02 | 2.57e-01 | 3.73e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 17 | 6.62e-02 | -2.57e-01 | 4.69e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 1.59e-01 | -2.57e-01 | 6.19e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 25 | 2.60e-02 | -2.57e-01 | 3.28e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 8 | 2.08e-01 | -2.57e-01 | 6.74e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 28 | 1.85e-02 | 2.57e-01 | 2.95e-01 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 2.75e-01 | 2.57e-01 | 7.38e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 17 | 6.64e-02 | -2.57e-01 | 4.69e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 8 | 2.08e-01 | -2.57e-01 | 6.75e-01 |
| GOBP TRACHEA FORMATION | 6 | 2.76e-01 | -2.57e-01 | 7.38e-01 |
| GOMF RDNA BINDING | 9 | 1.82e-01 | 2.57e-01 | 6.50e-01 |
| GOBP UTERINE SMOOTH MUSCLE CONTRACTION | 5 | 3.20e-01 | 2.57e-01 | 7.69e-01 |
| GOBP NEURAL PLATE DEVELOPMENT | 5 | 3.21e-01 | 2.57e-01 | 7.69e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 8 | 2.09e-01 | 2.56e-01 | 6.75e-01 |
| GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 8 | 2.09e-01 | -2.56e-01 | 6.75e-01 |
| GOBP PROTEIN GERANYLGERANYLATION | 6 | 2.77e-01 | -2.56e-01 | 7.38e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 11 | 1.42e-01 | -2.56e-01 | 6.00e-01 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 15 | 8.63e-02 | -2.56e-01 | 5.09e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 8 | 2.10e-01 | -2.56e-01 | 6.75e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 29 | 1.72e-02 | 2.56e-01 | 2.93e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 9 | 1.84e-01 | -2.56e-01 | 6.52e-01 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 11 | 1.42e-01 | -2.55e-01 | 6.00e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 12 | 1.25e-01 | -2.55e-01 | 5.75e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 16 | 7.69e-02 | -2.55e-01 | 4.93e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 25 | 2.72e-02 | -2.55e-01 | 3.34e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 2.79e-01 | -2.55e-01 | 7.39e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 7 | 2.43e-01 | -2.55e-01 | 7.08e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 17 | 6.91e-02 | 2.55e-01 | 4.75e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 32 | 1.27e-02 | -2.55e-01 | 2.53e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 2.12e-01 | 2.55e-01 | 6.77e-01 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 2.44e-01 | 2.54e-01 | 7.08e-01 |
| GOBP THERMOCEPTION | 5 | 3.25e-01 | -2.54e-01 | 7.73e-01 |
| GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 5 | 3.25e-01 | -2.54e-01 | 7.73e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 28 | 1.99e-02 | -2.54e-01 | 3.02e-01 |
| GOCC COLLAGEN TRIMER | 33 | 1.15e-02 | 2.54e-01 | 2.47e-01 |
| GOBP VIRION ASSEMBLY | 33 | 1.15e-02 | -2.54e-01 | 2.47e-01 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 8.84e-02 | -2.54e-01 | 5.10e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 9 | 1.87e-01 | 2.54e-01 | 6.56e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 8 | 2.14e-01 | 2.54e-01 | 6.79e-01 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 16 | 7.88e-02 | 2.54e-01 | 4.97e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 20 | 4.94e-02 | -2.54e-01 | 4.12e-01 |
| GOBP SNORNA LOCALIZATION | 6 | 2.82e-01 | -2.54e-01 | 7.42e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 34 | 1.05e-02 | -2.54e-01 | 2.40e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 11 | 1.45e-01 | 2.54e-01 | 6.05e-01 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 1.28e-01 | 2.54e-01 | 5.80e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 6 | 2.82e-01 | -2.54e-01 | 7.42e-01 |
| GOBP REGULATION OF HISTONE MODIFICATION | 35 | 9.46e-03 | 2.54e-01 | 2.27e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 39 | 6.21e-03 | 2.53e-01 | 1.87e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 13 | 1.14e-01 | 2.53e-01 | 5.62e-01 |
| GOMF FLIPPASE ACTIVITY | 13 | 1.14e-01 | 2.53e-01 | 5.62e-01 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 5 | 3.27e-01 | -2.53e-01 | 7.76e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 13 | 1.14e-01 | 2.53e-01 | 5.62e-01 |
| GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 12 | 1.29e-01 | 2.53e-01 | 5.82e-01 |
| GOBP CARTILAGE CONDENSATION | 5 | 3.28e-01 | 2.53e-01 | 7.76e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 23 | 3.59e-02 | -2.53e-01 | 3.69e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 7 | 2.47e-01 | -2.53e-01 | 7.12e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 27 | 2.31e-02 | -2.53e-01 | 3.18e-01 |
| GOMF ADENYLATE KINASE ACTIVITY | 8 | 2.16e-01 | 2.53e-01 | 6.80e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.90e-01 | 2.53e-01 | 6.61e-01 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 8 | 2.16e-01 | -2.52e-01 | 6.80e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 6 | 2.85e-01 | 2.52e-01 | 7.44e-01 |
| GOMF CTPASE ACTIVITY | 5 | 3.29e-01 | -2.52e-01 | 7.77e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.91e-01 | -2.52e-01 | 6.61e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 7 | 2.48e-01 | 2.52e-01 | 7.14e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 9 | 1.91e-01 | -2.52e-01 | 6.61e-01 |
| GOMF RAGE RECEPTOR BINDING | 9 | 1.91e-01 | -2.52e-01 | 6.61e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 7 | 2.49e-01 | 2.52e-01 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 6 | 2.86e-01 | 2.52e-01 | 7.46e-01 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 8 | 2.19e-01 | 2.51e-01 | 6.82e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 7 | 2.50e-01 | -2.51e-01 | 7.16e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 9 | 1.92e-01 | 2.51e-01 | 6.64e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 12 | 1.32e-01 | 2.51e-01 | 5.84e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 10 | 1.69e-01 | -2.51e-01 | 6.33e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 3.31e-01 | -2.51e-01 | 7.78e-01 |
| GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS | 5 | 3.32e-01 | 2.51e-01 | 7.78e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 25 | 3.01e-02 | -2.51e-01 | 3.50e-01 |
| GOBP RIBOSOME ASSEMBLY | 57 | 1.07e-03 | -2.51e-01 | 7.28e-02 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 1.70e-01 | 2.51e-01 | 6.34e-01 |
| GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY | 5 | 3.32e-01 | -2.51e-01 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 8 | 2.20e-01 | 2.51e-01 | 6.82e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 24 | 3.37e-02 | 2.50e-01 | 3.63e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 13 | 1.18e-01 | -2.50e-01 | 5.69e-01 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 5 | 3.33e-01 | 2.50e-01 | 7.78e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 18 | 6.62e-02 | 2.50e-01 | 4.69e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 9 | 1.94e-01 | 2.50e-01 | 6.66e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 14 | 1.05e-01 | 2.50e-01 | 5.43e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 8 | 2.21e-01 | -2.50e-01 | 6.83e-01 |
| GOCC AZUROPHIL GRANULE | 133 | 6.72e-07 | -2.50e-01 | 2.55e-04 |
| GOMF RNA POLYMERASE I ACTIVITY | 9 | 1.94e-01 | -2.50e-01 | 6.66e-01 |
| GOMF HISTONE READER ACTIVITY | 11 | 1.52e-01 | 2.50e-01 | 6.13e-01 |
| GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 5 | 3.34e-01 | -2.50e-01 | 7.80e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 11 | 1.52e-01 | -2.50e-01 | 6.13e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 7 | 2.53e-01 | -2.49e-01 | 7.18e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 1.72e-01 | -2.49e-01 | 6.36e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 22 | 4.31e-02 | -2.49e-01 | 3.91e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 11 | 1.53e-01 | 2.49e-01 | 6.13e-01 |
| GOBP SPERM EGG RECOGNITION | 23 | 3.86e-02 | -2.49e-01 | 3.80e-01 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 9 | 1.96e-01 | 2.49e-01 | 6.67e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 9 | 1.96e-01 | -2.49e-01 | 6.67e-01 |
| GOCC RIBBON SYNAPSE | 9 | 1.96e-01 | -2.49e-01 | 6.67e-01 |
| GOCC LYSOSOMAL LUMEN | 71 | 2.91e-04 | -2.49e-01 | 3.14e-02 |
| GOBP FRUCTOSE METABOLIC PROCESS | 11 | 1.53e-01 | 2.49e-01 | 6.14e-01 |
| GOBP CELL MIGRATION INVOLVED IN GASTRULATION | 5 | 3.36e-01 | 2.49e-01 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 7 | 2.55e-01 | -2.48e-01 | 7.18e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 1.74e-01 | -2.48e-01 | 6.38e-01 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 11 | 1.54e-01 | -2.48e-01 | 6.15e-01 |
| GOBP VOCALIZATION BEHAVIOR | 11 | 1.54e-01 | 2.48e-01 | 6.15e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 7 | 2.56e-01 | -2.48e-01 | 7.18e-01 |
| GOBP CYTOPLASM ORGANIZATION | 12 | 1.37e-01 | 2.48e-01 | 5.93e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 5 | 3.37e-01 | -2.48e-01 | 7.82e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 2.56e-01 | 2.48e-01 | 7.18e-01 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 9 | 1.98e-01 | -2.48e-01 | 6.67e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 15 | 9.66e-02 | -2.48e-01 | 5.26e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 38 | 8.23e-03 | -2.48e-01 | 2.14e-01 |
| GOCC MIB COMPLEX | 13 | 1.22e-01 | -2.48e-01 | 5.71e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 25 | 3.23e-02 | 2.47e-01 | 3.56e-01 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 8 | 2.26e-01 | -2.47e-01 | 6.90e-01 |
| GOCC MSL COMPLEX | 5 | 3.38e-01 | -2.47e-01 | 7.83e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 22 | 4.47e-02 | -2.47e-01 | 3.95e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 10 | 1.76e-01 | 2.47e-01 | 6.39e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 13 | 1.23e-01 | -2.47e-01 | 5.71e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 32 | 1.56e-02 | -2.47e-01 | 2.79e-01 |
| GOBP DEHYDROASCORBIC ACID TRANSPORT | 5 | 3.39e-01 | 2.47e-01 | 7.83e-01 |
| GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.39e-01 | 2.47e-01 | 7.83e-01 |
| GOMF D GLUCOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.39e-01 | 2.47e-01 | 7.83e-01 |
| GOBP BLOOD VESSEL REMODELING | 24 | 3.61e-02 | 2.47e-01 | 3.71e-01 |
| GOBP REGULATION OF LIGASE ACTIVITY | 9 | 1.99e-01 | -2.47e-01 | 6.68e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 20 | 5.58e-02 | 2.47e-01 | 4.34e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 9 | 1.99e-01 | 2.47e-01 | 6.68e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 13 | 1.23e-01 | -2.47e-01 | 5.71e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 20 | 5.61e-02 | 2.47e-01 | 4.36e-01 |
| GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 9 | 2.00e-01 | 2.47e-01 | 6.68e-01 |
| GOBP MALATE METABOLIC PROCESS | 7 | 2.59e-01 | -2.46e-01 | 7.21e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 7 | 2.59e-01 | 2.46e-01 | 7.21e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 13 | 1.24e-01 | -2.46e-01 | 5.72e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 21 | 5.09e-02 | -2.46e-01 | 4.17e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 6 | 2.96e-01 | -2.46e-01 | 7.54e-01 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 18 | 7.09e-02 | 2.46e-01 | 4.78e-01 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 1.58e-01 | -2.46e-01 | 6.19e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 6 | 2.97e-01 | -2.46e-01 | 7.54e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 28 | 2.46e-02 | 2.45e-01 | 3.22e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 70 | 3.92e-04 | -2.45e-01 | 3.71e-02 |
| GOCC CYTOLYTIC GRANULE | 8 | 2.30e-01 | -2.45e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 5 | 3.43e-01 | -2.45e-01 | 7.87e-01 |
| GOBP RESPONSE TO INTERFERON BETA | 26 | 3.07e-02 | -2.45e-01 | 3.50e-01 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 24 | 3.80e-02 | -2.45e-01 | 3.78e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE | 6 | 2.99e-01 | -2.45e-01 | 7.55e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 11 | 1.60e-01 | -2.45e-01 | 6.20e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 15 | 1.01e-01 | 2.45e-01 | 5.35e-01 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 2.31e-01 | -2.45e-01 | 6.94e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 15 | 1.01e-01 | 2.45e-01 | 5.35e-01 |
| GOCC MICROTUBULE PLUS END | 19 | 6.51e-02 | 2.45e-01 | 4.66e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 38 | 9.12e-03 | -2.45e-01 | 2.22e-01 |
| GOCC RSC TYPE COMPLEX | 14 | 1.13e-01 | 2.44e-01 | 5.61e-01 |
| GOBP PLASMINOGEN ACTIVATION | 18 | 7.30e-02 | -2.44e-01 | 4.84e-01 |
| GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.63e-01 | 2.44e-01 | 7.24e-01 |
| GOMF GABA RECEPTOR BINDING | 11 | 1.61e-01 | -2.44e-01 | 6.20e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 20 | 5.90e-02 | 2.44e-01 | 4.45e-01 |
| GOBP KETONE CATABOLIC PROCESS | 10 | 1.82e-01 | -2.44e-01 | 6.50e-01 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 2.64e-01 | 2.44e-01 | 7.24e-01 |
| GOBP LUTEINIZATION | 7 | 2.64e-01 | 2.44e-01 | 7.24e-01 |
| GOMF PROTON CHANNEL ACTIVITY | 20 | 5.92e-02 | -2.44e-01 | 4.45e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 9 | 2.06e-01 | 2.44e-01 | 6.73e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 21 | 5.33e-02 | -2.44e-01 | 4.27e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 3.45e-01 | 2.44e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 3.45e-01 | 2.44e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF TORC2 SIGNALING | 5 | 3.45e-01 | 2.44e-01 | 7.88e-01 |
| GOCC CILIARY TRANSITION FIBER | 7 | 2.64e-01 | 2.44e-01 | 7.25e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 145 | 4.27e-07 | -2.44e-01 | 1.77e-04 |
| GOBP GLYCOLIPID TRANSPORT | 8 | 2.33e-01 | -2.43e-01 | 6.97e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 32 | 1.72e-02 | 2.43e-01 | 2.93e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 9 | 2.07e-01 | 2.43e-01 | 6.74e-01 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 12 | 1.45e-01 | -2.43e-01 | 6.04e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 16 | 9.23e-02 | -2.43e-01 | 5.18e-01 |
| GOBP GENOMIC IMPRINTING | 14 | 1.15e-01 | 2.43e-01 | 5.65e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 10 | 1.83e-01 | -2.43e-01 | 6.51e-01 |
| GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY | 5 | 3.47e-01 | -2.43e-01 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS | 5 | 3.47e-01 | -2.43e-01 | 7.89e-01 |
| GOCC ORIGIN RECOGNITION COMPLEX | 8 | 2.34e-01 | -2.43e-01 | 6.98e-01 |
| GOBP COBALAMIN TRANSPORT | 5 | 3.47e-01 | -2.43e-01 | 7.89e-01 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 8 | 2.35e-01 | 2.43e-01 | 6.98e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 87 | 9.26e-05 | -2.43e-01 | 1.32e-02 |
| GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY | 6 | 3.03e-01 | 2.43e-01 | 7.59e-01 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 3.48e-01 | 2.43e-01 | 7.89e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 19 | 6.75e-02 | -2.42e-01 | 4.72e-01 |
| GOCC A BAND | 21 | 5.47e-02 | 2.42e-01 | 4.31e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 18 | 7.53e-02 | -2.42e-01 | 4.89e-01 |
| GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 3.48e-01 | 2.42e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 14 | 1.17e-01 | -2.42e-01 | 5.67e-01 |
| GOCC GID COMPLEX | 5 | 3.49e-01 | 2.42e-01 | 7.90e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 102 | 2.45e-05 | -2.42e-01 | 4.22e-03 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 10 | 1.85e-01 | 2.42e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 10 | 1.86e-01 | -2.42e-01 | 6.54e-01 |
| GOBP RESPONSE TO FUNGUS | 34 | 1.48e-02 | -2.42e-01 | 2.72e-01 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 2.09e-01 | 2.42e-01 | 6.75e-01 |
| GOCC CALYX OF HELD | 9 | 2.10e-01 | -2.41e-01 | 6.75e-01 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 8 | 2.37e-01 | 2.41e-01 | 7.01e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 39 | 9.16e-03 | -2.41e-01 | 2.22e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 22 | 5.03e-02 | -2.41e-01 | 4.15e-01 |
| GOBP MDA 5 SIGNALING PATHWAY | 10 | 1.87e-01 | -2.41e-01 | 6.56e-01 |
| GOBP NEUROTRANSMITTER METABOLIC PROCESS | 12 | 1.49e-01 | -2.41e-01 | 6.08e-01 |
| GOBP LYSOSOMAL MICROAUTOPHAGY | 13 | 1.33e-01 | 2.41e-01 | 5.86e-01 |
| GOBP REGULATION OF PROTON TRANSPORT | 13 | 1.33e-01 | -2.41e-01 | 5.86e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 6 | 3.08e-01 | 2.41e-01 | 7.62e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 10 | 1.88e-01 | -2.41e-01 | 6.57e-01 |
| GOMF DNA HELICASE ACTIVITY | 55 | 2.04e-03 | 2.41e-01 | 1.04e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 19 | 6.97e-02 | -2.40e-01 | 4.77e-01 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 6 | 3.08e-01 | -2.40e-01 | 7.62e-01 |
| GOBP LACTATE METABOLIC PROCESS | 13 | 1.34e-01 | -2.40e-01 | 5.86e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 2.71e-01 | -2.40e-01 | 7.33e-01 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 16 | 9.63e-02 | 2.40e-01 | 5.26e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 9 | 2.12e-01 | -2.40e-01 | 6.77e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 9 | 2.12e-01 | 2.40e-01 | 6.77e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 12 | 1.50e-01 | 2.40e-01 | 6.11e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 3.53e-01 | -2.40e-01 | 7.92e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 2.31e-02 | -2.40e-01 | 3.18e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 25 | 3.80e-02 | 2.40e-01 | 3.78e-01 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 46 | 4.92e-03 | -2.40e-01 | 1.67e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 8 | 2.40e-01 | 2.40e-01 | 7.05e-01 |
| GOMF LIPOPEPTIDE BINDING | 7 | 2.72e-01 | 2.40e-01 | 7.35e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 48 | 4.11e-03 | 2.40e-01 | 1.53e-01 |
| GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 3.54e-01 | 2.39e-01 | 7.92e-01 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 2.73e-01 | -2.39e-01 | 7.36e-01 |
| GOBP HEART VALVE DEVELOPMENT | 42 | 7.34e-03 | 2.39e-01 | 2.03e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 9 | 2.14e-01 | 2.39e-01 | 6.79e-01 |
| GOBP MITOCHONDRIAL TRANSLATION | 128 | 3.10e-06 | -2.39e-01 | 8.72e-04 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 7 | 2.74e-01 | -2.39e-01 | 7.36e-01 |
| GOBP FORELIMB MORPHOGENESIS | 17 | 8.84e-02 | 2.39e-01 | 5.10e-01 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 8 | 2.42e-01 | 2.39e-01 | 7.08e-01 |
| GOCC CONE PHOTORECEPTOR OUTER SEGMENT | 5 | 3.56e-01 | 2.38e-01 | 7.92e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 3.56e-01 | -2.38e-01 | 7.92e-01 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 31 | 2.16e-02 | -2.38e-01 | 3.12e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 17 | 8.90e-02 | -2.38e-01 | 5.12e-01 |
| GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 7 | 2.75e-01 | 2.38e-01 | 7.38e-01 |
| GOCC COSTAMERE | 14 | 1.23e-01 | 2.38e-01 | 5.71e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 9 | 2.16e-01 | 2.38e-01 | 6.80e-01 |
| GOMF OXYSTEROL BINDING | 7 | 2.76e-01 | 2.38e-01 | 7.38e-01 |
| GOBP LIPID EXPORT FROM CELL | 28 | 2.93e-02 | 2.38e-01 | 3.46e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 6 | 3.13e-01 | -2.38e-01 | 7.66e-01 |
| GOBP GENITALIA MORPHOGENESIS | 5 | 3.57e-01 | 2.38e-01 | 7.92e-01 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 2.76e-01 | -2.38e-01 | 7.38e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 45 | 5.80e-03 | 2.38e-01 | 1.81e-01 |
| GOCC LUMENAL SIDE OF MEMBRANE | 33 | 1.82e-02 | -2.38e-01 | 2.95e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 10 | 1.93e-01 | -2.38e-01 | 6.65e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 13 | 1.38e-01 | -2.38e-01 | 5.95e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 17 | 9.00e-02 | -2.38e-01 | 5.13e-01 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 5 | 3.58e-01 | 2.38e-01 | 7.92e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 2.77e-01 | 2.37e-01 | 7.38e-01 |
| GOMF PEPTIDE HORMONE RECEPTOR BINDING | 6 | 3.14e-01 | 2.37e-01 | 7.66e-01 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 59 | 1.62e-03 | -2.37e-01 | 9.00e-02 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 13 | 1.38e-01 | 2.37e-01 | 5.96e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 7.34e-02 | 2.37e-01 | 4.84e-01 |
| GOCC PEPTIDASE COMPLEX | 106 | 2.47e-05 | -2.37e-01 | 4.22e-03 |
| GOBP MYOBLAST DIFFERENTIATION | 73 | 4.63e-04 | 2.37e-01 | 4.00e-02 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 284 | 6.87e-12 | -2.37e-01 | 7.49e-09 |
| GOBP OSTEOBLAST DEVELOPMENT | 9 | 2.18e-01 | 2.37e-01 | 6.82e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 15 | 1.12e-01 | 2.37e-01 | 5.57e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 11 | 1.73e-01 | 2.37e-01 | 6.38e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS | 5 | 3.59e-01 | -2.37e-01 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 8 | 2.46e-01 | -2.37e-01 | 7.10e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 12 | 1.55e-01 | 2.37e-01 | 6.19e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 7 | 2.78e-01 | 2.37e-01 | 7.39e-01 |
| GOBP HEART FORMATION | 15 | 1.13e-01 | 2.37e-01 | 5.58e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 33 | 1.86e-02 | -2.37e-01 | 2.95e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 11 | 1.74e-01 | -2.37e-01 | 6.38e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 16 | 1.02e-01 | 2.36e-01 | 5.36e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 14 | 1.26e-01 | 2.36e-01 | 5.75e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 11 | 1.75e-01 | 2.36e-01 | 6.38e-01 |
| GOBP B CELL CHEMOTAXIS | 5 | 3.60e-01 | -2.36e-01 | 7.94e-01 |
| GOBP ERBB2 EGFR SIGNALING PATHWAY | 5 | 3.60e-01 | 2.36e-01 | 7.94e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 8 | 2.47e-01 | -2.36e-01 | 7.12e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 14 | 1.26e-01 | 2.36e-01 | 5.75e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 2.79e-01 | 2.36e-01 | 7.39e-01 |
| GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.47e-01 | 2.36e-01 | 7.13e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 2.20e-01 | 2.36e-01 | 6.82e-01 |
| GOBP NUCLEOTIDE SALVAGE | 17 | 9.23e-02 | -2.36e-01 | 5.18e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 43 | 7.48e-03 | -2.36e-01 | 2.04e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 11 | 1.76e-01 | -2.36e-01 | 6.40e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 12 | 1.58e-01 | 2.35e-01 | 6.19e-01 |
| GOBP GERM CELL PROLIFERATION | 9 | 2.21e-01 | -2.35e-01 | 6.84e-01 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 52 | 3.37e-03 | -2.35e-01 | 1.39e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 13 | 1.42e-01 | -2.35e-01 | 6.00e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 13 | 1.42e-01 | -2.35e-01 | 6.00e-01 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 9 | 2.22e-01 | -2.35e-01 | 6.85e-01 |
| GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 5 | 3.63e-01 | 2.35e-01 | 7.97e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 16 | 1.04e-01 | -2.35e-01 | 5.41e-01 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 2.50e-01 | -2.35e-01 | 7.16e-01 |
| GOBP DETECTION OF CELL DENSITY | 6 | 3.19e-01 | -2.35e-01 | 7.67e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 10 | 1.99e-01 | -2.35e-01 | 6.68e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 43 | 7.75e-03 | -2.35e-01 | 2.08e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 46 | 5.91e-03 | -2.35e-01 | 1.81e-01 |
| GOMF RNA STEM LOOP BINDING | 15 | 1.16e-01 | 2.35e-01 | 5.65e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 10 | 1.99e-01 | 2.34e-01 | 6.68e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 20 | 6.98e-02 | 2.34e-01 | 4.77e-01 |
| GOBP LEUKOCYTE AGGREGATION | 10 | 2.00e-01 | -2.34e-01 | 6.68e-01 |
| GOMF INSULIN BINDING | 5 | 3.65e-01 | 2.34e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 25 | 4.31e-02 | 2.34e-01 | 3.91e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 6 | 3.22e-01 | -2.34e-01 | 7.70e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 12 | 1.61e-01 | 2.34e-01 | 6.20e-01 |
| GOCC TERTIARY GRANULE | 134 | 3.09e-06 | -2.34e-01 | 8.72e-04 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 6 | 3.22e-01 | -2.34e-01 | 7.70e-01 |
| GOMF PROTEIN PHOSPHATASE 2B BINDING | 5 | 3.66e-01 | -2.33e-01 | 7.99e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 19 | 7.81e-02 | -2.33e-01 | 4.96e-01 |
| GOBP AORTA MORPHOGENESIS | 19 | 7.86e-02 | 2.33e-01 | 4.96e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 19 | 7.87e-02 | 2.33e-01 | 4.96e-01 |
| GOBP REGULATION OF DNA METHYLATION | 13 | 1.46e-01 | 2.33e-01 | 6.06e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 10 | 2.02e-01 | -2.33e-01 | 6.69e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 27 | 3.63e-02 | -2.33e-01 | 3.71e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 6 | 3.24e-01 | -2.32e-01 | 7.72e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 21 | 6.53e-02 | -2.32e-01 | 4.66e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 5 | 3.68e-01 | 2.32e-01 | 8.01e-01 |
| GOBP REGULATION OF URINE VOLUME | 10 | 2.03e-01 | 2.32e-01 | 6.72e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 29 | 3.05e-02 | 2.32e-01 | 3.50e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 31 | 2.53e-02 | 2.32e-01 | 3.23e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 1.33e-01 | -2.32e-01 | 5.85e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 13 | 1.48e-01 | -2.32e-01 | 6.07e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 13 | 1.48e-01 | -2.32e-01 | 6.07e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 11 | 1.83e-01 | -2.32e-01 | 6.51e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING | 8 | 2.56e-01 | 2.32e-01 | 7.19e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 10 | 2.05e-01 | 2.32e-01 | 6.72e-01 |
| GOBP GOLGI RIBBON FORMATION | 9 | 2.29e-01 | 2.32e-01 | 6.91e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 3.70e-01 | -2.32e-01 | 8.02e-01 |
| GOBP RNA 5 END PROCESSING | 22 | 6.02e-02 | -2.32e-01 | 4.47e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 7 | 2.89e-01 | 2.32e-01 | 7.49e-01 |
| GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY | 5 | 3.70e-01 | 2.31e-01 | 8.02e-01 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 11 | 1.84e-01 | -2.31e-01 | 6.52e-01 |
| GOBP LEUCINE TRANSPORT | 8 | 2.57e-01 | -2.31e-01 | 7.21e-01 |
| GOBP RESPONSE TO COPPER ION | 26 | 4.14e-02 | 2.31e-01 | 3.86e-01 |
| GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 3.71e-01 | -2.31e-01 | 8.02e-01 |
| GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 6 | 3.27e-01 | -2.31e-01 | 7.75e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 9 | 2.30e-01 | -2.31e-01 | 6.93e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 21 | 6.69e-02 | 2.31e-01 | 4.70e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 8.97e-02 | 2.31e-01 | 5.12e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 1.85e-01 | 2.31e-01 | 6.53e-01 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 73 | 6.52e-04 | -2.31e-01 | 4.99e-02 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 7 | 2.90e-01 | 2.31e-01 | 7.49e-01 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 7 | 2.90e-01 | -2.31e-01 | 7.49e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 14 | 1.35e-01 | -2.31e-01 | 5.90e-01 |
| GOCC ASTER | 8 | 2.59e-01 | 2.31e-01 | 7.21e-01 |
| GOCC CHROMAFFIN GRANULE | 9 | 2.31e-01 | 2.31e-01 | 6.94e-01 |
| GOBP CAMP METABOLIC PROCESS | 15 | 1.22e-01 | 2.31e-01 | 5.71e-01 |
| GOBP RESPONSE TO ZINC ION | 34 | 2.01e-02 | 2.30e-01 | 3.02e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 13 | 1.50e-01 | -2.30e-01 | 6.12e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 5 | 3.73e-01 | 2.30e-01 | 8.04e-01 |
| GOCC SEPTIN CYTOSKELETON | 13 | 1.51e-01 | -2.30e-01 | 6.12e-01 |
| GOBP SPERM CAPACITATION | 10 | 2.08e-01 | 2.30e-01 | 6.74e-01 |
| GOCC AZUROPHIL GRANULE LUMEN | 76 | 5.30e-04 | -2.30e-01 | 4.32e-02 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 3.30e-01 | -2.30e-01 | 7.77e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 97 | 9.26e-05 | -2.30e-01 | 1.32e-02 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 1.68e-01 | 2.30e-01 | 6.32e-01 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 6 | 3.30e-01 | 2.29e-01 | 7.78e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 3.30e-01 | 2.29e-01 | 7.78e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 28 | 3.57e-02 | 2.29e-01 | 3.68e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 9 | 2.34e-01 | 2.29e-01 | 6.97e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 12 | 1.69e-01 | 2.29e-01 | 6.33e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 1.69e-01 | 2.29e-01 | 6.33e-01 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 6 | 3.31e-01 | 2.29e-01 | 7.78e-01 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 15 | 1.24e-01 | 2.29e-01 | 5.72e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 8 | 2.62e-01 | -2.29e-01 | 7.24e-01 |
| GOBP OVULATION CYCLE | 37 | 1.60e-02 | 2.29e-01 | 2.82e-01 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 6 | 3.32e-01 | -2.29e-01 | 7.78e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 9 | 2.34e-01 | -2.29e-01 | 6.98e-01 |
| GOBP RESPONSE TO COBALT ION | 10 | 2.11e-01 | 2.29e-01 | 6.75e-01 |
| GOBP KETONE BODY METABOLIC PROCESS | 6 | 3.32e-01 | -2.29e-01 | 7.78e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 9 | 2.35e-01 | 2.28e-01 | 6.99e-01 |
| GOMF NOTCH BINDING | 18 | 9.35e-02 | 2.28e-01 | 5.21e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 7 | 2.96e-01 | 2.28e-01 | 7.54e-01 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 6 | 3.33e-01 | -2.28e-01 | 7.78e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 1.26e-01 | 2.28e-01 | 5.75e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 1.72e-01 | 2.28e-01 | 6.36e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 116 | 2.29e-05 | -2.28e-01 | 4.22e-03 |
| GOBP DENDRITIC TRANSPORT | 10 | 2.13e-01 | 2.28e-01 | 6.77e-01 |
| GOBP L PHENYLALANINE METABOLIC PROCESS | 5 | 3.78e-01 | -2.28e-01 | 8.05e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 23 | 5.89e-02 | -2.28e-01 | 4.45e-01 |
| GOCC HEMIDESMOSOME | 6 | 3.34e-01 | -2.28e-01 | 7.80e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 29 | 3.39e-02 | -2.28e-01 | 3.63e-01 |
| GOBP HEXOSE PHOSPHATE TRANSPORT | 5 | 3.78e-01 | 2.28e-01 | 8.05e-01 |
| GOBP EXCRETION | 10 | 2.13e-01 | 2.27e-01 | 6.79e-01 |
| GOCC SERINE TYPE PEPTIDASE COMPLEX | 6 | 3.35e-01 | -2.27e-01 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 7 | 2.98e-01 | -2.27e-01 | 7.55e-01 |
| GOMF WW DOMAIN BINDING | 16 | 1.16e-01 | 2.27e-01 | 5.65e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 12 | 1.74e-01 | -2.27e-01 | 6.38e-01 |
| GOBP RESPONSE TO VITAMIN E | 5 | 3.80e-01 | 2.27e-01 | 8.07e-01 |
| GOMF AMINO ACID BINDING | 28 | 3.79e-02 | 2.27e-01 | 3.78e-01 |
| GOBP INNATE IMMUNE RESPONSE IN MUCOSA | 5 | 3.80e-01 | -2.27e-01 | 8.07e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 12 | 1.74e-01 | -2.27e-01 | 6.38e-01 |
| GOBP NEUROBLAST PROLIFERATION | 36 | 1.88e-02 | 2.26e-01 | 2.95e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 12 | 1.75e-01 | 2.26e-01 | 6.38e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 6 | 3.37e-01 | 2.26e-01 | 7.83e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR BINDING | 5 | 3.81e-01 | 2.26e-01 | 8.07e-01 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 7 | 3.00e-01 | -2.26e-01 | 7.56e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 13 | 1.58e-01 | 2.26e-01 | 6.19e-01 |
| GOBP RESPONSE TO NEMATODE | 5 | 3.81e-01 | 2.26e-01 | 8.07e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 45 | 8.82e-03 | 2.26e-01 | 2.19e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 1.30e-01 | -2.26e-01 | 5.82e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 7 | 3.01e-01 | 2.26e-01 | 7.56e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 26 | 4.65e-02 | -2.26e-01 | 4.03e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 7 | 3.02e-01 | -2.25e-01 | 7.57e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 11 | 1.96e-01 | -2.25e-01 | 6.67e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL BUD | 5 | 3.83e-01 | 2.25e-01 | 8.09e-01 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 23 | 6.16e-02 | -2.25e-01 | 4.51e-01 |
| GOBP PROTEIN REFOLDING | 22 | 6.75e-02 | -2.25e-01 | 4.72e-01 |
| GOBP RESPONSE TO L ASCORBIC ACID | 5 | 3.83e-01 | 2.25e-01 | 8.09e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 16 | 1.19e-01 | -2.25e-01 | 5.69e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 35 | 2.13e-02 | -2.25e-01 | 3.09e-01 |
| GOBP TRNA 5 LEADER REMOVAL | 13 | 1.61e-01 | -2.25e-01 | 6.20e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 11 | 1.97e-01 | 2.25e-01 | 6.67e-01 |
| GOBP SCARNA LOCALIZATION TO CAJAL BODY | 5 | 3.84e-01 | -2.25e-01 | 8.09e-01 |
| GOBP INTESTINAL ABSORPTION | 22 | 6.84e-02 | 2.24e-01 | 4.74e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 9 | 2.44e-01 | 2.24e-01 | 7.08e-01 |
| GOBP PANCREATIC JUICE SECRETION | 5 | 3.85e-01 | 2.24e-01 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 16 | 1.20e-01 | -2.24e-01 | 5.70e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 7 | 3.04e-01 | 2.24e-01 | 7.59e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.04e-01 | 2.24e-01 | 7.59e-01 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 9 | 2.44e-01 | -2.24e-01 | 7.08e-01 |
| GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 6 | 3.41e-01 | -2.24e-01 | 7.85e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 9 | 2.44e-01 | -2.24e-01 | 7.08e-01 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 10 | 2.20e-01 | -2.24e-01 | 6.82e-01 |
| GOCC METHYLOSOME | 12 | 1.79e-01 | -2.24e-01 | 6.45e-01 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 3.86e-01 | 2.24e-01 | 8.09e-01 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 7 | 3.05e-01 | 2.24e-01 | 7.60e-01 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 11 | 1.99e-01 | -2.24e-01 | 6.68e-01 |
| GOBP ESTABLISHMENT OF SERTOLI CELL BARRIER | 5 | 3.86e-01 | -2.24e-01 | 8.10e-01 |
| GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 7 | 3.06e-01 | 2.24e-01 | 7.61e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 19 | 9.22e-02 | -2.23e-01 | 5.18e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 29 | 3.76e-02 | -2.23e-01 | 3.78e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 8 | 2.75e-01 | -2.23e-01 | 7.38e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 15 | 1.36e-01 | 2.23e-01 | 5.90e-01 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 11 | 2.01e-01 | -2.22e-01 | 6.69e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 9 | 2.48e-01 | -2.22e-01 | 7.14e-01 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 5 | 3.89e-01 | -2.22e-01 | 8.11e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 23 | 6.51e-02 | -2.22e-01 | 4.66e-01 |
| GOMF NF KAPPAB BINDING | 28 | 4.18e-02 | -2.22e-01 | 3.86e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.76e-01 | -2.22e-01 | 7.38e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 31 | 3.24e-02 | -2.22e-01 | 3.56e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 25 | 5.46e-02 | 2.22e-01 | 4.31e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 3.90e-01 | -2.22e-01 | 8.11e-01 |
| GOBP MIRNA CATABOLIC PROCESS | 16 | 1.24e-01 | 2.22e-01 | 5.72e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 11 | 2.02e-01 | -2.22e-01 | 6.69e-01 |
| GOBP IRIS MORPHOGENESIS | 5 | 3.90e-01 | -2.22e-01 | 8.11e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 25 | 5.47e-02 | -2.22e-01 | 4.31e-01 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 19 | 9.39e-02 | -2.22e-01 | 5.21e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 11 | 2.02e-01 | 2.22e-01 | 6.69e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 12 | 1.83e-01 | -2.22e-01 | 6.51e-01 |
| GOMF CHONDROITIN SULFATE BINDING | 7 | 3.10e-01 | -2.22e-01 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 8 | 2.78e-01 | -2.22e-01 | 7.38e-01 |
| GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 3.91e-01 | -2.22e-01 | 8.11e-01 |
| GOCC VACUOLAR LUMEN | 134 | 1.01e-05 | -2.21e-01 | 2.44e-03 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 11 | 2.04e-01 | 2.21e-01 | 6.72e-01 |
| GOBP MANNOSYLATION | 20 | 8.70e-02 | 2.21e-01 | 5.09e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 31 | 3.33e-02 | -2.21e-01 | 3.61e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 18 | 1.05e-01 | 2.21e-01 | 5.42e-01 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 20 | 8.73e-02 | 2.21e-01 | 5.10e-01 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 6 | 3.50e-01 | -2.21e-01 | 7.90e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 10 | 2.27e-01 | -2.20e-01 | 6.91e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 10 | 2.28e-01 | 2.20e-01 | 6.91e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 13 | 1.69e-01 | 2.20e-01 | 6.33e-01 |
| GOBP RESPONSE TO INDOLE 3 METHANOL | 6 | 3.51e-01 | 2.20e-01 | 7.90e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 2.54e-01 | -2.20e-01 | 7.18e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 8 | 2.82e-01 | -2.20e-01 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 25 | 5.76e-02 | -2.19e-01 | 4.43e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 8 | 2.83e-01 | 2.19e-01 | 7.42e-01 |
| GOBP DETECTION OF VIRUS | 5 | 3.96e-01 | 2.19e-01 | 8.14e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 6 | 3.52e-01 | -2.19e-01 | 7.91e-01 |
| GOCC LSM2 8 COMPLEX | 7 | 3.15e-01 | -2.19e-01 | 7.66e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 1.71e-01 | -2.19e-01 | 6.36e-01 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 33 | 2.95e-02 | 2.19e-01 | 3.46e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 3.16e-01 | -2.19e-01 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 3.16e-01 | 2.19e-01 | 7.66e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 40 | 1.66e-02 | 2.19e-01 | 2.87e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 12 | 1.89e-01 | -2.19e-01 | 6.61e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 9 | 2.56e-01 | 2.19e-01 | 7.18e-01 |
| GOBP SYNAPSE MATURATION | 17 | 1.19e-01 | 2.19e-01 | 5.69e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 23 | 6.95e-02 | 2.19e-01 | 4.77e-01 |
| GOBP REGULATION OF HEART GROWTH | 31 | 3.53e-02 | 2.19e-01 | 3.68e-01 |
| GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 5 | 3.98e-01 | -2.18e-01 | 8.15e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 13 | 1.73e-01 | -2.18e-01 | 6.37e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 29 | 4.21e-02 | 2.18e-01 | 3.87e-01 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 11 | 2.10e-01 | 2.18e-01 | 6.75e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 31 | 3.56e-02 | 2.18e-01 | 3.68e-01 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 2.85e-01 | -2.18e-01 | 7.45e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 7 | 3.18e-01 | -2.18e-01 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION | 6 | 3.55e-01 | 2.18e-01 | 7.92e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 10 | 2.33e-01 | 2.18e-01 | 6.97e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 12 | 1.91e-01 | 2.18e-01 | 6.62e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 57 | 4.48e-03 | 2.18e-01 | 1.58e-01 |
| GOMF ALPHA CATENIN BINDING | 5 | 3.99e-01 | -2.18e-01 | 8.15e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 14 | 1.59e-01 | -2.18e-01 | 6.19e-01 |
| GOCC OXIDOREDUCTASE COMPLEX | 111 | 7.58e-05 | -2.18e-01 | 1.16e-02 |
| GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 11 | 2.12e-01 | -2.18e-01 | 6.77e-01 |
| GOBP PROSTHETIC GROUP METABOLIC PROCESS | 5 | 4.00e-01 | 2.17e-01 | 8.15e-01 |
| GOMF PRE MRNA 3 SPLICE SITE BINDING | 5 | 4.00e-01 | -2.17e-01 | 8.15e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 13 | 1.75e-01 | -2.17e-01 | 6.38e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 17 | 1.21e-01 | -2.17e-01 | 5.70e-01 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 9 | 2.59e-01 | -2.17e-01 | 7.21e-01 |
| GOBP GLUTAMATE SECRETION | 14 | 1.59e-01 | -2.17e-01 | 6.19e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 26 | 5.53e-02 | 2.17e-01 | 4.33e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 12 | 1.93e-01 | 2.17e-01 | 6.64e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 14 | 1.60e-01 | 2.17e-01 | 6.20e-01 |
| GOBP RESPONSE TO LEAD ION | 16 | 1.33e-01 | -2.17e-01 | 5.85e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 14 | 1.60e-01 | -2.17e-01 | 6.20e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 23 | 7.16e-02 | -2.17e-01 | 4.79e-01 |
| GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 6 | 3.58e-01 | -2.17e-01 | 7.92e-01 |
| GOBP NEGATIVE T CELL SELECTION | 6 | 3.58e-01 | -2.17e-01 | 7.92e-01 |
| GOMF SUMO BINDING | 17 | 1.22e-01 | 2.17e-01 | 5.71e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 13 | 1.76e-01 | 2.17e-01 | 6.40e-01 |
| GOBP SELF PROTEOLYSIS | 8 | 2.89e-01 | -2.17e-01 | 7.49e-01 |
| GOBP ADP TRANSPORT | 10 | 2.36e-01 | -2.16e-01 | 7.00e-01 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 59 | 4.05e-03 | 2.16e-01 | 1.52e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 29 | 4.38e-02 | 2.16e-01 | 3.92e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 17 | 1.23e-01 | 2.16e-01 | 5.71e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 9 | 2.61e-01 | -2.16e-01 | 7.23e-01 |
| GOCC BRAHMA COMPLEX | 12 | 1.95e-01 | 2.16e-01 | 6.66e-01 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 10 | 2.36e-01 | -2.16e-01 | 7.00e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 8 | 2.90e-01 | -2.16e-01 | 7.49e-01 |
| GOBP PROSTAGLANDIN SECRETION | 12 | 1.95e-01 | 2.16e-01 | 6.66e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 6 | 3.59e-01 | -2.16e-01 | 7.94e-01 |
| GOBP PRIMITIVE HEMOPOIESIS | 6 | 3.60e-01 | 2.16e-01 | 7.94e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 2.63e-01 | -2.16e-01 | 7.24e-01 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 51 | 7.83e-03 | -2.15e-01 | 2.09e-01 |
| GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 45 | 1.25e-02 | 2.15e-01 | 2.53e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 7 | 3.24e-01 | 2.15e-01 | 7.72e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 7 | 3.24e-01 | -2.15e-01 | 7.72e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 16 | 1.36e-01 | 2.15e-01 | 5.91e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 9 | 2.64e-01 | 2.15e-01 | 7.24e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 9 | 2.64e-01 | -2.15e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 12 | 1.97e-01 | -2.15e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 8 | 2.93e-01 | 2.15e-01 | 7.52e-01 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 5 | 4.06e-01 | -2.15e-01 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 7 | 3.25e-01 | -2.15e-01 | 7.73e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 19 | 1.05e-01 | 2.15e-01 | 5.43e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 8 | 2.93e-01 | 2.15e-01 | 7.52e-01 |
| GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT | 5 | 4.06e-01 | -2.14e-01 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 20 | 9.69e-02 | -2.14e-01 | 5.26e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 11 | 2.18e-01 | -2.14e-01 | 6.82e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 3.64e-01 | -2.14e-01 | 7.97e-01 |
| GOBP FUCOSYLATION | 11 | 2.19e-01 | 2.14e-01 | 6.82e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 12 | 1.99e-01 | 2.14e-01 | 6.68e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 33 | 3.36e-02 | 2.14e-01 | 3.62e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 71 | 1.85e-03 | -2.14e-01 | 9.84e-02 |
| GOBP PROTEIN NEDDYLATION | 27 | 5.46e-02 | -2.14e-01 | 4.31e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 11 | 2.20e-01 | -2.14e-01 | 6.82e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 27 | 5.47e-02 | 2.14e-01 | 4.31e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 27 | 5.47e-02 | -2.14e-01 | 4.31e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 4.08e-01 | -2.13e-01 | 8.19e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 9 | 2.68e-01 | 2.13e-01 | 7.29e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 14 | 1.67e-01 | 2.13e-01 | 6.29e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 69 | 2.21e-03 | 2.13e-01 | 1.09e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 12 | 2.01e-01 | 2.13e-01 | 6.68e-01 |
| GOBP RESPONSE TO LITHIUM ION | 9 | 2.68e-01 | -2.13e-01 | 7.30e-01 |
| GOBP BLASTOCYST FORMATION | 34 | 3.15e-02 | 2.13e-01 | 3.52e-01 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 7 | 3.29e-01 | 2.13e-01 | 7.77e-01 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 7 | 3.29e-01 | -2.13e-01 | 7.77e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 25 | 6.53e-02 | 2.13e-01 | 4.66e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 8 | 2.97e-01 | 2.13e-01 | 7.54e-01 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 7 | 3.30e-01 | -2.13e-01 | 7.78e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 84 | 7.60e-04 | 2.13e-01 | 5.57e-02 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 5 | 4.11e-01 | -2.12e-01 | 8.19e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 64 | 3.34e-03 | -2.12e-01 | 1.39e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 29 | 4.80e-02 | -2.12e-01 | 4.06e-01 |
| GOBP SPERMIDINE METABOLIC PROCESS | 8 | 2.99e-01 | -2.12e-01 | 7.55e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 5 | 4.12e-01 | 2.12e-01 | 8.19e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 11 | 2.24e-01 | 2.12e-01 | 6.87e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 3.32e-01 | -2.12e-01 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 7 | 3.32e-01 | -2.12e-01 | 7.78e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 14 | 1.71e-01 | -2.12e-01 | 6.35e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 27 | 5.75e-02 | -2.11e-01 | 4.43e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 14 | 1.71e-01 | -2.11e-01 | 6.36e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 18 | 1.21e-01 | -2.11e-01 | 5.70e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 104 | 2.06e-04 | -2.11e-01 | 2.46e-02 |
| GOBP RESPONSE TO ACETYLCHOLINE | 18 | 1.22e-01 | -2.11e-01 | 5.71e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 9 | 2.74e-01 | -2.11e-01 | 7.36e-01 |
| GOBP PUTRESCINE BIOSYNTHETIC PROCESS | 5 | 4.15e-01 | 2.11e-01 | 8.21e-01 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 35 | 3.12e-02 | -2.10e-01 | 3.52e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 34 | 3.38e-02 | 2.10e-01 | 3.63e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 30 | 4.62e-02 | 2.10e-01 | 4.01e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 12 | 2.07e-01 | -2.10e-01 | 6.74e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 49 | 1.09e-02 | -2.10e-01 | 2.43e-01 |
| GOBP DENDRITE SELF AVOIDANCE | 7 | 3.35e-01 | 2.10e-01 | 7.81e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 10 | 2.50e-01 | -2.10e-01 | 7.16e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 23 | 8.10e-02 | 2.10e-01 | 4.99e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 11 | 2.28e-01 | 2.10e-01 | 6.91e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 27 | 5.90e-02 | -2.10e-01 | 4.45e-01 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 8 | 3.04e-01 | 2.10e-01 | 7.59e-01 |
| GOBP FIBROBLAST ACTIVATION | 11 | 2.28e-01 | 2.10e-01 | 6.91e-01 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 42 | 1.87e-02 | -2.10e-01 | 2.95e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 18 | 1.24e-01 | 2.10e-01 | 5.72e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN VENTRAL SPINAL CORD PATTERNING | 5 | 4.17e-01 | 2.10e-01 | 8.22e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 3.37e-01 | 2.10e-01 | 7.82e-01 |
| GOBP MANGANESE ION TRANSPORT | 9 | 2.76e-01 | 2.10e-01 | 7.38e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 21 | 9.66e-02 | -2.10e-01 | 5.26e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 29 | 5.10e-02 | -2.09e-01 | 4.17e-01 |
| GOBP RESPONSE TO SORBITOL | 6 | 3.75e-01 | 2.09e-01 | 8.05e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 25 | 7.01e-02 | 2.09e-01 | 4.77e-01 |
| GOBP ERYTHROCYTE MATURATION | 12 | 2.09e-01 | 2.09e-01 | 6.75e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 17 | 1.35e-01 | -2.09e-01 | 5.90e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 8 | 3.05e-01 | 2.09e-01 | 7.60e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 6 | 3.75e-01 | 2.09e-01 | 8.05e-01 |
| GOBP PROTEIN AUTOPROCESSING | 18 | 1.24e-01 | -2.09e-01 | 5.72e-01 |
| GOBP ZINC ION TRANSPORT | 20 | 1.05e-01 | 2.09e-01 | 5.43e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY | 5 | 4.18e-01 | 2.09e-01 | 8.22e-01 |
| GOCC PRONUCLEUS | 12 | 2.10e-01 | -2.09e-01 | 6.75e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 8 | 3.06e-01 | -2.09e-01 | 7.61e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 14 | 1.76e-01 | 2.09e-01 | 6.40e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 10 | 2.53e-01 | -2.09e-01 | 7.18e-01 |
| GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 4.19e-01 | -2.09e-01 | 8.23e-01 |
| GOBP SEROTONIN TRANSPORT | 9 | 2.78e-01 | -2.09e-01 | 7.39e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 14 | 1.77e-01 | 2.09e-01 | 6.40e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 24 | 7.70e-02 | -2.09e-01 | 4.94e-01 |
| GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 6 | 3.76e-01 | 2.09e-01 | 8.05e-01 |
| GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL | 5 | 4.20e-01 | 2.08e-01 | 8.23e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 3.07e-01 | -2.08e-01 | 7.62e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 30 | 4.83e-02 | 2.08e-01 | 4.08e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 6 | 3.77e-01 | 2.08e-01 | 8.05e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 15 | 1.63e-01 | -2.08e-01 | 6.24e-01 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 13 | 1.94e-01 | -2.08e-01 | 6.66e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 24 | 7.79e-02 | -2.08e-01 | 4.96e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 7 | 3.41e-01 | 2.08e-01 | 7.85e-01 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 25 | 7.22e-02 | -2.08e-01 | 4.81e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 6 | 3.78e-01 | -2.08e-01 | 8.05e-01 |
| GOMF UBIQUINONE BINDING | 6 | 3.78e-01 | -2.08e-01 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 24 | 7.85e-02 | -2.08e-01 | 4.96e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 2.56e-01 | -2.08e-01 | 7.18e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 6 | 3.79e-01 | -2.07e-01 | 8.05e-01 |
| GOBP ICOSANOID SECRETION | 19 | 1.18e-01 | 2.07e-01 | 5.68e-01 |
| GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 9 | 2.81e-01 | 2.07e-01 | 7.42e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 13 | 1.96e-01 | 2.07e-01 | 6.67e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 7 | 3.42e-01 | -2.07e-01 | 7.87e-01 |
| GOBP STRIATUM DEVELOPMENT | 15 | 1.65e-01 | -2.07e-01 | 6.26e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 11 | 2.34e-01 | -2.07e-01 | 6.98e-01 |
| GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 7 | 3.43e-01 | 2.07e-01 | 7.87e-01 |
| GOCC PRERIBOSOME | 103 | 2.87e-04 | -2.07e-01 | 3.12e-02 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 25 | 7.33e-02 | 2.07e-01 | 4.84e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 52 | 9.86e-03 | -2.07e-01 | 2.33e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 25 | 7.33e-02 | 2.07e-01 | 4.84e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 12 | 2.15e-01 | -2.07e-01 | 6.79e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 36 | 3.18e-02 | 2.07e-01 | 3.53e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 9 | 2.83e-01 | 2.07e-01 | 7.42e-01 |
| GOBP VACUOLAR ACIDIFICATION | 32 | 4.29e-02 | -2.07e-01 | 3.91e-01 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 8 | 3.11e-01 | 2.07e-01 | 7.64e-01 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 5 | 4.23e-01 | -2.07e-01 | 8.26e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 12 | 2.15e-01 | -2.07e-01 | 6.80e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 9 | 2.84e-01 | -2.06e-01 | 7.43e-01 |
| GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 6 | 3.82e-01 | -2.06e-01 | 8.07e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 10 | 2.59e-01 | -2.06e-01 | 7.21e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 37 | 3.00e-02 | -2.06e-01 | 3.50e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 9 | 2.84e-01 | -2.06e-01 | 7.44e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 3.82e-01 | -2.06e-01 | 8.08e-01 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 20 | 1.11e-01 | 2.06e-01 | 5.54e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 3.45e-01 | -2.06e-01 | 7.88e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 49 | 1.27e-02 | -2.06e-01 | 2.53e-01 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 8 | 3.14e-01 | 2.06e-01 | 7.66e-01 |
| GOBP VACUOLE FUSION | 12 | 2.17e-01 | -2.06e-01 | 6.81e-01 |
| GOBP ASPARAGINE METABOLIC PROCESS | 5 | 4.26e-01 | 2.06e-01 | 8.28e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 22 | 9.50e-02 | 2.06e-01 | 5.23e-01 |
| GOBP NEGATIVE REGULATION OF FIBRINOLYSIS | 7 | 3.46e-01 | -2.06e-01 | 7.89e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 5 | 4.26e-01 | -2.06e-01 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 3.83e-01 | -2.06e-01 | 8.09e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 10 | 2.60e-01 | -2.06e-01 | 7.23e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 12 | 2.18e-01 | -2.06e-01 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 2.38e-01 | -2.05e-01 | 7.03e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 14 | 1.83e-01 | -2.05e-01 | 6.51e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 8 | 3.15e-01 | -2.05e-01 | 7.66e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 17 | 1.43e-01 | -2.05e-01 | 6.01e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 17 | 1.43e-01 | 2.05e-01 | 6.01e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 33 | 4.17e-02 | 2.05e-01 | 3.86e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 7 | 3.48e-01 | -2.05e-01 | 7.90e-01 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 6 | 3.85e-01 | -2.05e-01 | 8.09e-01 |
| GOCC SPECTRIN | 6 | 3.85e-01 | 2.05e-01 | 8.09e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 25 | 7.66e-02 | 2.05e-01 | 4.92e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 27 | 6.58e-02 | -2.05e-01 | 4.68e-01 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 23 | 8.95e-02 | -2.05e-01 | 5.12e-01 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 61 | 5.74e-03 | 2.05e-01 | 1.81e-01 |
| GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION | 6 | 3.86e-01 | 2.05e-01 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 15 | 1.70e-01 | -2.05e-01 | 6.35e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 10 | 2.63e-01 | 2.04e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 13 | 2.02e-01 | 2.04e-01 | 6.69e-01 |
| GOBP CELL KILLING | 121 | 1.06e-04 | -2.04e-01 | 1.47e-02 |
| GOBP RESPONSE TO NICOTINE | 25 | 7.72e-02 | 2.04e-01 | 4.94e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 26 | 7.15e-02 | -2.04e-01 | 4.79e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 10 | 2.64e-01 | -2.04e-01 | 7.24e-01 |
| GOBP TOLL SIGNALING PATHWAY | 10 | 2.64e-01 | -2.04e-01 | 7.24e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 4.29e-01 | -2.04e-01 | 8.30e-01 |
| GOMF ACTIVIN RECEPTOR BINDING | 5 | 4.29e-01 | 2.04e-01 | 8.30e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 5 | 4.29e-01 | 2.04e-01 | 8.30e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 7 | 3.50e-01 | -2.04e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 18 | 1.34e-01 | -2.04e-01 | 5.88e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 4.30e-01 | -2.04e-01 | 8.30e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 14 | 1.87e-01 | -2.04e-01 | 6.56e-01 |
| GOBP THIAMINE TRANSPORT | 5 | 4.31e-01 | 2.04e-01 | 8.30e-01 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 3.19e-01 | 2.04e-01 | 7.67e-01 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 20 | 1.15e-01 | -2.03e-01 | 5.65e-01 |
| GOCC ENDOLYSOSOME LUMEN | 5 | 4.31e-01 | -2.03e-01 | 8.30e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 92 | 7.59e-04 | -2.03e-01 | 5.57e-02 |
| GOBP ARGININE METABOLIC PROCESS | 14 | 1.88e-01 | 2.03e-01 | 6.58e-01 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 7 | 3.52e-01 | 2.03e-01 | 7.91e-01 |
| GOBP THREONINE METABOLIC PROCESS | 5 | 4.32e-01 | 2.03e-01 | 8.31e-01 |
| GOCC NODE OF RANVIER | 8 | 3.21e-01 | 2.03e-01 | 7.69e-01 |
| GOBP TAURINE METABOLIC PROCESS | 5 | 4.33e-01 | 2.03e-01 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 44 | 2.01e-02 | -2.03e-01 | 3.02e-01 |
| GOBP COBALT ION TRANSPORT | 6 | 3.91e-01 | 2.02e-01 | 8.11e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 12 | 2.25e-01 | -2.02e-01 | 6.88e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 39 | 2.88e-02 | 2.02e-01 | 3.43e-01 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 3.91e-01 | 2.02e-01 | 8.11e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 53 | 1.09e-02 | 2.02e-01 | 2.43e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 8 | 3.22e-01 | 2.02e-01 | 7.70e-01 |
| GOBP REGULATION OF FEAR RESPONSE | 7 | 3.55e-01 | 2.02e-01 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 6 | 3.91e-01 | -2.02e-01 | 8.12e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 57 | 8.38e-03 | 2.02e-01 | 2.16e-01 |
| GOCC BBAF COMPLEX | 9 | 2.94e-01 | 2.02e-01 | 7.53e-01 |
| GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 5 | 4.34e-01 | 2.02e-01 | 8.32e-01 |
| GOMF U4 SNRNA BINDING | 6 | 3.92e-01 | -2.02e-01 | 8.12e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 7 | 3.56e-01 | 2.02e-01 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 33 | 4.52e-02 | 2.02e-01 | 3.97e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 41 | 2.56e-02 | -2.02e-01 | 3.25e-01 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 19 | 1.28e-01 | -2.01e-01 | 5.80e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 15 | 1.77e-01 | -2.01e-01 | 6.40e-01 |
| GOBP TRABECULA FORMATION | 13 | 2.09e-01 | 2.01e-01 | 6.75e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 24 | 8.79e-02 | -2.01e-01 | 5.10e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 28 | 6.54e-02 | 2.01e-01 | 4.66e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 12 | 2.27e-01 | 2.01e-01 | 6.91e-01 |
| GOBP BODY MORPHOGENESIS | 31 | 5.26e-02 | 2.01e-01 | 4.25e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 9 | 2.96e-01 | -2.01e-01 | 7.54e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 16 | 1.64e-01 | 2.01e-01 | 6.25e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 17 | 1.52e-01 | -2.01e-01 | 6.13e-01 |
| GOBP STEROID CATABOLIC PROCESS | 14 | 1.93e-01 | -2.01e-01 | 6.65e-01 |
| GOCC COMPACT MYELIN | 9 | 2.97e-01 | -2.01e-01 | 7.54e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 9 | 2.97e-01 | -2.01e-01 | 7.54e-01 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 20 | 1.20e-01 | 2.01e-01 | 5.70e-01 |
| GOBP PROLINE TRANSPORT | 7 | 3.58e-01 | -2.01e-01 | 7.92e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 12 | 2.29e-01 | 2.01e-01 | 6.91e-01 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 35 | 4.02e-02 | -2.00e-01 | 3.86e-01 |
| GOCC MYOFILAMENT | 14 | 1.95e-01 | -2.00e-01 | 6.66e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 45 | 2.03e-02 | -2.00e-01 | 3.02e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 9 | 2.99e-01 | -2.00e-01 | 7.55e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 109 | 3.15e-04 | 2.00e-01 | 3.23e-02 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 12 | 2.31e-01 | 2.00e-01 | 6.94e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 5 | 4.39e-01 | -2.00e-01 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 6 | 3.97e-01 | 2.00e-01 | 8.15e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 22 | 1.05e-01 | 2.00e-01 | 5.42e-01 |
| GOMF RETINOIC ACID BINDING | 6 | 3.97e-01 | -2.00e-01 | 8.15e-01 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 6 | 3.97e-01 | 2.00e-01 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 7 | 3.61e-01 | -2.00e-01 | 7.94e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 21 | 1.14e-01 | 1.99e-01 | 5.61e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 26 | 7.85e-02 | 1.99e-01 | 4.96e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 150 | 2.57e-05 | -1.99e-01 | 4.32e-03 |
| GOCC PERICILIARY MEMBRANE COMPARTMENT | 5 | 4.40e-01 | 1.99e-01 | 8.37e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 677 | 1.56e-18 | -1.99e-01 | 4.52e-15 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 6 | 3.98e-01 | 1.99e-01 | 8.15e-01 |
| GOBP GLUCOCORTICOID SECRETION | 8 | 3.29e-01 | 1.99e-01 | 7.77e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 21 | 1.14e-01 | 1.99e-01 | 5.62e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 13 | 2.14e-01 | -1.99e-01 | 6.79e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 1.82e-01 | -1.99e-01 | 6.50e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 27 | 7.35e-02 | -1.99e-01 | 4.84e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 12 | 2.33e-01 | 1.99e-01 | 6.97e-01 |
| GOBP OSMOSENSORY SIGNALING PATHWAY | 5 | 4.41e-01 | -1.99e-01 | 8.37e-01 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 45 | 2.11e-02 | -1.99e-01 | 3.07e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 4.42e-01 | 1.99e-01 | 8.37e-01 |
| GOCC IKAPPAB KINASE COMPLEX | 6 | 4.00e-01 | -1.99e-01 | 8.15e-01 |
| GOMF STEROL TRANSPORTER ACTIVITY | 26 | 7.98e-02 | 1.99e-01 | 4.98e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 29 | 6.43e-02 | -1.99e-01 | 4.64e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 12 | 2.34e-01 | -1.98e-01 | 6.98e-01 |
| GOCC VESICLE LUMEN | 257 | 4.65e-08 | -1.98e-01 | 2.70e-05 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 10 | 2.77e-01 | 1.98e-01 | 7.38e-01 |
| GOBP LATERAL MESODERM DEVELOPMENT | 6 | 4.01e-01 | -1.98e-01 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 13 | 2.16e-01 | 1.98e-01 | 6.80e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 11 | 2.55e-01 | -1.98e-01 | 7.18e-01 |
| GOCC EXCITATORY SYNAPSE | 31 | 5.66e-02 | 1.98e-01 | 4.37e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 4.43e-01 | -1.98e-01 | 8.38e-01 |
| GOCC 90S PRERIBOSOME | 25 | 8.68e-02 | -1.98e-01 | 5.09e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 22 | 1.08e-01 | -1.98e-01 | 5.49e-01 |
| GOCC M BAND | 16 | 1.71e-01 | 1.98e-01 | 6.35e-01 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 6 | 4.02e-01 | 1.98e-01 | 8.16e-01 |
| GOBP PHOTOTRANSDUCTION | 17 | 1.58e-01 | -1.98e-01 | 6.19e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 77 | 2.73e-03 | 1.98e-01 | 1.22e-01 |
| GOBP MITOTIC RECOMBINATION | 22 | 1.09e-01 | 1.98e-01 | 5.50e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 13 | 2.17e-01 | -1.98e-01 | 6.81e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 12 | 2.36e-01 | 1.98e-01 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 58 | 9.28e-03 | 1.98e-01 | 2.24e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 12 | 2.36e-01 | 1.98e-01 | 7.00e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 52 | 1.38e-02 | -1.98e-01 | 2.65e-01 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 3.66e-01 | -1.98e-01 | 7.99e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 19 | 1.36e-01 | 1.98e-01 | 5.91e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 17 | 1.59e-01 | 1.97e-01 | 6.19e-01 |
| GOBP ADHERENS JUNCTION MAINTENANCE | 5 | 4.45e-01 | -1.97e-01 | 8.40e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 25 | 8.77e-02 | 1.97e-01 | 5.10e-01 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 6 | 4.03e-01 | 1.97e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 24 | 9.46e-02 | 1.97e-01 | 5.22e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 11 | 2.58e-01 | 1.97e-01 | 7.21e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 14 | 2.02e-01 | 1.97e-01 | 6.69e-01 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 91 | 1.17e-03 | -1.97e-01 | 7.76e-02 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 3.68e-01 | -1.97e-01 | 8.00e-01 |
| GOMF ICOSANOID BINDING | 7 | 3.68e-01 | -1.97e-01 | 8.00e-01 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 12 | 2.38e-01 | 1.97e-01 | 7.03e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY | 5 | 4.47e-01 | 1.97e-01 | 8.40e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 54 | 1.25e-02 | -1.97e-01 | 2.53e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 34 | 4.74e-02 | 1.97e-01 | 4.06e-01 |
| GOMF SIALIC ACID BINDING | 11 | 2.59e-01 | -1.96e-01 | 7.21e-01 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 7 | 3.68e-01 | -1.96e-01 | 8.01e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 49 | 1.74e-02 | -1.96e-01 | 2.95e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 5 | 4.47e-01 | 1.96e-01 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 28 | 7.23e-02 | 1.96e-01 | 4.81e-01 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 12 | 2.39e-01 | 1.96e-01 | 7.04e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 28 | 7.27e-02 | 1.96e-01 | 4.83e-01 |
| GOCC ENZYME ACTIVATOR COMPLEX | 16 | 1.75e-01 | -1.96e-01 | 6.38e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 3.37e-01 | -1.96e-01 | 7.83e-01 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 10 | 2.84e-01 | -1.96e-01 | 7.43e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 16 | 1.75e-01 | 1.96e-01 | 6.39e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 67 | 5.62e-03 | 1.96e-01 | 1.80e-01 |
| GOBP REGULATION OF DNA LIGATION | 6 | 4.06e-01 | -1.96e-01 | 8.18e-01 |
| GOMF CYCLASE ACTIVITY | 18 | 1.51e-01 | 1.96e-01 | 6.12e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 7 | 3.70e-01 | 1.96e-01 | 8.02e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 19 | 1.40e-01 | 1.96e-01 | 5.98e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 35 | 4.53e-02 | 1.96e-01 | 3.97e-01 |
| GOCC CYTOCHROME COMPLEX | 32 | 5.57e-02 | -1.95e-01 | 4.34e-01 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 12 | 2.41e-01 | 1.95e-01 | 7.06e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 6 | 4.08e-01 | 1.95e-01 | 8.18e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 9 | 3.11e-01 | 1.95e-01 | 7.64e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 10 | 2.86e-01 | -1.95e-01 | 7.46e-01 |
| GOCC BOX C D RNP COMPLEX | 5 | 4.51e-01 | -1.95e-01 | 8.42e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 14 | 2.07e-01 | 1.95e-01 | 6.74e-01 |
| GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS | 5 | 4.51e-01 | 1.95e-01 | 8.42e-01 |
| GOMF SYMPORTER ACTIVITY | 84 | 2.08e-03 | 1.94e-01 | 1.04e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 161 | 2.15e-05 | -1.94e-01 | 4.17e-03 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 12 | 2.44e-01 | 1.94e-01 | 7.08e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 15 | 1.93e-01 | -1.94e-01 | 6.64e-01 |
| GOCC GATOR2 COMPLEX | 5 | 4.52e-01 | 1.94e-01 | 8.42e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 14 | 2.08e-01 | 1.94e-01 | 6.75e-01 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 14 | 2.09e-01 | 1.94e-01 | 6.75e-01 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 4.10e-01 | 1.94e-01 | 8.19e-01 |
| GOBP ARGININE CATABOLIC PROCESS | 7 | 3.74e-01 | 1.94e-01 | 8.05e-01 |
| GOBP NEURON PROJECTION REGENERATION | 38 | 3.85e-02 | 1.94e-01 | 3.80e-01 |
| GOBP LIVER REGENERATION | 20 | 1.33e-01 | 1.94e-01 | 5.86e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 24 | 1.00e-01 | -1.94e-01 | 5.32e-01 |
| GOBP LEYDIG CELL DIFFERENTIATION | 5 | 4.53e-01 | 1.94e-01 | 8.42e-01 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 4.11e-01 | -1.94e-01 | 8.19e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 10 | 2.89e-01 | 1.94e-01 | 7.49e-01 |
| GOBP EMBRYONIC CLEAVAGE | 7 | 3.75e-01 | 1.94e-01 | 8.05e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 7 | 3.75e-01 | 1.94e-01 | 8.05e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 55 | 1.30e-02 | 1.94e-01 | 2.57e-01 |
| GOBP COPPER ION IMPORT | 5 | 4.53e-01 | 1.94e-01 | 8.42e-01 |
| GOBP FATTY ACID ELONGATION | 10 | 2.89e-01 | -1.94e-01 | 7.49e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 7 | 3.75e-01 | -1.93e-01 | 8.05e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 2.90e-01 | 1.93e-01 | 7.49e-01 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 4.12e-01 | 1.93e-01 | 8.19e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 3.76e-01 | -1.93e-01 | 8.05e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 7 | 3.76e-01 | 1.93e-01 | 8.05e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 56 | 1.24e-02 | -1.93e-01 | 2.53e-01 |
| GOBP STEROID HORMONE SECRETION | 14 | 2.11e-01 | 1.93e-01 | 6.75e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 5 | 4.55e-01 | 1.93e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 4.55e-01 | 1.93e-01 | 8.42e-01 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 45 | 2.51e-02 | 1.93e-01 | 3.23e-01 |
| GOCC POLYSOME | 63 | 8.08e-03 | -1.93e-01 | 2.13e-01 |
| GOCC PRESYNAPTIC CYTOSKELETON | 5 | 4.55e-01 | 1.93e-01 | 8.42e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 14 | 2.11e-01 | -1.93e-01 | 6.76e-01 |
| GOBP MATURATION OF SSU RRNA | 50 | 1.83e-02 | -1.93e-01 | 2.95e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 18 | 1.57e-01 | -1.93e-01 | 6.19e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 21 | 1.26e-01 | 1.93e-01 | 5.75e-01 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 22 | 1.17e-01 | 1.93e-01 | 5.68e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 50 | 1.84e-02 | -1.93e-01 | 2.95e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 51 | 1.73e-02 | -1.93e-01 | 2.94e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 23 | 1.10e-01 | -1.93e-01 | 5.52e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 8 | 3.46e-01 | 1.92e-01 | 7.89e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 26 | 8.96e-02 | 1.92e-01 | 5.12e-01 |
| GOMF TAT PROTEIN BINDING | 10 | 2.93e-01 | -1.92e-01 | 7.52e-01 |
| GOBP FEAR RESPONSE | 24 | 1.04e-01 | 1.92e-01 | 5.41e-01 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 4.16e-01 | -1.92e-01 | 8.21e-01 |
| GOBP IRON ION TRANSPORT | 39 | 3.81e-02 | 1.92e-01 | 3.78e-01 |
| GOBP SISTER CHROMATID COHESION | 49 | 2.03e-02 | 1.92e-01 | 3.02e-01 |
| GOBP PROTEIN HEXAMERIZATION | 9 | 3.19e-01 | 1.92e-01 | 7.67e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 8 | 3.48e-01 | -1.92e-01 | 7.89e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 19 | 1.48e-01 | -1.92e-01 | 6.07e-01 |
| GOMF SH2 DOMAIN BINDING | 33 | 5.70e-02 | 1.91e-01 | 4.40e-01 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 7 | 3.80e-01 | -1.91e-01 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 27 | 8.51e-02 | -1.91e-01 | 5.05e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 96 | 1.20e-03 | -1.91e-01 | 7.76e-02 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 17 | 1.72e-01 | -1.91e-01 | 6.36e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 15 | 2.00e-01 | 1.91e-01 | 6.68e-01 |
| GOBP MRNA POLYADENYLATION | 23 | 1.13e-01 | 1.91e-01 | 5.58e-01 |
| GOCC CELL CELL CONTACT ZONE | 49 | 2.07e-02 | 1.91e-01 | 3.05e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 37 | 4.44e-02 | -1.91e-01 | 3.94e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 10 | 2.96e-01 | -1.91e-01 | 7.54e-01 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 6 | 4.18e-01 | -1.91e-01 | 8.22e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 23 | 1.13e-01 | -1.91e-01 | 5.60e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 6 | 4.18e-01 | 1.91e-01 | 8.23e-01 |
| GOCC COPI VESICLE COAT | 13 | 2.34e-01 | 1.91e-01 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 14 | 2.17e-01 | -1.91e-01 | 6.80e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 36 | 4.78e-02 | 1.91e-01 | 4.06e-01 |
| GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT | 5 | 4.61e-01 | 1.91e-01 | 8.45e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 11 | 2.74e-01 | -1.90e-01 | 7.37e-01 |
| GOCC POLAR MICROTUBULE | 5 | 4.61e-01 | 1.90e-01 | 8.45e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 2.97e-01 | -1.90e-01 | 7.54e-01 |
| GOMF RIBONUCLEASE P RNA BINDING | 10 | 2.97e-01 | -1.90e-01 | 7.54e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 18 | 1.62e-01 | 1.90e-01 | 6.22e-01 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 10 | 2.98e-01 | -1.90e-01 | 7.54e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 13 | 2.35e-01 | 1.90e-01 | 6.99e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 20 | 1.41e-01 | -1.90e-01 | 5.99e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 14 | 2.18e-01 | -1.90e-01 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 48 | 2.29e-02 | -1.90e-01 | 3.18e-01 |
| GOBP RNA CAPPING | 37 | 4.57e-02 | -1.90e-01 | 3.99e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 31 | 6.74e-02 | 1.90e-01 | 4.72e-01 |
| GOBP TRANSPOSITION | 21 | 1.32e-01 | 1.90e-01 | 5.84e-01 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 32 | 6.34e-02 | -1.90e-01 | 4.59e-01 |
| GOCC RIBONUCLEASE MRP COMPLEX | 10 | 2.99e-01 | -1.90e-01 | 7.55e-01 |
| GOBP TORC2 SIGNALING | 15 | 2.04e-01 | 1.90e-01 | 6.72e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 23 | 1.16e-01 | -1.90e-01 | 5.65e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 12 | 2.55e-01 | 1.90e-01 | 7.18e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 1.89e-01 | -1.90e-01 | 6.61e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 22 | 1.24e-01 | 1.89e-01 | 5.72e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 12 | 2.56e-01 | 1.89e-01 | 7.19e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 11 | 2.77e-01 | 1.89e-01 | 7.38e-01 |
| GOBP PORE COMPLEX ASSEMBLY | 20 | 1.43e-01 | 1.89e-01 | 6.01e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 11 | 2.77e-01 | -1.89e-01 | 7.38e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 24 | 1.09e-01 | 1.89e-01 | 5.50e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 23 | 1.16e-01 | 1.89e-01 | 5.66e-01 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 6 | 4.23e-01 | -1.89e-01 | 8.25e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT | 5 | 4.64e-01 | 1.89e-01 | 8.47e-01 |
| GOBP ATP TRANSPORT | 15 | 2.05e-01 | -1.89e-01 | 6.73e-01 |
| GOCC STEREOCILIUM TIP | 11 | 2.78e-01 | 1.89e-01 | 7.38e-01 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 8 | 3.55e-01 | 1.89e-01 | 7.92e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 20 | 1.44e-01 | 1.89e-01 | 6.03e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 10 | 3.01e-01 | 1.89e-01 | 7.56e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 20 | 1.44e-01 | -1.89e-01 | 6.03e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 20 | 1.44e-01 | 1.89e-01 | 6.03e-01 |
| GOMF MYOSIN II BINDING | 7 | 3.87e-01 | -1.89e-01 | 8.10e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 7 | 3.87e-01 | 1.89e-01 | 8.10e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 12 | 2.58e-01 | 1.89e-01 | 7.21e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 50 | 2.10e-02 | -1.89e-01 | 3.07e-01 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 22 | 1.26e-01 | -1.89e-01 | 5.75e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 35 | 5.36e-02 | 1.89e-01 | 4.29e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 11 | 2.79e-01 | -1.88e-01 | 7.39e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 20 | 1.45e-01 | -1.88e-01 | 6.04e-01 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 72 | 5.74e-03 | 1.88e-01 | 1.81e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 26 | 9.66e-02 | -1.88e-01 | 5.26e-01 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 14 | 2.23e-01 | -1.88e-01 | 6.86e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 7 | 3.89e-01 | -1.88e-01 | 8.11e-01 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 7 | 3.89e-01 | -1.88e-01 | 8.11e-01 |
| GOBP FACE MORPHOGENESIS | 19 | 1.56e-01 | 1.88e-01 | 6.19e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 88 | 2.34e-03 | -1.88e-01 | 1.14e-01 |
| GOBP STEM CELL PROLIFERATION | 61 | 1.13e-02 | 1.88e-01 | 2.45e-01 |
| GOMF POLY G BINDING | 8 | 3.58e-01 | 1.88e-01 | 7.92e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 84 | 2.96e-03 | 1.88e-01 | 1.29e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 26 | 9.82e-02 | 1.87e-01 | 5.28e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 14 | 2.25e-01 | 1.87e-01 | 6.88e-01 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 4.68e-01 | 1.87e-01 | 8.49e-01 |
| GOMF LIPOPROTEIN LIPASE ACTIVITY | 6 | 4.27e-01 | -1.87e-01 | 8.29e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 13 | 2.42e-01 | -1.87e-01 | 7.08e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 18 | 1.69e-01 | 1.87e-01 | 6.33e-01 |
| GOBP VIRAL TRANSLATION | 20 | 1.47e-01 | -1.87e-01 | 6.07e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 7 | 3.91e-01 | -1.87e-01 | 8.11e-01 |
| GOMF DEATH RECEPTOR BINDING | 16 | 1.95e-01 | -1.87e-01 | 6.66e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 68 | 7.66e-03 | -1.87e-01 | 2.07e-01 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 7 | 3.91e-01 | -1.87e-01 | 8.12e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 19 | 1.59e-01 | 1.87e-01 | 6.19e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 27 | 9.29e-02 | 1.87e-01 | 5.19e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 75 | 5.17e-03 | 1.87e-01 | 1.74e-01 |
| GOBP FACIAL NERVE MORPHOGENESIS | 6 | 4.28e-01 | -1.87e-01 | 8.30e-01 |
| GOBP T CELL CHEMOTAXIS | 15 | 2.10e-01 | 1.87e-01 | 6.75e-01 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 7 | 3.92e-01 | 1.87e-01 | 8.12e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 16 | 1.96e-01 | -1.87e-01 | 6.67e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 19 | 1.59e-01 | 1.87e-01 | 6.19e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 24 | 1.13e-01 | -1.87e-01 | 5.61e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 17 | 1.83e-01 | -1.87e-01 | 6.51e-01 |
| GOBP REGULATION OF SENSORY PERCEPTION | 8 | 3.61e-01 | -1.87e-01 | 7.94e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 15 | 2.11e-01 | 1.87e-01 | 6.76e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 35 | 5.63e-02 | 1.87e-01 | 4.36e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 11 | 2.84e-01 | 1.86e-01 | 7.44e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 12 | 2.63e-01 | 1.86e-01 | 7.24e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 26 | 1.00e-01 | 1.86e-01 | 5.32e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 12 | 2.64e-01 | 1.86e-01 | 7.24e-01 |
| GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS | 5 | 4.71e-01 | 1.86e-01 | 8.49e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 5 | 4.71e-01 | -1.86e-01 | 8.49e-01 |
| GOBP ARTERY MORPHOGENESIS | 40 | 4.17e-02 | 1.86e-01 | 3.86e-01 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 8 | 3.62e-01 | 1.86e-01 | 7.96e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 28 | 8.86e-02 | -1.86e-01 | 5.11e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 29 | 8.31e-02 | -1.86e-01 | 5.01e-01 |
| GOMF PROTEASOME BINDING | 16 | 1.98e-01 | 1.86e-01 | 6.67e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 25 | 1.08e-01 | -1.86e-01 | 5.48e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME | 6 | 4.31e-01 | -1.86e-01 | 8.30e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 5 | 4.72e-01 | -1.86e-01 | 8.50e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 69 | 7.66e-03 | 1.86e-01 | 2.07e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 12 | 2.65e-01 | -1.86e-01 | 7.27e-01 |
| GOBP ER OVERLOAD RESPONSE | 11 | 2.87e-01 | -1.86e-01 | 7.47e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 7 | 3.95e-01 | -1.85e-01 | 8.14e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 5 | 4.73e-01 | 1.85e-01 | 8.50e-01 |
| GOBP PROTEIN LOCALIZATION TO AXON | 5 | 4.73e-01 | -1.85e-01 | 8.50e-01 |
| GOMF OXIDIZED DNA BINDING | 10 | 3.10e-01 | -1.85e-01 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 6 | 4.32e-01 | 1.85e-01 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 8 | 3.64e-01 | 1.85e-01 | 7.98e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 6 | 4.32e-01 | -1.85e-01 | 8.31e-01 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 3.96e-01 | -1.85e-01 | 8.14e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 6 | 4.32e-01 | -1.85e-01 | 8.31e-01 |
| GOBP TRANSFERRIN TRANSPORT | 8 | 3.64e-01 | 1.85e-01 | 7.98e-01 |
| GOBP INTEGRIN ACTIVATION | 16 | 2.00e-01 | 1.85e-01 | 6.68e-01 |
| GOBP BODY FLUID SECRETION | 50 | 2.37e-02 | 1.85e-01 | 3.19e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 22 | 1.33e-01 | -1.85e-01 | 5.86e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 20 | 1.53e-01 | 1.85e-01 | 6.13e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 58 | 1.51e-02 | 1.85e-01 | 2.75e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 25 | 1.10e-01 | 1.85e-01 | 5.53e-01 |
| GOBP MACROPINOCYTOSIS | 10 | 3.12e-01 | 1.85e-01 | 7.66e-01 |
| GOMF PORIN ACTIVITY | 6 | 4.34e-01 | -1.84e-01 | 8.32e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 190 | 1.21e-05 | -1.84e-01 | 2.63e-03 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 31 | 7.56e-02 | 1.84e-01 | 4.90e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 48 | 2.72e-02 | 1.84e-01 | 3.34e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 26 | 1.04e-01 | 1.84e-01 | 5.41e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 15 | 2.17e-01 | 1.84e-01 | 6.80e-01 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 12 | 2.69e-01 | -1.84e-01 | 7.31e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 11 | 2.90e-01 | -1.84e-01 | 7.49e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 8 | 3.67e-01 | 1.84e-01 | 8.00e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 15 | 2.17e-01 | 1.84e-01 | 6.80e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 8 | 3.67e-01 | -1.84e-01 | 8.00e-01 |
| GOCC EARLY PHAGOSOME | 10 | 3.13e-01 | 1.84e-01 | 7.66e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 11 | 2.90e-01 | 1.84e-01 | 7.49e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 9 | 3.39e-01 | -1.84e-01 | 7.84e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 57 | 1.64e-02 | -1.84e-01 | 2.84e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 36 | 5.64e-02 | -1.84e-01 | 4.36e-01 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 10 | 3.14e-01 | -1.84e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 11 | 2.91e-01 | -1.84e-01 | 7.51e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 4.36e-01 | 1.84e-01 | 8.33e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 28 | 9.28e-02 | -1.84e-01 | 5.18e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 10 | 3.15e-01 | -1.84e-01 | 7.66e-01 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 16 | 2.04e-01 | -1.84e-01 | 6.72e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 5 | 4.78e-01 | 1.83e-01 | 8.52e-01 |
| GOBP GLUCOSE IMPORT | 50 | 2.49e-02 | 1.83e-01 | 3.23e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 12 | 2.71e-01 | -1.83e-01 | 7.34e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 62 | 1.26e-02 | -1.83e-01 | 2.53e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 16 | 2.04e-01 | -1.83e-01 | 6.72e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 15 | 2.19e-01 | 1.83e-01 | 6.82e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 26 | 1.06e-01 | 1.83e-01 | 5.43e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 23 | 1.28e-01 | 1.83e-01 | 5.80e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 43 | 3.79e-02 | 1.83e-01 | 3.78e-01 |
| GOMF TAP BINDING | 7 | 4.02e-01 | -1.83e-01 | 8.16e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 14 | 2.36e-01 | -1.83e-01 | 7.00e-01 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 30 | 8.30e-02 | -1.83e-01 | 5.01e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 11 | 2.94e-01 | -1.83e-01 | 7.53e-01 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 7 | 4.02e-01 | -1.83e-01 | 8.16e-01 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 2.95e-01 | -1.83e-01 | 7.54e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 20 | 1.58e-01 | 1.82e-01 | 6.19e-01 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 11 | 2.95e-01 | -1.82e-01 | 7.54e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 7 | 4.04e-01 | -1.82e-01 | 8.17e-01 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 9 | 3.44e-01 | -1.82e-01 | 7.88e-01 |
| GOBP AMINE METABOLIC PROCESS | 67 | 9.91e-03 | -1.82e-01 | 2.33e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 19 | 1.69e-01 | 1.82e-01 | 6.33e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 1.39e-01 | 1.82e-01 | 5.96e-01 |
| GOBP RESPONSE TO BILE ACID | 5 | 4.81e-01 | 1.82e-01 | 8.53e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 78 | 5.50e-03 | -1.82e-01 | 1.79e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 12 | 2.75e-01 | 1.82e-01 | 7.38e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 5 | 4.81e-01 | 1.82e-01 | 8.54e-01 |
| GOBP MITOTIC DNA REPLICATION | 15 | 2.23e-01 | 1.82e-01 | 6.86e-01 |
| GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX | 5 | 4.82e-01 | -1.82e-01 | 8.54e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 6 | 4.41e-01 | -1.82e-01 | 8.37e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 11 | 2.97e-01 | -1.81e-01 | 7.54e-01 |
| GOCC INTERSTITIAL MATRIX | 6 | 4.42e-01 | -1.81e-01 | 8.37e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 44 | 3.75e-02 | 1.81e-01 | 3.77e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 7 | 4.06e-01 | 1.81e-01 | 8.18e-01 |
| GOCC NEUROMUSCULAR JUNCTION | 50 | 2.67e-02 | 1.81e-01 | 3.33e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 17 | 1.96e-01 | -1.81e-01 | 6.67e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 6 | 4.42e-01 | 1.81e-01 | 8.37e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 6 | 4.43e-01 | 1.81e-01 | 8.37e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 43 | 4.00e-02 | 1.81e-01 | 3.86e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 4.83e-01 | 1.81e-01 | 8.54e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 16 | 2.10e-01 | 1.81e-01 | 6.75e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 94 | 2.45e-03 | 1.81e-01 | 1.16e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 8 | 3.76e-01 | -1.81e-01 | 8.05e-01 |
| GOCC PIGMENT GRANULE | 100 | 1.80e-03 | -1.81e-01 | 9.68e-02 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 10 | 3.22e-01 | 1.81e-01 | 7.70e-01 |
| GOBP RESPONSE TO SALT STRESS | 18 | 1.84e-01 | -1.81e-01 | 6.52e-01 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 4.08e-01 | 1.81e-01 | 8.18e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 4.08e-01 | 1.81e-01 | 8.18e-01 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 11 | 3.00e-01 | -1.81e-01 | 7.56e-01 |
| GOBP NEURON MIGRATION | 100 | 1.82e-03 | 1.81e-01 | 9.74e-02 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 40 | 4.82e-02 | -1.81e-01 | 4.07e-01 |
| GOCC MICROFIBRIL | 5 | 4.85e-01 | 1.81e-01 | 8.55e-01 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 12 | 2.79e-01 | 1.81e-01 | 7.39e-01 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 5 | 4.85e-01 | 1.81e-01 | 8.55e-01 |
| GOMF CERAMIDE 1 PHOSPHATE BINDING | 5 | 4.85e-01 | -1.80e-01 | 8.55e-01 |
| GOMF DEAMINASE ACTIVITY | 24 | 1.26e-01 | 1.80e-01 | 5.75e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 7 | 4.09e-01 | 1.80e-01 | 8.19e-01 |
| GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 5 | 4.85e-01 | 1.80e-01 | 8.55e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 25 | 1.19e-01 | -1.80e-01 | 5.69e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 6 | 4.45e-01 | -1.80e-01 | 8.40e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 3.78e-01 | -1.80e-01 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 10 | 3.25e-01 | -1.80e-01 | 7.73e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 7 | 4.10e-01 | -1.80e-01 | 8.19e-01 |
| GOBP SKIN MORPHOGENESIS | 9 | 3.51e-01 | 1.80e-01 | 7.90e-01 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 15 | 2.28e-01 | 1.80e-01 | 6.91e-01 |
| GOBP PROTEIN OXIDATION | 6 | 4.46e-01 | -1.80e-01 | 8.40e-01 |
| GOBP LACTATION | 28 | 1.00e-01 | 1.79e-01 | 5.33e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 6 | 4.47e-01 | 1.79e-01 | 8.41e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 7 | 4.12e-01 | 1.79e-01 | 8.19e-01 |
| GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 7 | 4.12e-01 | -1.79e-01 | 8.19e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 11 | 3.04e-01 | 1.79e-01 | 7.59e-01 |
| GOMF 7S RNA BINDING | 7 | 4.12e-01 | -1.79e-01 | 8.19e-01 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 6 | 4.48e-01 | 1.79e-01 | 8.41e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 17 | 2.01e-01 | -1.79e-01 | 6.69e-01 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 27 | 1.08e-01 | 1.79e-01 | 5.47e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 35 | 6.71e-02 | -1.79e-01 | 4.71e-01 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 7 | 4.13e-01 | -1.79e-01 | 8.20e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 4.48e-01 | -1.79e-01 | 8.41e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 6 | 4.48e-01 | -1.79e-01 | 8.41e-01 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 6 | 4.48e-01 | -1.79e-01 | 8.41e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 12 | 2.84e-01 | -1.79e-01 | 7.43e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 4.89e-01 | -1.79e-01 | 8.57e-01 |
| GOBP SULFUR AMINO ACID TRANSPORT | 9 | 3.53e-01 | -1.79e-01 | 7.92e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 27 | 1.08e-01 | 1.79e-01 | 5.49e-01 |
| GOBP HISTONE METHYLATION | 34 | 7.16e-02 | 1.79e-01 | 4.79e-01 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.49e-01 | 1.79e-01 | 8.42e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 7 | 4.14e-01 | -1.78e-01 | 8.20e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 20 | 1.67e-01 | -1.78e-01 | 6.29e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 32 | 8.10e-02 | 1.78e-01 | 4.99e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 3.83e-01 | 1.78e-01 | 8.09e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 7.22e-02 | 1.78e-01 | 4.81e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 23 | 1.39e-01 | -1.78e-01 | 5.96e-01 |
| GOBP L LYSINE TRANSPORT | 5 | 4.90e-01 | 1.78e-01 | 8.58e-01 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.90e-01 | 1.78e-01 | 8.58e-01 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 7 | 4.14e-01 | -1.78e-01 | 8.21e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 11 | 3.07e-01 | 1.78e-01 | 7.62e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 34 | 7.25e-02 | -1.78e-01 | 4.82e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 3.07e-01 | -1.78e-01 | 7.62e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 43 | 4.37e-02 | -1.78e-01 | 3.92e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 32 | 8.20e-02 | -1.78e-01 | 4.99e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 8 | 3.84e-01 | -1.78e-01 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 9 | 3.56e-01 | -1.78e-01 | 7.92e-01 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 18 | 1.92e-01 | 1.78e-01 | 6.64e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 12 | 2.87e-01 | 1.78e-01 | 7.47e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 4.92e-01 | 1.78e-01 | 8.59e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 10 | 3.31e-01 | 1.77e-01 | 7.78e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 19 | 1.81e-01 | 1.77e-01 | 6.48e-01 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 1.81e-01 | -1.77e-01 | 6.48e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 9 | 3.57e-01 | 1.77e-01 | 7.92e-01 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 8 | 3.85e-01 | -1.77e-01 | 8.09e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 5 | 4.93e-01 | -1.77e-01 | 8.59e-01 |
| GOMF DEATH DOMAIN BINDING | 11 | 3.09e-01 | -1.77e-01 | 7.63e-01 |
| GOMF DYNACTIN BINDING | 10 | 3.32e-01 | 1.77e-01 | 7.78e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 3.32e-01 | 1.77e-01 | 7.78e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 48 | 3.40e-02 | 1.77e-01 | 3.63e-01 |
| GOBP FLUID TRANSPORT | 17 | 2.07e-01 | 1.77e-01 | 6.74e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 8 | 3.86e-01 | -1.77e-01 | 8.10e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 41 | 5.02e-02 | 1.77e-01 | 4.15e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 7 | 4.18e-01 | -1.77e-01 | 8.23e-01 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 11 | 3.11e-01 | 1.77e-01 | 7.64e-01 |
| GOCC NPBAF COMPLEX | 14 | 2.53e-01 | 1.77e-01 | 7.18e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 60 | 1.81e-02 | 1.77e-01 | 2.95e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 4.54e-01 | -1.77e-01 | 8.42e-01 |
| GOBP RESPONSE TO GLUCAGON | 12 | 2.90e-01 | 1.77e-01 | 7.49e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 10 | 3.34e-01 | 1.76e-01 | 7.80e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 87 | 4.47e-03 | -1.76e-01 | 1.58e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 13 | 2.71e-01 | -1.76e-01 | 7.33e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 10 | 3.34e-01 | 1.76e-01 | 7.80e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 6 | 4.54e-01 | -1.76e-01 | 8.42e-01 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 6 | 4.54e-01 | -1.76e-01 | 8.42e-01 |
| GOBP WATER TRANSPORT | 11 | 3.12e-01 | 1.76e-01 | 7.65e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 34 | 7.56e-02 | 1.76e-01 | 4.90e-01 |
| GOCC MON1 CCZ1 COMPLEX | 5 | 4.95e-01 | -1.76e-01 | 8.61e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 6 | 4.55e-01 | 1.76e-01 | 8.43e-01 |
| GOBP OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE | 5 | 4.96e-01 | 1.76e-01 | 8.62e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 7 | 4.20e-01 | -1.76e-01 | 8.24e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 33 | 8.06e-02 | -1.76e-01 | 4.99e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 26 | 1.21e-01 | -1.76e-01 | 5.70e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 20 | 1.74e-01 | -1.76e-01 | 6.38e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 12 | 2.92e-01 | 1.76e-01 | 7.52e-01 |
| GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 6 | 4.56e-01 | 1.76e-01 | 8.43e-01 |
| GOMF MALATE DEHYDROGENASE ACTIVITY | 6 | 4.56e-01 | -1.76e-01 | 8.43e-01 |
| GOBP NADPH REGENERATION | 20 | 1.74e-01 | -1.76e-01 | 6.38e-01 |
| GOCC AMPHISOME MEMBRANE | 11 | 3.13e-01 | -1.76e-01 | 7.66e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 7 | 4.21e-01 | -1.76e-01 | 8.25e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 11 | 3.14e-01 | 1.76e-01 | 7.66e-01 |
| GOBP TRANSCYTOSIS | 17 | 2.10e-01 | -1.75e-01 | 6.75e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 26 | 1.22e-01 | 1.75e-01 | 5.71e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 19 | 1.86e-01 | 1.75e-01 | 6.54e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 74 | 9.16e-03 | -1.75e-01 | 2.22e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 61 | 1.80e-02 | 1.75e-01 | 2.95e-01 |
| GOBP GLUTAMINE TRANSPORT | 7 | 4.22e-01 | -1.75e-01 | 8.25e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.22e-01 | -1.75e-01 | 8.25e-01 |
| GOCC SPLICEOSOMAL SNRNP COMPLEX | 65 | 1.46e-02 | -1.75e-01 | 2.72e-01 |
| GOMF SUPERCOILED DNA BINDING | 6 | 4.58e-01 | -1.75e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 5 | 4.98e-01 | 1.75e-01 | 8.63e-01 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 10 | 3.38e-01 | -1.75e-01 | 7.83e-01 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 9 | 3.63e-01 | 1.75e-01 | 7.97e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 67 | 1.33e-02 | 1.75e-01 | 2.61e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 33 | 8.21e-02 | 1.75e-01 | 4.99e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 8 | 3.92e-01 | -1.75e-01 | 8.12e-01 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 7 | 4.23e-01 | -1.75e-01 | 8.26e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 17 | 2.12e-01 | 1.75e-01 | 6.77e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 40 | 5.58e-02 | 1.75e-01 | 4.34e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 7 | 4.23e-01 | -1.75e-01 | 8.26e-01 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY | 6 | 4.59e-01 | -1.75e-01 | 8.45e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 15 | 2.42e-01 | 1.75e-01 | 7.06e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 18 | 2.00e-01 | 1.75e-01 | 6.68e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 11 | 3.16e-01 | -1.75e-01 | 7.66e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 59 | 2.04e-02 | 1.75e-01 | 3.04e-01 |
| GOBP HYPERSENSITIVITY | 11 | 3.16e-01 | -1.75e-01 | 7.66e-01 |
| GOCC INTEGRATOR COMPLEX | 16 | 2.27e-01 | 1.75e-01 | 6.91e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 8 | 3.93e-01 | -1.74e-01 | 8.13e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 10 | 3.40e-01 | -1.74e-01 | 7.84e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 58 | 2.17e-02 | -1.74e-01 | 3.12e-01 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 6 | 4.60e-01 | 1.74e-01 | 8.45e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 4.60e-01 | -1.74e-01 | 8.45e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 12 | 2.96e-01 | 1.74e-01 | 7.54e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 16 | 2.28e-01 | 1.74e-01 | 6.91e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 76 | 8.70e-03 | 1.74e-01 | 2.19e-01 |
| GOBP OVULATION CYCLE PROCESS | 25 | 1.32e-01 | 1.74e-01 | 5.84e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 34 | 7.91e-02 | -1.74e-01 | 4.97e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 41 | 5.40e-02 | -1.74e-01 | 4.30e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 19 | 1.90e-01 | -1.74e-01 | 6.61e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 5.01e-01 | 1.74e-01 | 8.63e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 7 | 4.27e-01 | 1.74e-01 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 52 | 3.05e-02 | -1.74e-01 | 3.50e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 11 | 3.19e-01 | -1.74e-01 | 7.67e-01 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 5.02e-01 | -1.73e-01 | 8.63e-01 |
| GOCC R2TP COMPLEX | 5 | 5.02e-01 | -1.73e-01 | 8.63e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 8 | 3.96e-01 | 1.73e-01 | 8.14e-01 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 5.03e-01 | -1.73e-01 | 8.63e-01 |
| GOMF PEPTIDE ANTIGEN BINDING | 31 | 9.53e-02 | -1.73e-01 | 5.24e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 12 | 2.99e-01 | 1.73e-01 | 7.55e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 10 | 3.43e-01 | -1.73e-01 | 7.87e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 24 | 1.43e-01 | 1.73e-01 | 6.01e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 6 | 4.64e-01 | 1.73e-01 | 8.47e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 116 | 1.33e-03 | -1.73e-01 | 8.28e-02 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 13 | 2.81e-01 | -1.73e-01 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 54 | 2.82e-02 | 1.73e-01 | 3.41e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 8 | 3.98e-01 | 1.73e-01 | 8.15e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 25 | 1.35e-01 | -1.73e-01 | 5.90e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 27 | 1.21e-01 | -1.73e-01 | 5.70e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 14 | 2.64e-01 | -1.73e-01 | 7.24e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 56 | 2.56e-02 | 1.73e-01 | 3.25e-01 |
| GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY | 5 | 5.04e-01 | 1.73e-01 | 8.64e-01 |
| GOBP NEURON REMODELING | 7 | 4.29e-01 | 1.72e-01 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 14 | 2.64e-01 | -1.72e-01 | 7.25e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 17 | 2.19e-01 | -1.72e-01 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 9 | 3.71e-01 | 1.72e-01 | 8.03e-01 |
| GOBP OXIDATIVE DEMETHYLATION | 7 | 4.31e-01 | -1.72e-01 | 8.30e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 33 | 8.75e-02 | 1.72e-01 | 5.10e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 8 | 4.00e-01 | 1.72e-01 | 8.15e-01 |
| GOBP SNRNA TRANSPORT | 6 | 4.66e-01 | -1.72e-01 | 8.48e-01 |
| GOMF ALCOHOL BINDING | 54 | 2.92e-02 | 1.72e-01 | 3.45e-01 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 11 | 3.24e-01 | 1.72e-01 | 7.73e-01 |
| GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 8 | 4.01e-01 | 1.72e-01 | 8.15e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 24 | 1.46e-01 | 1.72e-01 | 6.06e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 17 | 2.21e-01 | -1.72e-01 | 6.83e-01 |
| GOBP MYOBLAST PROLIFERATION | 15 | 2.50e-01 | 1.71e-01 | 7.16e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 6 | 4.68e-01 | -1.71e-01 | 8.49e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 35 | 7.96e-02 | 1.71e-01 | 4.98e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 207 | 2.26e-05 | -1.71e-01 | 4.22e-03 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 7 | 4.33e-01 | -1.71e-01 | 8.31e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 31 | 9.95e-02 | -1.71e-01 | 5.31e-01 |
| GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 7 | 4.33e-01 | 1.71e-01 | 8.31e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 2.22e-01 | -1.71e-01 | 6.85e-01 |
| GOCC NURD COMPLEX | 15 | 2.52e-01 | -1.71e-01 | 7.18e-01 |
| GOBP BLOOD VESSEL MATURATION | 6 | 4.68e-01 | 1.71e-01 | 8.49e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 53 | 3.15e-02 | -1.71e-01 | 3.52e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 29 | 1.11e-01 | -1.71e-01 | 5.57e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 14 | 2.69e-01 | 1.71e-01 | 7.31e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 26 | 1.32e-01 | -1.71e-01 | 5.84e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 32 | 9.47e-02 | 1.71e-01 | 5.22e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 5.09e-01 | -1.71e-01 | 8.67e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 21 | 1.76e-01 | 1.71e-01 | 6.39e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 32 | 9.50e-02 | -1.71e-01 | 5.23e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 29 | 1.12e-01 | -1.71e-01 | 5.57e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 10 | 3.51e-01 | 1.70e-01 | 7.90e-01 |
| GOBP RESPONSE TO TYPE III INTERFERON | 7 | 4.35e-01 | -1.70e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 5 | 5.09e-01 | -1.70e-01 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 22 | 1.67e-01 | -1.70e-01 | 6.28e-01 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 28 | 1.19e-01 | 1.70e-01 | 5.69e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 9 | 3.76e-01 | -1.70e-01 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 5 | 5.10e-01 | -1.70e-01 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 49 | 3.95e-02 | -1.70e-01 | 3.84e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 5 | 5.10e-01 | -1.70e-01 | 8.67e-01 |
| GOCC ATAC COMPLEX | 13 | 2.89e-01 | -1.70e-01 | 7.49e-01 |
| GOMF S100 PROTEIN BINDING | 12 | 3.08e-01 | -1.70e-01 | 7.62e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 56 | 2.80e-02 | -1.70e-01 | 3.40e-01 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 6 | 4.71e-01 | 1.70e-01 | 8.50e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 35 | 8.24e-02 | -1.70e-01 | 4.99e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 8 | 4.06e-01 | -1.70e-01 | 8.18e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 23 | 1.59e-01 | -1.70e-01 | 6.19e-01 |
| GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 5 | 5.11e-01 | 1.70e-01 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 33 | 9.20e-02 | 1.70e-01 | 5.18e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 31 | 1.02e-01 | -1.70e-01 | 5.39e-01 |
| GOCC FEMALE GERM CELL NUCLEUS | 9 | 3.79e-01 | -1.69e-01 | 8.05e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 14 | 2.73e-01 | 1.69e-01 | 7.36e-01 |
| GOBP ORGAN GROWTH | 95 | 4.40e-03 | 1.69e-01 | 1.58e-01 |
| GOBP EOSINOPHIL ACTIVATION | 6 | 4.73e-01 | -1.69e-01 | 8.50e-01 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 8 | 4.07e-01 | -1.69e-01 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 20 | 1.91e-01 | -1.69e-01 | 6.61e-01 |
| GOMF ACETYLCHOLINE RECEPTOR ACTIVITY | 5 | 5.13e-01 | 1.69e-01 | 8.67e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 28 | 1.22e-01 | -1.69e-01 | 5.71e-01 |
| GOCC CILIARY BASE | 30 | 1.10e-01 | 1.69e-01 | 5.52e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 23 | 1.61e-01 | 1.69e-01 | 6.20e-01 |
| GOCC FILOPODIUM | 77 | 1.05e-02 | 1.69e-01 | 2.40e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 4.74e-01 | -1.69e-01 | 8.50e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 30 | 1.10e-01 | 1.69e-01 | 5.52e-01 |
| GOMF HYDRO LYASE ACTIVITY | 42 | 5.87e-02 | -1.69e-01 | 4.45e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 28 | 1.23e-01 | -1.69e-01 | 5.71e-01 |
| GOBP HEAD MORPHOGENESIS | 23 | 1.62e-01 | 1.69e-01 | 6.21e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 9 | 3.81e-01 | -1.69e-01 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 12 | 3.12e-01 | -1.68e-01 | 7.66e-01 |
| GOBP AUTOPHAGY OF PEROXISOME | 10 | 3.56e-01 | 1.68e-01 | 7.92e-01 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 12 | 3.12e-01 | -1.68e-01 | 7.66e-01 |
| GOBP REGULATION OF GTP BINDING | 9 | 3.82e-01 | -1.68e-01 | 8.07e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 62 | 2.19e-02 | 1.68e-01 | 3.12e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 5.15e-01 | 1.68e-01 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 5 | 5.15e-01 | 1.68e-01 | 8.68e-01 |
| GOBP RESPONSE TO PROGESTERONE | 27 | 1.30e-01 | 1.68e-01 | 5.82e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 8 | 4.10e-01 | 1.68e-01 | 8.19e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 14 | 2.76e-01 | 1.68e-01 | 7.38e-01 |
| GOBP RESPONSE TO STEROL DEPLETION | 15 | 2.60e-01 | -1.68e-01 | 7.22e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 15 | 2.60e-01 | 1.68e-01 | 7.22e-01 |
| GOCC DNA POLYMERASE COMPLEX | 19 | 2.05e-01 | 1.68e-01 | 6.73e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 59 | 2.59e-02 | -1.68e-01 | 3.28e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 23 | 1.64e-01 | -1.68e-01 | 6.25e-01 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 14 | 2.77e-01 | 1.68e-01 | 7.38e-01 |
| GOBP MATURATION OF LSU RRNA | 28 | 1.25e-01 | -1.68e-01 | 5.74e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 7 | 4.43e-01 | 1.67e-01 | 8.38e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 37 | 7.82e-02 | 1.67e-01 | 4.96e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 10 | 3.60e-01 | -1.67e-01 | 7.94e-01 |
| GOCC ANAPHASE PROMOTING COMPLEX | 19 | 2.07e-01 | 1.67e-01 | 6.74e-01 |
| GOCC SMN COMPLEX | 10 | 3.60e-01 | -1.67e-01 | 7.94e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 9 | 3.85e-01 | 1.67e-01 | 8.09e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 5 | 5.18e-01 | 1.67e-01 | 8.69e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 35 | 8.72e-02 | -1.67e-01 | 5.10e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 49 | 4.31e-02 | -1.67e-01 | 3.91e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 51 | 3.92e-02 | -1.67e-01 | 3.82e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 35 | 8.74e-02 | 1.67e-01 | 5.10e-01 |
| GOCC PORE COMPLEX | 20 | 1.96e-01 | -1.67e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 4.79e-01 | -1.67e-01 | 8.52e-01 |
| GOBP IMP METABOLIC PROCESS | 13 | 2.97e-01 | -1.67e-01 | 7.54e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 9 | 3.86e-01 | -1.67e-01 | 8.09e-01 |
| GOMF MANNOSE BINDING | 15 | 2.63e-01 | 1.67e-01 | 7.24e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 4.79e-01 | 1.67e-01 | 8.52e-01 |
| GOBP VESICLE UNCOATING | 6 | 4.79e-01 | 1.67e-01 | 8.52e-01 |
| GOBP REGULATION OF VESICLE SIZE | 18 | 2.21e-01 | -1.67e-01 | 6.83e-01 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 16 | 2.48e-01 | 1.67e-01 | 7.14e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 35 | 8.79e-02 | -1.67e-01 | 5.10e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 43 | 5.90e-02 | 1.67e-01 | 4.45e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 11 | 3.39e-01 | 1.66e-01 | 7.84e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 9 | 3.87e-01 | 1.66e-01 | 8.10e-01 |
| GOCC SORTING ENDOSOME | 5 | 5.19e-01 | -1.66e-01 | 8.71e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 19 | 2.10e-01 | -1.66e-01 | 6.75e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 42 | 6.27e-02 | 1.66e-01 | 4.56e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 9 | 3.89e-01 | -1.66e-01 | 8.11e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 18 | 2.23e-01 | 1.66e-01 | 6.86e-01 |
| GOBP AXIS ELONGATION | 9 | 3.89e-01 | 1.66e-01 | 8.11e-01 |
| GOMF GLYCOGEN BINDING | 6 | 4.82e-01 | -1.66e-01 | 8.54e-01 |
| GOBP ERBB4 SIGNALING PATHWAY | 5 | 5.21e-01 | 1.66e-01 | 8.72e-01 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.89e-01 | 1.66e-01 | 8.11e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 32 | 1.05e-01 | -1.66e-01 | 5.42e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 27 | 1.36e-01 | 1.66e-01 | 5.91e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 36 | 8.56e-02 | -1.66e-01 | 5.07e-01 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 3.65e-01 | -1.66e-01 | 7.98e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 7 | 4.48e-01 | 1.66e-01 | 8.41e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 7 | 4.48e-01 | 1.66e-01 | 8.41e-01 |
| GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 4.18e-01 | -1.66e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 4.83e-01 | 1.65e-01 | 8.54e-01 |
| GOBP GAS TRANSPORT | 5 | 5.22e-01 | 1.65e-01 | 8.72e-01 |
| GOMF 7SK SNRNA BINDING | 8 | 4.18e-01 | 1.65e-01 | 8.22e-01 |
| GOCC DENDRITE CYTOPLASM | 21 | 1.90e-01 | 1.65e-01 | 6.61e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.49e-01 | 1.65e-01 | 8.42e-01 |
| GOBP UTP BIOSYNTHETIC PROCESS | 9 | 3.91e-01 | -1.65e-01 | 8.11e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 24 | 1.61e-01 | 1.65e-01 | 6.20e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 14 | 2.85e-01 | 1.65e-01 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 4.84e-01 | 1.65e-01 | 8.54e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION CENTROMERIC | 5 | 5.23e-01 | 1.65e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 12 | 3.22e-01 | -1.65e-01 | 7.70e-01 |
| GOBP RESPONSE TO TESTOSTERONE | 32 | 1.06e-01 | 1.65e-01 | 5.43e-01 |
| GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION | 5 | 5.23e-01 | 1.65e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 50 | 4.37e-02 | 1.65e-01 | 3.92e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 5 | 5.23e-01 | 1.65e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 6 | 4.85e-01 | -1.65e-01 | 8.55e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 3.23e-01 | 1.65e-01 | 7.71e-01 |
| GOBP PROTEIN HYDROXYLATION | 19 | 2.14e-01 | -1.65e-01 | 6.79e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 11 | 3.45e-01 | -1.65e-01 | 7.88e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 150 | 5.12e-04 | -1.65e-01 | 4.21e-02 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 16 | 2.55e-01 | 1.65e-01 | 7.18e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 16 | 2.55e-01 | 1.65e-01 | 7.18e-01 |
| GOBP CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY | 5 | 5.24e-01 | 1.65e-01 | 8.73e-01 |
| GOBP HEART VALVE FORMATION | 7 | 4.51e-01 | 1.64e-01 | 8.42e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 9 | 3.93e-01 | 1.64e-01 | 8.13e-01 |
| GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL | 5 | 5.24e-01 | -1.64e-01 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 16 | 2.55e-01 | 1.64e-01 | 7.18e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 39 | 7.58e-02 | -1.64e-01 | 4.90e-01 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 5 | 5.25e-01 | -1.64e-01 | 8.73e-01 |
| GOMF CGMP BINDING | 7 | 4.52e-01 | 1.64e-01 | 8.42e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 8 | 4.22e-01 | 1.64e-01 | 8.25e-01 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 7 | 4.53e-01 | 1.64e-01 | 8.42e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 113 | 2.65e-03 | 1.64e-01 | 1.22e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 24 | 1.65e-01 | 1.64e-01 | 6.26e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 1.65e-01 | 1.64e-01 | 6.26e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 3.95e-01 | -1.64e-01 | 8.14e-01 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 11 | 3.47e-01 | -1.64e-01 | 7.89e-01 |
| GOBP REGULATION OF SYNAPSE MATURATION | 12 | 3.26e-01 | 1.64e-01 | 7.74e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 19 | 2.17e-01 | 1.64e-01 | 6.80e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 13 | 3.07e-01 | -1.64e-01 | 7.62e-01 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 7 | 4.54e-01 | -1.63e-01 | 8.42e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 14 | 2.90e-01 | -1.63e-01 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 16 | 2.58e-01 | -1.63e-01 | 7.21e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 54 | 3.81e-02 | -1.63e-01 | 3.78e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 19 | 2.18e-01 | -1.63e-01 | 6.82e-01 |
| GOBP VASOCONSTRICTION | 40 | 7.42e-02 | 1.63e-01 | 4.87e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 7 | 4.55e-01 | -1.63e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 41 | 7.08e-02 | -1.63e-01 | 4.78e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY | 6 | 4.89e-01 | 1.63e-01 | 8.57e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 20 | 2.07e-01 | 1.63e-01 | 6.74e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 31 | 1.16e-01 | 1.63e-01 | 5.65e-01 |
| GOBP RIBOSOME BIOGENESIS | 310 | 8.53e-07 | -1.63e-01 | 2.98e-04 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 17 | 2.45e-01 | 1.63e-01 | 7.09e-01 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 7 | 4.55e-01 | 1.63e-01 | 8.43e-01 |
| GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS | 5 | 5.28e-01 | 1.63e-01 | 8.74e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 50 | 4.63e-02 | 1.63e-01 | 4.02e-01 |
| GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 4.89e-01 | 1.63e-01 | 8.57e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 13 | 3.09e-01 | -1.63e-01 | 7.63e-01 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 7 | 4.55e-01 | -1.63e-01 | 8.43e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 11 | 3.50e-01 | -1.63e-01 | 7.90e-01 |
| GOMF MUTSALPHA COMPLEX BINDING | 6 | 4.90e-01 | -1.63e-01 | 8.57e-01 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 7 | 4.56e-01 | -1.63e-01 | 8.43e-01 |
| GOCC DENDRITE MEMBRANE | 14 | 2.92e-01 | -1.63e-01 | 7.51e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 5.29e-01 | 1.63e-01 | 8.74e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 11 | 3.50e-01 | -1.63e-01 | 7.90e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 18 | 2.32e-01 | -1.63e-01 | 6.97e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 10 | 3.73e-01 | 1.63e-01 | 8.04e-01 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 12 | 3.30e-01 | 1.62e-01 | 7.78e-01 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 10 | 3.74e-01 | 1.62e-01 | 8.05e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 1.98e-01 | 1.62e-01 | 6.67e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 1.61e-01 | -1.62e-01 | 6.20e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 10 | 3.75e-01 | 1.62e-01 | 8.05e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 20 | 2.10e-01 | -1.62e-01 | 6.75e-01 |
| GOMF CO SMAD BINDING | 8 | 4.28e-01 | -1.62e-01 | 8.30e-01 |
| GOCC ENDOCYTIC VESICLE LUMEN | 10 | 3.76e-01 | -1.62e-01 | 8.05e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 63 | 2.65e-02 | -1.62e-01 | 3.31e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 37 | 8.89e-02 | -1.62e-01 | 5.12e-01 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 5 | 5.31e-01 | -1.62e-01 | 8.75e-01 |
| GOBP LYMPH VESSEL DEVELOPMENT | 15 | 2.79e-01 | 1.62e-01 | 7.39e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 10 | 3.77e-01 | -1.62e-01 | 8.05e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 57 | 3.50e-02 | -1.61e-01 | 3.67e-01 |
| GOBP CELLULAR RESPONSE TO UV A | 6 | 4.94e-01 | -1.61e-01 | 8.59e-01 |
| GOBP REGULATION OF CELL KILLING | 70 | 1.97e-02 | -1.61e-01 | 3.00e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 41 | 7.41e-02 | 1.61e-01 | 4.87e-01 |
| GOMF OXO ACID LYASE ACTIVITY | 5 | 5.32e-01 | -1.61e-01 | 8.75e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 4.02e-01 | 1.61e-01 | 8.16e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 7 | 4.60e-01 | 1.61e-01 | 8.45e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 10 | 3.78e-01 | 1.61e-01 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 10 | 3.78e-01 | -1.61e-01 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 18 | 2.37e-01 | -1.61e-01 | 7.01e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 12 | 3.35e-01 | -1.61e-01 | 7.80e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 25 | 1.64e-01 | 1.61e-01 | 6.25e-01 |
| GOBP AMINO ACID SALVAGE | 5 | 5.34e-01 | -1.61e-01 | 8.75e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 5.34e-01 | -1.61e-01 | 8.75e-01 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 8 | 4.31e-01 | -1.61e-01 | 8.30e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 32 | 1.16e-01 | -1.61e-01 | 5.65e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 81 | 1.24e-02 | 1.61e-01 | 2.53e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 125 | 1.93e-03 | -1.61e-01 | 1.01e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 138 | 1.13e-03 | 1.61e-01 | 7.60e-02 |
| GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 110 | 3.63e-03 | -1.61e-01 | 1.46e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 7 | 4.62e-01 | 1.61e-01 | 8.45e-01 |
| GOBP PROTEIN STABILIZATION | 177 | 2.32e-04 | -1.61e-01 | 2.67e-02 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 17 | 2.52e-01 | 1.61e-01 | 7.18e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 9 | 4.04e-01 | 1.61e-01 | 8.18e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 9 | 4.04e-01 | -1.61e-01 | 8.18e-01 |
| GOCC WNT SIGNALOSOME | 9 | 4.05e-01 | -1.60e-01 | 8.18e-01 |
| GOMF ISOMERASE ACTIVITY | 140 | 1.06e-03 | -1.60e-01 | 7.28e-02 |
| GOBP DOPAMINE TRANSPORT | 20 | 2.14e-01 | -1.60e-01 | 6.79e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 11 | 3.57e-01 | 1.60e-01 | 7.92e-01 |
| GOCC NUCLEAR REPLICATION FORK | 29 | 1.35e-01 | 1.60e-01 | 5.90e-01 |
| GOMF E BOX BINDING | 25 | 1.66e-01 | 1.60e-01 | 6.27e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 27 | 1.50e-01 | 1.60e-01 | 6.11e-01 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 8 | 4.33e-01 | -1.60e-01 | 8.31e-01 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 8 | 4.33e-01 | -1.60e-01 | 8.31e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 17 | 2.53e-01 | -1.60e-01 | 7.18e-01 |
| GOMF HELICASE ACTIVITY | 140 | 1.10e-03 | 1.60e-01 | 7.42e-02 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 63 | 2.83e-02 | 1.60e-01 | 3.41e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 29 | 1.36e-01 | 1.60e-01 | 5.92e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 20 | 2.16e-01 | 1.60e-01 | 6.80e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 38 | 8.86e-02 | -1.60e-01 | 5.11e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 9 | 4.07e-01 | 1.59e-01 | 8.18e-01 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 12 | 3.39e-01 | -1.59e-01 | 7.83e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 67 | 2.41e-02 | -1.59e-01 | 3.21e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 22 | 1.96e-01 | -1.59e-01 | 6.67e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 50 | 5.13e-02 | 1.59e-01 | 4.18e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 8 | 4.35e-01 | 1.59e-01 | 8.33e-01 |
| GOMF T CELL RECEPTOR BINDING | 8 | 4.35e-01 | -1.59e-01 | 8.33e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 19 | 2.30e-01 | 1.59e-01 | 6.93e-01 |
| GOBP MONOCYTE EXTRAVASATION | 6 | 5.00e-01 | -1.59e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 57 | 3.78e-02 | 1.59e-01 | 3.78e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 9 | 4.08e-01 | 1.59e-01 | 8.19e-01 |
| GOBP REGENERATION | 115 | 3.23e-03 | 1.59e-01 | 1.36e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 53 | 4.53e-02 | -1.59e-01 | 3.97e-01 |
| GOBP MISMATCH REPAIR | 27 | 1.53e-01 | 1.59e-01 | 6.13e-01 |
| GOBP HYPOTHALAMUS CELL MIGRATION | 5 | 5.38e-01 | 1.59e-01 | 8.76e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 4.66e-01 | -1.59e-01 | 8.48e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 9 | 4.09e-01 | 1.59e-01 | 8.19e-01 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 63 | 2.92e-02 | 1.59e-01 | 3.45e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 7 | 4.67e-01 | -1.59e-01 | 8.48e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 3.41e-01 | -1.59e-01 | 7.85e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 12 | 3.41e-01 | -1.59e-01 | 7.85e-01 |
| GOBP CAMP MEDIATED SIGNALING | 31 | 1.26e-01 | 1.59e-01 | 5.75e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 18 | 2.44e-01 | -1.59e-01 | 7.08e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB | 5 | 5.39e-01 | 1.59e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 5.01e-01 | 1.59e-01 | 8.63e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 49 | 5.49e-02 | 1.59e-01 | 4.32e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 13 | 3.22e-01 | 1.59e-01 | 7.70e-01 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 3.05e-01 | -1.58e-01 | 7.60e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 10 | 3.86e-01 | 1.58e-01 | 8.09e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 44 | 6.91e-02 | -1.58e-01 | 4.75e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 15 | 2.88e-01 | -1.58e-01 | 7.49e-01 |
| GOBP PROTEIN TETRAMERIZATION | 70 | 2.20e-02 | -1.58e-01 | 3.12e-01 |
| GOBP EATING BEHAVIOR | 16 | 2.73e-01 | 1.58e-01 | 7.36e-01 |
| GOBP AEROBIC RESPIRATION | 178 | 2.78e-04 | -1.58e-01 | 3.06e-02 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 4.38e-01 | -1.58e-01 | 8.36e-01 |
| GOBP ARTERY DEVELOPMENT | 61 | 3.27e-02 | 1.58e-01 | 3.57e-01 |
| GOMF MRF BINDING | 5 | 5.40e-01 | 1.58e-01 | 8.76e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 2.59e-01 | 1.58e-01 | 7.21e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 18 | 2.46e-01 | 1.58e-01 | 7.10e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 17 | 2.59e-01 | 1.58e-01 | 7.22e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 199 | 1.25e-04 | -1.58e-01 | 1.61e-02 |
| GOBP FERROPTOSIS | 5 | 5.41e-01 | -1.58e-01 | 8.76e-01 |
| GOBP ENDOTHELIAL CELL FATE COMMITMENT | 5 | 5.41e-01 | 1.58e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 33 | 1.17e-01 | 1.58e-01 | 5.67e-01 |
| GOBP FOREBRAIN REGIONALIZATION | 5 | 5.41e-01 | -1.58e-01 | 8.76e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 451 | 1.08e-08 | -1.58e-01 | 7.84e-06 |
| GOBP REGULATION OF FEVER GENERATION | 5 | 5.41e-01 | 1.58e-01 | 8.76e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 5.42e-01 | 1.58e-01 | 8.76e-01 |
| GOBP ORNITHINE METABOLIC PROCESS | 7 | 4.70e-01 | 1.58e-01 | 8.49e-01 |
| GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 8 | 4.40e-01 | -1.58e-01 | 8.37e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 12 | 3.45e-01 | 1.58e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 8 | 4.41e-01 | 1.57e-01 | 8.37e-01 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 6 | 5.05e-01 | 1.57e-01 | 8.64e-01 |
| GOBP ANIMAL ORGAN FORMATION | 29 | 1.43e-01 | 1.57e-01 | 6.01e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 20 | 2.24e-01 | 1.57e-01 | 6.87e-01 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 6 | 5.05e-01 | 1.57e-01 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 8 | 4.42e-01 | 1.57e-01 | 8.37e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 8 | 4.42e-01 | -1.57e-01 | 8.37e-01 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 9 | 4.14e-01 | -1.57e-01 | 8.21e-01 |
| GOCC DENDRITIC SPINE HEAD | 5 | 5.43e-01 | 1.57e-01 | 8.76e-01 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 4.42e-01 | -1.57e-01 | 8.37e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 12 | 3.46e-01 | -1.57e-01 | 7.89e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 7 | 4.72e-01 | -1.57e-01 | 8.50e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 12 | 3.47e-01 | 1.57e-01 | 7.89e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 16 | 2.77e-01 | 1.57e-01 | 7.38e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 7 | 4.72e-01 | 1.57e-01 | 8.50e-01 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 6 | 5.06e-01 | 1.57e-01 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 14 | 3.10e-01 | 1.57e-01 | 7.64e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 109 | 4.79e-03 | 1.57e-01 | 1.65e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 9 | 4.16e-01 | -1.57e-01 | 8.22e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 18 | 2.51e-01 | -1.56e-01 | 7.16e-01 |
| GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE | 5 | 5.45e-01 | -1.56e-01 | 8.77e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 8 | 4.44e-01 | -1.56e-01 | 8.38e-01 |
| GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 5 | 5.45e-01 | 1.56e-01 | 8.77e-01 |
| GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY | 5 | 5.45e-01 | 1.56e-01 | 8.77e-01 |
| GOCC CLATHRIN COMPLEX | 5 | 5.45e-01 | -1.56e-01 | 8.77e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 133 | 1.89e-03 | -1.56e-01 | 9.99e-02 |
| GOCC PRP19 COMPLEX | 12 | 3.49e-01 | -1.56e-01 | 7.90e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 6 | 5.08e-01 | -1.56e-01 | 8.66e-01 |
| GOBP SYNAPTIC VESICLE COATING | 5 | 5.45e-01 | -1.56e-01 | 8.77e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 7 | 4.74e-01 | -1.56e-01 | 8.50e-01 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 30 | 1.39e-01 | 1.56e-01 | 5.96e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 3.93e-01 | -1.56e-01 | 8.13e-01 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 7 | 4.75e-01 | -1.56e-01 | 8.50e-01 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 19 | 2.39e-01 | -1.56e-01 | 7.04e-01 |
| GOBP MIDBODY ABSCISSION | 16 | 2.81e-01 | -1.56e-01 | 7.42e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 15 | 2.96e-01 | -1.56e-01 | 7.54e-01 |
| GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 5.46e-01 | -1.56e-01 | 8.78e-01 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 6 | 5.09e-01 | -1.56e-01 | 8.67e-01 |
| GOBP RESPONSE TO BMP | 87 | 1.22e-02 | 1.56e-01 | 2.53e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 20 | 2.28e-01 | 1.56e-01 | 6.91e-01 |
| GOBP PRE MIRNA PROCESSING | 14 | 3.14e-01 | 1.56e-01 | 7.66e-01 |
| GOMF PRE MIRNA BINDING | 8 | 4.46e-01 | -1.56e-01 | 8.40e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 14 | 3.14e-01 | 1.55e-01 | 7.66e-01 |
| GOMF MAP KINASE ACTIVITY | 12 | 3.51e-01 | 1.55e-01 | 7.91e-01 |
| GOCC BASEMENT MEMBRANE | 40 | 8.91e-02 | 1.55e-01 | 5.12e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 12 | 3.51e-01 | 1.55e-01 | 7.91e-01 |
| GOMF NAD BINDING | 52 | 5.27e-02 | -1.55e-01 | 4.25e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 5 | 5.48e-01 | -1.55e-01 | 8.78e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 53 | 5.06e-02 | -1.55e-01 | 4.16e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 15 | 2.98e-01 | 1.55e-01 | 7.55e-01 |
| GOCC U7 SNRNP | 7 | 4.78e-01 | -1.55e-01 | 8.52e-01 |
| GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 5.48e-01 | -1.55e-01 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 5 | 5.48e-01 | 1.55e-01 | 8.78e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 5.49e-01 | -1.55e-01 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 20 | 2.30e-01 | -1.55e-01 | 6.94e-01 |
| GOMF PROTEIN KINASE B BINDING | 9 | 4.21e-01 | -1.55e-01 | 8.25e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 10 | 3.96e-01 | -1.55e-01 | 8.15e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 14 | 3.16e-01 | -1.55e-01 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 17 | 2.69e-01 | -1.55e-01 | 7.31e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 26 | 1.72e-01 | 1.55e-01 | 6.36e-01 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 54 | 4.93e-02 | 1.55e-01 | 4.12e-01 |
| GOBP CHROMOSOME SEPARATION | 71 | 2.43e-02 | 1.55e-01 | 3.22e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 40 | 9.08e-02 | 1.55e-01 | 5.16e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 21 | 2.20e-01 | 1.55e-01 | 6.83e-01 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 12 | 3.54e-01 | -1.55e-01 | 7.92e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 37 | 1.04e-01 | 1.55e-01 | 5.41e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 6 | 5.13e-01 | 1.54e-01 | 8.67e-01 |
| GOCC SWI SNF COMPLEX | 26 | 1.73e-01 | 1.54e-01 | 6.37e-01 |
| GOBP TORC1 SIGNALING | 91 | 1.10e-02 | 1.54e-01 | 2.44e-01 |
| GOMF MHC CLASS IB PROTEIN BINDING | 5 | 5.50e-01 | 1.54e-01 | 8.78e-01 |
| GOBP AORTA DEVELOPMENT | 36 | 1.09e-01 | 1.54e-01 | 5.51e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 59 | 4.04e-02 | -1.54e-01 | 3.86e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 49 | 6.17e-02 | 1.54e-01 | 4.51e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 62 | 3.57e-02 | -1.54e-01 | 3.68e-01 |
| GOCC MYOSIN II COMPLEX | 11 | 3.76e-01 | -1.54e-01 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 14 | 3.18e-01 | 1.54e-01 | 7.67e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 7 | 4.80e-01 | 1.54e-01 | 8.53e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 14 | 3.18e-01 | -1.54e-01 | 7.67e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 11 | 3.77e-01 | 1.54e-01 | 8.05e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 35 | 1.15e-01 | -1.54e-01 | 5.65e-01 |
| GOBP SLEEP | 8 | 4.51e-01 | 1.54e-01 | 8.42e-01 |
| GOBP REGULATION OF RENAL SYSTEM PROCESS | 8 | 4.51e-01 | 1.54e-01 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 12 | 3.57e-01 | -1.54e-01 | 7.92e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 18 | 2.59e-01 | -1.54e-01 | 7.21e-01 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 7 | 4.81e-01 | 1.54e-01 | 8.54e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION | 5 | 5.52e-01 | 1.54e-01 | 8.79e-01 |
| GOBP CHLORIDE TRANSPORT | 59 | 4.15e-02 | 1.54e-01 | 3.86e-01 |
| GOBP TONGUE DEVELOPMENT | 8 | 4.52e-01 | -1.53e-01 | 8.42e-01 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 11 | 3.78e-01 | 1.53e-01 | 8.05e-01 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 9 | 4.26e-01 | -1.53e-01 | 8.28e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 11 | 3.79e-01 | 1.53e-01 | 8.05e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 26 | 1.76e-01 | -1.53e-01 | 6.40e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 5.16e-01 | -1.53e-01 | 8.68e-01 |
| GOCC INTERCALATED DISC | 34 | 1.22e-01 | 1.53e-01 | 5.71e-01 |
| GOCC SET1C COMPASS COMPLEX | 13 | 3.39e-01 | 1.53e-01 | 7.83e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 129 | 2.69e-03 | 1.53e-01 | 1.22e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 32 | 1.34e-01 | -1.53e-01 | 5.86e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 16 | 2.89e-01 | 1.53e-01 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 12 | 3.58e-01 | -1.53e-01 | 7.93e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 18 | 2.61e-01 | 1.53e-01 | 7.23e-01 |
| GOBP SYNAPTIC VESICLE DOCKING | 6 | 5.16e-01 | 1.53e-01 | 8.69e-01 |
| GOBP MEMBRANE INVAGINATION | 56 | 4.77e-02 | -1.53e-01 | 4.06e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 55 | 4.99e-02 | 1.53e-01 | 4.14e-01 |
| GOBP FOLIC ACID METABOLIC PROCESS | 15 | 3.05e-01 | 1.53e-01 | 7.60e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 22 | 2.15e-01 | -1.53e-01 | 6.79e-01 |
| GOBP ATP METABOLIC PROCESS | 119 | 4.04e-03 | -1.53e-01 | 1.52e-01 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 9 | 4.28e-01 | 1.53e-01 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 5.54e-01 | -1.53e-01 | 8.79e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 146 | 1.47e-03 | -1.53e-01 | 8.63e-02 |
| GOMF MUTLALPHA COMPLEX BINDING | 6 | 5.17e-01 | -1.53e-01 | 8.69e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 10 | 4.03e-01 | -1.53e-01 | 8.17e-01 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 23 | 2.05e-01 | -1.53e-01 | 6.73e-01 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 8 | 4.55e-01 | 1.53e-01 | 8.42e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 19 | 2.50e-01 | 1.53e-01 | 7.16e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 106 | 6.72e-03 | 1.53e-01 | 1.94e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 58 | 4.47e-02 | -1.53e-01 | 3.95e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 9 | 4.28e-01 | 1.52e-01 | 8.30e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 47 | 7.12e-02 | -1.52e-01 | 4.78e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 93 | 1.13e-02 | 1.52e-01 | 2.45e-01 |
| GOBP PUTRESCINE METABOLIC PROCESS | 8 | 4.56e-01 | 1.52e-01 | 8.43e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 15 | 3.08e-01 | 1.52e-01 | 7.62e-01 |
| GOCC INO80 COMPLEX | 15 | 3.08e-01 | 1.52e-01 | 7.62e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 24 | 1.98e-01 | 1.52e-01 | 6.67e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 95 | 1.06e-02 | 1.52e-01 | 2.41e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 15 | 3.09e-01 | -1.52e-01 | 7.63e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 5 | 5.57e-01 | -1.52e-01 | 8.79e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 46 | 7.52e-02 | -1.52e-01 | 4.89e-01 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 7 | 4.87e-01 | -1.52e-01 | 8.56e-01 |
| GOCC X CHROMOSOME | 8 | 4.58e-01 | 1.52e-01 | 8.44e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 10 | 4.06e-01 | 1.52e-01 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 98 | 9.57e-03 | 1.52e-01 | 2.28e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 23 | 2.09e-01 | -1.52e-01 | 6.75e-01 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 8 | 4.58e-01 | 1.51e-01 | 8.44e-01 |
| GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS | 5 | 5.58e-01 | 1.51e-01 | 8.79e-01 |
| GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT | 5 | 5.58e-01 | -1.51e-01 | 8.79e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 3.85e-01 | -1.51e-01 | 8.09e-01 |
| GOBP NEGATIVE REGULATION OF STEROL TRANSPORT | 5 | 5.58e-01 | 1.51e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 10 | 4.07e-01 | -1.51e-01 | 8.18e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 106 | 7.18e-03 | -1.51e-01 | 2.00e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 45 | 7.93e-02 | 1.51e-01 | 4.98e-01 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 28 | 1.66e-01 | 1.51e-01 | 6.28e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 35 | 1.22e-01 | -1.51e-01 | 5.71e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 10 | 4.09e-01 | -1.51e-01 | 8.19e-01 |
| GOBP INORGANIC ANION TRANSPORT | 89 | 1.40e-02 | 1.51e-01 | 2.66e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 5 | 5.59e-01 | -1.51e-01 | 8.79e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 39 | 1.04e-01 | -1.51e-01 | 5.41e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 5 | 5.60e-01 | 1.51e-01 | 8.79e-01 |
| GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY | 5 | 5.60e-01 | 1.51e-01 | 8.79e-01 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 21 | 2.33e-01 | 1.50e-01 | 6.97e-01 |
| GOBP UV PROTECTION | 10 | 4.10e-01 | -1.50e-01 | 8.19e-01 |
| GOMF GROWTH FACTOR BINDING | 76 | 2.35e-02 | 1.50e-01 | 3.18e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 18 | 2.69e-01 | -1.50e-01 | 7.31e-01 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 52 | 6.08e-02 | -1.50e-01 | 4.50e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 2.70e-01 | -1.50e-01 | 7.32e-01 |
| GOCC U5 SNRNP | 19 | 2.57e-01 | -1.50e-01 | 7.20e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 5.24e-01 | 1.50e-01 | 8.73e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 6 | 5.24e-01 | -1.50e-01 | 8.73e-01 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 5 | 5.61e-01 | -1.50e-01 | 8.79e-01 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 5.61e-01 | -1.50e-01 | 8.79e-01 |
| GOBP CRANIAL NERVE DEVELOPMENT | 31 | 1.48e-01 | -1.50e-01 | 6.07e-01 |
| GOMF INSULIN RECEPTOR BINDING | 16 | 2.99e-01 | 1.50e-01 | 7.55e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 61 | 4.29e-02 | -1.50e-01 | 3.91e-01 |
| GOCC BRUSH BORDER MEMBRANE | 31 | 1.49e-01 | 1.50e-01 | 6.08e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 36 | 1.20e-01 | -1.50e-01 | 5.69e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 43 | 8.91e-02 | -1.50e-01 | 5.12e-01 |
| GOBP AUTOPHAGOSOME MATURATION | 61 | 4.31e-02 | -1.50e-01 | 3.91e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 4.36e-01 | 1.50e-01 | 8.34e-01 |
| GOBP STARTLE RESPONSE | 13 | 3.50e-01 | 1.50e-01 | 7.90e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 17 | 2.85e-01 | -1.50e-01 | 7.45e-01 |
| GOBP BLEB ASSEMBLY | 11 | 3.90e-01 | 1.50e-01 | 8.11e-01 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 75 | 2.50e-02 | 1.50e-01 | 3.23e-01 |
| GOBP SEROTONIN UPTAKE | 5 | 5.62e-01 | -1.50e-01 | 8.80e-01 |
| GOBP C TERMINAL PROTEIN LIPIDATION | 5 | 5.62e-01 | 1.50e-01 | 8.80e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 28 | 1.71e-01 | 1.50e-01 | 6.35e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 26 | 1.87e-01 | -1.50e-01 | 6.56e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 57 | 5.10e-02 | -1.50e-01 | 4.17e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 16 | 3.01e-01 | 1.49e-01 | 7.56e-01 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 12 | 3.70e-01 | -1.49e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 10 | 4.13e-01 | 1.49e-01 | 8.20e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 36 | 1.21e-01 | 1.49e-01 | 5.70e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 32 | 1.44e-01 | 1.49e-01 | 6.03e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 8 | 4.65e-01 | 1.49e-01 | 8.48e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 15 | 3.17e-01 | 1.49e-01 | 7.67e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 2.48e-01 | -1.49e-01 | 7.14e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 8 | 4.65e-01 | -1.49e-01 | 8.48e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 484 | 2.24e-08 | -1.49e-01 | 1.50e-05 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 5.64e-01 | 1.49e-01 | 8.80e-01 |
| GOBP ZYMOGEN ACTIVATION | 41 | 9.87e-02 | -1.49e-01 | 5.29e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 19 | 2.61e-01 | 1.49e-01 | 7.23e-01 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 5 | 5.64e-01 | -1.49e-01 | 8.80e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 3.72e-01 | -1.49e-01 | 8.03e-01 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 8 | 4.66e-01 | -1.49e-01 | 8.48e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 17 | 2.88e-01 | 1.49e-01 | 7.49e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 11 | 3.93e-01 | -1.49e-01 | 8.13e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 25 | 1.98e-01 | -1.49e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 10 | 4.16e-01 | -1.49e-01 | 8.21e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 38 | 1.13e-01 | -1.49e-01 | 5.60e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 13 | 3.54e-01 | -1.49e-01 | 7.92e-01 |
| GOBP T CELL MEDIATED IMMUNITY | 95 | 1.24e-02 | -1.49e-01 | 2.53e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 30 | 1.59e-01 | -1.49e-01 | 6.19e-01 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 14 | 3.36e-01 | 1.49e-01 | 7.82e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 46 | 8.16e-02 | 1.48e-01 | 4.99e-01 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 7 | 4.96e-01 | 1.48e-01 | 8.62e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 12 | 3.73e-01 | 1.48e-01 | 8.04e-01 |
| GOCC FILOPODIUM TIP | 14 | 3.36e-01 | 1.48e-01 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 19 | 2.63e-01 | 1.48e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 8 | 4.67e-01 | 1.48e-01 | 8.49e-01 |
| GOMF MISMATCHED DNA BINDING | 14 | 3.37e-01 | 1.48e-01 | 7.82e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 34 | 1.35e-01 | 1.48e-01 | 5.89e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 37 | 1.19e-01 | -1.48e-01 | 5.69e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 18 | 2.77e-01 | -1.48e-01 | 7.38e-01 |
| GOBP MEIOTIC CELL CYCLE | 194 | 3.86e-04 | 1.48e-01 | 3.70e-02 |
| GOMF KINETOCHORE BINDING | 6 | 5.30e-01 | 1.48e-01 | 8.75e-01 |
| GOBP NODAL SIGNALING PATHWAY | 7 | 4.98e-01 | 1.48e-01 | 8.63e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 8 | 4.69e-01 | 1.48e-01 | 8.49e-01 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 6 | 5.31e-01 | -1.48e-01 | 8.75e-01 |
| GOBP DUMP CATABOLIC PROCESS | 5 | 5.67e-01 | -1.48e-01 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 61 | 4.61e-02 | 1.48e-01 | 4.01e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 8 | 4.69e-01 | -1.48e-01 | 8.49e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 89 | 1.61e-02 | -1.48e-01 | 2.82e-01 |
| GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 20 | 2.53e-01 | -1.48e-01 | 7.18e-01 |
| GOMF PALMITOYL COA HYDROLASE ACTIVITY | 13 | 3.57e-01 | -1.48e-01 | 7.92e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 3.39e-01 | -1.48e-01 | 7.83e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 4.70e-01 | -1.47e-01 | 8.49e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 43 | 9.45e-02 | 1.47e-01 | 5.22e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 5 | 5.68e-01 | 1.47e-01 | 8.82e-01 |
| GOMF CYCLOSPORIN A BINDING | 17 | 2.93e-01 | -1.47e-01 | 7.52e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 17 | 2.93e-01 | -1.47e-01 | 7.52e-01 |
| GOBP BLASTOCYST GROWTH | 19 | 2.67e-01 | 1.47e-01 | 7.28e-01 |
| GOBP LIPOPROTEIN LOCALIZATION | 14 | 3.40e-01 | -1.47e-01 | 7.85e-01 |
| GOBP MITOCHONDRIAL FISSION | 35 | 1.32e-01 | 1.47e-01 | 5.84e-01 |
| GOBP PHOSPHATE ION TRANSPORT | 18 | 2.80e-01 | 1.47e-01 | 7.41e-01 |
| GOCC THO COMPLEX | 6 | 5.33e-01 | -1.47e-01 | 8.75e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 85 | 1.93e-02 | -1.47e-01 | 2.98e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 11 | 3.99e-01 | 1.47e-01 | 8.15e-01 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 13 | 3.59e-01 | -1.47e-01 | 7.94e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 21 | 2.44e-01 | -1.47e-01 | 7.08e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 29 | 1.71e-01 | 1.47e-01 | 6.36e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 8 | 4.72e-01 | -1.47e-01 | 8.50e-01 |
| GOMF CAMP BINDING | 14 | 3.43e-01 | 1.47e-01 | 7.87e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 11 | 4.00e-01 | 1.46e-01 | 8.15e-01 |
| GOBP RRNA METABOLIC PROCESS | 246 | 7.90e-05 | -1.46e-01 | 1.19e-02 |
| GOCC CORVET COMPLEX | 7 | 5.02e-01 | 1.46e-01 | 8.63e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 4.73e-01 | 1.46e-01 | 8.50e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 11 | 4.01e-01 | 1.46e-01 | 8.15e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 12 | 3.80e-01 | -1.46e-01 | 8.07e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 18 | 2.83e-01 | 1.46e-01 | 7.42e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 26 | 1.97e-01 | 1.46e-01 | 6.67e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 16 | 3.11e-01 | 1.46e-01 | 7.64e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 98 | 1.24e-02 | -1.46e-01 | 2.53e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 31 | 1.59e-01 | 1.46e-01 | 6.19e-01 |
| GOMF ALPHA ACTININ BINDING | 14 | 3.44e-01 | -1.46e-01 | 7.88e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 5 | 5.72e-01 | -1.46e-01 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 26 | 1.98e-01 | -1.46e-01 | 6.67e-01 |
| GOBP DNA CONFORMATION CHANGE | 85 | 2.01e-02 | 1.46e-01 | 3.02e-01 |
| GOBP DNA DEAMINATION | 12 | 3.81e-01 | -1.46e-01 | 8.07e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 21 | 2.47e-01 | -1.46e-01 | 7.12e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 7 | 5.04e-01 | -1.46e-01 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 32 | 1.53e-01 | 1.46e-01 | 6.14e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 10 | 4.25e-01 | -1.46e-01 | 8.27e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 24 | 2.17e-01 | 1.46e-01 | 6.80e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 32 | 1.54e-01 | 1.46e-01 | 6.15e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 10 | 4.25e-01 | 1.46e-01 | 8.27e-01 |
| GOBP DTMP METABOLIC PROCESS | 6 | 5.37e-01 | -1.46e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 44 | 9.47e-02 | -1.46e-01 | 5.22e-01 |
| GOBP KINETOCHORE ORGANIZATION | 21 | 2.48e-01 | 1.46e-01 | 7.14e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 2.48e-01 | 1.46e-01 | 7.14e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 6 | 5.37e-01 | -1.46e-01 | 8.76e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 9 | 4.50e-01 | 1.46e-01 | 8.42e-01 |
| GOMF TORC2 COMPLEX BINDING | 5 | 5.73e-01 | 1.45e-01 | 8.85e-01 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 16 | 3.14e-01 | 1.45e-01 | 7.66e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 43 | 9.92e-02 | 1.45e-01 | 5.31e-01 |
| GOBP PARTURITION | 7 | 5.05e-01 | 1.45e-01 | 8.65e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 5.37e-01 | -1.45e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 101 | 1.18e-02 | -1.45e-01 | 2.50e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 9 | 4.51e-01 | -1.45e-01 | 8.42e-01 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 5.38e-01 | -1.45e-01 | 8.76e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 21 | 2.50e-01 | -1.45e-01 | 7.16e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 14 | 3.47e-01 | 1.45e-01 | 7.89e-01 |
| GOMF STEROL ESTERASE ACTIVITY | 5 | 5.75e-01 | -1.45e-01 | 8.86e-01 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 5.75e-01 | -1.45e-01 | 8.86e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 91 | 1.70e-02 | 1.45e-01 | 2.91e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 8 | 4.78e-01 | -1.45e-01 | 8.52e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 15 | 3.32e-01 | 1.45e-01 | 7.78e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 69 | 3.79e-02 | -1.45e-01 | 3.78e-01 |
| GOCC CTF18 RFC LIKE COMPLEX | 6 | 5.40e-01 | -1.45e-01 | 8.76e-01 |
| GOBP GLOMERULUS DEVELOPMENT | 36 | 1.34e-01 | 1.45e-01 | 5.86e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 5.08e-01 | -1.44e-01 | 8.66e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 42 | 1.06e-01 | 1.44e-01 | 5.43e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 11 | 4.07e-01 | 1.44e-01 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 29 | 1.79e-01 | -1.44e-01 | 6.45e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 18 | 2.89e-01 | 1.44e-01 | 7.49e-01 |
| GOBP RESPONSE TO CAFFEINE | 11 | 4.08e-01 | 1.44e-01 | 8.18e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 9 | 4.54e-01 | 1.44e-01 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 5 | 5.77e-01 | 1.44e-01 | 8.87e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 192 | 5.90e-04 | 1.44e-01 | 4.67e-02 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 83 | 2.34e-02 | -1.44e-01 | 3.18e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 32 | 1.59e-01 | 1.44e-01 | 6.19e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 3.04e-01 | 1.44e-01 | 7.59e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 25 | 2.13e-01 | -1.44e-01 | 6.78e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 10 | 4.31e-01 | -1.44e-01 | 8.30e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 17 | 3.05e-01 | 1.44e-01 | 7.60e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 13 | 3.70e-01 | -1.44e-01 | 8.02e-01 |
| GOBP LIVER MORPHOGENESIS | 16 | 3.20e-01 | -1.44e-01 | 7.69e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 10 | 4.32e-01 | 1.44e-01 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 7 | 5.11e-01 | -1.44e-01 | 8.67e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 7 | 5.11e-01 | 1.43e-01 | 8.67e-01 |
| GOBP CAMP BIOSYNTHETIC PROCESS | 7 | 5.11e-01 | 1.43e-01 | 8.67e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 163 | 1.62e-03 | -1.43e-01 | 9.00e-02 |
| GOBP ENAMEL MINERALIZATION | 10 | 4.33e-01 | -1.43e-01 | 8.31e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 15 | 3.37e-01 | -1.43e-01 | 7.82e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 48 | 8.64e-02 | 1.43e-01 | 5.09e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 45 | 9.69e-02 | -1.43e-01 | 5.26e-01 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY | 6 | 5.44e-01 | -1.43e-01 | 8.77e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 17 | 3.08e-01 | 1.43e-01 | 7.62e-01 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 22 | 2.46e-01 | 1.43e-01 | 7.10e-01 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 9 | 4.58e-01 | -1.43e-01 | 8.44e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 72 | 3.62e-02 | 1.43e-01 | 3.71e-01 |
| GOBP NAD METABOLIC PROCESS | 32 | 1.62e-01 | -1.43e-01 | 6.22e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 127 | 5.54e-03 | 1.43e-01 | 1.79e-01 |
| GOCC BLOC COMPLEX | 14 | 3.56e-01 | -1.43e-01 | 7.92e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 24 | 2.27e-01 | -1.43e-01 | 6.91e-01 |
| GOCC BLEB | 9 | 4.59e-01 | 1.43e-01 | 8.45e-01 |
| GOMF MRNA 5 UTR BINDING | 24 | 2.27e-01 | -1.42e-01 | 6.91e-01 |
| GOBP CRANIAL NERVE FORMATION | 6 | 5.46e-01 | -1.42e-01 | 8.77e-01 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 9 | 4.60e-01 | -1.42e-01 | 8.45e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 36 | 1.40e-01 | 1.42e-01 | 5.97e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 6 | 5.46e-01 | 1.42e-01 | 8.77e-01 |
| GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION | 6 | 5.46e-01 | 1.42e-01 | 8.77e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 20 | 2.71e-01 | 1.42e-01 | 7.33e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 20 | 2.71e-01 | 1.42e-01 | 7.33e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 6 | 5.47e-01 | 1.42e-01 | 8.78e-01 |
| GOBP REGULATION OF CILIUM MOVEMENT | 15 | 3.41e-01 | -1.42e-01 | 7.85e-01 |
| GOBP RRNA BASE METHYLATION | 8 | 4.87e-01 | 1.42e-01 | 8.56e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 14 | 3.58e-01 | 1.42e-01 | 7.92e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 33 | 1.58e-01 | -1.42e-01 | 6.19e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 69 | 4.16e-02 | 1.42e-01 | 3.86e-01 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 4.87e-01 | 1.42e-01 | 8.56e-01 |
| GOCC TORC1 COMPLEX | 6 | 5.47e-01 | 1.42e-01 | 8.78e-01 |
| GOBP VESICLE COATING | 38 | 1.30e-01 | -1.42e-01 | 5.82e-01 |
| GOBP DIGESTION | 49 | 8.60e-02 | 1.42e-01 | 5.08e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 19 | 2.85e-01 | -1.42e-01 | 7.44e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 126 | 6.04e-03 | -1.42e-01 | 1.83e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 6 | 5.48e-01 | -1.42e-01 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 9 | 4.62e-01 | 1.42e-01 | 8.45e-01 |
| GOCC INNER KINETOCHORE | 17 | 3.12e-01 | -1.42e-01 | 7.65e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 6 | 5.48e-01 | 1.42e-01 | 8.78e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 15 | 3.43e-01 | 1.42e-01 | 7.87e-01 |
| GOMF THIOESTERASE BINDING | 9 | 4.62e-01 | -1.42e-01 | 8.46e-01 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 5.84e-01 | -1.41e-01 | 8.90e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 7 | 5.17e-01 | 1.41e-01 | 8.69e-01 |
| GOMF JUN KINASE BINDING | 9 | 4.63e-01 | -1.41e-01 | 8.46e-01 |
| GOBP OPSONIZATION | 5 | 5.84e-01 | 1.41e-01 | 8.90e-01 |
| GOBP GLIAL CELL PROLIFERATION | 36 | 1.42e-01 | 1.41e-01 | 6.00e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 19 | 2.86e-01 | -1.41e-01 | 7.46e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 409 | 1.03e-06 | -1.41e-01 | 3.36e-04 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 13 | 3.78e-01 | 1.41e-01 | 8.05e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 116 | 8.66e-03 | 1.41e-01 | 2.19e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 134 | 4.84e-03 | -1.41e-01 | 1.65e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 36 | 1.43e-01 | 1.41e-01 | 6.01e-01 |
| GOBP MEMBRANE REPOLARIZATION | 25 | 2.22e-01 | -1.41e-01 | 6.85e-01 |
| GOBP LATE ENDOSOME TO GOLGI TRANSPORT | 5 | 5.85e-01 | 1.41e-01 | 8.91e-01 |
| GOBP SARCOMERE ORGANIZATION | 22 | 2.52e-01 | 1.41e-01 | 7.18e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 46 | 9.83e-02 | -1.41e-01 | 5.28e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 8 | 4.90e-01 | -1.41e-01 | 8.58e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 5.50e-01 | -1.41e-01 | 8.78e-01 |
| GOBP TONGUE MORPHOGENESIS | 6 | 5.50e-01 | -1.41e-01 | 8.78e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 28 | 1.97e-01 | -1.41e-01 | 6.67e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 24 | 2.33e-01 | 1.41e-01 | 6.97e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 12 | 3.99e-01 | 1.41e-01 | 8.15e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 21 | 2.64e-01 | -1.41e-01 | 7.25e-01 |
| GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.19e-01 | 1.41e-01 | 8.71e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 7 | 5.19e-01 | -1.41e-01 | 8.71e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 89 | 2.20e-02 | -1.41e-01 | 3.12e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 5.86e-01 | -1.41e-01 | 8.92e-01 |
| GOBP PHOTOPERIODISM | 24 | 2.33e-01 | -1.41e-01 | 6.97e-01 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 15 | 3.46e-01 | 1.41e-01 | 7.89e-01 |
| GOBP MEMBRANE FISSION | 41 | 1.20e-01 | -1.40e-01 | 5.69e-01 |
| GOMF ATPASE INHIBITOR ACTIVITY | 5 | 5.86e-01 | -1.40e-01 | 8.92e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 23 | 2.44e-01 | -1.40e-01 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 48 | 9.25e-02 | -1.40e-01 | 5.18e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 34 | 1.57e-01 | -1.40e-01 | 6.19e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 8 | 4.92e-01 | -1.40e-01 | 8.59e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 65 | 5.04e-02 | 1.40e-01 | 4.15e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 27 | 2.07e-01 | -1.40e-01 | 6.74e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 8 | 4.92e-01 | 1.40e-01 | 8.59e-01 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 4.21e-01 | -1.40e-01 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 25 | 2.25e-01 | -1.40e-01 | 6.88e-01 |
| GOMF HSP90 PROTEIN BINDING | 34 | 1.57e-01 | -1.40e-01 | 6.19e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 54 | 7.49e-02 | 1.40e-01 | 4.88e-01 |
| GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION | 5 | 5.87e-01 | -1.40e-01 | 8.92e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 4.01e-01 | 1.40e-01 | 8.15e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 31 | 1.77e-01 | -1.40e-01 | 6.42e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 16 | 3.32e-01 | -1.40e-01 | 7.78e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 52 | 8.10e-02 | 1.40e-01 | 4.99e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 89 | 2.26e-02 | 1.40e-01 | 3.16e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 95 | 1.86e-02 | 1.40e-01 | 2.95e-01 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 36 | 1.47e-01 | -1.40e-01 | 6.07e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 90 | 2.20e-02 | 1.40e-01 | 3.12e-01 |
| GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 12 | 4.02e-01 | 1.40e-01 | 8.16e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 7 | 5.22e-01 | 1.40e-01 | 8.72e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 33 | 1.65e-01 | -1.40e-01 | 6.26e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 51 | 8.47e-02 | 1.40e-01 | 5.05e-01 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 9 | 4.68e-01 | -1.40e-01 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 13 | 3.84e-01 | 1.39e-01 | 8.09e-01 |
| GOBP HEART GROWTH | 46 | 1.02e-01 | 1.39e-01 | 5.37e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 16 | 3.34e-01 | 1.39e-01 | 7.80e-01 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 26 | 2.19e-01 | 1.39e-01 | 6.82e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 25 | 2.28e-01 | 1.39e-01 | 6.91e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 35 | 1.54e-01 | 1.39e-01 | 6.16e-01 |
| GOCC CKM COMPLEX | 5 | 5.90e-01 | 1.39e-01 | 8.93e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 42 | 1.19e-01 | -1.39e-01 | 5.69e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 8 | 4.96e-01 | -1.39e-01 | 8.62e-01 |
| GOBP GOLGI DISASSEMBLY | 6 | 5.56e-01 | -1.39e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 17 | 3.22e-01 | -1.39e-01 | 7.70e-01 |
| GOCC MICOS COMPLEX | 8 | 4.97e-01 | -1.39e-01 | 8.62e-01 |
| GOBP INTESTINAL EPITHELIAL CELL MATURATION | 5 | 5.91e-01 | 1.39e-01 | 8.94e-01 |
| GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 7 | 5.25e-01 | 1.39e-01 | 8.73e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 17 | 3.23e-01 | 1.39e-01 | 7.71e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 31 | 1.82e-01 | 1.39e-01 | 6.50e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 15 | 3.53e-01 | 1.39e-01 | 7.92e-01 |
| GOBP CARTILAGE DEVELOPMENT | 102 | 1.58e-02 | 1.38e-01 | 2.81e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 71 | 4.38e-02 | 1.38e-01 | 3.92e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 19 | 2.96e-01 | -1.38e-01 | 7.54e-01 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 10 | 4.49e-01 | -1.38e-01 | 8.41e-01 |
| GOBP INNER EAR MORPHOGENESIS | 40 | 1.30e-01 | 1.38e-01 | 5.82e-01 |
| GOBP RNA GUANINE N7 METHYLATION | 7 | 5.27e-01 | -1.38e-01 | 8.74e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 13 | 3.89e-01 | 1.38e-01 | 8.11e-01 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 8 | 4.99e-01 | -1.38e-01 | 8.63e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 8 | 4.99e-01 | -1.38e-01 | 8.63e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 30 | 1.91e-01 | 1.38e-01 | 6.61e-01 |
| GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 9 | 4.74e-01 | -1.38e-01 | 8.50e-01 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 7 | 5.28e-01 | 1.38e-01 | 8.74e-01 |
| GOBP AXONAL FASCICULATION | 11 | 4.29e-01 | 1.38e-01 | 8.30e-01 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 7 | 5.28e-01 | -1.38e-01 | 8.74e-01 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 5 | 5.94e-01 | -1.38e-01 | 8.94e-01 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 8 | 5.00e-01 | -1.38e-01 | 8.63e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 14 | 3.72e-01 | 1.38e-01 | 8.04e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 4.09e-01 | 1.38e-01 | 8.19e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 13 | 3.90e-01 | 1.38e-01 | 8.11e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 8 | 5.00e-01 | -1.38e-01 | 8.63e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 4.51e-01 | 1.38e-01 | 8.42e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 27 | 2.16e-01 | 1.38e-01 | 6.80e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 107 | 1.40e-02 | -1.38e-01 | 2.66e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 10 | 4.51e-01 | 1.38e-01 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 32 | 1.78e-01 | -1.38e-01 | 6.44e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH | 6 | 5.60e-01 | -1.37e-01 | 8.79e-01 |
| GOBP STEM CELL DIVISION | 21 | 2.76e-01 | 1.37e-01 | 7.38e-01 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 156 | 3.11e-03 | 1.37e-01 | 1.33e-01 |
| GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 5 | 5.95e-01 | 1.37e-01 | 8.95e-01 |
| GOMF ATP DEPENDENT DNA DNA ANNEALING ACTIVITY | 5 | 5.95e-01 | 1.37e-01 | 8.95e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 39 | 1.38e-01 | 1.37e-01 | 5.95e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 160 | 2.77e-03 | 1.37e-01 | 1.23e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 65 | 5.57e-02 | -1.37e-01 | 4.34e-01 |
| GOBP NEUROMUSCULAR PROCESS | 89 | 2.54e-02 | 1.37e-01 | 3.23e-01 |
| GOCC DENDRITIC SHAFT | 24 | 2.45e-01 | 1.37e-01 | 7.09e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 11 | 4.31e-01 | 1.37e-01 | 8.30e-01 |
| GOBP EMBRYONIC HEMOPOIESIS | 15 | 3.58e-01 | 1.37e-01 | 7.92e-01 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 5.95e-01 | -1.37e-01 | 8.95e-01 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 16 | 3.43e-01 | -1.37e-01 | 7.87e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 24 | 2.45e-01 | 1.37e-01 | 7.09e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 23 | 2.56e-01 | -1.37e-01 | 7.18e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 8 | 5.02e-01 | 1.37e-01 | 8.63e-01 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 4.77e-01 | 1.37e-01 | 8.52e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 15 | 3.59e-01 | -1.37e-01 | 7.93e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 41 | 1.30e-01 | 1.37e-01 | 5.82e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 37 | 1.50e-01 | -1.37e-01 | 6.11e-01 |
| GOBP REGULATION OF CYTOKINESIS | 72 | 4.50e-02 | 1.37e-01 | 3.96e-01 |
| GOCC CALCINEURIN COMPLEX | 5 | 5.96e-01 | 1.37e-01 | 8.96e-01 |
| GOBP NAIL DEVELOPMENT | 6 | 5.62e-01 | -1.37e-01 | 8.80e-01 |
| GOMF DNA CLAMP LOADER ACTIVITY | 8 | 5.03e-01 | -1.37e-01 | 8.64e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 26 | 2.28e-01 | 1.37e-01 | 6.91e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 21 | 2.79e-01 | -1.37e-01 | 7.39e-01 |
| GOCC REPLISOME | 14 | 3.76e-01 | 1.37e-01 | 8.05e-01 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 38 | 1.45e-01 | -1.37e-01 | 6.05e-01 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 84 | 3.06e-02 | -1.37e-01 | 3.50e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 6 | 5.63e-01 | 1.36e-01 | 8.80e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 5 | 5.97e-01 | 1.36e-01 | 8.97e-01 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 7 | 5.32e-01 | -1.36e-01 | 8.75e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 14 | 3.77e-01 | -1.36e-01 | 8.05e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 5.63e-01 | 1.36e-01 | 8.80e-01 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 5.63e-01 | -1.36e-01 | 8.80e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 12 | 4.14e-01 | 1.36e-01 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 45 | 1.14e-01 | -1.36e-01 | 5.61e-01 |
| GOBP RNA DESTABILIZATION | 96 | 2.11e-02 | 1.36e-01 | 3.07e-01 |
| GOMF TROPOMYOSIN BINDING | 8 | 5.04e-01 | -1.36e-01 | 8.64e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 47 | 1.06e-01 | -1.36e-01 | 5.43e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 5.33e-01 | 1.36e-01 | 8.75e-01 |
| GOBP NEURAL CREST FORMATION | 9 | 4.80e-01 | -1.36e-01 | 8.52e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 9 | 4.80e-01 | 1.36e-01 | 8.52e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 25 | 2.39e-01 | 1.36e-01 | 7.04e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 98 | 2.00e-02 | -1.36e-01 | 3.02e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 62 | 6.41e-02 | 1.36e-01 | 4.63e-01 |
| GOBP NEPHRON MORPHOGENESIS | 31 | 1.90e-01 | 1.36e-01 | 6.61e-01 |
| GOBP NUCLEOSIDE SALVAGE | 10 | 4.57e-01 | -1.36e-01 | 8.43e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 8 | 5.05e-01 | 1.36e-01 | 8.65e-01 |
| GOCC SARCOLEMMA | 87 | 2.86e-02 | 1.36e-01 | 3.42e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 84 | 3.15e-02 | -1.36e-01 | 3.52e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING | 5 | 5.99e-01 | -1.36e-01 | 8.97e-01 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 5 | 6.00e-01 | 1.36e-01 | 8.97e-01 |
| GOBP INTERLEUKIN 12 PRODUCTION | 50 | 9.75e-02 | -1.36e-01 | 5.27e-01 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 8 | 5.07e-01 | 1.36e-01 | 8.66e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 67 | 5.52e-02 | 1.36e-01 | 4.33e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 86 | 3.00e-02 | 1.35e-01 | 3.50e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 12 | 4.17e-01 | -1.35e-01 | 8.22e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 7 | 5.35e-01 | 1.35e-01 | 8.76e-01 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 5.66e-01 | -1.35e-01 | 8.81e-01 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 36 | 1.60e-01 | -1.35e-01 | 6.20e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 25 | 2.42e-01 | 1.35e-01 | 7.07e-01 |
| GOBP PROTEIN DELIPIDATION | 5 | 6.01e-01 | -1.35e-01 | 8.97e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 14 | 3.81e-01 | 1.35e-01 | 8.07e-01 |
| GOBP UBIQUITIN RECYCLING | 13 | 3.99e-01 | -1.35e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 39 | 1.45e-01 | 1.35e-01 | 6.04e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 23 | 2.62e-01 | -1.35e-01 | 7.24e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 7 | 5.36e-01 | 1.35e-01 | 8.76e-01 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 8 | 5.09e-01 | 1.35e-01 | 8.67e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 5.09e-01 | 1.35e-01 | 8.67e-01 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 6 | 5.67e-01 | 1.35e-01 | 8.82e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 58 | 7.61e-02 | 1.35e-01 | 4.91e-01 |
| GOBP FEMALE GAMETE GENERATION | 95 | 2.34e-02 | 1.35e-01 | 3.18e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 9 | 4.84e-01 | 1.35e-01 | 8.55e-01 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 5.68e-01 | 1.35e-01 | 8.82e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 50 | 9.99e-02 | -1.35e-01 | 5.32e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 64 | 6.28e-02 | -1.35e-01 | 4.57e-01 |
| GOBP REGULATION OF BONE REMODELING | 34 | 1.75e-01 | 1.35e-01 | 6.38e-01 |
| GOBP AMYLOID BETA CLEARANCE | 30 | 2.02e-01 | -1.35e-01 | 6.69e-01 |
| GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 6.02e-01 | -1.35e-01 | 8.97e-01 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 5 | 6.02e-01 | -1.35e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 10 | 4.61e-01 | -1.35e-01 | 8.45e-01 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 11 | 4.40e-01 | 1.34e-01 | 8.37e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 38 | 1.52e-01 | 1.34e-01 | 6.13e-01 |
| GOBP NEURON FATE COMMITMENT | 18 | 3.24e-01 | 1.34e-01 | 7.72e-01 |
| GOMF SIRNA BINDING | 9 | 4.85e-01 | -1.34e-01 | 8.55e-01 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 4.85e-01 | 1.34e-01 | 8.55e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 5 | 6.03e-01 | -1.34e-01 | 8.97e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 22 | 2.76e-01 | 1.34e-01 | 7.38e-01 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 5.69e-01 | 1.34e-01 | 8.83e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 6 | 5.70e-01 | 1.34e-01 | 8.83e-01 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.70e-01 | 1.34e-01 | 8.83e-01 |
| GOBP SYNAPSE PRUNING | 8 | 5.12e-01 | 1.34e-01 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 5 | 6.04e-01 | -1.34e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 10 | 4.64e-01 | 1.34e-01 | 8.47e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 105 | 1.79e-02 | -1.34e-01 | 2.95e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 10 | 4.64e-01 | 1.34e-01 | 8.47e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION | 6 | 5.70e-01 | 1.34e-01 | 8.83e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 179 | 2.06e-03 | -1.34e-01 | 1.04e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 31 | 1.98e-01 | 1.34e-01 | 6.67e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 7 | 5.40e-01 | 1.34e-01 | 8.76e-01 |
| GOMF MHC PROTEIN BINDING | 21 | 2.89e-01 | -1.34e-01 | 7.49e-01 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 12 | 4.23e-01 | -1.34e-01 | 8.25e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 8 | 5.13e-01 | -1.34e-01 | 8.67e-01 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 7 | 5.40e-01 | 1.34e-01 | 8.76e-01 |
| GOBP RESPONSE TO VITAMIN D | 22 | 2.78e-01 | 1.34e-01 | 7.39e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 43 | 1.30e-01 | -1.34e-01 | 5.82e-01 |
| GOMF PRIMARY MIRNA BINDING | 10 | 4.65e-01 | -1.34e-01 | 8.48e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 33 | 1.85e-01 | 1.33e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 18 | 3.27e-01 | 1.33e-01 | 7.75e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 8 | 5.14e-01 | 1.33e-01 | 8.67e-01 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 19 | 3.14e-01 | -1.33e-01 | 7.66e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 132 | 8.26e-03 | -1.33e-01 | 2.14e-01 |
| GOBP ICOSANOID METABOLIC PROCESS | 65 | 6.32e-02 | -1.33e-01 | 4.59e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 21 | 2.90e-01 | 1.33e-01 | 7.49e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 26 | 2.40e-01 | 1.33e-01 | 7.05e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 4.66e-01 | 1.33e-01 | 8.48e-01 |
| GOBP TUBULIN DEACETYLATION | 19 | 3.15e-01 | -1.33e-01 | 7.66e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 14 | 3.88e-01 | 1.33e-01 | 8.11e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 55 | 8.80e-02 | 1.33e-01 | 5.10e-01 |
| GOBP NEGATIVE REGULATION OF G0 TO G1 TRANSITION | 5 | 6.07e-01 | 1.33e-01 | 8.99e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 26 | 2.41e-01 | 1.33e-01 | 7.06e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 20 | 3.04e-01 | 1.33e-01 | 7.59e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.43e-01 | 1.33e-01 | 8.76e-01 |
| GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 8 | 5.16e-01 | -1.33e-01 | 8.68e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 14 | 3.90e-01 | -1.33e-01 | 8.11e-01 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 9 | 4.91e-01 | -1.33e-01 | 8.58e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 17 | 3.44e-01 | 1.33e-01 | 7.88e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 34 | 1.81e-01 | -1.33e-01 | 6.49e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 8 | 5.16e-01 | 1.33e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 21 | 2.93e-01 | 1.32e-01 | 7.52e-01 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 162 | 3.68e-03 | -1.32e-01 | 1.46e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 6.08e-01 | -1.32e-01 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 18 | 3.31e-01 | 1.32e-01 | 7.78e-01 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 6 | 5.75e-01 | -1.32e-01 | 8.86e-01 |
| GOBP EPITHELIAL CELL CELL ADHESION | 12 | 4.28e-01 | 1.32e-01 | 8.30e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 29 | 2.18e-01 | 1.32e-01 | 6.82e-01 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 39 | 1.53e-01 | 1.32e-01 | 6.14e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 9 | 4.92e-01 | -1.32e-01 | 8.59e-01 |
| GOMF SNORNA BINDING | 32 | 1.96e-01 | -1.32e-01 | 6.67e-01 |
| GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 78 | 4.38e-02 | -1.32e-01 | 3.92e-01 |
| GOBP CARDIAC CELL FATE COMMITMENT | 5 | 6.09e-01 | -1.32e-01 | 8.99e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 23 | 2.73e-01 | -1.32e-01 | 7.36e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 37 | 1.65e-01 | -1.32e-01 | 6.26e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 142 | 6.68e-03 | -1.32e-01 | 1.93e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 8 | 5.18e-01 | -1.32e-01 | 8.70e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 24 | 2.63e-01 | 1.32e-01 | 7.24e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 29 | 2.19e-01 | -1.32e-01 | 6.82e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 10 | 4.70e-01 | 1.32e-01 | 8.49e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 32 | 1.97e-01 | -1.32e-01 | 6.67e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 25 | 2.54e-01 | -1.32e-01 | 7.18e-01 |
| GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX | 5 | 6.10e-01 | 1.32e-01 | 8.99e-01 |
| GOBP INTRACILIARY TRANSPORT | 41 | 1.44e-01 | 1.32e-01 | 6.04e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 16 | 3.62e-01 | 1.32e-01 | 7.95e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 28 | 2.28e-01 | -1.32e-01 | 6.91e-01 |
| GOBP TISSUE REGENERATION | 43 | 1.35e-01 | 1.32e-01 | 5.90e-01 |
| GOMF ANNEALING ACTIVITY | 10 | 4.71e-01 | 1.32e-01 | 8.49e-01 |
| GOMF STEROL BINDING | 45 | 1.27e-01 | 1.32e-01 | 5.76e-01 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 5 | 6.10e-01 | 1.32e-01 | 8.99e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 23 | 2.75e-01 | -1.32e-01 | 7.38e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 11 | 4.50e-01 | -1.32e-01 | 8.42e-01 |
| GOMF NADPH BINDING | 15 | 3.78e-01 | 1.32e-01 | 8.05e-01 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 14 | 3.95e-01 | -1.31e-01 | 8.14e-01 |
| GOBP ENDODERM DEVELOPMENT | 48 | 1.16e-01 | 1.31e-01 | 5.65e-01 |
| GOMF FERRIC IRON BINDING | 5 | 6.11e-01 | -1.31e-01 | 9.00e-01 |
| GOBP AXON GUIDANCE | 110 | 1.75e-02 | 1.31e-01 | 2.95e-01 |
| GOBP RHYTHMIC PROCESS | 195 | 1.61e-03 | 1.31e-01 | 9.00e-02 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 73 | 5.28e-02 | 1.31e-01 | 4.25e-01 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 23 | 2.76e-01 | -1.31e-01 | 7.38e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 82 | 4.02e-02 | -1.31e-01 | 3.86e-01 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 20 | 3.10e-01 | -1.31e-01 | 7.64e-01 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 50 | 1.09e-01 | 1.31e-01 | 5.51e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 45 | 1.28e-01 | -1.31e-01 | 5.80e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 10 | 4.73e-01 | 1.31e-01 | 8.50e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 10 | 4.73e-01 | -1.31e-01 | 8.50e-01 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 85 | 3.72e-02 | 1.31e-01 | 3.76e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 8 | 5.22e-01 | -1.31e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 13 | 4.14e-01 | 1.31e-01 | 8.21e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 273 | 2.10e-04 | -1.31e-01 | 2.47e-02 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 11 | 4.53e-01 | 1.31e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 17 | 3.51e-01 | 1.31e-01 | 7.90e-01 |
| GOBP SALIVARY GLAND DEVELOPMENT | 19 | 3.24e-01 | 1.31e-01 | 7.73e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 70 | 5.89e-02 | 1.31e-01 | 4.45e-01 |
| GOBP DENSE CORE GRANULE LOCALIZATION | 5 | 6.13e-01 | -1.31e-01 | 9.01e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 8 | 5.23e-01 | 1.31e-01 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 6 | 5.80e-01 | 1.31e-01 | 8.88e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 67 | 6.48e-02 | 1.31e-01 | 4.66e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 14 | 3.98e-01 | 1.31e-01 | 8.15e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 70 | 5.92e-02 | -1.31e-01 | 4.45e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 7 | 5.50e-01 | 1.30e-01 | 8.78e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 59 | 8.34e-02 | -1.30e-01 | 5.02e-01 |
| GOBP G0 TO G1 TRANSITION | 33 | 1.95e-01 | 1.30e-01 | 6.66e-01 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 18 | 3.38e-01 | -1.30e-01 | 7.83e-01 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 17 | 3.52e-01 | 1.30e-01 | 7.91e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 14 | 3.98e-01 | -1.30e-01 | 8.15e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 73 | 5.44e-02 | -1.30e-01 | 4.31e-01 |
| GOBP INSULIN METABOLIC PROCESS | 11 | 4.55e-01 | -1.30e-01 | 8.42e-01 |
| GOCC INCLUSION BODY | 57 | 8.92e-02 | 1.30e-01 | 5.12e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 52 | 1.05e-01 | 1.30e-01 | 5.42e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 46 | 1.27e-01 | -1.30e-01 | 5.77e-01 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 6 | 5.81e-01 | -1.30e-01 | 8.89e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 112 | 1.76e-02 | 1.30e-01 | 2.95e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 27 | 2.43e-01 | 1.30e-01 | 7.08e-01 |
| GOBP TRYPTOPHAN TRANSPORT | 5 | 6.15e-01 | -1.30e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 27 | 2.43e-01 | -1.30e-01 | 7.08e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 8 | 5.25e-01 | -1.30e-01 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 97 | 2.74e-02 | -1.30e-01 | 3.35e-01 |
| GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 20 | 3.16e-01 | 1.30e-01 | 7.66e-01 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 6.16e-01 | 1.30e-01 | 9.02e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS | 6 | 5.83e-01 | -1.30e-01 | 8.90e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 19 | 3.28e-01 | 1.30e-01 | 7.77e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 5.26e-01 | 1.30e-01 | 8.73e-01 |
| GOBP FEVER GENERATION | 7 | 5.53e-01 | 1.30e-01 | 8.79e-01 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 7 | 5.53e-01 | 1.29e-01 | 8.79e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 24 | 2.72e-01 | 1.29e-01 | 7.36e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 5.53e-01 | 1.29e-01 | 8.79e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 101 | 2.48e-02 | -1.29e-01 | 3.23e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 10 | 4.79e-01 | -1.29e-01 | 8.52e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 46 | 1.29e-01 | 1.29e-01 | 5.82e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 36 | 1.79e-01 | -1.29e-01 | 6.46e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 13 | 4.20e-01 | 1.29e-01 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 76 | 5.17e-02 | 1.29e-01 | 4.19e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 33 | 1.99e-01 | -1.29e-01 | 6.68e-01 |
| GOBP BONE MORPHOGENESIS | 49 | 1.18e-01 | 1.29e-01 | 5.69e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 61 | 8.13e-02 | 1.29e-01 | 4.99e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 18 | 3.43e-01 | -1.29e-01 | 7.87e-01 |
| GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 10 | 4.80e-01 | -1.29e-01 | 8.52e-01 |
| GOBP TRANSLATIONAL ELONGATION | 61 | 8.14e-02 | -1.29e-01 | 4.99e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 76 | 5.19e-02 | 1.29e-01 | 4.20e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 18 | 3.43e-01 | 1.29e-01 | 7.87e-01 |
| GOBP DETECTION OF LIPOPOLYSACCHARIDE | 5 | 6.17e-01 | -1.29e-01 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 13 | 4.21e-01 | -1.29e-01 | 8.24e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 20 | 3.18e-01 | 1.29e-01 | 7.67e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 30 | 2.21e-01 | 1.29e-01 | 6.84e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 12 | 4.39e-01 | 1.29e-01 | 8.36e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 237 | 6.45e-04 | -1.29e-01 | 4.98e-02 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 12 | 4.40e-01 | 1.29e-01 | 8.36e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 19 | 3.31e-01 | -1.29e-01 | 7.78e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 22 | 2.96e-01 | -1.29e-01 | 7.54e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 9 | 5.03e-01 | 1.29e-01 | 8.64e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 24 | 2.75e-01 | 1.29e-01 | 7.38e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 42 | 1.49e-01 | 1.29e-01 | 6.08e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 10 | 4.81e-01 | 1.29e-01 | 8.53e-01 |
| GOMF PRERIBOSOME BINDING | 8 | 5.28e-01 | 1.29e-01 | 8.74e-01 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 12 | 4.40e-01 | 1.29e-01 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 5.29e-01 | -1.29e-01 | 8.74e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 56 | 9.60e-02 | -1.29e-01 | 5.26e-01 |
| GOBP AORTIC VALVE MORPHOGENESIS | 17 | 3.58e-01 | 1.29e-01 | 7.93e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 20 | 3.19e-01 | -1.29e-01 | 7.68e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 14 | 4.05e-01 | -1.29e-01 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 29 | 2.31e-01 | -1.29e-01 | 6.94e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 11 | 4.60e-01 | -1.29e-01 | 8.45e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 88 | 3.73e-02 | -1.29e-01 | 3.76e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 44 | 1.40e-01 | 1.28e-01 | 5.98e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 6 | 5.86e-01 | 1.28e-01 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 21 | 3.08e-01 | -1.28e-01 | 7.62e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 48 | 1.24e-01 | 1.28e-01 | 5.72e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 6 | 5.86e-01 | 1.28e-01 | 8.92e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 9 | 5.05e-01 | 1.28e-01 | 8.65e-01 |
| GOBP GROWTH HORMONE SECRETION | 7 | 5.57e-01 | 1.28e-01 | 8.79e-01 |
| GOBP PONS DEVELOPMENT | 7 | 5.57e-01 | -1.28e-01 | 8.79e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 17 | 3.60e-01 | -1.28e-01 | 7.94e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 56 | 9.72e-02 | -1.28e-01 | 5.27e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 16 | 3.75e-01 | 1.28e-01 | 8.05e-01 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 7 | 5.57e-01 | -1.28e-01 | 8.79e-01 |
| GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY | 5 | 6.20e-01 | -1.28e-01 | 9.03e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 12 | 4.42e-01 | -1.28e-01 | 8.37e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 270 | 3.02e-04 | -1.28e-01 | 3.16e-02 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 7 | 5.57e-01 | 1.28e-01 | 8.79e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 40 | 1.61e-01 | 1.28e-01 | 6.20e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 7 | 5.58e-01 | -1.28e-01 | 8.79e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 38 | 1.72e-01 | 1.28e-01 | 6.36e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL CHEMOTAXIS | 5 | 6.20e-01 | 1.28e-01 | 9.03e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 49 | 1.22e-01 | -1.28e-01 | 5.71e-01 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 9 | 5.07e-01 | 1.28e-01 | 8.66e-01 |
| GOMF LYSINE ACETYLATED HISTONE BINDING | 22 | 2.99e-01 | 1.28e-01 | 7.55e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 5.31e-01 | -1.28e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 94 | 3.24e-02 | 1.28e-01 | 3.56e-01 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 7 | 5.58e-01 | 1.28e-01 | 8.79e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 16 | 3.76e-01 | -1.28e-01 | 8.05e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 105 | 2.39e-02 | -1.28e-01 | 3.19e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 10 | 4.85e-01 | 1.28e-01 | 8.55e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 7 | 5.59e-01 | -1.28e-01 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 71 | 6.31e-02 | 1.28e-01 | 4.58e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 5 | 6.21e-01 | -1.28e-01 | 9.03e-01 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 63 | 7.99e-02 | -1.28e-01 | 4.98e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 5.59e-01 | 1.28e-01 | 8.79e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 31 | 2.19e-01 | 1.28e-01 | 6.82e-01 |
| GOBP IRON SULFUR CLUSTER ASSEMBLY | 29 | 2.34e-01 | -1.28e-01 | 6.98e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 67 | 7.11e-02 | 1.28e-01 | 4.78e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 91 | 3.56e-02 | -1.28e-01 | 3.68e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 9 | 5.08e-01 | 1.28e-01 | 8.66e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 531 | 5.73e-07 | -1.27e-01 | 2.27e-04 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 17 | 3.63e-01 | 1.27e-01 | 7.97e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 18 | 3.49e-01 | -1.27e-01 | 7.90e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 5.08e-01 | 1.27e-01 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 12 | 4.45e-01 | 1.27e-01 | 8.40e-01 |
| GOBP UTERUS DEVELOPMENT | 12 | 4.45e-01 | 1.27e-01 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 124 | 1.44e-02 | -1.27e-01 | 2.70e-01 |
| GOBP HEME TRANSPORT | 8 | 5.33e-01 | 1.27e-01 | 8.75e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 5.33e-01 | 1.27e-01 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 11 | 4.65e-01 | 1.27e-01 | 8.48e-01 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 27 | 2.53e-01 | 1.27e-01 | 7.18e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 14 | 4.10e-01 | -1.27e-01 | 8.19e-01 |
| GOBP LIPID IMPORT INTO CELL | 15 | 3.94e-01 | 1.27e-01 | 8.14e-01 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 7 | 5.60e-01 | 1.27e-01 | 8.79e-01 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 6 | 5.90e-01 | -1.27e-01 | 8.93e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 31 | 2.21e-01 | -1.27e-01 | 6.83e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 40 | 1.65e-01 | 1.27e-01 | 6.26e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 40 | 1.65e-01 | -1.27e-01 | 6.26e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 8 | 5.34e-01 | 1.27e-01 | 8.75e-01 |
| GOCC SNARE COMPLEX | 41 | 1.60e-01 | -1.27e-01 | 6.20e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 5.90e-01 | -1.27e-01 | 8.93e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 8 | 5.34e-01 | -1.27e-01 | 8.75e-01 |
| GOMF ACTININ BINDING | 19 | 3.38e-01 | -1.27e-01 | 7.83e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 55 | 1.04e-01 | 1.27e-01 | 5.41e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 187 | 2.83e-03 | 1.27e-01 | 1.25e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 177 | 3.67e-03 | 1.27e-01 | 1.46e-01 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 13 | 4.29e-01 | -1.27e-01 | 8.30e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 44 | 1.46e-01 | -1.27e-01 | 6.06e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 46 | 1.38e-01 | -1.27e-01 | 5.95e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 94 | 3.41e-02 | -1.27e-01 | 3.63e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 77 | 5.51e-02 | -1.27e-01 | 4.33e-01 |
| GOCC COMMITMENT COMPLEX | 5 | 6.24e-01 | 1.27e-01 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 8 | 5.36e-01 | -1.26e-01 | 8.76e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 24 | 2.84e-01 | -1.26e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 98 | 3.07e-02 | -1.26e-01 | 3.50e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 91 | 3.73e-02 | 1.26e-01 | 3.76e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 19 | 3.40e-01 | 1.26e-01 | 7.85e-01 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 12 | 4.49e-01 | 1.26e-01 | 8.41e-01 |
| GOMF TELOMERASE RNA BINDING | 21 | 3.16e-01 | 1.26e-01 | 7.66e-01 |
| GOCC SECRETORY GRANULE | 624 | 8.75e-08 | -1.26e-01 | 4.77e-05 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 10 | 4.90e-01 | 1.26e-01 | 8.57e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 12 | 4.49e-01 | -1.26e-01 | 8.42e-01 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 26 | 2.66e-01 | 1.26e-01 | 7.27e-01 |
| GOCC GOLGI CIS CISTERNA | 9 | 5.12e-01 | 1.26e-01 | 8.67e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 29 | 2.40e-01 | -1.26e-01 | 7.05e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 4.90e-01 | -1.26e-01 | 8.58e-01 |
| GOBP PROTEIN POLYGLUTAMYLATION | 7 | 5.64e-01 | 1.26e-01 | 8.80e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 33 | 2.11e-01 | 1.26e-01 | 6.75e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 14 | 4.15e-01 | -1.26e-01 | 8.21e-01 |
| GOBP ORGANIC CATION TRANSPORT | 34 | 2.04e-01 | 1.26e-01 | 6.72e-01 |
| GOMF FILAMIN BINDING | 9 | 5.13e-01 | -1.26e-01 | 8.67e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 29 | 2.41e-01 | 1.26e-01 | 7.06e-01 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 12 | 4.51e-01 | -1.26e-01 | 8.42e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 8 | 5.38e-01 | 1.26e-01 | 8.76e-01 |
| GOMF BH DOMAIN BINDING | 8 | 5.38e-01 | -1.26e-01 | 8.76e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 32 | 2.18e-01 | -1.26e-01 | 6.82e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 177 | 4.02e-03 | -1.26e-01 | 1.52e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 8 | 5.39e-01 | 1.26e-01 | 8.76e-01 |
| GOBP T CELL HOMEOSTASIS | 36 | 1.93e-01 | -1.25e-01 | 6.65e-01 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 16 | 3.85e-01 | -1.25e-01 | 8.09e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 81 | 5.13e-02 | -1.25e-01 | 4.18e-01 |
| GOBP DNA REPLICATION INITIATION | 31 | 2.27e-01 | 1.25e-01 | 6.91e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 154 | 7.35e-03 | -1.25e-01 | 2.03e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 21 | 3.20e-01 | -1.25e-01 | 7.69e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 23 | 2.98e-01 | -1.25e-01 | 7.55e-01 |
| GOBP V D J RECOMBINATION | 16 | 3.86e-01 | 1.25e-01 | 8.09e-01 |
| GOBP CELLULAR RESPIRATION | 214 | 1.62e-03 | -1.25e-01 | 9.00e-02 |
| GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS | 5 | 6.28e-01 | 1.25e-01 | 9.04e-01 |
| GOMF QUINONE BINDING | 14 | 4.17e-01 | -1.25e-01 | 8.22e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 10 | 4.93e-01 | 1.25e-01 | 8.59e-01 |
| GOBP HISTONE H3 K4 METHYLATION | 19 | 3.45e-01 | 1.25e-01 | 7.88e-01 |
| GOBP AMINE CATABOLIC PROCESS | 11 | 4.72e-01 | -1.25e-01 | 8.50e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 20 | 3.33e-01 | -1.25e-01 | 7.78e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 24 | 2.89e-01 | 1.25e-01 | 7.49e-01 |
| GOBP ORGAN INDUCTION | 6 | 5.96e-01 | -1.25e-01 | 8.96e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 11 | 4.73e-01 | -1.25e-01 | 8.50e-01 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 7 | 5.67e-01 | 1.25e-01 | 8.82e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 72 | 6.68e-02 | -1.25e-01 | 4.70e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 8 | 5.41e-01 | -1.25e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 5 | 6.29e-01 | -1.25e-01 | 9.04e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 15 | 4.02e-01 | 1.25e-01 | 8.16e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 8 | 5.41e-01 | -1.25e-01 | 8.76e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 43 | 1.57e-01 | 1.25e-01 | 6.19e-01 |
| GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL | 5 | 6.29e-01 | -1.25e-01 | 9.04e-01 |
| GOCC GROWTH CONE MEMBRANE | 5 | 6.29e-01 | -1.25e-01 | 9.04e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 64 | 8.45e-02 | 1.25e-01 | 5.04e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 11 | 4.74e-01 | -1.25e-01 | 8.50e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 44 | 1.53e-01 | -1.25e-01 | 6.13e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 30 | 2.37e-01 | -1.25e-01 | 7.01e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 168 | 5.38e-03 | 1.25e-01 | 1.77e-01 |
| GOBP NEURAL FOLD FORMATION | 5 | 6.30e-01 | -1.25e-01 | 9.04e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 21 | 3.23e-01 | -1.25e-01 | 7.71e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 49 | 1.32e-01 | -1.24e-01 | 5.84e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 17 | 3.75e-01 | -1.24e-01 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 22 | 3.13e-01 | -1.24e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 6.30e-01 | -1.24e-01 | 9.04e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 102 | 3.03e-02 | 1.24e-01 | 3.50e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 21 | 3.25e-01 | 1.24e-01 | 7.73e-01 |
| GOMF PH DOMAIN BINDING | 7 | 5.70e-01 | 1.24e-01 | 8.83e-01 |
| GOCC ASTROCYTE PROJECTION | 7 | 5.70e-01 | 1.24e-01 | 8.83e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 5.99e-01 | -1.24e-01 | 8.97e-01 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 52 | 1.23e-01 | 1.24e-01 | 5.71e-01 |
| GOBP GLIAL CELL MIGRATION | 43 | 1.61e-01 | 1.24e-01 | 6.20e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 102 | 3.10e-02 | -1.24e-01 | 3.52e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 91 | 4.16e-02 | -1.24e-01 | 3.86e-01 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 48 | 1.38e-01 | 1.24e-01 | 5.96e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 30 | 2.42e-01 | -1.24e-01 | 7.06e-01 |
| GOBP MOLTING CYCLE PROCESS | 47 | 1.43e-01 | 1.24e-01 | 6.01e-01 |
| GOBP POLYOL TRANSMEMBRANE TRANSPORT | 5 | 6.33e-01 | -1.23e-01 | 9.04e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 9 | 5.22e-01 | -1.23e-01 | 8.72e-01 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 9 | 5.22e-01 | -1.23e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 7 | 5.72e-01 | 1.23e-01 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 78 | 6.01e-02 | 1.23e-01 | 4.47e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 13 | 4.42e-01 | -1.23e-01 | 8.37e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 22 | 3.18e-01 | -1.23e-01 | 7.67e-01 |
| GOCC EXOCYST | 11 | 4.80e-01 | -1.23e-01 | 8.52e-01 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 6 | 6.02e-01 | 1.23e-01 | 8.97e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 10 | 5.01e-01 | 1.23e-01 | 8.63e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 41 | 1.73e-01 | 1.23e-01 | 6.37e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 15 | 4.10e-01 | 1.23e-01 | 8.19e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 12 | 4.61e-01 | -1.23e-01 | 8.45e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 11 | 4.80e-01 | -1.23e-01 | 8.53e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 6 | 6.02e-01 | 1.23e-01 | 8.97e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 9 | 5.23e-01 | 1.23e-01 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 9 | 5.24e-01 | -1.23e-01 | 8.73e-01 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 8 | 5.48e-01 | -1.23e-01 | 8.78e-01 |
| GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 10 | 5.02e-01 | -1.23e-01 | 8.63e-01 |
| GOBP TOXIN METABOLIC PROCESS | 7 | 5.74e-01 | 1.23e-01 | 8.85e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 19 | 3.55e-01 | -1.23e-01 | 7.92e-01 |
| GOCC APICAL DENDRITE | 10 | 5.02e-01 | -1.23e-01 | 8.63e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 17 | 3.81e-01 | 1.23e-01 | 8.07e-01 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 17 | 3.81e-01 | -1.23e-01 | 8.07e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 7 | 5.74e-01 | 1.23e-01 | 8.86e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 10 | 5.03e-01 | -1.22e-01 | 8.63e-01 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 7 | 5.75e-01 | -1.22e-01 | 8.86e-01 |
| GOBP HISTONE UBIQUITINATION | 9 | 5.25e-01 | -1.22e-01 | 8.73e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 10 | 5.03e-01 | 1.22e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 16 | 3.97e-01 | 1.22e-01 | 8.15e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 4.45e-01 | 1.22e-01 | 8.40e-01 |
| GOCC MULTIVESICULAR BODY | 44 | 1.61e-01 | -1.22e-01 | 6.20e-01 |
| GOCC SPERM ANNULUS | 5 | 6.36e-01 | -1.22e-01 | 9.04e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 38 | 1.93e-01 | -1.22e-01 | 6.64e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 6.04e-01 | 1.22e-01 | 8.98e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 5.50e-01 | -1.22e-01 | 8.78e-01 |
| GOMF LYASE ACTIVITY | 149 | 1.02e-02 | -1.22e-01 | 2.36e-01 |
| GOBP RESPONSE TO UV C | 12 | 4.64e-01 | 1.22e-01 | 8.48e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 95 | 4.01e-02 | 1.22e-01 | 3.86e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 41 | 1.77e-01 | 1.22e-01 | 6.41e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 19 | 3.58e-01 | -1.22e-01 | 7.92e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 10 | 5.05e-01 | -1.22e-01 | 8.64e-01 |
| GOMF NUCLEOSIDE BINDING | 7 | 5.77e-01 | -1.22e-01 | 8.87e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 24 | 3.02e-01 | 1.22e-01 | 7.57e-01 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 5.27e-01 | -1.22e-01 | 8.74e-01 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 8 | 5.51e-01 | 1.22e-01 | 8.79e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 67 | 8.52e-02 | -1.22e-01 | 5.06e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 20 | 3.46e-01 | 1.22e-01 | 7.89e-01 |
| GOCC COPII VESICLE COAT | 16 | 4.00e-01 | 1.22e-01 | 8.15e-01 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 5.78e-01 | -1.22e-01 | 8.87e-01 |
| GOBP FACE DEVELOPMENT | 33 | 2.27e-01 | 1.22e-01 | 6.91e-01 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 5.28e-01 | 1.22e-01 | 8.74e-01 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 11 | 4.86e-01 | -1.21e-01 | 8.55e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 15 | 4.16e-01 | 1.21e-01 | 8.21e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 93 | 4.32e-02 | -1.21e-01 | 3.91e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 5 | 6.39e-01 | 1.21e-01 | 9.05e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 9 | 5.29e-01 | 1.21e-01 | 8.74e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 15 | 4.16e-01 | 1.21e-01 | 8.22e-01 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 8 | 5.53e-01 | -1.21e-01 | 8.79e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 6.39e-01 | 1.21e-01 | 9.05e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 6 | 6.07e-01 | 1.21e-01 | 8.99e-01 |
| GOCC CIS GOLGI NETWORK | 50 | 1.38e-01 | 1.21e-01 | 5.96e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 6.39e-01 | -1.21e-01 | 9.05e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 18 | 3.74e-01 | -1.21e-01 | 8.05e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 40 | 1.85e-01 | 1.21e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 19 | 3.61e-01 | -1.21e-01 | 7.94e-01 |
| GOBP SYMPATHETIC GANGLION DEVELOPMENT | 6 | 6.07e-01 | -1.21e-01 | 8.99e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 23 | 3.15e-01 | -1.21e-01 | 7.66e-01 |
| GOBP RESPONSE TO AXON INJURY | 53 | 1.27e-01 | 1.21e-01 | 5.78e-01 |
| GOCC XY BODY | 12 | 4.68e-01 | 1.21e-01 | 8.49e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 18 | 3.74e-01 | 1.21e-01 | 8.05e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 31 | 2.44e-01 | 1.21e-01 | 7.08e-01 |
| GOBP LEUKOTRIENE TRANSPORT | 6 | 6.08e-01 | 1.21e-01 | 8.99e-01 |
| GOBP REGULATION OF ANOIKIS | 17 | 3.88e-01 | 1.21e-01 | 8.11e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 41 | 1.80e-01 | -1.21e-01 | 6.48e-01 |
| GOBP PROTEASOME ASSEMBLY | 12 | 4.68e-01 | -1.21e-01 | 8.49e-01 |
| GOBP MESODERM DEVELOPMENT | 66 | 8.94e-02 | 1.21e-01 | 5.12e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 16 | 4.02e-01 | -1.21e-01 | 8.16e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 92 | 4.52e-02 | 1.21e-01 | 3.97e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 38 | 1.97e-01 | 1.21e-01 | 6.67e-01 |
| GOBP TRANSLATIONAL INITIATION | 112 | 2.73e-02 | -1.21e-01 | 3.35e-01 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 144 | 1.24e-02 | 1.21e-01 | 2.53e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 15 | 4.18e-01 | 1.21e-01 | 8.22e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 38 | 1.98e-01 | 1.21e-01 | 6.67e-01 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 20 | 3.50e-01 | 1.21e-01 | 7.90e-01 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 4.69e-01 | 1.21e-01 | 8.49e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 12 | 4.69e-01 | 1.21e-01 | 8.49e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 7 | 5.80e-01 | -1.21e-01 | 8.88e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 5 | 6.40e-01 | 1.21e-01 | 9.06e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 93 | 4.44e-02 | 1.21e-01 | 3.94e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY | 5 | 6.40e-01 | 1.21e-01 | 9.06e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 15 | 4.19e-01 | -1.21e-01 | 8.23e-01 |
| GOCC AMPHISOME | 13 | 4.51e-01 | -1.21e-01 | 8.42e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 38 | 1.99e-01 | -1.21e-01 | 6.68e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 8 | 5.55e-01 | 1.20e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 6 | 6.09e-01 | -1.20e-01 | 8.99e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 19 | 3.64e-01 | 1.20e-01 | 7.97e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 20 | 3.52e-01 | -1.20e-01 | 7.91e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 86 | 5.40e-02 | -1.20e-01 | 4.30e-01 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 41 | 1.83e-01 | -1.20e-01 | 6.51e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 72 | 7.80e-02 | -1.20e-01 | 4.96e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 50 | 1.42e-01 | 1.20e-01 | 6.00e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 30 | 2.55e-01 | -1.20e-01 | 7.18e-01 |
| GOCC MALE GERM CELL NUCLEUS | 38 | 2.01e-01 | 1.20e-01 | 6.68e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 3.78e-01 | -1.20e-01 | 8.05e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 303 | 3.45e-04 | -1.20e-01 | 3.46e-02 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 15 | 4.22e-01 | -1.20e-01 | 8.25e-01 |
| GOBP OOCYTE DIFFERENTIATION | 36 | 2.14e-01 | 1.20e-01 | 6.79e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 25 | 3.00e-01 | -1.20e-01 | 7.56e-01 |
| GOBP FAT PAD DEVELOPMENT | 7 | 5.83e-01 | 1.20e-01 | 8.90e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 41 | 1.85e-01 | -1.20e-01 | 6.53e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 53 | 1.32e-01 | 1.20e-01 | 5.84e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 6.43e-01 | -1.20e-01 | 9.06e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 5.12e-01 | -1.20e-01 | 8.67e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 136 | 1.61e-02 | 1.20e-01 | 2.82e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 8 | 5.58e-01 | -1.20e-01 | 8.79e-01 |
| GOCC G PROTEIN COUPLED RECEPTOR DIMERIC COMPLEX | 5 | 6.43e-01 | -1.20e-01 | 9.06e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 57 | 1.19e-01 | -1.20e-01 | 5.69e-01 |
| GOCC FILOPODIUM MEMBRANE | 13 | 4.56e-01 | 1.19e-01 | 8.43e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 6 | 6.12e-01 | 1.19e-01 | 9.00e-01 |
| GOBP REGULATION OF OSSIFICATION | 70 | 8.42e-02 | 1.19e-01 | 5.04e-01 |
| GOBP HISTONE DEACETYLATION | 22 | 3.32e-01 | -1.19e-01 | 7.78e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 78 | 6.87e-02 | 1.19e-01 | 4.75e-01 |
| GOMF PROTEIN FOLDING CHAPERONE | 51 | 1.41e-01 | -1.19e-01 | 5.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 57 | 1.20e-01 | -1.19e-01 | 5.69e-01 |
| GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 5 | 6.44e-01 | 1.19e-01 | 9.07e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 19 | 3.68e-01 | -1.19e-01 | 8.01e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 17 | 3.95e-01 | -1.19e-01 | 8.14e-01 |
| GOBP PEPTIDE CATABOLIC PROCESS | 17 | 3.96e-01 | -1.19e-01 | 8.14e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 25 | 3.03e-01 | -1.19e-01 | 7.59e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 15 | 4.25e-01 | 1.19e-01 | 8.28e-01 |
| GOBP AMINO ACID ACTIVATION | 26 | 2.94e-01 | 1.19e-01 | 7.53e-01 |
| GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 5.37e-01 | -1.19e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 7 | 5.86e-01 | 1.19e-01 | 8.92e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 5.87e-01 | -1.19e-01 | 8.92e-01 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 8 | 5.61e-01 | 1.19e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 6 | 6.15e-01 | -1.19e-01 | 9.02e-01 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 15 | 4.27e-01 | -1.19e-01 | 8.29e-01 |
| GOBP HEART DEVELOPMENT | 357 | 1.27e-04 | 1.18e-01 | 1.61e-02 |
| GOCC MYELIN SHEATH | 31 | 2.54e-01 | -1.18e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 5.17e-01 | -1.18e-01 | 8.69e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 26 | 2.96e-01 | 1.18e-01 | 7.54e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 13 | 4.60e-01 | 1.18e-01 | 8.45e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 6 | 6.16e-01 | -1.18e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 49 | 1.52e-01 | -1.18e-01 | 6.13e-01 |
| GOMF HORMONE ACTIVITY | 29 | 2.71e-01 | 1.18e-01 | 7.33e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 56 | 1.26e-01 | -1.18e-01 | 5.75e-01 |
| GOBP COPPER ION HOMEOSTASIS | 18 | 3.85e-01 | -1.18e-01 | 8.09e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 86 | 5.84e-02 | 1.18e-01 | 4.45e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 25 | 3.07e-01 | -1.18e-01 | 7.62e-01 |
| GOBP MYELIN MAINTENANCE | 13 | 4.61e-01 | 1.18e-01 | 8.45e-01 |
| GOBP REGULATION OF DNA BINDING | 62 | 1.08e-01 | -1.18e-01 | 5.49e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 5.63e-01 | 1.18e-01 | 8.80e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 23 | 3.27e-01 | 1.18e-01 | 7.76e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 28 | 2.80e-01 | -1.18e-01 | 7.41e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 13 | 4.62e-01 | -1.18e-01 | 8.45e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 6 | 6.17e-01 | 1.18e-01 | 9.02e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 23 | 3.28e-01 | -1.18e-01 | 7.76e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 10 | 5.19e-01 | 1.18e-01 | 8.70e-01 |
| GOBP MOLTING CYCLE | 55 | 1.31e-01 | 1.18e-01 | 5.83e-01 |
| GOMF ACYL COA OXIDASE ACTIVITY | 5 | 6.48e-01 | -1.18e-01 | 9.08e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 23 | 3.28e-01 | 1.18e-01 | 7.76e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 6.48e-01 | 1.18e-01 | 9.08e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 21 | 3.50e-01 | -1.18e-01 | 7.90e-01 |
| GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT | 8 | 5.64e-01 | 1.18e-01 | 8.80e-01 |
| GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY | 5 | 6.48e-01 | -1.18e-01 | 9.08e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 37 | 2.16e-01 | -1.18e-01 | 6.80e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 5.65e-01 | -1.18e-01 | 8.81e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 30 | 2.65e-01 | 1.18e-01 | 7.27e-01 |
| GOCC NBAF COMPLEX | 13 | 4.63e-01 | 1.18e-01 | 8.47e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 59 | 1.19e-01 | 1.18e-01 | 5.69e-01 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 6 | 6.18e-01 | -1.18e-01 | 9.02e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 28 | 2.82e-01 | 1.17e-01 | 7.42e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 12 | 4.81e-01 | -1.17e-01 | 8.54e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 20 | 3.64e-01 | 1.17e-01 | 7.97e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 7 | 5.91e-01 | -1.17e-01 | 8.94e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 36 | 2.23e-01 | 1.17e-01 | 6.86e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 30 | 2.66e-01 | -1.17e-01 | 7.28e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 705 | 1.40e-07 | -1.17e-01 | 6.76e-05 |
| GOBP MESENCHYMAL STEM CELL PROLIFERATION | 5 | 6.50e-01 | 1.17e-01 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION | 5 | 6.50e-01 | 1.17e-01 | 9.08e-01 |
| GOCC AXONAL GROWTH CONE | 19 | 3.77e-01 | 1.17e-01 | 8.05e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 16 | 4.18e-01 | -1.17e-01 | 8.22e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 107 | 3.66e-02 | 1.17e-01 | 3.73e-01 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 12 | 4.83e-01 | -1.17e-01 | 8.54e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 17 | 4.04e-01 | -1.17e-01 | 8.17e-01 |
| GOCC CILIARY BASAL BODY | 136 | 1.86e-02 | 1.17e-01 | 2.95e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 11 | 5.02e-01 | -1.17e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 8 | 5.68e-01 | 1.17e-01 | 8.82e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 7 | 5.93e-01 | 1.17e-01 | 8.94e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 4.50e-01 | -1.17e-01 | 8.42e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 21 | 3.55e-01 | -1.17e-01 | 7.92e-01 |
| GOCC AGGRESOME | 28 | 2.86e-01 | 1.17e-01 | 7.46e-01 |
| GOBP RETINOL METABOLIC PROCESS | 24 | 3.23e-01 | -1.17e-01 | 7.71e-01 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 102 | 4.22e-02 | -1.17e-01 | 3.88e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 36 | 2.26e-01 | 1.17e-01 | 6.91e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 20 | 3.67e-01 | 1.16e-01 | 8.00e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 48 | 1.63e-01 | 1.16e-01 | 6.24e-01 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 76 | 7.95e-02 | -1.16e-01 | 4.98e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 36 | 2.27e-01 | 1.16e-01 | 6.91e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 46 | 1.73e-01 | 1.16e-01 | 6.37e-01 |
| GOBP PROTEIN FOLDING | 183 | 6.80e-03 | -1.16e-01 | 1.94e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 10 | 5.25e-01 | 1.16e-01 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 119 | 2.88e-02 | -1.16e-01 | 3.43e-01 |
| GOBP T CELL EXTRAVASATION | 11 | 5.05e-01 | -1.16e-01 | 8.64e-01 |
| GOBP PLATELET AGGREGATION | 51 | 1.52e-01 | -1.16e-01 | 6.13e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 6.22e-01 | 1.16e-01 | 9.03e-01 |
| GOCC PRC1 COMPLEX | 16 | 4.21e-01 | -1.16e-01 | 8.25e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 126 | 2.46e-02 | -1.16e-01 | 3.22e-01 |
| GOBP RESPONSE TO ESTROGEN | 43 | 1.88e-01 | 1.16e-01 | 6.58e-01 |
| GOBP NEURAL TUBE PATTERNING | 25 | 3.15e-01 | -1.16e-01 | 7.66e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 23 | 3.36e-01 | 1.16e-01 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 13 | 4.69e-01 | 1.16e-01 | 8.49e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 31 | 2.64e-01 | 1.16e-01 | 7.24e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 26 | 3.06e-01 | 1.16e-01 | 7.61e-01 |
| GOMF PHOSPHOLIPASE BINDING | 16 | 4.22e-01 | 1.16e-01 | 8.25e-01 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 11 | 5.06e-01 | 1.16e-01 | 8.66e-01 |
| GOBP RESPONSE TO CAMP | 53 | 1.45e-01 | -1.16e-01 | 6.04e-01 |
| GOBP FOCAL ADHESION ASSEMBLY | 64 | 1.09e-01 | 1.16e-01 | 5.51e-01 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 5.96e-01 | 1.16e-01 | 8.96e-01 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 13 | 4.70e-01 | -1.16e-01 | 8.49e-01 |
| GOBP PODOSOME ASSEMBLY | 18 | 3.95e-01 | -1.16e-01 | 8.14e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 42 | 1.95e-01 | 1.16e-01 | 6.66e-01 |
| GOBP DENDRITIC SPINE MAINTENANCE | 18 | 3.96e-01 | -1.16e-01 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 15 | 4.38e-01 | -1.16e-01 | 8.36e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 29 | 2.81e-01 | 1.16e-01 | 7.42e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 12 | 4.88e-01 | -1.16e-01 | 8.56e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 13 | 4.71e-01 | -1.16e-01 | 8.49e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 26 | 3.08e-01 | -1.15e-01 | 7.62e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 7 | 5.97e-01 | -1.15e-01 | 8.97e-01 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 6.55e-01 | 1.15e-01 | 9.09e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 9 | 5.49e-01 | 1.15e-01 | 8.78e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 9 | 5.49e-01 | 1.15e-01 | 8.78e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 11 | 5.08e-01 | -1.15e-01 | 8.66e-01 |
| GOBP L SERINE METABOLIC PROCESS | 10 | 5.28e-01 | -1.15e-01 | 8.74e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 14 | 4.55e-01 | -1.15e-01 | 8.43e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 17 | 4.11e-01 | -1.15e-01 | 8.19e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 47 | 1.72e-01 | -1.15e-01 | 6.36e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 5.73e-01 | -1.15e-01 | 8.84e-01 |
| GOBP TISSUE REMODELING | 108 | 3.89e-02 | 1.15e-01 | 3.81e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 94 | 5.40e-02 | -1.15e-01 | 4.30e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 70 | 9.61e-02 | -1.15e-01 | 5.26e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 35 | 2.39e-01 | -1.15e-01 | 7.04e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 29 | 2.84e-01 | 1.15e-01 | 7.43e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 50 | 1.59e-01 | -1.15e-01 | 6.19e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 22 | 3.50e-01 | 1.15e-01 | 7.90e-01 |
| GOCC TRAPPII PROTEIN COMPLEX | 11 | 5.09e-01 | -1.15e-01 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 15 | 4.41e-01 | -1.15e-01 | 8.37e-01 |
| GOBP CITRULLINE METABOLIC PROCESS | 6 | 6.26e-01 | 1.15e-01 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 20 | 3.74e-01 | -1.15e-01 | 8.05e-01 |
| GOBP RESPONSE TO INACTIVITY | 6 | 6.26e-01 | 1.15e-01 | 9.04e-01 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 26 | 3.11e-01 | 1.15e-01 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 10 | 5.30e-01 | -1.15e-01 | 8.75e-01 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 13 | 4.74e-01 | -1.15e-01 | 8.50e-01 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 6 | 6.26e-01 | 1.15e-01 | 9.04e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 24 | 3.31e-01 | 1.15e-01 | 7.78e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 22 | 3.52e-01 | 1.15e-01 | 7.91e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 105 | 4.25e-02 | 1.15e-01 | 3.89e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 11 | 5.11e-01 | 1.15e-01 | 8.67e-01 |
| GOMF TRNA BINDING | 68 | 1.03e-01 | -1.15e-01 | 5.39e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 13 | 4.75e-01 | -1.15e-01 | 8.50e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 41 | 2.05e-01 | 1.14e-01 | 6.73e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 27 | 3.04e-01 | -1.14e-01 | 7.59e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 32 | 2.63e-01 | -1.14e-01 | 7.24e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 47 | 1.75e-01 | -1.14e-01 | 6.39e-01 |
| GOBP NEPHRON DEVELOPMENT | 73 | 9.14e-02 | 1.14e-01 | 5.18e-01 |
| GOMF GLYCOLIPID BINDING | 20 | 3.76e-01 | -1.14e-01 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 31 | 2.71e-01 | 1.14e-01 | 7.33e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 636 | 1.04e-06 | -1.14e-01 | 3.36e-04 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 26 | 3.14e-01 | 1.14e-01 | 7.66e-01 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 5.32e-01 | -1.14e-01 | 8.75e-01 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 42 | 2.01e-01 | 1.14e-01 | 6.68e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 13 | 4.76e-01 | -1.14e-01 | 8.52e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 14 | 4.60e-01 | 1.14e-01 | 8.45e-01 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 6.59e-01 | 1.14e-01 | 9.11e-01 |
| GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION | 5 | 6.59e-01 | -1.14e-01 | 9.11e-01 |
| GOCC CUTICULAR PLATE | 5 | 6.59e-01 | -1.14e-01 | 9.11e-01 |
| GOCC GOLGI LUMEN | 39 | 2.19e-01 | 1.14e-01 | 6.82e-01 |
| GOBP NEURONAL SIGNAL TRANSDUCTION | 5 | 6.59e-01 | 1.14e-01 | 9.12e-01 |
| GOBP LIPID PHOSPHORYLATION | 9 | 5.55e-01 | 1.14e-01 | 8.79e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 9 | 5.55e-01 | 1.14e-01 | 8.79e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 25 | 3.25e-01 | 1.14e-01 | 7.73e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 31 | 2.73e-01 | 1.14e-01 | 7.36e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 7 | 6.03e-01 | 1.14e-01 | 8.97e-01 |
| GOBP THYROID HORMONE TRANSPORT | 6 | 6.30e-01 | -1.14e-01 | 9.04e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 32 | 2.66e-01 | -1.14e-01 | 7.28e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 71 | 9.81e-02 | 1.14e-01 | 5.28e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 19 | 3.91e-01 | -1.14e-01 | 8.12e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 13 | 4.78e-01 | -1.14e-01 | 8.52e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 11 | 5.15e-01 | -1.13e-01 | 8.68e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 11 | 5.15e-01 | -1.13e-01 | 8.68e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 9 | 5.56e-01 | 1.13e-01 | 8.79e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 18 | 4.05e-01 | -1.13e-01 | 8.18e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 6 | 6.31e-01 | -1.13e-01 | 9.04e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 6 | 6.31e-01 | -1.13e-01 | 9.04e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 7 | 6.04e-01 | 1.13e-01 | 8.97e-01 |
| GOBP TUBE FORMATION | 98 | 5.29e-02 | 1.13e-01 | 4.26e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 6 | 6.31e-01 | 1.13e-01 | 9.04e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 10 | 5.36e-01 | -1.13e-01 | 8.76e-01 |
| GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 26 | 3.18e-01 | 1.13e-01 | 7.67e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 78 | 8.44e-02 | -1.13e-01 | 5.04e-01 |
| GOCC SECRETORY VESICLE | 731 | 2.39e-07 | -1.13e-01 | 1.04e-04 |
| GOBP HEART MORPHOGENESIS | 138 | 2.21e-02 | 1.13e-01 | 3.12e-01 |
| GOBP PRENYLATION | 10 | 5.36e-01 | -1.13e-01 | 8.76e-01 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 24 | 3.38e-01 | -1.13e-01 | 7.83e-01 |
| GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 19 | 3.94e-01 | 1.13e-01 | 8.14e-01 |
| GOBP IODIDE TRANSPORT | 6 | 6.32e-01 | 1.13e-01 | 9.04e-01 |
| GOBP NEURON FATE SPECIFICATION | 7 | 6.05e-01 | 1.13e-01 | 8.98e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 8 | 5.81e-01 | -1.13e-01 | 8.88e-01 |
| GOCC MMXD COMPLEX | 5 | 6.63e-01 | -1.13e-01 | 9.13e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 91 | 6.34e-02 | 1.13e-01 | 4.59e-01 |
| GOCC PARASPECKLES | 8 | 5.81e-01 | -1.13e-01 | 8.89e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 47 | 1.82e-01 | -1.13e-01 | 6.50e-01 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 35 | 2.49e-01 | 1.13e-01 | 7.15e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 19 | 3.96e-01 | -1.13e-01 | 8.14e-01 |
| GOBP SPHINGOLIPID CATABOLIC PROCESS | 20 | 3.84e-01 | 1.13e-01 | 8.09e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 46 | 1.87e-01 | 1.13e-01 | 6.56e-01 |
| GOCC PSEUDOPODIUM | 13 | 4.83e-01 | -1.13e-01 | 8.54e-01 |
| GOBP RESPONSE TO HYDROXYUREA | 10 | 5.38e-01 | 1.12e-01 | 8.76e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 67 | 1.12e-01 | -1.12e-01 | 5.57e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 27 | 3.12e-01 | -1.12e-01 | 7.66e-01 |
| GOBP CHOLESTEROL IMPORT | 6 | 6.34e-01 | 1.12e-01 | 9.04e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 15 | 4.52e-01 | -1.12e-01 | 8.42e-01 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 79 | 8.49e-02 | 1.12e-01 | 5.05e-01 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 14 | 4.67e-01 | -1.12e-01 | 8.49e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 7 | 6.07e-01 | 1.12e-01 | 8.99e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 15 | 4.52e-01 | -1.12e-01 | 8.42e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 5 | 6.64e-01 | 1.12e-01 | 9.14e-01 |
| GOBP RESPONSE TO NUTRIENT | 96 | 5.80e-02 | 1.12e-01 | 4.44e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 11 | 5.20e-01 | 1.12e-01 | 8.71e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 9 | 5.61e-01 | 1.12e-01 | 8.79e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 42 | 2.09e-01 | 1.12e-01 | 6.75e-01 |
| GOBP OSTEOCLAST FUSION | 6 | 6.35e-01 | -1.12e-01 | 9.04e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 17 | 4.24e-01 | 1.12e-01 | 8.27e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 8 | 5.84e-01 | 1.12e-01 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 42 | 2.10e-01 | -1.12e-01 | 6.75e-01 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 12 | 5.02e-01 | 1.12e-01 | 8.63e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 13 | 4.86e-01 | -1.12e-01 | 8.55e-01 |
| GOBP AXON DEVELOPMENT | 286 | 1.19e-03 | 1.12e-01 | 7.76e-02 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 20 | 3.88e-01 | -1.12e-01 | 8.11e-01 |
| GOBP DAMP METABOLIC PROCESS | 5 | 6.66e-01 | -1.12e-01 | 9.14e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 5.85e-01 | -1.12e-01 | 8.91e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 10 | 5.42e-01 | -1.11e-01 | 8.76e-01 |
| GOBP RESPONSE TO CADMIUM ION | 46 | 1.91e-01 | 1.11e-01 | 6.62e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 208 | 5.73e-03 | -1.11e-01 | 1.81e-01 |
| GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 10 | 5.42e-01 | 1.11e-01 | 8.76e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 17 | 4.27e-01 | 1.11e-01 | 8.30e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 36 | 2.49e-01 | -1.11e-01 | 7.15e-01 |
| GOBP PREPULSE INHIBITION | 6 | 6.38e-01 | 1.11e-01 | 9.05e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 28 | 3.10e-01 | 1.11e-01 | 7.63e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 15 | 4.57e-01 | 1.11e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 46 | 1.93e-01 | -1.11e-01 | 6.66e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 185 | 9.51e-03 | 1.11e-01 | 2.27e-01 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 29 | 3.02e-01 | 1.11e-01 | 7.57e-01 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 6.68e-01 | 1.11e-01 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 8 | 5.88e-01 | -1.11e-01 | 8.92e-01 |
| GOBP AMELOGENESIS | 14 | 4.74e-01 | -1.11e-01 | 8.50e-01 |
| GOBP TONIC SMOOTH MUSCLE CONTRACTION | 6 | 6.39e-01 | 1.11e-01 | 9.05e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 9 | 5.66e-01 | -1.11e-01 | 8.81e-01 |
| GOBP HYPOTONIC RESPONSE | 11 | 5.25e-01 | 1.11e-01 | 8.73e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 9 | 5.66e-01 | 1.11e-01 | 8.81e-01 |
| GOBP ENDOSOME ORGANIZATION | 89 | 7.16e-02 | -1.11e-01 | 4.79e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 52 | 1.68e-01 | 1.11e-01 | 6.32e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 451 | 6.26e-05 | 1.10e-01 | 9.75e-03 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 285 | 1.38e-03 | -1.10e-01 | 8.46e-02 |
| GOCC CELL SUBSTRATE JUNCTION | 366 | 3.00e-04 | -1.10e-01 | 3.16e-02 |
| GOBP L SERINE TRANSPORT | 6 | 6.39e-01 | 1.10e-01 | 9.05e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.39e-01 | 1.10e-01 | 9.05e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 40 | 2.27e-01 | 1.10e-01 | 6.91e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 56 | 1.53e-01 | -1.10e-01 | 6.14e-01 |
| GOBP CARNITINE TRANSMEMBRANE TRANSPORT | 5 | 6.69e-01 | 1.10e-01 | 9.15e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 3.30e-01 | 1.10e-01 | 7.78e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 15 | 4.59e-01 | 1.10e-01 | 8.45e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 6 | 6.40e-01 | 1.10e-01 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 12 | 5.08e-01 | 1.10e-01 | 8.66e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 32 | 2.80e-01 | 1.10e-01 | 7.41e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 5 | 6.69e-01 | 1.10e-01 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 9 | 5.67e-01 | -1.10e-01 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 29 | 3.05e-01 | 1.10e-01 | 7.60e-01 |
| GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS | 6 | 6.40e-01 | 1.10e-01 | 9.06e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 18 | 4.19e-01 | 1.10e-01 | 8.23e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 21 | 3.83e-01 | -1.10e-01 | 8.09e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 8 | 5.90e-01 | -1.10e-01 | 8.93e-01 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 6.70e-01 | 1.10e-01 | 9.15e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 4.77e-01 | 1.10e-01 | 8.52e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 39 | 2.35e-01 | -1.10e-01 | 6.99e-01 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 5.28e-01 | -1.10e-01 | 8.74e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 152 | 1.97e-02 | -1.10e-01 | 3.00e-01 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 11 | 5.29e-01 | -1.10e-01 | 8.74e-01 |
| GOBP RESPONSE TO PROTOZOAN | 21 | 3.85e-01 | -1.10e-01 | 8.09e-01 |
| GOCC ENDOSOME LUMEN | 23 | 3.63e-01 | -1.10e-01 | 7.97e-01 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 7 | 6.16e-01 | 1.10e-01 | 9.02e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 16 | 4.48e-01 | 1.10e-01 | 8.41e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 73 | 1.06e-01 | -1.10e-01 | 5.43e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 157 | 1.81e-02 | -1.09e-01 | 2.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 64 | 1.30e-01 | 1.09e-01 | 5.82e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 135 | 2.85e-02 | 1.09e-01 | 3.42e-01 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 20 | 3.97e-01 | -1.09e-01 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 12 | 5.12e-01 | -1.09e-01 | 8.67e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 15 | 4.64e-01 | 1.09e-01 | 8.47e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 16 | 4.49e-01 | -1.09e-01 | 8.42e-01 |
| GOBP R LOOP PROCESSING | 6 | 6.43e-01 | 1.09e-01 | 9.06e-01 |
| GOMF PRE MRNA INTRONIC BINDING | 10 | 5.51e-01 | -1.09e-01 | 8.78e-01 |
| GOCC FLOTILLIN COMPLEX | 8 | 5.94e-01 | 1.09e-01 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 26 | 3.37e-01 | -1.09e-01 | 7.82e-01 |
| GOBP CELL MATURATION | 99 | 6.16e-02 | 1.09e-01 | 4.51e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 16 | 4.51e-01 | 1.09e-01 | 8.42e-01 |
| GOCC VESICLE COAT | 55 | 1.63e-01 | 1.09e-01 | 6.24e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 11 | 5.32e-01 | -1.09e-01 | 8.75e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 167 | 1.55e-02 | 1.09e-01 | 2.79e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 39 | 2.40e-01 | -1.09e-01 | 7.05e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 16 | 4.52e-01 | -1.09e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 96 | 6.59e-02 | 1.09e-01 | 4.69e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 242 | 3.66e-03 | 1.09e-01 | 1.46e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 329 | 7.29e-04 | 1.09e-01 | 5.44e-02 |
| GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY | 5 | 6.74e-01 | -1.09e-01 | 9.16e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 74 | 1.06e-01 | 1.09e-01 | 5.43e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 4.98e-01 | 1.09e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 26 | 3.38e-01 | 1.09e-01 | 7.83e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 50 | 1.84e-01 | -1.09e-01 | 6.52e-01 |
| GOCC GAP JUNCTION | 10 | 5.52e-01 | 1.09e-01 | 8.79e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 86 | 8.21e-02 | 1.09e-01 | 4.99e-01 |
| GOBP CALCIUM ION IMPORT | 26 | 3.38e-01 | 1.09e-01 | 7.83e-01 |
| GOCC CYTOSOLIC REGION | 17 | 4.39e-01 | 1.08e-01 | 8.36e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 22 | 3.79e-01 | -1.08e-01 | 8.05e-01 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 6.46e-01 | 1.08e-01 | 9.07e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 26 | 3.39e-01 | 1.08e-01 | 7.83e-01 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 7 | 6.19e-01 | -1.08e-01 | 9.03e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 11 | 5.34e-01 | -1.08e-01 | 8.75e-01 |
| GOBP LEARNING | 87 | 8.08e-02 | 1.08e-01 | 4.99e-01 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 9 | 5.73e-01 | -1.08e-01 | 8.85e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 4.83e-01 | -1.08e-01 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 15 | 4.68e-01 | 1.08e-01 | 8.49e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 23 | 3.69e-01 | -1.08e-01 | 8.02e-01 |
| GOBP REGULATION OF PROTEOLYSIS | 456 | 8.10e-05 | -1.08e-01 | 1.20e-02 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 6.75e-01 | -1.08e-01 | 9.17e-01 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 6.75e-01 | -1.08e-01 | 9.17e-01 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 45 | 2.10e-01 | -1.08e-01 | 6.75e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 10 | 5.54e-01 | 1.08e-01 | 8.79e-01 |
| GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 7 | 6.20e-01 | 1.08e-01 | 9.03e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 6 | 6.47e-01 | -1.08e-01 | 9.08e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 39 | 2.43e-01 | -1.08e-01 | 7.08e-01 |
| GOMF CERAMIDE BINDING | 15 | 4.70e-01 | -1.08e-01 | 8.49e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 17 | 4.42e-01 | -1.08e-01 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 12 | 5.18e-01 | -1.08e-01 | 8.70e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 34 | 2.77e-01 | -1.08e-01 | 7.38e-01 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 14 | 4.85e-01 | 1.08e-01 | 8.55e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 63 | 1.40e-01 | 1.08e-01 | 5.97e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 8 | 5.98e-01 | 1.08e-01 | 8.97e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 56 | 1.64e-01 | -1.08e-01 | 6.25e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 236 | 4.51e-03 | 1.08e-01 | 1.58e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 15 | 4.71e-01 | -1.08e-01 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 21 | 3.94e-01 | 1.08e-01 | 8.14e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 17 | 4.43e-01 | 1.07e-01 | 8.38e-01 |
| GOBP REGULATION OF TUBE SIZE | 71 | 1.18e-01 | 1.07e-01 | 5.69e-01 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 8 | 5.99e-01 | -1.07e-01 | 8.97e-01 |
| GOBP HEXOSE CATABOLIC PROCESS | 32 | 2.94e-01 | -1.07e-01 | 7.53e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 20 | 4.06e-01 | -1.07e-01 | 8.18e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 16 | 4.58e-01 | 1.07e-01 | 8.44e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 64 | 1.38e-01 | -1.07e-01 | 5.95e-01 |
| GOMF CARBOXY LYASE ACTIVITY | 24 | 3.63e-01 | -1.07e-01 | 7.97e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 10 | 5.57e-01 | -1.07e-01 | 8.79e-01 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 12 | 5.21e-01 | -1.07e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 12 | 5.21e-01 | -1.07e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 15 | 4.73e-01 | 1.07e-01 | 8.50e-01 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 136 | 3.16e-02 | 1.07e-01 | 3.52e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 14 | 4.89e-01 | 1.07e-01 | 8.57e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 28 | 3.28e-01 | -1.07e-01 | 7.76e-01 |
| GOBP LONG TERM MEMORY | 21 | 3.97e-01 | 1.07e-01 | 8.15e-01 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 6 | 6.51e-01 | 1.07e-01 | 9.08e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 52 | 1.83e-01 | -1.07e-01 | 6.51e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 83 | 9.30e-02 | -1.07e-01 | 5.19e-01 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 24 | 3.66e-01 | 1.07e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 6.51e-01 | 1.07e-01 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 45 | 2.16e-01 | 1.07e-01 | 6.80e-01 |
| GOCC SODIUM CHANNEL COMPLEX | 9 | 5.80e-01 | 1.07e-01 | 8.88e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 68 | 1.29e-01 | 1.07e-01 | 5.81e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 6.02e-01 | -1.07e-01 | 8.97e-01 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 6.80e-01 | 1.07e-01 | 9.19e-01 |
| GOBP AXON EXTENSION | 87 | 8.62e-02 | 1.07e-01 | 5.08e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 21 | 3.98e-01 | 1.06e-01 | 8.15e-01 |
| GOBP SYNAPSE ASSEMBLY | 90 | 8.11e-02 | 1.06e-01 | 4.99e-01 |
| GOBP SECRETION BY TISSUE | 19 | 4.22e-01 | 1.06e-01 | 8.25e-01 |
| GOCC MITOCHONDRIAL MATRIX | 444 | 1.29e-04 | -1.06e-01 | 1.61e-02 |
| GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 5 | 6.80e-01 | 1.06e-01 | 9.19e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 6 | 6.52e-01 | -1.06e-01 | 9.09e-01 |
| GOCC CILIARY TRANSITION ZONE | 59 | 1.58e-01 | 1.06e-01 | 6.19e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 288 | 1.96e-03 | 1.06e-01 | 1.02e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 18 | 4.35e-01 | 1.06e-01 | 8.33e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 11 | 5.42e-01 | 1.06e-01 | 8.76e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 155 | 2.27e-02 | -1.06e-01 | 3.16e-01 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 9 | 5.81e-01 | -1.06e-01 | 8.89e-01 |
| GOBP MATURATION OF 5 8S RRNA | 36 | 2.70e-01 | -1.06e-01 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 12 | 5.24e-01 | -1.06e-01 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 6.81e-01 | -1.06e-01 | 9.19e-01 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 13 | 5.08e-01 | 1.06e-01 | 8.66e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 8 | 6.03e-01 | 1.06e-01 | 8.97e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 278 | 2.40e-03 | -1.06e-01 | 1.15e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 20 | 4.12e-01 | -1.06e-01 | 8.19e-01 |
| GOCC CORE MEDIATOR COMPLEX | 26 | 3.49e-01 | -1.06e-01 | 7.90e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 23 | 3.79e-01 | -1.06e-01 | 8.05e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 13 | 5.08e-01 | 1.06e-01 | 8.66e-01 |
| GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 6.82e-01 | 1.06e-01 | 9.19e-01 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 6.82e-01 | -1.06e-01 | 9.19e-01 |
| GOBP RESPONSE TO SODIUM ARSENITE | 5 | 6.82e-01 | -1.06e-01 | 9.19e-01 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 6.28e-01 | 1.06e-01 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS | 5 | 6.82e-01 | 1.06e-01 | 9.19e-01 |
| GOMF RETINAL DEHYDROGENASE ACTIVITY | 5 | 6.82e-01 | 1.06e-01 | 9.19e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 33 | 2.93e-01 | -1.06e-01 | 7.52e-01 |
| GOBP GASTRIC ACID SECRETION | 6 | 6.54e-01 | 1.06e-01 | 9.09e-01 |
| GOBP ICOSANOID TRANSPORT | 28 | 3.33e-01 | 1.06e-01 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 248 | 4.22e-03 | 1.06e-01 | 1.55e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 26 | 3.51e-01 | -1.06e-01 | 7.90e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 14 | 4.93e-01 | 1.06e-01 | 8.59e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 106 | 6.05e-02 | 1.06e-01 | 4.48e-01 |
| GOBP SPINAL CORD PATTERNING | 7 | 6.28e-01 | 1.06e-01 | 9.04e-01 |
| GOBP NEUROTRANSMITTER CATABOLIC PROCESS | 6 | 6.54e-01 | -1.06e-01 | 9.09e-01 |
| GOBP MACROPHAGE FUSION | 6 | 6.54e-01 | -1.06e-01 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 7 | 6.29e-01 | -1.06e-01 | 9.04e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 7 | 6.29e-01 | -1.05e-01 | 9.04e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 14 | 4.95e-01 | -1.05e-01 | 8.61e-01 |
| GOCC TERMINAL BOUTON | 18 | 4.39e-01 | 1.05e-01 | 8.36e-01 |
| GOBP RESPONSE TO ISCHEMIA | 45 | 2.22e-01 | 1.05e-01 | 6.84e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 19 | 4.27e-01 | 1.05e-01 | 8.29e-01 |
| GOBP TRNA METHYLATION | 43 | 2.32e-01 | 1.05e-01 | 6.97e-01 |
| GOCC GBAF COMPLEX | 13 | 5.11e-01 | 1.05e-01 | 8.67e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 12 | 5.28e-01 | -1.05e-01 | 8.74e-01 |
| GOBP RESPONSE TO MONOSACCHARIDE | 127 | 4.08e-02 | 1.05e-01 | 3.86e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 192 | 1.21e-02 | 1.05e-01 | 2.53e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 12 | 5.28e-01 | 1.05e-01 | 8.74e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 5.65e-01 | 1.05e-01 | 8.81e-01 |
| GOBP HEART FIELD SPECIFICATION | 6 | 6.56e-01 | 1.05e-01 | 9.09e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 11 | 5.46e-01 | 1.05e-01 | 8.77e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 5 | 6.84e-01 | -1.05e-01 | 9.19e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 13 | 5.12e-01 | -1.05e-01 | 8.67e-01 |
| GOBP SUCCINATE METABOLIC PROCESS | 5 | 6.84e-01 | 1.05e-01 | 9.19e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 75 | 1.16e-01 | -1.05e-01 | 5.65e-01 |
| GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 6.84e-01 | 1.05e-01 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 14 | 4.97e-01 | -1.05e-01 | 8.62e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 36 | 2.76e-01 | 1.05e-01 | 7.38e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 53 | 1.87e-01 | 1.05e-01 | 6.56e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 6.56e-01 | 1.05e-01 | 9.10e-01 |
| GOBP FIBROBLAST MIGRATION | 45 | 2.24e-01 | 1.05e-01 | 6.88e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 67 | 1.39e-01 | 1.05e-01 | 5.96e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 62 | 1.54e-01 | 1.05e-01 | 6.16e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 13 | 5.14e-01 | -1.05e-01 | 8.68e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 23 | 3.86e-01 | -1.05e-01 | 8.09e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 5.31e-01 | -1.05e-01 | 8.75e-01 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 6.58e-01 | 1.04e-01 | 9.11e-01 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 74 | 1.21e-01 | -1.04e-01 | 5.70e-01 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 7 | 6.33e-01 | 1.04e-01 | 9.04e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 11 | 5.49e-01 | 1.04e-01 | 8.78e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 29 | 3.32e-01 | 1.04e-01 | 7.78e-01 |
| GOBP RESPONSE TO STEROL | 21 | 4.09e-01 | 1.04e-01 | 8.19e-01 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.34e-01 | 1.04e-01 | 9.04e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 59 | 1.67e-01 | 1.04e-01 | 6.30e-01 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 5 | 6.87e-01 | -1.04e-01 | 9.20e-01 |
| GOMF TELOMERASE ACTIVITY | 5 | 6.87e-01 | -1.04e-01 | 9.20e-01 |
| GOBP ANOIKIS | 27 | 3.50e-01 | 1.04e-01 | 7.90e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 22 | 3.99e-01 | -1.04e-01 | 8.15e-01 |
| GOBP RNA SPLICING | 403 | 3.64e-04 | -1.04e-01 | 3.57e-02 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 11 | 5.51e-01 | -1.04e-01 | 8.79e-01 |
| GOMF GTPASE ACTIVITY | 254 | 4.49e-03 | -1.04e-01 | 1.58e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 87 | 9.47e-02 | -1.04e-01 | 5.22e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 175 | 1.82e-02 | -1.04e-01 | 2.95e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 10 | 5.70e-01 | 1.04e-01 | 8.83e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 29 | 3.34e-01 | -1.04e-01 | 7.80e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 10 | 5.70e-01 | 1.04e-01 | 8.83e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 11 | 5.52e-01 | 1.04e-01 | 8.79e-01 |
| GOCC SPINDLE MIDZONE | 33 | 3.03e-01 | 1.04e-01 | 7.59e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 85 | 9.89e-02 | -1.04e-01 | 5.30e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 18 | 4.48e-01 | -1.03e-01 | 8.41e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 21 | 4.12e-01 | 1.03e-01 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 19 | 4.36e-01 | -1.03e-01 | 8.33e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 14 | 5.04e-01 | 1.03e-01 | 8.64e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 5.72e-01 | -1.03e-01 | 8.83e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 278 | 3.15e-03 | -1.03e-01 | 1.34e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 56 | 1.82e-01 | -1.03e-01 | 6.50e-01 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 7 | 6.36e-01 | 1.03e-01 | 9.04e-01 |
| GOMF MYOSIN BINDING | 44 | 2.37e-01 | -1.03e-01 | 7.01e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 6.14e-01 | 1.03e-01 | 9.01e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 16 | 4.75e-01 | 1.03e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 34 | 2.99e-01 | -1.03e-01 | 7.55e-01 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 6 | 6.62e-01 | -1.03e-01 | 9.13e-01 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 18 | 4.50e-01 | 1.03e-01 | 8.42e-01 |
| GOBP MELANOCYTE DIFFERENTIATION | 13 | 5.21e-01 | 1.03e-01 | 8.72e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 45 | 2.33e-01 | 1.03e-01 | 6.97e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 20 | 4.27e-01 | -1.03e-01 | 8.29e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 262 | 4.34e-03 | -1.03e-01 | 1.57e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 5 | 6.91e-01 | 1.03e-01 | 9.22e-01 |
| GOBP SINGLE FERTILIZATION | 64 | 1.56e-01 | -1.03e-01 | 6.19e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 28 | 3.48e-01 | -1.03e-01 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 15 | 4.92e-01 | -1.02e-01 | 8.59e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 20 | 4.28e-01 | -1.02e-01 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 16 | 4.78e-01 | -1.02e-01 | 8.52e-01 |
| GOCC GLIAL CELL PROJECTION | 19 | 4.40e-01 | -1.02e-01 | 8.37e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 8 | 6.16e-01 | -1.02e-01 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 22 | 4.06e-01 | -1.02e-01 | 8.18e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 222 | 8.79e-03 | 1.02e-01 | 2.19e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 17 | 4.66e-01 | -1.02e-01 | 8.48e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 51 | 2.07e-01 | -1.02e-01 | 6.74e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 2.89e-01 | -1.02e-01 | 7.49e-01 |
| GOMF CHOLESTEROL BINDING | 36 | 2.89e-01 | 1.02e-01 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 40 | 2.64e-01 | -1.02e-01 | 7.24e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 173 | 2.08e-02 | 1.02e-01 | 3.06e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 70 | 1.40e-01 | -1.02e-01 | 5.98e-01 |
| GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 8 | 6.17e-01 | 1.02e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 9 | 5.96e-01 | 1.02e-01 | 8.96e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 34 | 3.03e-01 | 1.02e-01 | 7.59e-01 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 6 | 6.65e-01 | -1.02e-01 | 9.14e-01 |
| GOCC CHLORIDE CHANNEL COMPLEX | 18 | 4.54e-01 | 1.02e-01 | 8.42e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 231 | 7.75e-03 | 1.02e-01 | 2.08e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 27 | 3.60e-01 | 1.02e-01 | 7.94e-01 |
| GOCC INTERCELLULAR BRIDGE | 62 | 1.66e-01 | -1.02e-01 | 6.27e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 13 | 5.25e-01 | -1.02e-01 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 5.59e-01 | 1.02e-01 | 8.79e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 100 | 7.89e-02 | 1.02e-01 | 4.97e-01 |
| GOBP SNRNA MODIFICATION | 7 | 6.41e-01 | 1.02e-01 | 9.06e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 10 | 5.78e-01 | -1.02e-01 | 8.87e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 112 | 6.34e-02 | 1.02e-01 | 4.59e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 12 | 5.42e-01 | 1.02e-01 | 8.76e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 412 | 4.29e-04 | -1.02e-01 | 3.85e-02 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 30 | 3.36e-01 | -1.01e-01 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 69 | 1.45e-01 | -1.01e-01 | 6.05e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 25 | 3.80e-01 | -1.01e-01 | 8.07e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 30 | 3.36e-01 | -1.01e-01 | 7.82e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 64 | 1.61e-01 | 1.01e-01 | 6.20e-01 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 51 | 2.11e-01 | -1.01e-01 | 6.75e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 13 | 5.27e-01 | 1.01e-01 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 15 | 4.97e-01 | -1.01e-01 | 8.62e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 18 | 4.57e-01 | -1.01e-01 | 8.43e-01 |
| GOCC PLATELET DENSE GRANULE | 13 | 5.27e-01 | -1.01e-01 | 8.74e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 115 | 6.08e-02 | -1.01e-01 | 4.50e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 6.67e-01 | 1.01e-01 | 9.14e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 731 | 3.66e-06 | -1.01e-01 | 9.97e-04 |
| GOCC ENDONUCLEASE COMPLEX | 37 | 2.86e-01 | -1.01e-01 | 7.47e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 23 | 4.00e-01 | -1.01e-01 | 8.15e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 50 | 2.15e-01 | -1.01e-01 | 6.80e-01 |
| GOCC EARLY ENDOSOME LUMEN | 5 | 6.95e-01 | -1.01e-01 | 9.24e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 15 | 4.97e-01 | -1.01e-01 | 8.62e-01 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 10 | 5.80e-01 | 1.01e-01 | 8.88e-01 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 6.96e-01 | 1.01e-01 | 9.25e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 41 | 2.63e-01 | 1.01e-01 | 7.24e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 38 | 2.81e-01 | -1.01e-01 | 7.42e-01 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 14 | 5.13e-01 | 1.01e-01 | 8.67e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 8 | 6.21e-01 | 1.01e-01 | 9.03e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 34 | 3.08e-01 | 1.01e-01 | 7.62e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 21 | 4.23e-01 | 1.01e-01 | 8.26e-01 |
| GOMF CALMODULIN BINDING | 136 | 4.23e-02 | 1.01e-01 | 3.89e-01 |
| GOBP DEVELOPMENTAL GROWTH | 412 | 4.63e-04 | 1.01e-01 | 4.00e-02 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 5.29e-01 | -1.01e-01 | 8.74e-01 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 8 | 6.21e-01 | -1.01e-01 | 9.03e-01 |
| GOBP REGULATION OF GLIOGENESIS | 58 | 1.84e-01 | 1.01e-01 | 6.52e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY | 6 | 6.69e-01 | 1.01e-01 | 9.15e-01 |
| GOCC BLOC 1 COMPLEX | 9 | 6.00e-01 | -1.01e-01 | 8.97e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 10 | 5.81e-01 | -1.01e-01 | 8.89e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 97 | 8.66e-02 | -1.01e-01 | 5.09e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 20 | 4.35e-01 | -1.01e-01 | 8.33e-01 |
| GOBP DTTP METABOLIC PROCESS | 5 | 6.96e-01 | 1.01e-01 | 9.25e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 66 | 1.57e-01 | 1.01e-01 | 6.19e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 30 | 3.40e-01 | 1.01e-01 | 7.84e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 153 | 3.19e-02 | 1.01e-01 | 3.54e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 9 | 6.01e-01 | -1.01e-01 | 8.97e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 25 | 3.84e-01 | -1.01e-01 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 6 | 6.70e-01 | 1.01e-01 | 9.15e-01 |
| GOBP RRNA METHYLATION | 22 | 4.14e-01 | 1.01e-01 | 8.21e-01 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 7 | 6.45e-01 | -1.01e-01 | 9.07e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 28 | 3.57e-01 | 1.01e-01 | 7.92e-01 |
| GOBP ODONTOGENESIS | 56 | 1.94e-01 | 1.00e-01 | 6.66e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 20 | 4.37e-01 | 1.00e-01 | 8.34e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 28 | 3.58e-01 | -1.00e-01 | 7.92e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 18 | 4.61e-01 | 1.00e-01 | 8.45e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 7 | 6.46e-01 | 1.00e-01 | 9.07e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 129 | 4.94e-02 | 1.00e-01 | 4.12e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 42 | 2.61e-01 | -1.00e-01 | 7.23e-01 |
| GOCC T TUBULE | 30 | 3.42e-01 | 1.00e-01 | 7.86e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 416 | 4.79e-04 | 1.00e-01 | 4.01e-02 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 7 | 6.46e-01 | 1.00e-01 | 9.08e-01 |
| GOMF COA HYDROLASE ACTIVITY | 16 | 4.88e-01 | -1.00e-01 | 8.56e-01 |
| GOMF MICROTUBULE BINDING | 213 | 1.20e-02 | 1.00e-01 | 2.52e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 40 | 2.73e-01 | 1.00e-01 | 7.36e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 14 | 5.17e-01 | -1.00e-01 | 8.69e-01 |
| GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION | 6 | 6.71e-01 | -1.00e-01 | 9.15e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 20 | 4.38e-01 | 1.00e-01 | 8.36e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 15 | 5.02e-01 | -1.00e-01 | 8.63e-01 |
| GOBP ANIMAL ORGAN MATURATION | 17 | 4.75e-01 | 1.00e-01 | 8.51e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 7 | 6.47e-01 | 1.00e-01 | 9.08e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 103 | 7.97e-02 | 1.00e-01 | 4.98e-01 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 6.47e-01 | -1.00e-01 | 9.08e-01 |
| GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 13 | 5.33e-01 | 9.99e-02 | 8.75e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 10 | 5.85e-01 | -9.99e-02 | 8.91e-01 |
| GOBP TOR SIGNALING | 141 | 4.11e-02 | 9.98e-02 | 3.86e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 59 | 1.85e-01 | 9.98e-02 | 6.53e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 98 | 8.82e-02 | -9.97e-02 | 5.10e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 36 | 3.01e-01 | 9.97e-02 | 7.56e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 24 | 3.98e-01 | -9.97e-02 | 8.15e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 43 | 2.58e-01 | -9.97e-02 | 7.21e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 30 | 3.45e-01 | 9.97e-02 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 5.68e-01 | 9.93e-02 | 8.82e-01 |
| GOMF CHANNEL INHIBITOR ACTIVITY | 25 | 3.90e-01 | -9.93e-02 | 8.11e-01 |
| GOBP TRNA CATABOLIC PROCESS | 16 | 4.92e-01 | -9.93e-02 | 8.59e-01 |
| GOCC CORNIFIED ENVELOPE | 16 | 4.92e-01 | -9.92e-02 | 8.59e-01 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 6.27e-01 | -9.91e-02 | 9.04e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 3.73e-01 | 9.91e-02 | 8.04e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 33 | 3.25e-01 | 9.91e-02 | 7.73e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 21 | 4.32e-01 | 9.91e-02 | 8.31e-01 |
| GOBP DIAPHRAGM DEVELOPMENT | 5 | 7.01e-01 | -9.90e-02 | 9.25e-01 |
| GOBP CIRCADIAN RHYTHM | 139 | 4.42e-02 | 9.90e-02 | 3.94e-01 |
| GOCC SPECIFIC GRANULE | 132 | 4.98e-02 | -9.90e-02 | 4.14e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 6.28e-01 | -9.90e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 116 | 6.60e-02 | -9.89e-02 | 4.69e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 34 | 3.18e-01 | 9.89e-02 | 7.67e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 40 | 2.79e-01 | -9.89e-02 | 7.39e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 5.22e-01 | 9.89e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 153 | 3.51e-02 | -9.89e-02 | 3.67e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 15 | 5.08e-01 | -9.88e-02 | 8.66e-01 |
| GOMF AMP BINDING | 14 | 5.22e-01 | -9.88e-02 | 8.72e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 50 | 2.27e-01 | 9.88e-02 | 6.91e-01 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 5.54e-01 | -9.88e-02 | 8.79e-01 |
| GOBP CELLULAR RESPONSE TO PH | 14 | 5.23e-01 | -9.87e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 28 | 3.66e-01 | 9.86e-02 | 8.00e-01 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 8 | 6.29e-01 | 9.86e-02 | 9.04e-01 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 87 | 1.12e-01 | -9.85e-02 | 5.58e-01 |
| GOBP SIRNA PROCESSING | 8 | 6.29e-01 | 9.85e-02 | 9.04e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 35 | 3.13e-01 | -9.85e-02 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 37 | 3.00e-01 | 9.85e-02 | 7.56e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 5.24e-01 | -9.85e-02 | 8.73e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 129 | 5.37e-02 | 9.85e-02 | 4.30e-01 |
| GOBP PEPTIDE CROSS LINKING | 8 | 6.30e-01 | -9.85e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 7 | 6.52e-01 | -9.84e-02 | 9.09e-01 |
| GOCC MKS COMPLEX | 13 | 5.39e-01 | 9.84e-02 | 8.76e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 83 | 1.21e-01 | -9.84e-02 | 5.71e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 264 | 6.05e-03 | -9.84e-02 | 1.83e-01 |
| GOBP DENDRITE EXTENSION | 24 | 4.04e-01 | 9.84e-02 | 8.18e-01 |
| GOBP GRANULOCYTE ACTIVATION | 37 | 3.01e-01 | -9.83e-02 | 7.56e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 25 | 3.95e-01 | -9.83e-02 | 8.14e-01 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 7.04e-01 | -9.83e-02 | 9.25e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 170 | 2.73e-02 | -9.83e-02 | 3.35e-01 |
| GOMF IRON ION BINDING | 76 | 1.39e-01 | -9.82e-02 | 5.96e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 40 | 2.83e-01 | -9.82e-02 | 7.42e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 5.91e-01 | 9.82e-02 | 8.94e-01 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 11 | 5.73e-01 | -9.82e-02 | 8.84e-01 |
| GOBP EXIT FROM MITOSIS | 29 | 3.60e-01 | 9.82e-02 | 7.94e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 31 | 3.44e-01 | -9.81e-02 | 7.88e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 32 | 3.37e-01 | -9.81e-02 | 7.82e-01 |
| GOBP REGULATION OF MUCUS SECRETION | 5 | 7.04e-01 | 9.81e-02 | 9.25e-01 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 14 | 5.25e-01 | -9.81e-02 | 8.73e-01 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 8 | 6.31e-01 | -9.81e-02 | 9.04e-01 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 24 | 4.06e-01 | -9.80e-02 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 48 | 2.40e-01 | -9.80e-02 | 7.05e-01 |
| GOBP GOLGI LOCALIZATION | 13 | 5.41e-01 | 9.80e-02 | 8.76e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 150 | 3.86e-02 | -9.80e-02 | 3.80e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 7 | 6.54e-01 | 9.79e-02 | 9.09e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 263 | 6.39e-03 | 9.79e-02 | 1.89e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 828 | 2.07e-06 | -9.79e-02 | 6.44e-04 |
| GOBP ADHESION OF SYMBIONT TO HOST CELL | 5 | 7.05e-01 | -9.79e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 6.32e-01 | 9.79e-02 | 9.04e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 14 | 5.27e-01 | -9.78e-02 | 8.74e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 9 | 6.12e-01 | -9.78e-02 | 9.00e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 22 | 4.28e-01 | 9.77e-02 | 8.30e-01 |
| GOMF CYTOKINE BINDING | 83 | 1.25e-01 | 9.75e-02 | 5.74e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 16 | 5.00e-01 | -9.75e-02 | 8.63e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 6.55e-01 | 9.75e-02 | 9.09e-01 |
| GOBP RESPONSE TO ATP | 20 | 4.50e-01 | -9.75e-02 | 8.42e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 119 | 6.66e-02 | -9.75e-02 | 4.70e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 13 | 5.43e-01 | -9.74e-02 | 8.76e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 8 | 6.33e-01 | -9.74e-02 | 9.04e-01 |
| GOBP MRNA 3 END PROCESSING | 48 | 2.43e-01 | 9.74e-02 | 7.08e-01 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 18 | 4.75e-01 | -9.73e-02 | 8.50e-01 |
| GOCC NEURON SPINE | 101 | 9.13e-02 | 9.73e-02 | 5.18e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 6 | 6.80e-01 | -9.73e-02 | 9.19e-01 |
| GOMF SUMO LIGASE ACTIVITY | 13 | 5.44e-01 | 9.72e-02 | 8.77e-01 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 150 | 4.02e-02 | 9.72e-02 | 3.86e-01 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 11 | 5.77e-01 | -9.72e-02 | 8.87e-01 |
| GOBP NADH METABOLIC PROCESS | 10 | 5.95e-01 | -9.72e-02 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 37 | 3.07e-01 | -9.71e-02 | 7.62e-01 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 12 | 5.60e-01 | -9.71e-02 | 8.79e-01 |
| GOBP ELASTIN METABOLIC PROCESS | 7 | 6.56e-01 | 9.71e-02 | 9.10e-01 |
| GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 6 | 6.81e-01 | 9.71e-02 | 9.19e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 13 | 5.45e-01 | -9.71e-02 | 8.77e-01 |
| GOBP LIPID DROPLET FORMATION | 11 | 5.77e-01 | -9.71e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 24 | 4.11e-01 | 9.70e-02 | 8.19e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 8 | 6.35e-01 | 9.70e-02 | 9.04e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY | 8 | 6.35e-01 | 9.70e-02 | 9.04e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 9 | 6.15e-01 | 9.69e-02 | 9.02e-01 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 74 | 1.50e-01 | 9.69e-02 | 6.11e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 19 | 4.65e-01 | -9.69e-02 | 8.48e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 12 | 5.61e-01 | 9.69e-02 | 8.80e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 35 | 3.22e-01 | 9.68e-02 | 7.70e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 19 | 4.65e-01 | 9.68e-02 | 8.48e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 11 | 5.78e-01 | -9.68e-02 | 8.88e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 736 | 9.08e-06 | -9.68e-02 | 2.26e-03 |
| GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 5 | 7.08e-01 | -9.68e-02 | 9.26e-01 |
| GOMF CHLORIDE ION BINDING | 5 | 7.08e-01 | -9.68e-02 | 9.26e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 11 | 5.78e-01 | -9.68e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 59 | 1.99e-01 | 9.67e-02 | 6.68e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 21 | 4.43e-01 | -9.67e-02 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 65 | 1.78e-01 | -9.67e-02 | 6.43e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 19 | 4.66e-01 | -9.67e-02 | 8.48e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 22 | 4.33e-01 | 9.66e-02 | 8.31e-01 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 11 | 5.79e-01 | 9.66e-02 | 8.88e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 76 | 1.46e-01 | -9.65e-02 | 6.06e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 17 | 4.91e-01 | -9.65e-02 | 8.58e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 13 | 5.47e-01 | 9.65e-02 | 8.78e-01 |
| GOBP SOMITOGENESIS | 31 | 3.53e-01 | -9.64e-02 | 7.92e-01 |
| GOBP DIOL METABOLIC PROCESS | 23 | 4.23e-01 | 9.64e-02 | 8.26e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 18 | 4.79e-01 | -9.64e-02 | 8.52e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 10 | 5.98e-01 | -9.63e-02 | 8.97e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 40 | 2.92e-01 | 9.63e-02 | 7.52e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 13 | 5.48e-01 | -9.63e-02 | 8.78e-01 |
| GOCC FLEMMING BODY | 32 | 3.46e-01 | 9.62e-02 | 7.89e-01 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 31 | 3.54e-01 | -9.62e-02 | 7.92e-01 |
| GOMF MANNOSIDASE ACTIVITY | 15 | 5.20e-01 | -9.61e-02 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 7.10e-01 | 9.60e-02 | 9.27e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 222 | 1.39e-02 | 9.60e-02 | 2.65e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 18 | 4.81e-01 | -9.60e-02 | 8.53e-01 |
| GOBP REGULATION OF DNA REPLICATION | 106 | 8.80e-02 | 9.60e-02 | 5.10e-01 |
| GOBP RESPONSE TO TUMOR CELL | 32 | 3.48e-01 | -9.59e-02 | 7.89e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 25 | 4.07e-01 | 9.59e-02 | 8.18e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 8 | 6.39e-01 | 9.59e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 35 | 3.27e-01 | 9.59e-02 | 7.75e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 75 | 1.52e-01 | -9.58e-02 | 6.13e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 9 | 6.19e-01 | 9.57e-02 | 9.03e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 60 | 2.00e-01 | 9.57e-02 | 6.68e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 44 | 2.73e-01 | -9.56e-02 | 7.36e-01 |
| GOCC APICAL PART OF CELL | 254 | 8.86e-03 | 9.56e-02 | 2.19e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 47 | 2.57e-01 | 9.56e-02 | 7.20e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 36 | 3.21e-01 | 9.56e-02 | 7.69e-01 |
| GOBP MAST CELL PROLIFERATION | 6 | 6.85e-01 | 9.55e-02 | 9.19e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 18 | 4.83e-01 | -9.55e-02 | 8.54e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 13 | 5.51e-01 | 9.54e-02 | 8.79e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 27 | 3.91e-01 | 9.53e-02 | 8.12e-01 |
| GOMF GLUTATHIONE BINDING | 9 | 6.21e-01 | -9.53e-02 | 9.03e-01 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 7 | 6.62e-01 | -9.53e-02 | 9.13e-01 |
| GOMF PROTEASE BINDING | 104 | 9.36e-02 | -9.53e-02 | 5.21e-01 |
| GOCC CHYLOMICRON | 6 | 6.86e-01 | -9.53e-02 | 9.20e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 123 | 6.85e-02 | -9.52e-02 | 4.74e-01 |
| GOBP ORGANELLE FISSION | 382 | 1.46e-03 | 9.52e-02 | 8.63e-02 |
| GOBP REGULATION OF FIBRINOLYSIS | 11 | 5.84e-01 | -9.52e-02 | 8.91e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 26 | 4.01e-01 | 9.52e-02 | 8.15e-01 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 38 | 3.10e-01 | 9.52e-02 | 7.64e-01 |
| GOBP TYPE II INTERFERON PRODUCTION | 73 | 1.60e-01 | -9.52e-02 | 6.20e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 10 | 6.02e-01 | -9.52e-02 | 8.97e-01 |
| GOBP CELLULAR RESPONSE TO COCAINE | 6 | 6.87e-01 | 9.51e-02 | 9.20e-01 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 7.13e-01 | -9.51e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 5 | 7.13e-01 | -9.50e-02 | 9.29e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 53 | 2.32e-01 | -9.49e-02 | 6.96e-01 |
| GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY | 5 | 7.13e-01 | 9.49e-02 | 9.29e-01 |
| GOBP DEPYRIMIDINATION | 8 | 6.42e-01 | -9.49e-02 | 9.06e-01 |
| GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 8 | 6.42e-01 | -9.49e-02 | 9.06e-01 |
| GOMF BETA CATENIN BINDING | 56 | 2.20e-01 | 9.49e-02 | 6.82e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 18 | 4.86e-01 | -9.49e-02 | 8.55e-01 |
| GOCC SYNAPTIC MEMBRANE | 187 | 2.56e-02 | 9.49e-02 | 3.25e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 16 | 5.11e-01 | 9.49e-02 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 31 | 3.61e-01 | 9.48e-02 | 7.94e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 5.54e-01 | 9.48e-02 | 8.79e-01 |
| GOBP DITERPENOID BIOSYNTHETIC PROCESS | 7 | 6.64e-01 | 9.48e-02 | 9.14e-01 |
| GOBP IMPORT INTO NUCLEUS | 138 | 5.49e-02 | 9.48e-02 | 4.32e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 8 | 6.43e-01 | 9.48e-02 | 9.06e-01 |
| GOBP FIBRINOLYSIS | 14 | 5.39e-01 | -9.47e-02 | 8.76e-01 |
| GOBP CELL CELL RECOGNITION | 37 | 3.19e-01 | -9.47e-02 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 20 | 4.63e-01 | -9.47e-02 | 8.47e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 10 | 6.04e-01 | -9.47e-02 | 8.97e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 14 | 5.40e-01 | 9.47e-02 | 8.76e-01 |
| GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 7.14e-01 | -9.46e-02 | 9.30e-01 |
| GOBP MEMBRANE RAFT LOCALIZATION | 6 | 6.88e-01 | -9.46e-02 | 9.20e-01 |
| GOMF PDZ DOMAIN BINDING | 55 | 2.25e-01 | 9.46e-02 | 6.89e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 12 | 5.71e-01 | -9.46e-02 | 8.83e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 16 | 5.13e-01 | -9.45e-02 | 8.67e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 12 | 5.71e-01 | 9.45e-02 | 8.83e-01 |
| GOMF FERROUS IRON BINDING | 19 | 4.76e-01 | -9.45e-02 | 8.51e-01 |
| GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 11 | 5.88e-01 | -9.45e-02 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 58 | 2.14e-01 | 9.44e-02 | 6.79e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 56 | 2.22e-01 | -9.44e-02 | 6.84e-01 |
| GOCC CASPASE COMPLEX | 9 | 6.24e-01 | -9.44e-02 | 9.04e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 225 | 1.50e-02 | 9.43e-02 | 2.74e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 86 | 1.31e-01 | 9.43e-02 | 5.83e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 32 | 3.57e-01 | 9.42e-02 | 7.92e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 8 | 6.45e-01 | -9.42e-02 | 9.07e-01 |
| GOBP RETICULOPHAGY | 17 | 5.02e-01 | 9.42e-02 | 8.63e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 103 | 9.91e-02 | 9.41e-02 | 5.31e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 8 | 6.45e-01 | -9.41e-02 | 9.07e-01 |
| GOBP GLANDULAR EPITHELIAL CELL MATURATION | 5 | 7.16e-01 | 9.41e-02 | 9.30e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 40 | 3.03e-01 | -9.41e-02 | 7.59e-01 |
| GOBP XMP METABOLIC PROCESS | 7 | 6.66e-01 | -9.41e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 17 | 5.02e-01 | -9.41e-02 | 8.63e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 36 | 3.29e-01 | -9.41e-02 | 7.77e-01 |
| GOBP COPII COATED VESICLE BUDDING | 42 | 2.92e-01 | -9.40e-02 | 7.51e-01 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 9 | 6.25e-01 | -9.40e-02 | 9.04e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 14 | 5.43e-01 | 9.40e-02 | 8.76e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 14 | 5.43e-01 | 9.40e-02 | 8.76e-01 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 10 | 6.07e-01 | -9.40e-02 | 8.99e-01 |
| GOBP CHROMOSOME LOCALIZATION | 104 | 9.82e-02 | 9.40e-02 | 5.28e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 89 | 1.26e-01 | 9.39e-02 | 5.75e-01 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 11 | 5.90e-01 | -9.39e-02 | 8.93e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 54 | 2.33e-01 | 9.39e-02 | 6.97e-01 |
| GOBP CELL MIGRATION IN HINDBRAIN | 10 | 6.07e-01 | 9.39e-02 | 8.99e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 93 | 1.18e-01 | -9.39e-02 | 5.69e-01 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 25 | 4.17e-01 | -9.38e-02 | 8.22e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 7 | 6.67e-01 | 9.38e-02 | 9.14e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 7 | 6.67e-01 | 9.38e-02 | 9.14e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 68 | 1.82e-01 | 9.38e-02 | 6.50e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 9 | 6.26e-01 | 9.38e-02 | 9.04e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 17 | 5.03e-01 | 9.37e-02 | 8.64e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 17 | 5.04e-01 | -9.37e-02 | 8.64e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 193 | 2.51e-02 | 9.37e-02 | 3.23e-01 |
| GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.17e-01 | 9.37e-02 | 9.31e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 27 | 4.00e-01 | -9.37e-02 | 8.15e-01 |
| GOBP OSSIFICATION | 243 | 1.21e-02 | 9.36e-02 | 2.53e-01 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 56 | 2.26e-01 | 9.36e-02 | 6.90e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 29 | 3.83e-01 | 9.35e-02 | 8.09e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 10 | 6.09e-01 | -9.35e-02 | 8.99e-01 |
| GOBP G1 TO G0 TRANSITION | 14 | 5.45e-01 | -9.35e-02 | 8.77e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 25 | 4.19e-01 | 9.34e-02 | 8.23e-01 |
| GOBP LATE NUCLEOPHAGY | 8 | 6.47e-01 | 9.34e-02 | 9.08e-01 |
| GOBP TRABECULA MORPHOGENESIS | 27 | 4.01e-01 | 9.34e-02 | 8.15e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 10 | 6.09e-01 | 9.34e-02 | 8.99e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 11 | 5.92e-01 | 9.33e-02 | 8.94e-01 |
| GOBP SEMICIRCULAR CANAL DEVELOPMENT | 5 | 7.18e-01 | -9.33e-02 | 9.31e-01 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 22 | 4.49e-01 | -9.33e-02 | 8.41e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 483 | 4.77e-04 | -9.33e-02 | 4.01e-02 |
| GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION | 7 | 6.69e-01 | 9.33e-02 | 9.15e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 46 | 2.75e-01 | 9.31e-02 | 7.38e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 9 | 6.29e-01 | 9.31e-02 | 9.04e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 9 | 6.29e-01 | 9.31e-02 | 9.04e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 16 | 5.19e-01 | 9.31e-02 | 8.71e-01 |
| GOCC PERIKARYON | 78 | 1.56e-01 | 9.30e-02 | 6.19e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 12 | 5.77e-01 | 9.30e-02 | 8.87e-01 |
| GOBP LUNG MORPHOGENESIS | 31 | 3.70e-01 | 9.30e-02 | 8.02e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 8 | 6.49e-01 | 9.30e-02 | 9.08e-01 |
| GOMF CHROMATIN DNA BINDING | 81 | 1.48e-01 | -9.30e-02 | 6.07e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR | 7 | 6.70e-01 | 9.30e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 5 | 7.19e-01 | -9.30e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 16 | 5.20e-01 | -9.30e-02 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 11 | 5.94e-01 | -9.29e-02 | 8.94e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 46 | 2.76e-01 | -9.29e-02 | 7.38e-01 |
| GOBP BONE MARROW DEVELOPMENT | 8 | 6.49e-01 | -9.28e-02 | 9.08e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 29 | 3.87e-01 | 9.28e-02 | 8.10e-01 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 9 | 6.30e-01 | -9.28e-02 | 9.04e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 7.20e-01 | -9.27e-02 | 9.32e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 18 | 4.96e-01 | 9.27e-02 | 8.62e-01 |
| GOCC CATENIN COMPLEX | 9 | 6.30e-01 | -9.27e-02 | 9.04e-01 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 6.50e-01 | 9.27e-02 | 9.08e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 67 | 1.90e-01 | 9.27e-02 | 6.61e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 498 | 4.25e-04 | -9.27e-02 | 3.85e-02 |
| GOBP POSITIVE REGULATION OF BINDING | 99 | 1.11e-01 | -9.27e-02 | 5.57e-01 |
| GOBP REGULATION OF AXON EXTENSION | 65 | 1.97e-01 | 9.26e-02 | 6.67e-01 |
| GOBP REGULATION OF GASTRULATION | 8 | 6.50e-01 | -9.26e-02 | 9.08e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 6.12e-01 | -9.26e-02 | 9.00e-01 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 9 | 6.31e-01 | 9.26e-02 | 9.04e-01 |
| GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 10 | 6.12e-01 | 9.26e-02 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 20 | 4.74e-01 | -9.25e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 7.20e-01 | -9.25e-02 | 9.32e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 13 | 5.64e-01 | -9.25e-02 | 8.80e-01 |
| GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 7 | 6.72e-01 | 9.24e-02 | 9.15e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 86 | 1.39e-01 | 9.24e-02 | 5.96e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 59 | 2.20e-01 | -9.24e-02 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 12 | 5.80e-01 | 9.24e-02 | 8.88e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 148 | 5.27e-02 | -9.24e-02 | 4.25e-01 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 18 | 4.98e-01 | 9.22e-02 | 8.63e-01 |
| GOBP MUSCLE ADAPTATION | 65 | 1.99e-01 | 9.22e-02 | 6.68e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 32 | 3.67e-01 | 9.22e-02 | 8.00e-01 |
| GOCC CHITOSOME | 14 | 5.50e-01 | 9.22e-02 | 8.78e-01 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 12 | 5.80e-01 | -9.22e-02 | 8.88e-01 |
| GOBP CYTOLYSIS | 6 | 6.96e-01 | -9.22e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS | 6 | 6.96e-01 | -9.21e-02 | 9.25e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 37 | 3.32e-01 | 9.21e-02 | 7.78e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 6.14e-01 | -9.20e-02 | 9.02e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 8 | 6.52e-01 | -9.20e-02 | 9.09e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 15 | 5.38e-01 | 9.19e-02 | 8.76e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 66 | 1.97e-01 | 9.18e-02 | 6.67e-01 |
| GOCC SPINDLE POLE | 155 | 4.89e-02 | 9.18e-02 | 4.11e-01 |
| GOBP MACROMOLECULE DEACYLATION | 62 | 2.12e-01 | -9.18e-02 | 6.77e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 8 | 6.53e-01 | 9.18e-02 | 9.09e-01 |
| GOMF G PROTEIN ACTIVITY | 37 | 3.34e-01 | -9.17e-02 | 7.80e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 14 | 5.53e-01 | -9.17e-02 | 8.79e-01 |
| GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 5 | 7.23e-01 | 9.16e-02 | 9.32e-01 |
| GOBP NUCLEOSIDE TRANSPORT | 5 | 7.23e-01 | 9.16e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 107 | 1.02e-01 | -9.16e-02 | 5.37e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 24 | 4.37e-01 | -9.16e-02 | 8.34e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 129 | 7.28e-02 | -9.16e-02 | 4.83e-01 |
| GOMF ER RETENTION SEQUENCE BINDING | 5 | 7.23e-01 | -9.15e-02 | 9.32e-01 |
| GOMF MYOSIN V BINDING | 10 | 6.16e-01 | -9.15e-02 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 273 | 9.49e-03 | -9.15e-02 | 2.27e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 122 | 8.15e-02 | -9.14e-02 | 4.99e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 13 | 5.68e-01 | 9.14e-02 | 8.82e-01 |
| GOMF PHOSPHATIDIC ACID BINDING | 17 | 5.14e-01 | -9.13e-02 | 8.68e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 11 | 6.00e-01 | 9.13e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 15 | 5.40e-01 | -9.13e-02 | 8.76e-01 |
| GOBP MICROTUBULE ANCHORING | 20 | 4.80e-01 | 9.13e-02 | 8.53e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 64 | 2.07e-01 | 9.12e-02 | 6.74e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 13 | 5.69e-01 | -9.12e-02 | 8.83e-01 |
| GOBP NOSE DEVELOPMENT | 8 | 6.55e-01 | 9.11e-02 | 9.09e-01 |
| GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY | 6 | 6.99e-01 | 9.11e-02 | 9.25e-01 |
| GOMF HORMONE BINDING | 35 | 3.51e-01 | 9.11e-02 | 7.91e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 33 | 3.66e-01 | -9.10e-02 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 17 | 5.16e-01 | -9.10e-02 | 8.69e-01 |
| GOBP ENDODERM FORMATION | 33 | 3.66e-01 | 9.10e-02 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 20 | 4.81e-01 | 9.10e-02 | 8.54e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 80 | 1.60e-01 | 9.10e-02 | 6.20e-01 |
| GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 6 | 7.00e-01 | 9.10e-02 | 9.25e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 10 | 6.19e-01 | -9.09e-02 | 9.03e-01 |
| GOBP GENITALIA DEVELOPMENT | 21 | 4.71e-01 | 9.09e-02 | 8.49e-01 |
| GOCC MPP7 DLG1 LIN7 COMPLEX | 5 | 7.25e-01 | 9.09e-02 | 9.33e-01 |
| GOBP RESPONSE TO ALKALOID | 60 | 2.24e-01 | 9.09e-02 | 6.87e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 6 | 7.00e-01 | -9.09e-02 | 9.25e-01 |
| GOBP REGULATION OF BILE ACID SECRETION | 5 | 7.25e-01 | 9.08e-02 | 9.33e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 7.00e-01 | 9.08e-02 | 9.25e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 30 | 3.90e-01 | 9.07e-02 | 8.11e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 50 | 2.68e-01 | -9.07e-02 | 7.29e-01 |
| GOCC PODOSOME | 30 | 3.90e-01 | -9.06e-02 | 8.11e-01 |
| GOBP T CELL PROLIFERATION | 158 | 4.97e-02 | -9.06e-02 | 4.13e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 23 | 4.52e-01 | -9.06e-02 | 8.42e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 9 | 6.38e-01 | -9.06e-02 | 9.05e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 5.72e-01 | -9.06e-02 | 8.83e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 6 | 7.01e-01 | -9.06e-02 | 9.25e-01 |
| GOMF GLUTAMATE RECEPTOR BINDING | 28 | 4.07e-01 | -9.05e-02 | 8.18e-01 |
| GOBP REGULATION OF CELL SIZE | 138 | 6.67e-02 | 9.05e-02 | 4.70e-01 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 15 | 5.44e-01 | 9.05e-02 | 8.77e-01 |
| GOBP PROTEIN PALMITOYLATION | 26 | 4.25e-01 | -9.04e-02 | 8.27e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 146 | 5.98e-02 | 9.04e-02 | 4.47e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 12 | 5.88e-01 | -9.03e-02 | 8.92e-01 |
| GOBP CELL FATE DETERMINATION | 15 | 5.45e-01 | 9.03e-02 | 8.77e-01 |
| GOCC SPERM MIDPIECE | 30 | 3.92e-01 | -9.03e-02 | 8.12e-01 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 9 | 6.39e-01 | -9.02e-02 | 9.05e-01 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 9 | 6.40e-01 | -9.02e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 29 | 4.01e-01 | -9.01e-02 | 8.15e-01 |
| GOMF SH3 DOMAIN BINDING | 94 | 1.31e-01 | 9.01e-02 | 5.84e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 232 | 1.83e-02 | -9.01e-02 | 2.95e-01 |
| GOMF TUBULIN BINDING | 292 | 8.28e-03 | 9.01e-02 | 2.14e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 19 | 4.97e-01 | 9.00e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 12 | 5.89e-01 | -9.00e-02 | 8.93e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 6 | 7.03e-01 | 9.00e-02 | 9.25e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 21 | 4.75e-01 | -9.00e-02 | 8.51e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 7 | 6.80e-01 | 9.00e-02 | 9.19e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 6 | 7.03e-01 | -9.00e-02 | 9.25e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 7.03e-01 | -9.00e-02 | 9.25e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 50 | 2.71e-01 | 9.00e-02 | 7.34e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 25 | 4.36e-01 | 9.00e-02 | 8.34e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 5.60e-01 | 9.00e-02 | 8.79e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 93 | 1.34e-01 | 8.99e-02 | 5.88e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 265 | 1.20e-02 | 8.99e-02 | 2.52e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 14 | 5.60e-01 | 8.99e-02 | 8.79e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 23 | 4.56e-01 | -8.99e-02 | 8.43e-01 |
| GOBP OXALATE TRANSPORT | 8 | 6.60e-01 | 8.99e-02 | 9.12e-01 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 24 | 4.46e-01 | -8.98e-02 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 37 | 3.45e-01 | -8.97e-02 | 7.88e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 17 | 5.22e-01 | -8.97e-02 | 8.72e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 16 | 5.35e-01 | 8.97e-02 | 8.75e-01 |
| GOBP HORMONE TRANSPORT | 174 | 4.18e-02 | 8.96e-02 | 3.86e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 6.24e-01 | -8.96e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 17 | 5.23e-01 | -8.96e-02 | 8.72e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 74 | 1.83e-01 | 8.96e-02 | 6.51e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 189 | 3.41e-02 | 8.96e-02 | 3.63e-01 |
| GOBP TELOMERE LOCALIZATION | 7 | 6.82e-01 | -8.96e-02 | 9.19e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 7 | 6.82e-01 | -8.95e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 13 | 5.76e-01 | -8.95e-02 | 8.87e-01 |
| GOBP RESPONSE TO LEPTIN | 13 | 5.76e-01 | -8.95e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 240 | 1.72e-02 | 8.95e-02 | 2.93e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 204 | 2.80e-02 | 8.94e-02 | 3.40e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 9 | 6.42e-01 | -8.94e-02 | 9.06e-01 |
| GOBP ENDOCRINE PROCESS | 42 | 3.16e-01 | 8.94e-02 | 7.66e-01 |
| GOBP RESPONSE TO ESTRADIOL | 69 | 2.00e-01 | -8.94e-02 | 6.68e-01 |
| GOMF P53 BINDING | 57 | 2.44e-01 | 8.93e-02 | 7.08e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 14 | 5.63e-01 | -8.93e-02 | 8.80e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 23 | 4.59e-01 | -8.93e-02 | 8.45e-01 |
| GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 6.62e-01 | -8.93e-02 | 9.13e-01 |
| GOBP LYMPHOCYTE MIGRATION | 76 | 1.79e-01 | 8.91e-02 | 6.46e-01 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 7.30e-01 | -8.91e-02 | 9.36e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 16 | 5.37e-01 | 8.91e-02 | 8.76e-01 |
| GOBP EMBRYO IMPLANTATION | 36 | 3.55e-01 | -8.91e-02 | 7.92e-01 |
| GOCC SAGA TYPE COMPLEX | 36 | 3.55e-01 | -8.91e-02 | 7.92e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 42 | 3.18e-01 | -8.90e-02 | 7.67e-01 |
| GOBP SULFATION | 8 | 6.63e-01 | -8.90e-02 | 9.13e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 37 | 3.49e-01 | 8.90e-02 | 7.90e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 8 | 6.63e-01 | 8.89e-02 | 9.13e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 6 | 7.06e-01 | 8.89e-02 | 9.26e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 3.99e-01 | -8.89e-02 | 8.15e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 58 | 2.42e-01 | -8.89e-02 | 7.07e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 8 | 6.63e-01 | -8.88e-02 | 9.14e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING | 61 | 2.30e-01 | 8.88e-02 | 6.94e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 79 | 1.73e-01 | -8.88e-02 | 6.37e-01 |
| GOBP RECEPTOR CLUSTERING | 40 | 3.31e-01 | -8.88e-02 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 35 | 3.64e-01 | -8.88e-02 | 7.97e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 13 | 5.80e-01 | 8.88e-02 | 8.88e-01 |
| GOCC MICROBODY MEMBRANE | 59 | 2.39e-01 | -8.88e-02 | 7.03e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 8 | 6.64e-01 | 8.87e-02 | 9.14e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 7 | 6.84e-01 | 8.87e-02 | 9.19e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 29 | 4.08e-01 | -8.87e-02 | 8.19e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 18 | 5.15e-01 | -8.86e-02 | 8.68e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 23 | 4.62e-01 | 8.86e-02 | 8.46e-01 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 20 | 4.93e-01 | -8.86e-02 | 8.59e-01 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 50 | 2.79e-01 | 8.86e-02 | 7.39e-01 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 7.32e-01 | 8.86e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 6 | 7.07e-01 | -8.85e-02 | 9.26e-01 |
| GOCC MICROBODY | 121 | 9.30e-02 | -8.85e-02 | 5.19e-01 |
| GOBP HEAT ACCLIMATION | 6 | 7.07e-01 | -8.85e-02 | 9.26e-01 |
| GOCC SPECIFIC GRANULE LUMEN | 48 | 2.89e-01 | -8.85e-02 | 7.49e-01 |
| GOBP EAR MORPHOGENESIS | 50 | 2.79e-01 | 8.85e-02 | 7.39e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 48 | 2.89e-01 | -8.84e-02 | 7.49e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 44 | 3.10e-01 | 8.84e-02 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 6 | 7.08e-01 | -8.84e-02 | 9.26e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 44 | 3.11e-01 | 8.84e-02 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 19 | 5.05e-01 | 8.83e-02 | 8.65e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 7.32e-01 | -8.83e-02 | 9.36e-01 |
| GOBP B CELL ACTIVATION | 203 | 3.05e-02 | -8.83e-02 | 3.50e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 11 | 6.12e-01 | -8.82e-02 | 9.00e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 53 | 2.67e-01 | 8.82e-02 | 7.28e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 94 | 1.40e-01 | -8.82e-02 | 5.97e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 47 | 2.96e-01 | 8.82e-02 | 7.54e-01 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 11 | 6.13e-01 | 8.82e-02 | 9.00e-01 |
| GOCC MITOCHONDRION | 1423 | 4.11e-08 | -8.82e-02 | 2.56e-05 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 25 | 4.46e-01 | 8.81e-02 | 8.40e-01 |
| GOCC BLOOD MICROPARTICLE | 55 | 2.59e-01 | -8.81e-02 | 7.21e-01 |
| GOBP VITAMIN TRANSPORT | 30 | 4.04e-01 | 8.81e-02 | 8.18e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 14 | 5.69e-01 | -8.80e-02 | 8.83e-01 |
| GOBP LIPOPHAGY | 7 | 6.87e-01 | -8.80e-02 | 9.20e-01 |
| GOCC DESMOSOME | 12 | 5.98e-01 | 8.80e-02 | 8.97e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 24 | 4.56e-01 | 8.79e-02 | 8.43e-01 |
| GOBP PLATELET DEGRANULATION | 6 | 7.09e-01 | 8.79e-02 | 9.27e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 90 | 1.50e-01 | 8.79e-02 | 6.11e-01 |
| GOCC CATSPER COMPLEX | 6 | 7.09e-01 | 8.79e-02 | 9.27e-01 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 53 | 2.69e-01 | 8.79e-02 | 7.31e-01 |
| GOBP AMINO ACID BETAINE TRANSPORT | 10 | 6.31e-01 | 8.78e-02 | 9.04e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 192 | 3.63e-02 | 8.78e-02 | 3.71e-01 |
| GOCC DENDRITIC GROWTH CONE | 7 | 6.88e-01 | 8.77e-02 | 9.20e-01 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 15 | 5.57e-01 | 8.77e-02 | 8.79e-01 |
| GOCC REPLICATION FORK | 61 | 2.37e-01 | 8.77e-02 | 7.01e-01 |
| GOCC CLATHRIN VESICLE COAT | 27 | 4.31e-01 | 8.76e-02 | 8.30e-01 |
| GOBP MRNA SPLICE SITE RECOGNITION | 29 | 4.14e-01 | -8.76e-02 | 8.21e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 37 | 3.57e-01 | 8.76e-02 | 7.92e-01 |
| GOBP ORGANELLE DISASSEMBLY | 136 | 7.81e-02 | -8.76e-02 | 4.96e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 11 | 6.15e-01 | 8.75e-02 | 9.02e-01 |
| GOBP ADAPTATION OF SIGNALING PATHWAY | 12 | 6.00e-01 | 8.75e-02 | 8.97e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 39 | 3.45e-01 | -8.74e-02 | 7.88e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 10 | 6.33e-01 | 8.73e-02 | 9.04e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 14 | 5.72e-01 | 8.73e-02 | 8.83e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 30 | 4.08e-01 | -8.73e-02 | 8.19e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 105 | 1.23e-01 | 8.73e-02 | 5.71e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 11 | 6.16e-01 | -8.73e-02 | 9.02e-01 |
| GOBP MEMBRANE DISASSEMBLY | 11 | 6.16e-01 | 8.72e-02 | 9.02e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 33 | 3.86e-01 | 8.72e-02 | 8.09e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 26 | 4.42e-01 | 8.72e-02 | 8.37e-01 |
| GOBP REGULATION OF NEUROGENESIS | 229 | 2.35e-02 | 8.71e-02 | 3.18e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 8 | 6.70e-01 | -8.70e-02 | 9.15e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 23 | 4.70e-01 | -8.70e-02 | 8.49e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 5 | 7.36e-01 | -8.70e-02 | 9.37e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY | 6 | 7.12e-01 | 8.70e-02 | 9.29e-01 |
| GOBP RESPONSE TO CHEMOKINE | 46 | 3.08e-01 | 8.70e-02 | 7.62e-01 |
| GOBP MRNA TRANSPORT | 114 | 1.09e-01 | 8.69e-02 | 5.51e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 21 | 4.90e-01 | -8.69e-02 | 8.58e-01 |
| GOBP PROTEIN DEACETYLATION | 51 | 2.83e-01 | -8.69e-02 | 7.43e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 126 | 9.28e-02 | 8.68e-02 | 5.18e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 201 | 3.42e-02 | 8.68e-02 | 3.63e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 123 | 9.68e-02 | -8.68e-02 | 5.26e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 164 | 5.55e-02 | -8.68e-02 | 4.34e-01 |
| GOBP PROTEIN NITROSYLATION | 12 | 6.03e-01 | -8.67e-02 | 8.97e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 15 | 5.61e-01 | -8.67e-02 | 8.79e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 24 | 4.62e-01 | -8.67e-02 | 8.46e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 88 | 1.60e-01 | -8.67e-02 | 6.20e-01 |
| GOBP MAMMALIAN OOGENESIS STAGE | 7 | 6.91e-01 | -8.67e-02 | 9.22e-01 |
| GOCC ISWI TYPE COMPLEX | 14 | 5.75e-01 | 8.66e-02 | 8.86e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 9 | 6.53e-01 | 8.66e-02 | 9.09e-01 |
| GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 7.37e-01 | -8.66e-02 | 9.37e-01 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 7.37e-01 | -8.66e-02 | 9.37e-01 |
| GOBP CRISTAE FORMATION | 17 | 5.37e-01 | -8.66e-02 | 8.76e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 8 | 6.72e-01 | -8.65e-02 | 9.15e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 16 | 5.49e-01 | -8.65e-02 | 8.78e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 134 | 8.44e-02 | -8.64e-02 | 5.04e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 30 | 4.13e-01 | -8.64e-02 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 7 | 6.92e-01 | -8.64e-02 | 9.23e-01 |
| GOCC ACTIN FILAMENT | 83 | 1.74e-01 | -8.64e-02 | 6.38e-01 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 7.38e-01 | 8.64e-02 | 9.37e-01 |
| GOBP RESPONSE TO GLYCOPROTEIN | 8 | 6.72e-01 | 8.64e-02 | 9.15e-01 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 7.14e-01 | -8.63e-02 | 9.30e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 17 | 5.38e-01 | 8.63e-02 | 8.76e-01 |
| GOCC RECEPTOR COMPLEX | 200 | 3.57e-02 | 8.63e-02 | 3.68e-01 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 58 | 2.56e-01 | -8.63e-02 | 7.18e-01 |
| GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 15 | 5.63e-01 | 8.62e-02 | 8.80e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 9 | 6.54e-01 | -8.62e-02 | 9.09e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 40 | 3.46e-01 | -8.61e-02 | 7.89e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 239 | 2.21e-02 | 8.61e-02 | 3.12e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 30 | 4.15e-01 | -8.61e-02 | 8.21e-01 |
| GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 8 | 6.73e-01 | 8.61e-02 | 9.16e-01 |
| GOBP BILE ACID SIGNALING PATHWAY | 6 | 7.15e-01 | -8.61e-02 | 9.30e-01 |
| GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 6.06e-01 | -8.60e-02 | 8.99e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 117 | 1.08e-01 | -8.60e-02 | 5.49e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 139 | 8.04e-02 | 8.60e-02 | 4.98e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 6.21e-01 | 8.60e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 34 | 3.86e-01 | -8.60e-02 | 8.09e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 60 | 2.50e-01 | 8.59e-02 | 7.16e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 66 | 2.28e-01 | -8.59e-02 | 6.91e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 9 | 6.56e-01 | 8.59e-02 | 9.09e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 17 | 5.40e-01 | 8.58e-02 | 8.76e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 88 | 1.65e-01 | 8.57e-02 | 6.26e-01 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 7 | 6.95e-01 | 8.57e-02 | 9.24e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 124 | 9.98e-02 | 8.57e-02 | 5.32e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 108 | 1.24e-01 | -8.57e-02 | 5.72e-01 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 32 | 4.02e-01 | 8.57e-02 | 8.16e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 33 | 3.95e-01 | 8.56e-02 | 8.14e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 45 | 3.20e-01 | -8.56e-02 | 7.69e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 43 | 3.31e-01 | -8.56e-02 | 7.78e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 79 | 1.89e-01 | 8.56e-02 | 6.60e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 25 | 4.59e-01 | 8.56e-02 | 8.45e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 33 | 3.95e-01 | 8.55e-02 | 8.14e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 74 | 2.04e-01 | -8.55e-02 | 6.72e-01 |
| GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS | 5 | 7.41e-01 | 8.55e-02 | 9.38e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 12 | 6.08e-01 | -8.55e-02 | 8.99e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 13 | 5.94e-01 | 8.55e-02 | 8.94e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 17 | 5.42e-01 | 8.55e-02 | 8.76e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 11 | 6.24e-01 | -8.54e-02 | 9.04e-01 |
| GOCC SWR1 COMPLEX | 13 | 5.94e-01 | -8.54e-02 | 8.94e-01 |
| GOBP ACTIN FILAMENT SEVERING | 15 | 5.67e-01 | -8.54e-02 | 8.82e-01 |
| GOBP COPULATION | 7 | 6.96e-01 | 8.53e-02 | 9.25e-01 |
| GOBP METANEPHROS DEVELOPMENT | 41 | 3.45e-01 | 8.53e-02 | 7.88e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 15 | 5.68e-01 | -8.52e-02 | 8.82e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 23 | 4.80e-01 | -8.52e-02 | 8.52e-01 |
| GOBP GENERATION OF NEURONS | 867 | 2.47e-05 | 8.52e-02 | 4.22e-03 |
| GOBP PROTEIN TARGETING | 290 | 1.29e-02 | -8.52e-02 | 2.55e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 34 | 3.90e-01 | 8.51e-02 | 8.11e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 16 | 5.56e-01 | 8.51e-02 | 8.79e-01 |
| GOBP DCMP CATABOLIC PROCESS | 5 | 7.42e-01 | -8.51e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 46 | 3.18e-01 | -8.51e-02 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 44 | 3.29e-01 | -8.51e-02 | 7.77e-01 |
| GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 5 | 7.42e-01 | 8.50e-02 | 9.38e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 14 | 5.82e-01 | -8.50e-02 | 8.89e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 6 | 7.19e-01 | -8.50e-02 | 9.31e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 32 | 4.06e-01 | 8.49e-02 | 8.18e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 28 | 4.37e-01 | -8.49e-02 | 8.34e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 20 | 5.11e-01 | 8.49e-02 | 8.67e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 29 | 4.29e-01 | -8.49e-02 | 8.30e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 77 | 1.98e-01 | 8.49e-02 | 6.67e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 21 | 5.01e-01 | 8.49e-02 | 8.63e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 96 | 1.51e-01 | 8.48e-02 | 6.13e-01 |
| GOCC SARCOPLASMIC RETICULUM | 48 | 3.09e-01 | 8.48e-02 | 7.63e-01 |
| GOBP RUFFLE ASSEMBLY | 35 | 3.86e-01 | 8.48e-02 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 11 | 6.27e-01 | 8.47e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 5 | 7.43e-01 | 8.47e-02 | 9.38e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 4.22e-01 | -8.47e-02 | 8.25e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 6.12e-01 | 8.46e-02 | 9.00e-01 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 10 | 6.43e-01 | -8.45e-02 | 9.07e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 5 | 7.43e-01 | -8.45e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 7.20e-01 | -8.45e-02 | 9.32e-01 |
| GOBP STRAND INVASION | 5 | 7.44e-01 | -8.45e-02 | 9.38e-01 |
| GOBP UTP METABOLIC PROCESS | 11 | 6.28e-01 | -8.44e-02 | 9.04e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 41 | 3.50e-01 | 8.44e-02 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 8 | 6.80e-01 | -8.44e-02 | 9.19e-01 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 97 | 1.52e-01 | 8.43e-02 | 6.13e-01 |
| GOBP REGULATION OF GROWTH | 402 | 3.88e-03 | 8.43e-02 | 1.51e-01 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 8 | 6.80e-01 | 8.43e-02 | 9.19e-01 |
| GOBP REGULATION OF HAIR CYCLE | 14 | 5.85e-01 | 8.43e-02 | 8.91e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 6.45e-01 | 8.42e-02 | 9.07e-01 |
| GOBP LOCOMOTOR RHYTHM | 11 | 6.29e-01 | 8.42e-02 | 9.04e-01 |
| GOBP ALANINE TRANSPORT | 12 | 6.14e-01 | -8.41e-02 | 9.01e-01 |
| GOBP PLASMA MEMBRANE TUBULATION | 16 | 5.60e-01 | -8.41e-02 | 8.79e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 47 | 3.19e-01 | -8.41e-02 | 7.67e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 26 | 4.58e-01 | 8.41e-02 | 8.44e-01 |
| GOBP POLYAMINE TRANSPORT | 12 | 6.14e-01 | 8.41e-02 | 9.01e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 24 | 4.77e-01 | -8.40e-02 | 8.52e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 17 | 5.49e-01 | -8.39e-02 | 8.78e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 134 | 9.39e-02 | 8.39e-02 | 5.21e-01 |
| GOCC CONDENSED CHROMOSOME | 246 | 2.37e-02 | 8.39e-02 | 3.19e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 20 | 5.16e-01 | -8.39e-02 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 17 | 5.50e-01 | 8.38e-02 | 8.78e-01 |
| GOBP AXONEME ASSEMBLY | 41 | 3.53e-01 | -8.38e-02 | 7.92e-01 |
| GOBP N GLYCAN PROCESSING | 14 | 5.87e-01 | -8.38e-02 | 8.92e-01 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 29 | 4.35e-01 | 8.37e-02 | 8.33e-01 |
| GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 5 | 7.46e-01 | -8.37e-02 | 9.39e-01 |
| GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION | 5 | 7.46e-01 | 8.37e-02 | 9.39e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 11 | 6.31e-01 | -8.37e-02 | 9.04e-01 |
| GOBP GAMETE GENERATION | 446 | 2.58e-03 | 8.36e-02 | 1.20e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 23 | 4.88e-01 | 8.36e-02 | 8.56e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 23 | 4.88e-01 | -8.36e-02 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 44 | 3.38e-01 | 8.36e-02 | 7.83e-01 |
| GOMF EXONUCLEASE ACTIVITY | 77 | 2.05e-01 | -8.36e-02 | 6.73e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 72 | 2.20e-01 | 8.36e-02 | 6.83e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 55 | 2.84e-01 | 8.36e-02 | 7.43e-01 |
| GOMF CUPROUS ION BINDING | 6 | 7.23e-01 | -8.36e-02 | 9.32e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 91 | 1.69e-01 | 8.36e-02 | 6.33e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 238 | 2.69e-02 | 8.35e-02 | 3.33e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.83e-01 | -8.35e-02 | 9.19e-01 |
| GOCC NUCLEOID | 43 | 3.44e-01 | -8.34e-02 | 7.88e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 71 | 2.25e-01 | 8.34e-02 | 6.88e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 50 | 3.08e-01 | 8.34e-02 | 7.62e-01 |
| GOBP INSULIN PROCESSING | 6 | 7.24e-01 | 8.34e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 82 | 1.92e-01 | 8.34e-02 | 6.64e-01 |
| GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 9 | 6.65e-01 | 8.34e-02 | 9.14e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 10 | 6.48e-01 | -8.34e-02 | 9.08e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 402 | 4.32e-03 | 8.33e-02 | 1.57e-01 |
| GOMF CHEMOKINE ACTIVITY | 18 | 5.41e-01 | 8.33e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 13 | 6.03e-01 | 8.32e-02 | 8.97e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 10 | 6.49e-01 | -8.32e-02 | 9.08e-01 |
| GOMF MIRNA BINDING | 33 | 4.08e-01 | 8.32e-02 | 8.19e-01 |
| GOBP SNRNA 3 END PROCESSING | 21 | 5.09e-01 | 8.32e-02 | 8.67e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 208 | 3.91e-02 | 8.32e-02 | 3.82e-01 |
| GOBP OSTEOCLAST PROLIFERATION | 7 | 7.03e-01 | 8.31e-02 | 9.25e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 130 | 1.02e-01 | 8.31e-02 | 5.37e-01 |
| GOCC CELL DIVISION SITE | 63 | 2.54e-01 | -8.31e-02 | 7.18e-01 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 13 | 6.04e-01 | 8.31e-02 | 8.97e-01 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 25 | 4.72e-01 | -8.31e-02 | 8.50e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 19 | 5.31e-01 | 8.31e-02 | 8.75e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 16 | 5.66e-01 | 8.30e-02 | 8.81e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 6.66e-01 | -8.30e-02 | 9.14e-01 |
| GOBP T CELL MIGRATION | 49 | 3.15e-01 | 8.30e-02 | 7.66e-01 |
| GOBP IMMATURE T CELL PROLIFERATION | 7 | 7.04e-01 | 8.29e-02 | 9.25e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 24 | 4.82e-01 | 8.29e-02 | 8.54e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 39 | 3.70e-01 | 8.29e-02 | 8.02e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 102 | 1.48e-01 | 8.29e-02 | 6.07e-01 |
| GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 16 | 5.66e-01 | -8.29e-02 | 8.81e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 24 | 4.83e-01 | 8.28e-02 | 8.54e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 49 | 3.16e-01 | 8.28e-02 | 7.66e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 11 | 6.35e-01 | 8.27e-02 | 9.04e-01 |
| GOBP GLIOGENESIS | 200 | 4.42e-02 | 8.27e-02 | 3.94e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 7.49e-01 | -8.27e-02 | 9.41e-01 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 7.26e-01 | -8.27e-02 | 9.34e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 7.26e-01 | 8.26e-02 | 9.34e-01 |
| GOMF L ASCORBIC ACID BINDING | 15 | 5.80e-01 | -8.26e-02 | 8.88e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 5.93e-01 | -8.26e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 22 | 5.02e-01 | -8.26e-02 | 8.63e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 15 | 5.80e-01 | 8.26e-02 | 8.88e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 19 | 5.33e-01 | 8.26e-02 | 8.75e-01 |
| GOBP ASTROCYTE DEVELOPMENT | 26 | 4.66e-01 | -8.26e-02 | 8.48e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 10 | 6.51e-01 | -8.25e-02 | 9.09e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 36 | 3.92e-01 | -8.25e-02 | 8.12e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 6.21e-01 | 8.25e-02 | 9.03e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 59 | 2.74e-01 | -8.24e-02 | 7.36e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 25 | 4.76e-01 | 8.24e-02 | 8.51e-01 |
| GOBP VALINE METABOLIC PROCESS | 7 | 7.06e-01 | -8.24e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 47 | 3.29e-01 | -8.23e-02 | 7.77e-01 |
| GOMF ANTIPORTER ACTIVITY | 95 | 1.66e-01 | 8.22e-02 | 6.28e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 139 | 9.46e-02 | 8.22e-02 | 5.22e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 20 | 5.25e-01 | 8.22e-02 | 8.73e-01 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 7 | 7.06e-01 | -8.22e-02 | 9.26e-01 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 15 | 5.82e-01 | 8.22e-02 | 8.89e-01 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 6 | 7.28e-01 | -8.21e-02 | 9.35e-01 |
| GOMF RETINAL BINDING | 6 | 7.28e-01 | 8.21e-02 | 9.35e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 338 | 9.76e-03 | 8.21e-02 | 2.32e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 63 | 2.60e-01 | 8.21e-02 | 7.22e-01 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 13 | 6.09e-01 | 8.21e-02 | 8.99e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 26 | 4.69e-01 | 8.20e-02 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 7.28e-01 | -8.20e-02 | 9.35e-01 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 5 | 7.51e-01 | 8.20e-02 | 9.42e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 11 | 6.38e-01 | -8.19e-02 | 9.05e-01 |
| GOCC BASAL PART OF CELL | 196 | 4.86e-02 | 8.19e-02 | 4.09e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 31 | 4.30e-01 | 8.19e-02 | 8.30e-01 |
| GOBP ACUTE PHASE RESPONSE | 24 | 4.88e-01 | 8.19e-02 | 8.56e-01 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 7.51e-01 | 8.19e-02 | 9.42e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 102 | 1.54e-01 | 8.18e-02 | 6.14e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 180 | 5.88e-02 | -8.18e-02 | 4.45e-01 |
| GOBP SENSORY PERCEPTION OF BITTER TASTE | 6 | 7.29e-01 | 8.18e-02 | 9.36e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 64 | 2.58e-01 | -8.18e-02 | 7.21e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 573 | 8.80e-04 | 8.18e-02 | 6.35e-02 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 36 | 3.96e-01 | -8.18e-02 | 8.14e-01 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 35 | 4.03e-01 | -8.18e-02 | 8.16e-01 |
| GOBP CYSTEINE METABOLIC PROCESS | 7 | 7.08e-01 | -8.18e-02 | 9.26e-01 |
| GOBP GLIAL CELL ACTIVATION | 38 | 3.83e-01 | -8.17e-02 | 8.09e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 16 | 5.71e-01 | -8.17e-02 | 8.83e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 66 | 2.51e-01 | -8.17e-02 | 7.18e-01 |
| GOCC ADHERENS JUNCTION | 127 | 1.12e-01 | 8.17e-02 | 5.58e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 7 | 7.08e-01 | 8.17e-02 | 9.26e-01 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 48 | 3.28e-01 | 8.17e-02 | 7.76e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 32 | 4.24e-01 | 8.17e-02 | 8.27e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 84 | 1.96e-01 | 8.16e-02 | 6.67e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 231 | 3.30e-02 | -8.16e-02 | 3.59e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 7.29e-01 | 8.16e-02 | 9.36e-01 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 6.72e-01 | -8.16e-02 | 9.15e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 222 | 3.66e-02 | 8.16e-02 | 3.73e-01 |
| GOBP CHROMOSOME SEGREGATION | 363 | 7.81e-03 | 8.16e-02 | 2.09e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 62 | 2.67e-01 | 8.16e-02 | 7.28e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 5.85e-01 | 8.16e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 12 | 6.25e-01 | -8.15e-02 | 9.04e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 43 | 3.55e-01 | -8.15e-02 | 7.92e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 7 | 7.09e-01 | -8.15e-02 | 9.27e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 14 | 5.98e-01 | -8.15e-02 | 8.97e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 79 | 2.11e-01 | 8.14e-02 | 6.76e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 120 | 1.24e-01 | 8.14e-02 | 5.72e-01 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 9 | 6.72e-01 | -8.14e-02 | 9.15e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 12 | 6.25e-01 | 8.14e-02 | 9.04e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 44 | 3.50e-01 | -8.14e-02 | 7.90e-01 |
| GOBP CELL CELL SIGNALING BY WNT | 296 | 1.64e-02 | 8.13e-02 | 2.84e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 17 | 5.62e-01 | 8.13e-02 | 8.80e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 153 | 8.31e-02 | 8.13e-02 | 5.01e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 123 | 1.20e-01 | 8.13e-02 | 5.70e-01 |
| GOBP PEPTIDE TRANSPORT | 151 | 8.54e-02 | 8.12e-02 | 5.06e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 101 | 1.59e-01 | 8.12e-02 | 6.19e-01 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 10 | 6.57e-01 | 8.11e-02 | 9.10e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 10 | 6.57e-01 | 8.11e-02 | 9.10e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 8 | 6.91e-01 | -8.11e-02 | 9.22e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 9 | 6.74e-01 | -8.11e-02 | 9.16e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 439 | 3.75e-03 | 8.10e-02 | 1.47e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 6.74e-01 | 8.10e-02 | 9.16e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 204 | 4.65e-02 | -8.10e-02 | 4.03e-01 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 7.11e-01 | -8.10e-02 | 9.28e-01 |
| GOMF GAMMA TUBULIN BINDING | 31 | 4.35e-01 | 8.10e-02 | 8.33e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 12 | 6.27e-01 | -8.09e-02 | 9.04e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 23 | 5.02e-01 | -8.09e-02 | 8.63e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 72 | 2.36e-01 | 8.09e-02 | 7.00e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 39 | 3.82e-01 | 8.09e-02 | 8.08e-01 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.32e-01 | 8.08e-02 | 9.36e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 52 | 3.14e-01 | -8.08e-02 | 7.66e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 12 | 6.28e-01 | 8.08e-02 | 9.04e-01 |
| GOBP PIGMENT CELL DIFFERENTIATION | 24 | 4.94e-01 | 8.08e-02 | 8.59e-01 |
| GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 22 | 5.12e-01 | 8.07e-02 | 8.67e-01 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 7 | 7.12e-01 | -8.07e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 7.32e-01 | -8.07e-02 | 9.36e-01 |
| GOBP RESPONSE TO ZINC ION STARVATION | 7 | 7.12e-01 | 8.06e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 6 | 7.32e-01 | 8.06e-02 | 9.36e-01 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 65 | 2.61e-01 | -8.06e-02 | 7.24e-01 |
| GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY | 6 | 7.32e-01 | -8.06e-02 | 9.36e-01 |
| GOCC CHROMOSOME PASSENGER COMPLEX | 6 | 7.32e-01 | -8.06e-02 | 9.36e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 56 | 2.98e-01 | 8.05e-02 | 7.54e-01 |
| GOMF COBALAMIN BINDING | 8 | 6.93e-01 | -8.05e-02 | 9.23e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 92 | 1.82e-01 | 8.05e-02 | 6.51e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 10 | 6.60e-01 | -8.05e-02 | 9.12e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 63 | 2.70e-01 | -8.04e-02 | 7.32e-01 |
| GOBP PHAGOCYTOSIS | 181 | 6.26e-02 | -8.04e-02 | 4.56e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 31 | 4.39e-01 | -8.04e-02 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 89 | 1.91e-01 | -8.04e-02 | 6.61e-01 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 7.33e-01 | 8.04e-02 | 9.36e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 20 | 5.35e-01 | -8.02e-02 | 8.75e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 87 | 1.97e-01 | -8.02e-02 | 6.67e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 42 | 3.69e-01 | 8.02e-02 | 8.02e-01 |
| GOCC AXON INITIAL SEGMENT | 11 | 6.46e-01 | 8.01e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 103 | 1.61e-01 | -8.01e-02 | 6.20e-01 |
| GOMF OXYGEN BINDING | 9 | 6.77e-01 | -8.01e-02 | 9.18e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 56 | 3.00e-01 | -8.01e-02 | 7.56e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 40 | 3.81e-01 | 8.01e-02 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 23 | 5.06e-01 | 8.01e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 156 | 8.50e-02 | 8.00e-02 | 5.05e-01 |
| GOBP DNA METHYLATION | 39 | 3.87e-01 | 8.00e-02 | 8.10e-01 |
| GOBP INTERLEUKIN 17 PRODUCTION | 28 | 4.64e-01 | -8.00e-02 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 62 | 2.76e-01 | 8.00e-02 | 7.38e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 71 | 2.44e-01 | 8.00e-02 | 7.08e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY | 5 | 7.57e-01 | 7.99e-02 | 9.43e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 41 | 3.76e-01 | 7.99e-02 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 20 | 5.36e-01 | 7.99e-02 | 8.76e-01 |
| GOMF UBIQUITIN BINDING | 100 | 1.68e-01 | -7.98e-02 | 6.32e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 6 | 7.35e-01 | -7.97e-02 | 9.37e-01 |
| GOMF NADPLUS BINDING | 17 | 5.69e-01 | -7.97e-02 | 8.83e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 45 | 3.55e-01 | 7.97e-02 | 7.92e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 147 | 9.58e-02 | 7.97e-02 | 5.26e-01 |
| GOBP HISTONE H4 ACETYLATION | 12 | 6.33e-01 | 7.97e-02 | 9.04e-01 |
| GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 9 | 6.79e-01 | -7.97e-02 | 9.19e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 22 | 5.18e-01 | -7.97e-02 | 8.69e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 40 | 3.84e-01 | -7.97e-02 | 8.09e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 11 | 6.48e-01 | 7.96e-02 | 9.08e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 155 | 8.81e-02 | -7.95e-02 | 5.10e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 5 | 7.58e-01 | -7.95e-02 | 9.44e-01 |
| GOMF CADHERIN BINDING | 272 | 2.45e-02 | -7.95e-02 | 3.22e-01 |
| GOBP GROWTH | 609 | 8.80e-04 | 7.94e-02 | 6.35e-02 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 7.36e-01 | -7.94e-02 | 9.37e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 46 | 3.52e-01 | -7.94e-02 | 7.91e-01 |
| GOBP BILE ACID SECRETION | 7 | 7.16e-01 | 7.94e-02 | 9.30e-01 |
| GOBP TISSUE MORPHOGENESIS | 347 | 1.13e-02 | 7.94e-02 | 2.45e-01 |
| GOBP RUFFLE ORGANIZATION | 45 | 3.57e-01 | 7.94e-02 | 7.92e-01 |
| GOBP VESICLE TARGETING | 61 | 2.84e-01 | -7.94e-02 | 7.43e-01 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 16 | 5.83e-01 | 7.94e-02 | 8.90e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 8 | 6.98e-01 | 7.93e-02 | 9.25e-01 |
| GOMF GLUCOSE BINDING | 9 | 6.80e-01 | 7.93e-02 | 9.19e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 242 | 3.41e-02 | -7.93e-02 | 3.63e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 13 | 6.21e-01 | -7.92e-02 | 9.03e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 33 | 4.31e-01 | 7.92e-02 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 46 | 3.53e-01 | -7.92e-02 | 7.92e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 43 | 3.69e-01 | -7.92e-02 | 8.02e-01 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 7 | 7.17e-01 | 7.92e-02 | 9.31e-01 |
| GOMF POLY PURINE TRACT BINDING | 26 | 4.85e-01 | 7.91e-02 | 8.55e-01 |
| GOCC KINETOCHORE MICROTUBULE | 19 | 5.51e-01 | 7.90e-02 | 8.79e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 6.99e-01 | -7.90e-02 | 9.25e-01 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 6 | 7.37e-01 | 7.90e-02 | 9.37e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 6.99e-01 | -7.90e-02 | 9.25e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 7.38e-01 | 7.90e-02 | 9.37e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 20 | 5.41e-01 | -7.90e-02 | 8.76e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 8 | 6.99e-01 | 7.90e-02 | 9.25e-01 |
| GOBP SPINDLE LOCALIZATION | 48 | 3.44e-01 | 7.90e-02 | 7.88e-01 |
| GOCC MLL3 4 COMPLEX | 12 | 6.36e-01 | -7.90e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 170 | 7.63e-02 | -7.89e-02 | 4.91e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 7 | 7.18e-01 | 7.89e-02 | 9.31e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 839 | 1.20e-04 | -7.89e-02 | 1.61e-02 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 33 | 4.33e-01 | -7.88e-02 | 8.31e-01 |
| GOBP KIDNEY MORPHOGENESIS | 43 | 3.72e-01 | 7.88e-02 | 8.03e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 87 | 2.05e-01 | -7.88e-02 | 6.72e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 111 | 1.52e-01 | -7.87e-02 | 6.13e-01 |
| GOCC RUFFLE MEMBRANE | 86 | 2.07e-01 | 7.87e-02 | 6.74e-01 |
| GOMF METHYL CPG BINDING | 21 | 5.33e-01 | 7.87e-02 | 8.75e-01 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 5 | 7.61e-01 | 7.86e-02 | 9.44e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 334 | 1.39e-02 | 7.86e-02 | 2.65e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 65 | 2.74e-01 | 7.86e-02 | 7.36e-01 |
| GOCC LATE ENDOSOME | 254 | 3.15e-02 | -7.86e-02 | 3.52e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 21 | 5.33e-01 | 7.85e-02 | 8.75e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 130 | 1.23e-01 | 7.85e-02 | 5.71e-01 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 11 | 6.52e-01 | -7.85e-02 | 9.09e-01 |
| GOBP DEVELOPMENTAL MATURATION | 183 | 6.77e-02 | 7.85e-02 | 4.72e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 73 | 2.47e-01 | -7.84e-02 | 7.13e-01 |
| GOBP MYELIN ASSEMBLY | 17 | 5.76e-01 | -7.84e-02 | 8.87e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 293 | 2.14e-02 | 7.84e-02 | 3.10e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 19 | 5.55e-01 | -7.83e-02 | 8.79e-01 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 8 | 7.01e-01 | -7.83e-02 | 9.25e-01 |
| GOCC MISMATCH REPAIR COMPLEX | 7 | 7.20e-01 | 7.83e-02 | 9.32e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 41 | 3.86e-01 | 7.82e-02 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 7.02e-01 | 7.81e-02 | 9.25e-01 |
| GOBP APPENDAGE DEVELOPMENT | 99 | 1.80e-01 | 7.81e-02 | 6.46e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 135 | 1.18e-01 | -7.81e-02 | 5.68e-01 |
| GOBP PANCREAS DEVELOPMENT | 39 | 3.99e-01 | -7.81e-02 | 8.15e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 9 | 6.85e-01 | 7.81e-02 | 9.19e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 31 | 4.52e-01 | -7.80e-02 | 8.42e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 48 | 3.50e-01 | -7.80e-02 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 12 | 6.40e-01 | -7.80e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 25 | 5.00e-01 | 7.79e-02 | 8.63e-01 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 37 | 4.12e-01 | 7.79e-02 | 8.19e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 15 | 6.01e-01 | -7.79e-02 | 8.97e-01 |
| GOBP NUCLEUS LOCALIZATION | 27 | 4.84e-01 | 7.79e-02 | 8.54e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 8 | 7.03e-01 | 7.79e-02 | 9.25e-01 |
| GOBP NADP METABOLIC PROCESS | 38 | 4.06e-01 | -7.79e-02 | 8.18e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 90 | 2.02e-01 | -7.79e-02 | 6.69e-01 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 7 | 7.21e-01 | 7.78e-02 | 9.32e-01 |
| GOBP AMIDE METABOLIC PROCESS | 948 | 5.88e-05 | -7.78e-02 | 9.33e-03 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 7.63e-01 | 7.77e-02 | 9.44e-01 |
| GOCC ENVELOPE | 1095 | 1.77e-05 | -7.77e-02 | 3.60e-03 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 8 | 7.03e-01 | -7.77e-02 | 9.25e-01 |
| GOBP REGULATION OF RNA SPLICING | 151 | 1.00e-01 | -7.76e-02 | 5.32e-01 |
| GOBP RESPONSE TO SELENIUM ION | 5 | 7.64e-01 | 7.76e-02 | 9.44e-01 |
| GOBP RRNA MODIFICATION | 31 | 4.55e-01 | 7.76e-02 | 8.42e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 16 | 5.91e-01 | -7.76e-02 | 8.94e-01 |
| GOCC AUTOLYSOSOME | 12 | 6.42e-01 | -7.76e-02 | 9.06e-01 |
| GOCC GABA ERGIC SYNAPSE | 24 | 5.11e-01 | 7.75e-02 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 8 | 7.04e-01 | -7.75e-02 | 9.25e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 44 | 3.74e-01 | 7.75e-02 | 8.05e-01 |
| GOBP NEURAL TUBE FORMATION | 80 | 2.31e-01 | 7.75e-02 | 6.94e-01 |
| GOBP NK T CELL ACTIVATION | 10 | 6.71e-01 | 7.75e-02 | 9.15e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 441 | 5.58e-03 | 7.73e-02 | 1.79e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 16 | 5.92e-01 | 7.73e-02 | 8.94e-01 |
| GOBP RESPONSE TO X RAY | 24 | 5.12e-01 | -7.73e-02 | 8.67e-01 |
| GOBP ACROSOME REACTION | 13 | 6.30e-01 | -7.73e-02 | 9.04e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 8 | 7.05e-01 | 7.72e-02 | 9.26e-01 |
| GOBP PROTEIN MATURATION | 415 | 7.19e-03 | -7.72e-02 | 2.00e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 16 | 5.93e-01 | 7.72e-02 | 8.94e-01 |
| GOMF PRE MRNA BINDING | 32 | 4.50e-01 | -7.72e-02 | 8.42e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 17 | 5.82e-01 | -7.72e-02 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 22 | 5.31e-01 | 7.71e-02 | 8.75e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 15 | 6.05e-01 | 7.71e-02 | 8.98e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 202 | 5.94e-02 | -7.71e-02 | 4.46e-01 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 11 | 6.58e-01 | 7.71e-02 | 9.11e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 7.24e-01 | -7.70e-02 | 9.33e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 14 | 6.18e-01 | 7.70e-02 | 9.02e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 42 | 3.88e-01 | -7.70e-02 | 8.11e-01 |
| GOBP SULFATE TRANSPORT | 13 | 6.31e-01 | -7.70e-02 | 9.04e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 64 | 2.88e-01 | 7.69e-02 | 7.48e-01 |
| GOBP CELL SUBSTRATE ADHESION | 227 | 4.66e-02 | 7.68e-02 | 4.03e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 97 | 1.91e-01 | 7.68e-02 | 6.62e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 15 | 6.07e-01 | 7.68e-02 | 8.99e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 38 | 4.13e-01 | -7.68e-02 | 8.20e-01 |
| GOMF DNA POLYMERASE ACTIVITY | 28 | 4.83e-01 | 7.67e-02 | 8.54e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 88 | 2.14e-01 | -7.67e-02 | 6.79e-01 |
| GOBP REGULATION OF BINDING | 201 | 6.17e-02 | -7.66e-02 | 4.51e-01 |
| GOBP INNERVATION | 13 | 6.33e-01 | 7.65e-02 | 9.04e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 12 | 6.46e-01 | -7.65e-02 | 9.08e-01 |
| GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 6.91e-01 | -7.65e-02 | 9.22e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 16 | 5.97e-01 | 7.64e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 36 | 4.28e-01 | 7.63e-02 | 8.30e-01 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 10 | 6.76e-01 | -7.63e-02 | 9.17e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 13 | 6.34e-01 | 7.63e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 43 | 3.87e-01 | 7.63e-02 | 8.10e-01 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 246 | 3.99e-02 | -7.63e-02 | 3.86e-01 |
| GOMF CLATHRIN BINDING | 47 | 3.66e-01 | 7.63e-02 | 7.99e-01 |
| GOBP RESPONSE TO VITAMIN | 49 | 3.56e-01 | 7.62e-02 | 7.92e-01 |
| GOBP PYRUVATE TRANSPORT | 5 | 7.68e-01 | 7.62e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 92 | 2.07e-01 | 7.62e-02 | 6.74e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 289 | 2.63e-02 | 7.62e-02 | 3.29e-01 |
| GOBP RNA PROCESSING | 864 | 1.66e-04 | -7.62e-02 | 2.01e-02 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 42 | 3.93e-01 | 7.62e-02 | 8.13e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 9 | 6.92e-01 | -7.62e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 8 | 7.09e-01 | -7.62e-02 | 9.27e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 10 | 6.77e-01 | -7.61e-02 | 9.18e-01 |
| GOCC MICROBODY LUMEN | 41 | 4.00e-01 | -7.60e-02 | 8.15e-01 |
| GOCC CONTRACTILE RING | 10 | 6.77e-01 | 7.60e-02 | 9.18e-01 |
| GOBP SNRNA PROCESSING | 26 | 5.03e-01 | 7.60e-02 | 8.63e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 9 | 6.93e-01 | -7.59e-02 | 9.23e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 146 | 1.14e-01 | 7.59e-02 | 5.62e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 28 | 4.87e-01 | -7.58e-02 | 8.56e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 26 | 5.03e-01 | 7.58e-02 | 8.64e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 14 | 6.23e-01 | -7.58e-02 | 9.04e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 344 | 1.61e-02 | -7.58e-02 | 2.82e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 64 | 2.95e-01 | -7.58e-02 | 7.54e-01 |
| GOCC VACUOLE | 699 | 7.07e-04 | -7.57e-02 | 5.36e-02 |
| GOBP NEUROTRANSMITTER UPTAKE | 19 | 5.68e-01 | 7.57e-02 | 8.82e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 85 | 2.28e-01 | 7.57e-02 | 6.91e-01 |
| GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS | 5 | 7.70e-01 | -7.57e-02 | 9.46e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 193 | 7.05e-02 | 7.57e-02 | 4.78e-01 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 322 | 2.00e-02 | -7.56e-02 | 3.02e-01 |
| GOBP NERVE DEVELOPMENT | 47 | 3.70e-01 | -7.56e-02 | 8.02e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 92 | 2.10e-01 | -7.56e-02 | 6.75e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 20 | 5.58e-01 | -7.56e-02 | 8.79e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 35 | 4.39e-01 | -7.56e-02 | 8.36e-01 |
| GOBP TRACHEA DEVELOPMENT | 12 | 6.50e-01 | -7.56e-02 | 9.08e-01 |
| GOBP FOREGUT MORPHOGENESIS | 6 | 7.49e-01 | 7.56e-02 | 9.41e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 7.49e-01 | 7.55e-02 | 9.41e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 14 | 6.25e-01 | -7.55e-02 | 9.04e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 12 | 6.51e-01 | -7.55e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 67 | 2.86e-01 | -7.54e-02 | 7.46e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 15 | 6.13e-01 | -7.54e-02 | 9.01e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 20 | 5.60e-01 | -7.53e-02 | 8.79e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 256 | 3.85e-02 | -7.53e-02 | 3.80e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 611 | 1.60e-03 | -7.52e-02 | 9.00e-02 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 70 | 2.77e-01 | 7.52e-02 | 7.38e-01 |
| GOBP XENOBIOTIC TRANSPORT | 32 | 4.62e-01 | 7.52e-02 | 8.45e-01 |
| GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 35 | 4.42e-01 | 7.52e-02 | 8.37e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 67 | 2.88e-01 | -7.52e-02 | 7.48e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 11 | 6.66e-01 | -7.52e-02 | 9.14e-01 |
| GOMF SULFOTRANSFERASE ACTIVITY | 20 | 5.61e-01 | 7.52e-02 | 8.79e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 11 | 6.66e-01 | -7.51e-02 | 9.14e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 9 | 6.96e-01 | -7.51e-02 | 9.25e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 37 | 4.29e-01 | -7.51e-02 | 8.30e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 23 | 5.33e-01 | -7.51e-02 | 8.75e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 7.50e-01 | -7.50e-02 | 9.41e-01 |
| GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 7.50e-01 | -7.50e-02 | 9.41e-01 |
| GOBP ASSOCIATIVE LEARNING | 48 | 3.69e-01 | 7.50e-02 | 8.01e-01 |
| GOBP GASTRULATION | 115 | 1.65e-01 | 7.50e-02 | 6.26e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 93 | 2.12e-01 | 7.50e-02 | 6.77e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 9 | 6.97e-01 | -7.50e-02 | 9.25e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 23 | 5.34e-01 | -7.49e-02 | 8.75e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 6.40e-01 | 7.49e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 40 | 4.13e-01 | 7.49e-02 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 33 | 4.57e-01 | -7.49e-02 | 8.44e-01 |
| GOBP T CELL CYTOKINE PRODUCTION | 28 | 4.93e-01 | -7.49e-02 | 8.59e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 50 | 3.61e-01 | -7.48e-02 | 7.94e-01 |
| GOMF U6 SNRNA BINDING | 14 | 6.28e-01 | 7.48e-02 | 9.04e-01 |
| GOMF LIGASE ACTIVITY | 125 | 1.50e-01 | 7.47e-02 | 6.11e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 15 | 6.17e-01 | 7.47e-02 | 9.02e-01 |
| GOBP MRNA METHYLATION | 18 | 5.83e-01 | -7.47e-02 | 8.90e-01 |
| GOBP P BODY ASSEMBLY | 21 | 5.54e-01 | 7.47e-02 | 8.79e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 7 | 7.32e-01 | -7.46e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 35 | 4.45e-01 | 7.46e-02 | 8.40e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 54 | 3.43e-01 | 7.46e-02 | 7.87e-01 |
| GOMF LAMININ BINDING | 17 | 5.95e-01 | -7.46e-02 | 8.95e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 9 | 6.99e-01 | 7.45e-02 | 9.25e-01 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 6 | 7.52e-01 | 7.45e-02 | 9.42e-01 |
| GOMF ANTIGEN BINDING | 49 | 3.67e-01 | -7.45e-02 | 8.00e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 6 | 7.52e-01 | 7.44e-02 | 9.42e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 16 | 6.06e-01 | 7.44e-02 | 8.99e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 25 | 5.20e-01 | 7.44e-02 | 8.71e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 99 | 2.01e-01 | -7.44e-02 | 6.69e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 28 | 4.96e-01 | 7.44e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 14 | 6.30e-01 | -7.44e-02 | 9.04e-01 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 6.84e-01 | 7.43e-02 | 9.19e-01 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 7 | 7.34e-01 | -7.43e-02 | 9.36e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 169 | 9.64e-02 | 7.43e-02 | 5.26e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 256 | 4.13e-02 | 7.43e-02 | 3.86e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 75 | 2.67e-01 | 7.43e-02 | 7.28e-01 |
| GOBP GDP METABOLIC PROCESS | 11 | 6.70e-01 | -7.42e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 46 | 3.84e-01 | 7.42e-02 | 8.09e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 45 | 3.90e-01 | 7.42e-02 | 8.11e-01 |
| GOBP THYMIC T CELL SELECTION | 11 | 6.70e-01 | -7.41e-02 | 9.15e-01 |
| GOCC MUSCLE MYOSIN COMPLEX | 5 | 7.74e-01 | -7.40e-02 | 9.48e-01 |
| GOBP PROTEOLYSIS | 1195 | 2.09e-05 | -7.40e-02 | 4.15e-03 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 7.74e-01 | 7.40e-02 | 9.48e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 160 | 1.07e-01 | 7.40e-02 | 5.44e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 17 | 5.98e-01 | 7.40e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 35 | 4.49e-01 | -7.39e-02 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 67 | 2.96e-01 | -7.39e-02 | 7.54e-01 |
| GOBP GTP METABOLIC PROCESS | 23 | 5.40e-01 | -7.39e-02 | 8.76e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 15 | 6.21e-01 | 7.38e-02 | 9.03e-01 |
| GOMF BETA TUBULIN BINDING | 34 | 4.57e-01 | -7.37e-02 | 8.44e-01 |
| GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 5 | 7.75e-01 | -7.37e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 16 | 6.10e-01 | 7.37e-02 | 8.99e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 14 | 6.33e-01 | -7.37e-02 | 9.04e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 80 | 2.55e-01 | -7.37e-02 | 7.18e-01 |
| GOBP RESPONSE TO COLD | 34 | 4.58e-01 | -7.37e-02 | 8.44e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 11 | 6.72e-01 | -7.36e-02 | 9.15e-01 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 24 | 5.32e-01 | -7.36e-02 | 8.75e-01 |
| GOCC TRAPP COMPLEX | 15 | 6.22e-01 | -7.36e-02 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 20 | 5.69e-01 | -7.35e-02 | 8.83e-01 |
| GOBP SODIUM ION TRANSPORT | 114 | 1.76e-01 | 7.35e-02 | 6.39e-01 |
| GOBP EMBRYO DEVELOPMENT | 703 | 9.81e-04 | 7.35e-02 | 6.90e-02 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 5 | 7.76e-01 | -7.35e-02 | 9.48e-01 |
| GOBP RESPONSE TO KETONE | 127 | 1.53e-01 | 7.34e-02 | 6.14e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 19 | 5.80e-01 | -7.34e-02 | 8.88e-01 |
| GOBP QUINONE METABOLIC PROCESS | 31 | 4.80e-01 | -7.34e-02 | 8.52e-01 |
| GOBP SIGNAL RELEASE | 272 | 3.78e-02 | 7.34e-02 | 3.78e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 36 | 4.46e-01 | -7.34e-02 | 8.40e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 22 | 5.52e-01 | 7.34e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 32 | 4.73e-01 | 7.34e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 7 | 7.37e-01 | -7.33e-02 | 9.37e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 7 | 7.37e-01 | -7.33e-02 | 9.37e-01 |
| GOBP T CELL SELECTION | 33 | 4.67e-01 | -7.33e-02 | 8.48e-01 |
| GOBP CELL FATE SPECIFICATION | 34 | 4.60e-01 | -7.32e-02 | 8.45e-01 |
| GOBP CENTRIOLE ASSEMBLY | 44 | 4.01e-01 | 7.32e-02 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 7 | 7.38e-01 | 7.31e-02 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 60 | 3.29e-01 | 7.30e-02 | 7.77e-01 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 222 | 6.16e-02 | -7.30e-02 | 4.51e-01 |
| GOMF ZINC ION BINDING | 589 | 2.65e-03 | 7.29e-02 | 1.22e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 38 | 4.37e-01 | 7.29e-02 | 8.34e-01 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 8 | 7.21e-01 | 7.29e-02 | 9.32e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 7.39e-01 | -7.28e-02 | 9.37e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 132 | 1.49e-01 | 7.28e-02 | 6.09e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 128 | 1.56e-01 | 7.28e-02 | 6.19e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 9 | 7.06e-01 | 7.28e-02 | 9.26e-01 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 12 | 6.63e-01 | 7.27e-02 | 9.13e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 298 | 3.14e-02 | -7.27e-02 | 3.52e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 7 | 7.39e-01 | 7.27e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 101 | 2.08e-01 | -7.26e-02 | 6.74e-01 |
| GOBP I KAPPAB PHOSPHORYLATION | 13 | 6.50e-01 | 7.26e-02 | 9.08e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 13 | 6.50e-01 | -7.26e-02 | 9.08e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 30 | 4.92e-01 | -7.26e-02 | 8.59e-01 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 7.58e-01 | -7.26e-02 | 9.44e-01 |
| GOBP LIPID CATABOLIC PROCESS | 220 | 6.44e-02 | -7.25e-02 | 4.64e-01 |
| GOCC AP 2 ADAPTOR COMPLEX | 7 | 7.40e-01 | 7.25e-02 | 9.38e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 43 | 4.11e-01 | 7.25e-02 | 8.19e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 43 | 4.11e-01 | -7.25e-02 | 8.19e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 43 | 4.11e-01 | -7.25e-02 | 8.19e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 31 | 4.85e-01 | 7.24e-02 | 8.55e-01 |
| GOBP MUSCLE CONTRACTION | 190 | 8.57e-02 | 7.24e-02 | 5.07e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1233 | 2.41e-05 | -7.24e-02 | 4.22e-03 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 33 | 4.72e-01 | 7.24e-02 | 8.50e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 64 | 3.17e-01 | -7.24e-02 | 7.67e-01 |
| GOBP NETRIN ACTIVATED SIGNALING PATHWAY | 5 | 7.79e-01 | 7.24e-02 | 9.48e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 143 | 1.36e-01 | 7.24e-02 | 5.90e-01 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 7 | 7.40e-01 | 7.24e-02 | 9.38e-01 |
| GOBP FOREBRAIN MORPHOGENESIS | 6 | 7.59e-01 | 7.24e-02 | 9.44e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 12 | 6.64e-01 | 7.24e-02 | 9.14e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 229 | 5.99e-02 | 7.23e-02 | 4.47e-01 |
| GOBP PHOSPHOLIPID TRANSLOCATION | 37 | 4.47e-01 | 7.23e-02 | 8.40e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 17 | 6.06e-01 | -7.23e-02 | 8.99e-01 |
| GOBP OOCYTE MATURATION | 17 | 6.06e-01 | 7.23e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 23 | 5.49e-01 | -7.22e-02 | 8.78e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 248 | 5.09e-02 | 7.22e-02 | 4.17e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 7.41e-01 | -7.22e-02 | 9.38e-01 |
| GOBP WALKING BEHAVIOR | 20 | 5.76e-01 | 7.22e-02 | 8.87e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 11 | 6.79e-01 | -7.21e-02 | 9.19e-01 |
| GOCC PCG PROTEIN COMPLEX | 35 | 4.60e-01 | -7.21e-02 | 8.45e-01 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 7.60e-01 | -7.21e-02 | 9.44e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 147 | 1.32e-01 | 7.21e-02 | 5.84e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 903 | 2.73e-04 | 7.21e-02 | 3.05e-02 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 13 | 6.53e-01 | -7.20e-02 | 9.09e-01 |
| GOBP RESPONSE TO ALDOSTERONE | 12 | 6.66e-01 | 7.19e-02 | 9.14e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 9 | 7.09e-01 | 7.18e-02 | 9.27e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 44 | 4.10e-01 | -7.18e-02 | 8.19e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 79 | 2.71e-01 | 7.18e-02 | 7.33e-01 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 11 | 6.80e-01 | 7.18e-02 | 9.19e-01 |
| GOBP RESPONSE TO LECTIN | 16 | 6.19e-01 | -7.17e-02 | 9.03e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 52 | 3.71e-01 | 7.17e-02 | 8.03e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 517 | 5.51e-03 | -7.17e-02 | 1.79e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 6 | 7.61e-01 | -7.16e-02 | 9.44e-01 |
| GOBP NEUROGENESIS | 1025 | 1.25e-04 | 7.16e-02 | 1.61e-02 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 91 | 2.38e-01 | -7.16e-02 | 7.03e-01 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 6 | 7.61e-01 | -7.16e-02 | 9.44e-01 |
| GOBP AXIS SPECIFICATION | 46 | 4.01e-01 | 7.16e-02 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 16 | 6.20e-01 | 7.16e-02 | 9.03e-01 |
| GOBP VITAMIN K METABOLIC PROCESS | 7 | 7.43e-01 | -7.16e-02 | 9.38e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 288 | 3.73e-02 | 7.15e-02 | 3.76e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 187 | 9.24e-02 | -7.15e-02 | 5.18e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 7.82e-01 | -7.15e-02 | 9.48e-01 |
| GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 221 | 6.78e-02 | 7.15e-02 | 4.72e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 140 | 1.45e-01 | -7.15e-02 | 6.04e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 43 | 4.18e-01 | 7.14e-02 | 8.22e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 18 | 6.00e-01 | 7.13e-02 | 8.97e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 21 | 5.72e-01 | -7.13e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 22 | 5.63e-01 | 7.13e-02 | 8.80e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 16 | 6.22e-01 | 7.13e-02 | 9.03e-01 |
| GOBP NUCLEOPHAGY | 19 | 5.91e-01 | 7.12e-02 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 202 | 8.16e-02 | -7.12e-02 | 4.99e-01 |
| GOMF PROTEOGLYCAN BINDING | 23 | 5.55e-01 | -7.12e-02 | 8.79e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 44 | 4.14e-01 | -7.12e-02 | 8.21e-01 |
| GOBP NEURON RECOGNITION | 25 | 5.38e-01 | 7.12e-02 | 8.76e-01 |
| GOBP CDP CHOLINE PATHWAY | 6 | 7.63e-01 | -7.12e-02 | 9.44e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 53 | 3.71e-01 | 7.11e-02 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 28 | 5.15e-01 | 7.11e-02 | 8.68e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 39 | 4.42e-01 | -7.11e-02 | 8.37e-01 |
| GOMF SPECTRIN BINDING | 19 | 5.92e-01 | 7.11e-02 | 8.94e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 529 | 5.44e-03 | 7.10e-02 | 1.78e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 9 | 7.12e-01 | -7.10e-02 | 9.29e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 146 | 1.39e-01 | 7.10e-02 | 5.96e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 14 | 6.46e-01 | -7.10e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 15 | 6.34e-01 | -7.10e-02 | 9.04e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 10 | 6.98e-01 | 7.10e-02 | 9.25e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 7 | 7.45e-01 | -7.10e-02 | 9.39e-01 |
| GOBP AMIDE TRANSPORT | 208 | 7.84e-02 | 7.10e-02 | 4.96e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 49 | 3.91e-01 | 7.09e-02 | 8.11e-01 |
| GOCC TIGHT JUNCTION | 75 | 2.89e-01 | 7.09e-02 | 7.49e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 12 | 6.71e-01 | 7.08e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 7 | 7.46e-01 | 7.07e-02 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 16 | 6.24e-01 | 7.07e-02 | 9.04e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 7.84e-01 | 7.07e-02 | 9.48e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 662 | 2.06e-03 | -7.07e-02 | 1.04e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 37 | 4.57e-01 | -7.07e-02 | 8.44e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 34 | 4.76e-01 | 7.07e-02 | 8.51e-01 |
| GOCC CORTICAL CYTOSKELETON | 75 | 2.90e-01 | -7.07e-02 | 7.49e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 243 | 5.84e-02 | -7.07e-02 | 4.45e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 54 | 3.69e-01 | -7.07e-02 | 8.02e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 41 | 4.34e-01 | 7.07e-02 | 8.32e-01 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 12 | 6.72e-01 | -7.06e-02 | 9.15e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 10 | 7.00e-01 | 7.04e-02 | 9.25e-01 |
| GOBP MULTICELLULAR ORGANISM REPRODUCTION | 528 | 5.92e-03 | 7.04e-02 | 1.81e-01 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 61 | 3.42e-01 | -7.03e-02 | 7.87e-01 |
| GOBP NEURON PROJECTION EXTENSION | 120 | 1.84e-01 | 7.03e-02 | 6.52e-01 |
| GOBP REGULATION OF P38MAPK CASCADE | 35 | 4.72e-01 | 7.03e-02 | 8.50e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 67 | 3.20e-01 | -7.03e-02 | 7.69e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL PROLIFERATION | 5 | 7.86e-01 | -7.02e-02 | 9.48e-01 |
| GOBP SNRNA METABOLIC PROCESS | 53 | 3.77e-01 | 7.02e-02 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 27 | 5.28e-01 | -7.02e-02 | 8.74e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 259 | 5.25e-02 | 7.02e-02 | 4.24e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 100 | 2.26e-01 | 7.02e-02 | 6.90e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 53 | 3.77e-01 | 7.02e-02 | 8.05e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 9 | 7.16e-01 | 7.01e-02 | 9.30e-01 |
| GOMF METAL CLUSTER BINDING | 64 | 3.32e-01 | -7.01e-02 | 7.78e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 16 | 6.27e-01 | -7.01e-02 | 9.04e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 79 | 2.82e-01 | -7.01e-02 | 7.42e-01 |
| GOMF FIBRONECTIN BINDING | 20 | 5.88e-01 | 7.00e-02 | 8.92e-01 |
| GOCC MEDIATOR COMPLEX | 36 | 4.67e-01 | -7.00e-02 | 8.49e-01 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 10 | 7.02e-01 | -7.00e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 8 | 7.32e-01 | -7.00e-02 | 9.36e-01 |
| GOCC APICOLATERAL PLASMA MEMBRANE | 10 | 7.02e-01 | 7.00e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 14 | 6.51e-01 | 6.99e-02 | 9.08e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 18 | 6.07e-01 | 6.99e-02 | 8.99e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 18 | 6.07e-01 | 6.99e-02 | 8.99e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 16 | 6.28e-01 | 6.99e-02 | 9.04e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 5 | 7.87e-01 | 6.99e-02 | 9.49e-01 |
| GOCC CELL POLE | 5 | 7.87e-01 | 6.99e-02 | 9.49e-01 |
| GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 17 | 6.18e-01 | 6.99e-02 | 9.02e-01 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 9 | 7.17e-01 | 6.99e-02 | 9.31e-01 |
| GOMF LIPASE ACTIVITY | 77 | 2.90e-01 | -6.99e-02 | 7.49e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 153 | 1.37e-01 | 6.98e-02 | 5.93e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1398 | 1.66e-05 | -6.98e-02 | 3.44e-03 |
| GOBP SCHWANN CELL DEVELOPMENT | 23 | 5.63e-01 | 6.98e-02 | 8.80e-01 |
| GOBP NK T CELL PROLIFERATION | 8 | 7.33e-01 | 6.98e-02 | 9.36e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 64 | 3.35e-01 | -6.97e-02 | 7.81e-01 |
| GOBP HORMONE CATABOLIC PROCESS | 8 | 7.33e-01 | 6.97e-02 | 9.36e-01 |
| GOBP NUCLEOBASE TRANSPORT | 9 | 7.18e-01 | -6.97e-02 | 9.31e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 158 | 1.32e-01 | 6.96e-02 | 5.84e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 80 | 2.83e-01 | 6.95e-02 | 7.42e-01 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 914 | 4.18e-04 | -6.95e-02 | 3.84e-02 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 10 | 7.04e-01 | -6.95e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 6 | 7.68e-01 | 6.95e-02 | 9.46e-01 |
| GOBP MACROPHAGE MIGRATION | 40 | 4.48e-01 | 6.94e-02 | 8.41e-01 |
| GOMF KINASE ACTIVITY | 584 | 4.45e-03 | 6.93e-02 | 1.58e-01 |
| GOBP FEEDING BEHAVIOR | 41 | 4.43e-01 | 6.92e-02 | 8.38e-01 |
| GOBP CELLULAR EXTRAVASATION | 48 | 4.07e-01 | 6.92e-02 | 8.18e-01 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 40 | 4.49e-01 | 6.92e-02 | 8.42e-01 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 7.51e-01 | -6.91e-02 | 9.42e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 54 | 3.80e-01 | 6.91e-02 | 8.07e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 19 | 6.02e-01 | -6.91e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 33 | 4.92e-01 | 6.91e-02 | 8.59e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 30 | 5.13e-01 | -6.91e-02 | 8.67e-01 |
| GOBP NUCLEOBASE CATABOLIC PROCESS | 6 | 7.70e-01 | 6.91e-02 | 9.46e-01 |
| GOCC SPINDLE | 370 | 2.31e-02 | 6.90e-02 | 3.18e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 64 | 3.40e-01 | 6.90e-02 | 7.84e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 388 | 2.01e-02 | -6.90e-02 | 3.02e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 214 | 8.27e-02 | 6.90e-02 | 5.00e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 127 | 1.80e-01 | 6.89e-02 | 6.48e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 5 | 7.90e-01 | 6.89e-02 | 9.49e-01 |
| GOMF KINASE INHIBITOR ACTIVITY | 61 | 3.52e-01 | 6.89e-02 | 7.91e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 29 | 5.21e-01 | -6.89e-02 | 8.72e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 26 | 5.43e-01 | 6.89e-02 | 8.76e-01 |
| GOBP RESPONSE TO HYPEROXIA | 14 | 6.56e-01 | 6.89e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 11 | 6.93e-01 | 6.88e-02 | 9.23e-01 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 17 | 6.24e-01 | -6.88e-02 | 9.04e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 19 | 6.04e-01 | 6.87e-02 | 8.97e-01 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 8 | 7.37e-01 | 6.87e-02 | 9.37e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 44 | 4.31e-01 | -6.87e-02 | 8.30e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 90 | 2.61e-01 | 6.87e-02 | 7.23e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 6 | 7.71e-01 | 6.87e-02 | 9.46e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 15 | 6.45e-01 | 6.86e-02 | 9.07e-01 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 7.91e-01 | -6.85e-02 | 9.50e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 78 | 2.96e-01 | 6.85e-02 | 7.54e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 7 | 7.54e-01 | 6.85e-02 | 9.42e-01 |
| GOCC SPINDLE POLE CENTROSOME | 13 | 6.69e-01 | 6.85e-02 | 9.15e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 12 | 6.82e-01 | 6.83e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 5 | 7.91e-01 | -6.83e-02 | 9.50e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 38 | 4.66e-01 | 6.83e-02 | 8.48e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 15 | 6.47e-01 | 6.83e-02 | 9.08e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 79 | 2.95e-01 | -6.83e-02 | 7.54e-01 |
| GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.72e-01 | -6.82e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 18 | 6.16e-01 | 6.82e-02 | 9.02e-01 |
| GOBP MICROTUBULE NUCLEATION | 44 | 4.34e-01 | -6.82e-02 | 8.32e-01 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 7 | 7.55e-01 | -6.82e-02 | 9.42e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 189 | 1.07e-01 | -6.82e-02 | 5.44e-01 |
| GOBP VESICLE ORGANIZATION | 306 | 4.10e-02 | -6.81e-02 | 3.86e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 123 | 1.92e-01 | -6.81e-02 | 6.64e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 88 | 2.70e-01 | -6.81e-02 | 7.32e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 41 | 4.52e-01 | 6.80e-02 | 8.42e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1280 | 5.63e-05 | 6.79e-02 | 9.10e-03 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 6 | 7.73e-01 | 6.79e-02 | 9.48e-01 |
| GOBP LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING | 5 | 7.93e-01 | -6.79e-02 | 9.51e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 57 | 3.76e-01 | 6.79e-02 | 8.05e-01 |
| GOMF STEROID BINDING | 63 | 3.52e-01 | 6.79e-02 | 7.91e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 15 | 6.49e-01 | -6.79e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 59 | 3.68e-01 | -6.79e-02 | 8.00e-01 |
| GOBP MRNA PROCESSING | 431 | 1.62e-02 | -6.79e-02 | 2.82e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 180 | 1.17e-01 | -6.79e-02 | 5.67e-01 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 12 | 6.84e-01 | -6.78e-02 | 9.19e-01 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 9 | 7.25e-01 | -6.78e-02 | 9.33e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 59 | 3.68e-01 | -6.78e-02 | 8.01e-01 |
| GOCC GAMMA TUBULIN RING COMPLEX | 7 | 7.56e-01 | -6.78e-02 | 9.43e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 23 | 5.74e-01 | 6.78e-02 | 8.85e-01 |
| GOBP STRESS GRANULE DISASSEMBLY | 5 | 7.93e-01 | 6.78e-02 | 9.51e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 768 | 1.55e-03 | 6.77e-02 | 8.98e-02 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 45 | 4.33e-01 | -6.76e-02 | 8.31e-01 |
| GOBP RESPONSE TO POTASSIUM ION | 11 | 6.98e-01 | -6.76e-02 | 9.25e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 9 | 7.26e-01 | 6.75e-02 | 9.34e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 7 | 7.57e-01 | 6.74e-02 | 9.44e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 526 | 8.50e-03 | -6.74e-02 | 2.16e-01 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 471 | 1.26e-02 | -6.74e-02 | 2.53e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 732 | 2.06e-03 | 6.74e-02 | 1.04e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 21 | 5.93e-01 | -6.74e-02 | 8.94e-01 |
| GOBP RESPONSE TO DSRNA | 34 | 4.97e-01 | -6.74e-02 | 8.62e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 232 | 7.79e-02 | 6.73e-02 | 4.96e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 86 | 2.81e-01 | 6.73e-02 | 7.42e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 13 | 6.74e-01 | 6.73e-02 | 9.17e-01 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 26 | 5.53e-01 | -6.73e-02 | 8.79e-01 |
| GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 7.94e-01 | 6.73e-02 | 9.52e-01 |
| GOMF FATTY ACID BINDING | 30 | 5.24e-01 | -6.73e-02 | 8.73e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 488 | 1.13e-02 | -6.73e-02 | 2.45e-01 |
| GOMF RNA POLYMERASE BINDING | 55 | 3.88e-01 | 6.73e-02 | 8.11e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 19 | 6.12e-01 | -6.73e-02 | 9.00e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 82 | 2.93e-01 | -6.72e-02 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 8 | 7.42e-01 | -6.72e-02 | 9.38e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 75 | 3.15e-01 | 6.72e-02 | 7.66e-01 |
| GOBP NEURON DEVELOPMENT | 697 | 2.70e-03 | 6.72e-02 | 1.22e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 49 | 4.16e-01 | -6.71e-02 | 8.22e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 38 | 4.74e-01 | -6.71e-02 | 8.50e-01 |
| GOBP HYPOTHALAMUS CELL DIFFERENTIATION | 6 | 7.76e-01 | 6.71e-02 | 9.48e-01 |
| GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION | 6 | 7.76e-01 | 6.71e-02 | 9.48e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 23 | 5.78e-01 | -6.71e-02 | 8.87e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 22 | 5.86e-01 | -6.71e-02 | 8.92e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 7 | 7.59e-01 | 6.71e-02 | 9.44e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 13 | 6.76e-01 | 6.70e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 51 | 4.08e-01 | 6.70e-02 | 8.18e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 20 | 6.04e-01 | -6.70e-02 | 8.97e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 15 | 6.53e-01 | -6.70e-02 | 9.09e-01 |
| GOBP GLIAL CELL DIFFERENTIATION | 141 | 1.71e-01 | 6.70e-02 | 6.35e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 18 | 6.23e-01 | 6.69e-02 | 9.04e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 115 | 2.16e-01 | 6.69e-02 | 6.80e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 106 | 2.35e-01 | -6.69e-02 | 6.98e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 253 | 6.79e-02 | -6.68e-02 | 4.72e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 254 | 6.76e-02 | 6.68e-02 | 4.72e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 13 | 6.77e-01 | -6.68e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 49 | 4.19e-01 | -6.67e-02 | 8.23e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 7 | 7.60e-01 | 6.67e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 43 | 4.50e-01 | 6.66e-02 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 12 | 6.89e-01 | -6.66e-02 | 9.20e-01 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 17 | 6.35e-01 | 6.66e-02 | 9.04e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 12 | 6.90e-01 | 6.66e-02 | 9.20e-01 |
| GOBP CHORION DEVELOPMENT | 7 | 7.60e-01 | 6.66e-02 | 9.44e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 7.16e-01 | -6.65e-02 | 9.30e-01 |
| GOBP HEAT GENERATION | 11 | 7.03e-01 | -6.65e-02 | 9.25e-01 |
| GOCC INO80 TYPE COMPLEX | 26 | 5.57e-01 | 6.65e-02 | 8.79e-01 |
| GOBP BONE REMODELING | 59 | 3.78e-01 | 6.64e-02 | 8.05e-01 |
| GOCC PML BODY | 97 | 2.59e-01 | 6.64e-02 | 7.21e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 93 | 2.69e-01 | -6.64e-02 | 7.31e-01 |
| GOMF CARBONATE DEHYDRATASE ACTIVITY | 5 | 7.97e-01 | -6.63e-02 | 9.53e-01 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 11 | 7.03e-01 | -6.63e-02 | 9.25e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 167 | 1.40e-01 | 6.63e-02 | 5.97e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 68 | 3.45e-01 | 6.63e-02 | 7.88e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 322 | 4.15e-02 | -6.63e-02 | 3.86e-01 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 7 | 7.62e-01 | 6.61e-02 | 9.44e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 148 | 1.66e-01 | -6.61e-02 | 6.27e-01 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 42 | 4.59e-01 | -6.61e-02 | 8.45e-01 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 14 | 6.69e-01 | 6.60e-02 | 9.15e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 21 | 6.01e-01 | 6.60e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 11 | 7.05e-01 | 6.60e-02 | 9.25e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 29 | 5.39e-01 | 6.60e-02 | 8.76e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 168 | 1.41e-01 | 6.60e-02 | 5.99e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 404 | 2.36e-02 | 6.59e-02 | 3.19e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 11 | 7.05e-01 | -6.59e-02 | 9.26e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 175 | 1.34e-01 | 6.59e-02 | 5.86e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 55 | 3.99e-01 | -6.58e-02 | 8.15e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 20 | 6.10e-01 | -6.58e-02 | 8.99e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 45 | 4.45e-01 | 6.58e-02 | 8.40e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 153 | 1.61e-01 | -6.58e-02 | 6.20e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 7.06e-01 | -6.58e-02 | 9.26e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 20 | 6.11e-01 | -6.57e-02 | 9.00e-01 |
| GOBP NEUTROPHIL HOMEOSTASIS | 15 | 6.60e-01 | -6.57e-02 | 9.12e-01 |
| GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 74 | 3.29e-01 | -6.56e-02 | 7.77e-01 |
| GOBP CELL PART MORPHOGENESIS | 409 | 2.34e-02 | 6.56e-02 | 3.18e-01 |
| GOBP DNA LIGATION | 16 | 6.50e-01 | -6.55e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 280 | 6.00e-02 | 6.55e-02 | 4.47e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 26 | 5.64e-01 | 6.55e-02 | 8.80e-01 |
| GOMF CHITIN BINDING | 6 | 7.82e-01 | -6.54e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 114 | 2.28e-01 | -6.54e-02 | 6.91e-01 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 220 | 9.56e-02 | -6.53e-02 | 5.25e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 25 | 5.72e-01 | 6.53e-02 | 8.83e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 148 | 1.71e-01 | 6.53e-02 | 6.36e-01 |
| GOCC VARICOSITY | 6 | 7.82e-01 | -6.52e-02 | 9.48e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 8 | 7.49e-01 | 6.52e-02 | 9.41e-01 |
| GOBP MALE GAMETE GENERATION | 333 | 4.15e-02 | 6.52e-02 | 3.86e-01 |
| GOBP CHROMOSOME ORGANIZATION | 515 | 1.18e-02 | 6.52e-02 | 2.50e-01 |
| GOBP RESPONSE TO PAIN | 17 | 6.42e-01 | 6.52e-02 | 9.06e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 528 | 1.09e-02 | -6.51e-02 | 2.43e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 8 | 7.50e-01 | 6.51e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 5 | 8.01e-01 | -6.51e-02 | 9.55e-01 |
| GOCC SEX CHROMOSOME | 27 | 5.58e-01 | 6.51e-02 | 8.79e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 63 | 3.72e-01 | -6.51e-02 | 8.04e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 20 | 6.15e-01 | -6.50e-02 | 9.02e-01 |
| GOMF NUCLEASE ACTIVITY | 183 | 1.30e-01 | -6.50e-02 | 5.82e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 7 | 7.66e-01 | -6.50e-02 | 9.45e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 1062 | 4.03e-04 | -6.50e-02 | 3.78e-02 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 122 | 2.16e-01 | 6.50e-02 | 6.80e-01 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 187 | 1.26e-01 | 6.50e-02 | 5.75e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 7 | 7.66e-01 | -6.50e-02 | 9.45e-01 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 83 | 3.07e-01 | -6.49e-02 | 7.62e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 56 | 4.01e-01 | -6.49e-02 | 8.15e-01 |
| GOBP ALCOHOL METABOLIC PROCESS | 244 | 8.14e-02 | -6.49e-02 | 4.99e-01 |
| GOBP ERBB SIGNALING PATHWAY | 87 | 2.96e-01 | 6.49e-02 | 7.54e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 80 | 3.16e-01 | 6.49e-02 | 7.66e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 105 | 2.51e-01 | -6.49e-02 | 7.18e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 32 | 5.26e-01 | -6.49e-02 | 8.73e-01 |
| GOBP MAST CELL CHEMOTAXIS | 8 | 7.51e-01 | 6.49e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 23 | 5.90e-01 | 6.49e-02 | 8.93e-01 |
| GOCC SIN3 TYPE COMPLEX | 22 | 5.99e-01 | 6.48e-02 | 8.97e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 9 | 7.36e-01 | 6.48e-02 | 9.37e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 240 | 8.45e-02 | -6.48e-02 | 5.04e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 8 | 7.51e-01 | 6.48e-02 | 9.42e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 102 | 2.59e-01 | 6.47e-02 | 7.21e-01 |
| GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 8.02e-01 | 6.47e-02 | 9.56e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 39 | 4.85e-01 | 6.46e-02 | 8.55e-01 |
| GOMF ACTIN MONOMER BINDING | 20 | 6.17e-01 | -6.46e-02 | 9.02e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 17 | 6.45e-01 | -6.46e-02 | 9.07e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 13 | 6.87e-01 | 6.46e-02 | 9.20e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 13 | 6.87e-01 | 6.46e-02 | 9.20e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 15 | 6.65e-01 | 6.46e-02 | 9.14e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 33 | 5.21e-01 | -6.46e-02 | 8.72e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 15 | 6.65e-01 | 6.45e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 17 | 6.45e-01 | 6.45e-02 | 9.07e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 160 | 1.60e-01 | -6.45e-02 | 6.20e-01 |
| GOCC SAGA COMPLEX | 23 | 5.93e-01 | -6.45e-02 | 8.94e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 5 | 8.03e-01 | 6.44e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 25 | 5.77e-01 | -6.44e-02 | 8.87e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 227 | 9.53e-02 | -6.44e-02 | 5.24e-01 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 23 | 5.93e-01 | 6.44e-02 | 8.94e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 91 | 2.89e-01 | -6.44e-02 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 19 | 6.27e-01 | -6.44e-02 | 9.04e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 136 | 1.96e-01 | 6.44e-02 | 6.67e-01 |
| GOBP RETINA HOMEOSTASIS | 39 | 4.87e-01 | -6.44e-02 | 8.56e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 207 | 1.12e-01 | -6.43e-02 | 5.57e-01 |
| GOBP FERTILIZATION | 83 | 3.12e-01 | -6.43e-02 | 7.65e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 6 | 7.85e-01 | -6.42e-02 | 9.48e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 221 | 1.01e-01 | 6.42e-02 | 5.34e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 49 | 4.37e-01 | 6.42e-02 | 8.34e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 29 | 5.50e-01 | 6.42e-02 | 8.78e-01 |
| GOBP MAST CELL MIGRATION | 11 | 7.12e-01 | -6.42e-02 | 9.29e-01 |
| GOMF SELENIUM BINDING | 5 | 8.04e-01 | -6.42e-02 | 9.56e-01 |
| GOCC PROTEIN KINASE COMPLEX | 126 | 2.14e-01 | 6.42e-02 | 6.79e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 135 | 1.99e-01 | -6.41e-02 | 6.68e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 9 | 7.39e-01 | -6.41e-02 | 9.38e-01 |
| GOMF TAU PROTEIN BINDING | 38 | 4.94e-01 | -6.41e-02 | 8.61e-01 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 7.86e-01 | 6.40e-02 | 9.49e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 28 | 5.58e-01 | 6.40e-02 | 8.79e-01 |
| GOBP ASTROCYTE ACTIVATION | 15 | 6.68e-01 | -6.40e-02 | 9.14e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 18 | 6.38e-01 | 6.40e-02 | 9.05e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 31 | 5.38e-01 | 6.40e-02 | 8.76e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 23 | 5.95e-01 | -6.40e-02 | 8.95e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 7 | 7.70e-01 | -6.39e-02 | 9.46e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 647 | 5.89e-03 | 6.39e-02 | 1.81e-01 |
| GOBP SEXUAL REPRODUCTION | 610 | 7.44e-03 | 6.39e-02 | 2.04e-01 |
| GOBP MACROPHAGE ACTIVATION | 78 | 3.30e-01 | -6.38e-02 | 7.78e-01 |
| GOBP STEROL METABOLIC PROCESS | 101 | 2.68e-01 | -6.38e-02 | 7.30e-01 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 287 | 6.36e-02 | -6.38e-02 | 4.60e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 190 | 1.30e-01 | 6.38e-02 | 5.82e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 152 | 1.75e-01 | 6.38e-02 | 6.39e-01 |
| GOBP PROTEIN METHYLATION | 70 | 3.56e-01 | 6.38e-02 | 7.92e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 6 | 7.87e-01 | 6.38e-02 | 9.49e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 6 | 7.87e-01 | 6.38e-02 | 9.49e-01 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 35 | 5.14e-01 | 6.37e-02 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 8 | 7.55e-01 | -6.37e-02 | 9.43e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 57 | 4.06e-01 | -6.37e-02 | 8.18e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 33 | 5.27e-01 | 6.37e-02 | 8.74e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 9 | 7.41e-01 | 6.37e-02 | 9.38e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 20 | 6.23e-01 | -6.36e-02 | 9.03e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 36 | 5.09e-01 | -6.36e-02 | 8.67e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 40 | 4.87e-01 | 6.36e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 27 | 5.68e-01 | 6.36e-02 | 8.82e-01 |
| GOBP VESICLE DOCKING | 52 | 4.28e-01 | 6.36e-02 | 8.30e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 56 | 4.11e-01 | -6.35e-02 | 8.19e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 588 | 8.97e-03 | 6.35e-02 | 2.20e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 12 | 7.04e-01 | 6.34e-02 | 9.25e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1091 | 4.76e-04 | -6.34e-02 | 4.01e-02 |
| GOCC AXON | 396 | 3.11e-02 | 6.34e-02 | 3.52e-01 |
| GOBP CELL CELL SIGNALING | 911 | 1.33e-03 | 6.33e-02 | 8.28e-02 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 13 | 6.93e-01 | -6.33e-02 | 9.23e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 64 | 3.81e-01 | -6.33e-02 | 8.07e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 54 | 4.21e-01 | -6.33e-02 | 8.25e-01 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 25 | 5.84e-01 | -6.33e-02 | 8.90e-01 |
| GOCC NUCLEAR PORE OUTER RING | 9 | 7.42e-01 | 6.33e-02 | 9.38e-01 |
| GOCC CLATHRIN COAT | 40 | 4.90e-01 | 6.32e-02 | 8.57e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 25 | 5.85e-01 | 6.31e-02 | 8.91e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 115 | 2.43e-01 | 6.31e-02 | 7.08e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 89 | 3.04e-01 | -6.31e-02 | 7.59e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 11 | 7.17e-01 | 6.31e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 10 | 7.30e-01 | -6.31e-02 | 9.36e-01 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 6 | 7.89e-01 | 6.31e-02 | 9.49e-01 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 10 | 7.30e-01 | -6.31e-02 | 9.36e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 29 | 5.57e-01 | 6.31e-02 | 8.79e-01 |
| GOMF KINESIN BINDING | 33 | 5.31e-01 | 6.30e-02 | 8.75e-01 |
| GOBP AGGREPHAGY | 8 | 7.58e-01 | -6.30e-02 | 9.44e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 24 | 5.93e-01 | -6.30e-02 | 8.94e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 61 | 3.95e-01 | 6.30e-02 | 8.14e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 56 | 4.15e-01 | 6.30e-02 | 8.21e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 7.18e-01 | 6.30e-02 | 9.31e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 15 | 6.73e-01 | -6.29e-02 | 9.16e-01 |
| GOBP GOLGI ORGANIZATION | 129 | 2.18e-01 | 6.29e-02 | 6.82e-01 |
| GOMF FRIZZLED BINDING | 12 | 7.06e-01 | 6.29e-02 | 9.26e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 18 | 6.44e-01 | -6.29e-02 | 9.07e-01 |
| GOBP CARNITINE TRANSPORT | 6 | 7.90e-01 | 6.29e-02 | 9.50e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1104 | 4.96e-04 | 6.28e-02 | 4.12e-02 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 25 | 5.87e-01 | 6.28e-02 | 8.92e-01 |
| GOBP COGNITION | 183 | 1.44e-01 | 6.28e-02 | 6.03e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 46 | 4.62e-01 | 6.28e-02 | 8.45e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 28 | 5.66e-01 | -6.27e-02 | 8.81e-01 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 8 | 7.59e-01 | -6.27e-02 | 9.44e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 31 | 5.46e-01 | -6.27e-02 | 8.77e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 10 | 7.31e-01 | -6.27e-02 | 9.36e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 22 | 6.11e-01 | -6.27e-02 | 9.00e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 50 | 4.43e-01 | -6.27e-02 | 8.38e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 12 | 7.07e-01 | 6.26e-02 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 7 | 7.74e-01 | 6.26e-02 | 9.48e-01 |
| GOBP RECEPTOR CATABOLIC PROCESS | 25 | 5.88e-01 | -6.26e-02 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 68 | 3.73e-01 | 6.25e-02 | 8.04e-01 |
| GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 6 | 7.91e-01 | -6.25e-02 | 9.50e-01 |
| GOBP SYNAPSE ORGANIZATION | 258 | 8.51e-02 | 6.24e-02 | 5.05e-01 |
| GOBP ACID SECRETION | 21 | 6.21e-01 | 6.24e-02 | 9.03e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 60 | 4.04e-01 | 6.24e-02 | 8.18e-01 |
| GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 6 | 7.92e-01 | 6.23e-02 | 9.50e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 50 | 4.46e-01 | 6.23e-02 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 29 | 5.62e-01 | 6.23e-02 | 8.80e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 19 | 6.39e-01 | 6.23e-02 | 9.05e-01 |
| GOCC CHROMOSOMAL REGION | 345 | 4.79e-02 | 6.22e-02 | 4.06e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 7 | 7.76e-01 | 6.22e-02 | 9.48e-01 |
| GOBP REGULATION OF CELL MATURATION | 11 | 7.21e-01 | -6.22e-02 | 9.32e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 17 | 6.57e-01 | 6.22e-02 | 9.10e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 270 | 7.97e-02 | -6.21e-02 | 4.98e-01 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 52 | 4.39e-01 | -6.21e-02 | 8.36e-01 |
| GOBP CELL MATRIX ADHESION | 153 | 1.86e-01 | 6.20e-02 | 6.54e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 58 | 4.14e-01 | -6.20e-02 | 8.21e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 17 | 6.58e-01 | 6.20e-02 | 9.11e-01 |
| GOBP MUCOCILIARY CLEARANCE | 5 | 8.10e-01 | -6.20e-02 | 9.57e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 71 | 3.67e-01 | -6.19e-02 | 8.00e-01 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 18 | 6.50e-01 | 6.19e-02 | 9.08e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 46 | 4.68e-01 | -6.18e-02 | 8.49e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 244 | 9.70e-02 | 6.18e-02 | 5.26e-01 |
| GOCC MITOCHONDRIAL CRISTA | 6 | 7.93e-01 | 6.18e-02 | 9.51e-01 |
| GOBP GERMINAL CENTER FORMATION | 12 | 7.11e-01 | 6.18e-02 | 9.28e-01 |
| GOBP FACIAL NERVE STRUCTURAL ORGANIZATION | 5 | 8.11e-01 | -6.18e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 102 | 2.82e-01 | 6.17e-02 | 7.42e-01 |
| GOBP PLATELET MORPHOGENESIS | 19 | 6.41e-01 | 6.17e-02 | 9.06e-01 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 24 | 6.01e-01 | -6.17e-02 | 8.97e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 33 | 5.40e-01 | 6.16e-02 | 8.76e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 8 | 7.63e-01 | 6.16e-02 | 9.44e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 431 | 2.91e-02 | 6.16e-02 | 3.45e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 271 | 8.23e-02 | -6.15e-02 | 4.99e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 55 | 4.31e-01 | -6.15e-02 | 8.30e-01 |
| GOMF COPPER ION BINDING | 38 | 5.12e-01 | -6.14e-02 | 8.67e-01 |
| GOCC GOLGI TRANS CISTERNA | 9 | 7.50e-01 | -6.14e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 8 | 7.64e-01 | -6.14e-02 | 9.44e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 10 | 7.37e-01 | -6.14e-02 | 9.37e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 17 | 6.61e-01 | 6.14e-02 | 9.13e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 43 | 4.87e-01 | 6.13e-02 | 8.56e-01 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 7 | 7.79e-01 | -6.13e-02 | 9.48e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 17 | 6.62e-01 | -6.12e-02 | 9.13e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 22 | 6.19e-01 | -6.12e-02 | 9.03e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 9 | 7.51e-01 | -6.12e-02 | 9.42e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 55 | 4.33e-01 | 6.12e-02 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 71 | 3.73e-01 | 6.12e-02 | 8.04e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 7.95e-01 | -6.11e-02 | 9.52e-01 |
| GOBP CENTROSOME SEPARATION | 12 | 7.14e-01 | 6.11e-02 | 9.30e-01 |
| GOMF SMAD BINDING | 61 | 4.09e-01 | 6.11e-02 | 8.19e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 273 | 8.32e-02 | 6.11e-02 | 5.01e-01 |
| GOMF ANKYRIN REPEAT BINDING | 6 | 7.96e-01 | 6.11e-02 | 9.52e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 10 | 7.38e-01 | -6.10e-02 | 9.37e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 282 | 7.86e-02 | 6.10e-02 | 4.96e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 39 | 5.10e-01 | 6.10e-02 | 8.67e-01 |
| GOBP STEM CELL DIFFERENTIATION | 153 | 1.94e-01 | 6.10e-02 | 6.66e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 32 | 5.51e-01 | 6.09e-02 | 8.79e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 12 | 7.15e-01 | -6.09e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 353 | 5.03e-02 | -6.09e-02 | 4.15e-01 |
| GOCC NUCLEAR CHROMOSOME | 192 | 1.47e-01 | 6.09e-02 | 6.07e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 149 | 2.01e-01 | -6.08e-02 | 6.68e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 32 | 5.52e-01 | 6.08e-02 | 8.79e-01 |
| GOBP PROTEIN POLYMERIZATION | 221 | 1.20e-01 | -6.08e-02 | 5.70e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 86 | 3.30e-01 | -6.08e-02 | 7.78e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 91 | 3.17e-01 | -6.08e-02 | 7.67e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 19 | 6.47e-01 | -6.08e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 41 | 5.01e-01 | 6.08e-02 | 8.63e-01 |
| GOBP PALLIUM DEVELOPMENT | 118 | 2.55e-01 | 6.07e-02 | 7.18e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 28 | 5.79e-01 | -6.06e-02 | 8.88e-01 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 5 | 8.14e-01 | -6.06e-02 | 9.59e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 20 | 6.39e-01 | -6.06e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 9 | 7.53e-01 | 6.05e-02 | 9.42e-01 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 9 | 7.54e-01 | -6.05e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 119 | 2.55e-01 | 6.04e-02 | 7.18e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 6 | 7.98e-01 | 6.04e-02 | 9.53e-01 |
| GOCC OUTER DYNEIN ARM | 5 | 8.15e-01 | 6.04e-02 | 9.59e-01 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 23 | 6.16e-01 | -6.03e-02 | 9.02e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 46 | 4.79e-01 | 6.03e-02 | 8.52e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 10 | 7.41e-01 | -6.03e-02 | 9.38e-01 |
| GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX | 5 | 8.15e-01 | 6.03e-02 | 9.59e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 44 | 4.89e-01 | -6.03e-02 | 8.57e-01 |
| GOBP CELL DIVISION | 519 | 1.94e-02 | 6.03e-02 | 2.99e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 21 | 6.33e-01 | 6.03e-02 | 9.04e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 176 | 1.69e-01 | 6.02e-02 | 6.33e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 28 | 5.82e-01 | 6.02e-02 | 8.89e-01 |
| GOBP MESENCHYMAL CELL APOPTOTIC PROCESS | 7 | 7.83e-01 | -6.02e-02 | 9.48e-01 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 23 | 6.18e-01 | -6.01e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 9 | 7.55e-01 | 6.01e-02 | 9.42e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 6 | 7.99e-01 | -6.01e-02 | 9.54e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 11 | 7.30e-01 | -6.00e-02 | 9.36e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 36 | 5.34e-01 | 6.00e-02 | 8.75e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 20 | 6.43e-01 | 5.99e-02 | 9.06e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 95 | 3.14e-01 | -5.99e-02 | 7.66e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 6.43e-01 | -5.99e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 14 | 6.98e-01 | 5.99e-02 | 9.25e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 6 | 8.00e-01 | 5.98e-02 | 9.55e-01 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 9 | 7.56e-01 | 5.98e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 22 | 6.28e-01 | -5.98e-02 | 9.04e-01 |
| GOCC MOTILE CILIUM | 146 | 2.13e-01 | -5.98e-02 | 6.79e-01 |
| GOMF MANGANESE ION BINDING | 55 | 4.44e-01 | -5.98e-02 | 8.38e-01 |
| GOBP URATE METABOLIC PROCESS | 5 | 8.17e-01 | -5.97e-02 | 9.59e-01 |
| GOCC EUCHROMATIN | 43 | 4.98e-01 | -5.97e-02 | 8.63e-01 |
| GOBP CONVERGENT EXTENSION | 8 | 7.71e-01 | 5.95e-02 | 9.46e-01 |
| GOBP EYE MORPHOGENESIS | 81 | 3.55e-01 | 5.95e-02 | 7.92e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 35 | 5.43e-01 | -5.95e-02 | 8.76e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 25 | 6.07e-01 | -5.95e-02 | 8.99e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 8.18e-01 | -5.94e-02 | 9.59e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 103 | 2.98e-01 | 5.94e-02 | 7.54e-01 |
| GOBP REPLICATIVE SENESCENCE | 13 | 7.11e-01 | -5.94e-02 | 9.28e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 24 | 6.14e-01 | 5.94e-02 | 9.02e-01 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 22 | 6.30e-01 | -5.94e-02 | 9.04e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 11 | 7.33e-01 | -5.94e-02 | 9.36e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 11 | 7.33e-01 | 5.94e-02 | 9.36e-01 |
| GOBP DENDRITE DEVELOPMENT | 158 | 1.99e-01 | 5.93e-02 | 6.68e-01 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 8.18e-01 | 5.93e-02 | 9.59e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1328 | 3.50e-04 | 5.93e-02 | 3.47e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 207 | 1.42e-01 | 5.93e-02 | 6.00e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 17 | 6.72e-01 | 5.93e-02 | 9.15e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 148 | 2.14e-01 | -5.92e-02 | 6.79e-01 |
| GOBP COENZYME A METABOLIC PROCESS | 19 | 6.55e-01 | -5.92e-02 | 9.09e-01 |
| GOBP BRAIN MORPHOGENESIS | 23 | 6.23e-01 | -5.92e-02 | 9.04e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 35 | 5.45e-01 | -5.92e-02 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 7.86e-01 | 5.92e-02 | 9.49e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 8 | 7.72e-01 | 5.91e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 14 | 7.02e-01 | 5.91e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 7 | 7.87e-01 | -5.91e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 9 | 7.59e-01 | 5.91e-02 | 9.44e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 11 | 7.35e-01 | 5.91e-02 | 9.37e-01 |
| GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 5 | 8.19e-01 | -5.90e-02 | 9.59e-01 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 37 | 5.35e-01 | -5.90e-02 | 8.75e-01 |
| GOBP RENAL FILTRATION | 12 | 7.23e-01 | -5.90e-02 | 9.32e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 35 | 5.46e-01 | -5.90e-02 | 8.77e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 66 | 4.08e-01 | 5.90e-02 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 114 | 2.77e-01 | -5.90e-02 | 7.38e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 148 | 2.16e-01 | 5.90e-02 | 6.80e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 16 | 6.83e-01 | -5.89e-02 | 9.19e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 11 | 7.35e-01 | 5.89e-02 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 39 | 5.25e-01 | -5.88e-02 | 8.73e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 20 | 6.49e-01 | -5.88e-02 | 9.08e-01 |
| GOBP CELLULAR COMPONENT MORPHOGENESIS | 468 | 3.01e-02 | 5.88e-02 | 3.50e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 10 | 7.48e-01 | -5.87e-02 | 9.41e-01 |
| GOBP ERAD PATHWAY | 98 | 3.16e-01 | -5.87e-02 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 40 | 5.21e-01 | -5.87e-02 | 8.72e-01 |
| GOBP STEROID METABOLIC PROCESS | 189 | 1.66e-01 | -5.86e-02 | 6.27e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 8 | 7.74e-01 | -5.86e-02 | 9.48e-01 |
| GOBP GLYCINE METABOLIC PROCESS | 10 | 7.49e-01 | -5.86e-02 | 9.41e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 48 | 4.83e-01 | 5.85e-02 | 8.54e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 8.21e-01 | -5.85e-02 | 9.60e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 34 | 5.55e-01 | 5.85e-02 | 8.79e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1151 | 9.50e-04 | -5.85e-02 | 6.74e-02 |
| GOMF PHOSPHOPROTEIN BINDING | 78 | 3.72e-01 | 5.85e-02 | 8.04e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 133 | 2.45e-01 | 5.85e-02 | 7.09e-01 |
| GOBP MEIOTIC CYTOKINESIS | 6 | 8.04e-01 | 5.84e-02 | 9.56e-01 |
| GOBP STEM CELL DEVELOPMENT | 51 | 4.71e-01 | 5.84e-02 | 8.49e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 27 | 6.00e-01 | 5.84e-02 | 8.97e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 5 | 8.21e-01 | 5.83e-02 | 9.60e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 9 | 7.62e-01 | 5.83e-02 | 9.44e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 272 | 9.91e-02 | 5.83e-02 | 5.31e-01 |
| GOBP ALLANTOIN METABOLIC PROCESS | 5 | 8.22e-01 | -5.82e-02 | 9.60e-01 |
| GOMF HYALURONIC ACID BINDING | 10 | 7.50e-01 | 5.82e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 39 | 5.30e-01 | -5.82e-02 | 8.75e-01 |
| GOBP REGULATION OF NCRNA TRANSCRIPTION | 65 | 4.18e-01 | -5.82e-02 | 8.22e-01 |
| GOMF MRNA 3 UTR BINDING | 85 | 3.54e-01 | 5.82e-02 | 7.92e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 113 | 2.87e-01 | -5.80e-02 | 7.48e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 85 | 3.56e-01 | 5.80e-02 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 8 | 7.76e-01 | -5.80e-02 | 9.48e-01 |
| GOBP SPINDLE ASSEMBLY | 119 | 2.75e-01 | -5.80e-02 | 7.38e-01 |
| GOBP IMMUNE EFFECTOR PROCESS | 430 | 4.01e-02 | -5.80e-02 | 3.86e-01 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 29 | 5.89e-01 | -5.80e-02 | 8.93e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 127 | 2.60e-01 | 5.80e-02 | 7.22e-01 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 57 | 4.50e-01 | 5.79e-02 | 8.42e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 18 | 6.70e-01 | -5.79e-02 | 9.15e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 32 | 5.71e-01 | 5.79e-02 | 8.83e-01 |
| GOBP MICROVILLUS ORGANIZATION | 23 | 6.31e-01 | -5.79e-02 | 9.04e-01 |
| GOCC INTEGRIN COMPLEX | 24 | 6.23e-01 | 5.79e-02 | 9.04e-01 |
| GOBP SECRETORY GRANULE LOCALIZATION | 8 | 7.77e-01 | -5.79e-02 | 9.48e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 148 | 2.25e-01 | 5.79e-02 | 6.88e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 16 | 6.89e-01 | -5.79e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 7.77e-01 | 5.79e-02 | 9.48e-01 |
| GOCC PHAGOCYTIC CUP | 25 | 6.17e-01 | 5.78e-02 | 9.02e-01 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 8.23e-01 | -5.78e-02 | 9.60e-01 |
| GOCC GOLGI STACK | 102 | 3.14e-01 | -5.78e-02 | 7.66e-01 |
| GOBP MONONUCLEAR CELL MIGRATION | 137 | 2.44e-01 | 5.78e-02 | 7.08e-01 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 6.98e-01 | -5.78e-02 | 9.25e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 226 | 1.35e-01 | -5.78e-02 | 5.90e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 13 | 7.18e-01 | 5.78e-02 | 9.31e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 173 | 1.91e-01 | 5.77e-02 | 6.61e-01 |
| GOBP LIPID GLYCOSYLATION | 5 | 8.23e-01 | -5.77e-02 | 9.60e-01 |
| GOCC ACROSOMAL VESICLE | 68 | 4.11e-01 | 5.77e-02 | 8.19e-01 |
| GOCC LAMELLAR BODY | 6 | 8.07e-01 | -5.76e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 6 | 8.07e-01 | -5.76e-02 | 9.57e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 99 | 3.22e-01 | 5.76e-02 | 7.70e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 12 | 7.30e-01 | -5.75e-02 | 9.36e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 80 | 3.74e-01 | -5.75e-02 | 8.05e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 162 | 2.07e-01 | -5.75e-02 | 6.74e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 5.92e-01 | -5.75e-02 | 8.94e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 8 | 7.78e-01 | -5.75e-02 | 9.48e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 25 | 6.20e-01 | 5.73e-02 | 9.03e-01 |
| GOBP BONE TRABECULA MORPHOGENESIS | 6 | 8.08e-01 | 5.73e-02 | 9.57e-01 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 11 | 7.42e-01 | 5.73e-02 | 9.38e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 17 | 6.83e-01 | -5.73e-02 | 9.19e-01 |
| GOCC PLATELET ALPHA GRANULE | 63 | 4.32e-01 | -5.73e-02 | 8.31e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 27 | 6.07e-01 | -5.72e-02 | 8.99e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 15 | 7.01e-01 | -5.72e-02 | 9.25e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 688 | 1.12e-02 | 5.71e-02 | 2.45e-01 |
| GOCC CELL BODY FIBER | 5 | 8.25e-01 | -5.71e-02 | 9.60e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 8.25e-01 | 5.71e-02 | 9.60e-01 |
| GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY | 6 | 8.09e-01 | -5.71e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 37 | 5.48e-01 | 5.71e-02 | 8.78e-01 |
| GOBP FATTY ACID BETA OXIDATION | 64 | 4.30e-01 | -5.71e-02 | 8.30e-01 |
| GOBP PEROXISOME FISSION | 9 | 7.67e-01 | -5.71e-02 | 9.45e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 253 | 1.19e-01 | -5.70e-02 | 5.69e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 49 | 4.90e-01 | 5.70e-02 | 8.58e-01 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 13 | 7.22e-01 | -5.69e-02 | 9.32e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 18 | 6.76e-01 | -5.69e-02 | 9.17e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 27 | 6.09e-01 | 5.69e-02 | 8.99e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 16 | 6.94e-01 | -5.69e-02 | 9.24e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION | 5 | 8.26e-01 | -5.68e-02 | 9.60e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 9 | 7.68e-01 | 5.68e-02 | 9.46e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 124 | 2.75e-01 | 5.68e-02 | 7.38e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 15 | 7.03e-01 | 5.68e-02 | 9.25e-01 |
| GOBP STEROL TRANSPORT | 87 | 3.60e-01 | 5.68e-02 | 7.94e-01 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 11 | 7.44e-01 | 5.68e-02 | 9.39e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 5.56e-01 | -5.68e-02 | 8.79e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 16 | 6.94e-01 | -5.67e-02 | 9.24e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 22 | 6.46e-01 | -5.67e-02 | 9.07e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 32 | 5.79e-01 | -5.67e-02 | 8.88e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 27 | 6.10e-01 | -5.67e-02 | 8.99e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 380 | 5.91e-02 | 5.66e-02 | 4.45e-01 |
| GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 6 | 8.10e-01 | -5.66e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 81 | 3.79e-01 | 5.66e-02 | 8.06e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 16 | 6.95e-01 | 5.66e-02 | 9.24e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 11 | 7.45e-01 | -5.65e-02 | 9.39e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 73 | 4.04e-01 | -5.65e-02 | 8.18e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 36 | 5.58e-01 | 5.65e-02 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 84 | 3.71e-01 | 5.65e-02 | 8.03e-01 |
| GOCC ACROSOMAL MEMBRANE | 12 | 7.35e-01 | -5.65e-02 | 9.37e-01 |
| GOMF R SMAD BINDING | 21 | 6.54e-01 | -5.64e-02 | 9.09e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 7 | 7.96e-01 | -5.64e-02 | 9.52e-01 |
| GOCC DENDRITIC SPINE MEMBRANE | 7 | 7.96e-01 | -5.64e-02 | 9.52e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 8.27e-01 | 5.64e-02 | 9.61e-01 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 36 | 5.59e-01 | -5.63e-02 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 39 | 5.43e-01 | 5.63e-02 | 8.76e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 64 | 4.36e-01 | -5.63e-02 | 8.34e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 5 | 8.27e-01 | 5.63e-02 | 9.61e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 37 | 5.54e-01 | -5.63e-02 | 8.79e-01 |
| GOBP VACUOLAR LOCALIZATION | 70 | 4.16e-01 | -5.63e-02 | 8.22e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 12 | 7.36e-01 | 5.62e-02 | 9.37e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 32 | 5.83e-01 | 5.62e-02 | 8.90e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 12 | 7.36e-01 | 5.62e-02 | 9.37e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 151 | 2.35e-01 | -5.61e-02 | 6.98e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 16 | 6.98e-01 | 5.61e-02 | 9.25e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 269 | 1.14e-01 | 5.61e-02 | 5.62e-01 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 49 | 4.97e-01 | 5.61e-02 | 8.62e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 11 | 7.48e-01 | -5.61e-02 | 9.41e-01 |
| GOBP SECOND MESSENGER MEDIATED SIGNALING | 176 | 2.01e-01 | 5.60e-02 | 6.68e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 68 | 4.25e-01 | -5.60e-02 | 8.27e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 15 | 7.08e-01 | 5.60e-02 | 9.26e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.98e-01 | -5.60e-02 | 9.53e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 11 | 7.48e-01 | -5.59e-02 | 9.41e-01 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 5 | 8.29e-01 | 5.58e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 38 | 5.52e-01 | 5.58e-02 | 8.79e-01 |
| GOBP TRANSLESION SYNTHESIS | 24 | 6.36e-01 | 5.58e-02 | 9.04e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 8.29e-01 | -5.58e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 50 | 4.95e-01 | 5.58e-02 | 8.61e-01 |
| GOBP CELLULAR RESPONSE TO SALT | 128 | 2.77e-01 | -5.57e-02 | 7.38e-01 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 189 | 1.87e-01 | -5.57e-02 | 6.56e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 8 | 7.85e-01 | 5.56e-02 | 9.48e-01 |
| GOBP RESPONSE TO HEAT | 78 | 3.96e-01 | 5.56e-02 | 8.14e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 36 | 5.64e-01 | -5.56e-02 | 8.80e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 120 | 2.93e-01 | 5.56e-02 | 7.52e-01 |
| GOBP NCRNA PROCESSING | 398 | 5.82e-02 | -5.56e-02 | 4.44e-01 |
| GOBP VIRAL LIFE CYCLE | 263 | 1.22e-01 | -5.56e-02 | 5.71e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 8.30e-01 | 5.54e-02 | 9.61e-01 |
| GOMF ADENINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.30e-01 | 5.54e-02 | 9.61e-01 |
| GOBP CYTOKINETIC PROCESS | 41 | 5.39e-01 | -5.54e-02 | 8.76e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 16 | 7.01e-01 | -5.54e-02 | 9.25e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 7.62e-01 | 5.54e-02 | 9.44e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 100 | 3.40e-01 | -5.53e-02 | 7.84e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 8 | 7.87e-01 | -5.53e-02 | 9.49e-01 |
| GOCC STEREOCILIUM BUNDLE | 39 | 5.50e-01 | 5.53e-02 | 8.78e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 25 | 6.33e-01 | -5.53e-02 | 9.04e-01 |
| GOCC SIDE OF MEMBRANE | 413 | 5.52e-02 | -5.52e-02 | 4.33e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 30 | 6.01e-01 | -5.52e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 670 | 1.55e-02 | 5.52e-02 | 2.79e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 30 | 6.01e-01 | 5.52e-02 | 8.97e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 9 | 7.75e-01 | 5.51e-02 | 9.48e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 205 | 1.75e-01 | -5.51e-02 | 6.38e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 9 | 7.75e-01 | 5.51e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 111 | 3.17e-01 | -5.50e-02 | 7.67e-01 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 6 | 8.16e-01 | -5.50e-02 | 9.59e-01 |
| GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 8.31e-01 | -5.50e-02 | 9.61e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 85 | 3.81e-01 | 5.50e-02 | 8.07e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 16 | 7.03e-01 | 5.50e-02 | 9.25e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 119 | 3.01e-01 | -5.50e-02 | 7.56e-01 |
| GOCC SARCOPLASM | 62 | 4.55e-01 | 5.49e-02 | 8.42e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 51 | 4.98e-01 | 5.49e-02 | 8.63e-01 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 6 | 8.16e-01 | 5.49e-02 | 9.59e-01 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 5 | 8.32e-01 | -5.49e-02 | 9.61e-01 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 5 | 8.32e-01 | 5.48e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 8.16e-01 | -5.48e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 13 | 7.32e-01 | 5.48e-02 | 9.36e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 18 | 6.88e-01 | 5.48e-02 | 9.20e-01 |
| GOBP RESPONSE TO INSULIN | 201 | 1.82e-01 | 5.47e-02 | 6.50e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 24 | 6.43e-01 | 5.47e-02 | 9.06e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 365 | 7.41e-02 | 5.46e-02 | 4.87e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 217 | 1.66e-01 | 5.46e-02 | 6.28e-01 |
| GOMF PHOSPHATE ION BINDING | 6 | 8.17e-01 | -5.46e-02 | 9.59e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 57 | 4.76e-01 | 5.46e-02 | 8.51e-01 |
| GOCC NUCLEOLUS | 900 | 5.94e-03 | -5.46e-02 | 1.81e-01 |
| GOCC RUFFLE | 158 | 2.37e-01 | 5.46e-02 | 7.01e-01 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 150 | 2.50e-01 | -5.45e-02 | 7.16e-01 |
| GOBP TRANSPORT OF VIRUS | 19 | 6.81e-01 | 5.45e-02 | 9.19e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 84 | 3.88e-01 | -5.45e-02 | 8.11e-01 |
| GOMF FK506 BINDING | 9 | 7.77e-01 | 5.45e-02 | 9.48e-01 |
| GOMF MACROLIDE BINDING | 9 | 7.77e-01 | 5.45e-02 | 9.48e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 25 | 6.37e-01 | -5.45e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 26 | 6.31e-01 | -5.44e-02 | 9.04e-01 |
| GOBP MICROVILLUS ASSEMBLY | 20 | 6.74e-01 | -5.44e-02 | 9.16e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 100 | 3.49e-01 | 5.43e-02 | 7.90e-01 |
| GOBP BASE EXCISION REPAIR | 41 | 5.48e-01 | -5.43e-02 | 8.78e-01 |
| GOBP RESPONSE TO FOOD | 18 | 6.90e-01 | -5.42e-02 | 9.21e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 17 | 6.99e-01 | 5.42e-02 | 9.25e-01 |
| GOBP RNA DECAPPING | 19 | 6.83e-01 | -5.42e-02 | 9.19e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 16 | 7.08e-01 | 5.42e-02 | 9.26e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 97 | 3.58e-01 | 5.41e-02 | 7.92e-01 |
| GOBP STRESS FIBER ASSEMBLY | 83 | 3.95e-01 | -5.41e-02 | 8.14e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 70 | 4.34e-01 | 5.41e-02 | 8.32e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 92 | 3.71e-01 | 5.41e-02 | 8.02e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 186 | 2.04e-01 | -5.41e-02 | 6.72e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 210 | 1.78e-01 | -5.41e-02 | 6.43e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 6.83e-01 | 5.40e-02 | 9.19e-01 |
| GOBP FEMALE MEIOSIS I | 9 | 7.79e-01 | -5.40e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 923 | 5.86e-03 | 5.40e-02 | 1.81e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE | 5 | 8.34e-01 | 5.40e-02 | 9.61e-01 |
| GOBP DNA REPLICATION | 248 | 1.44e-01 | 5.40e-02 | 6.03e-01 |
| GOMF GTPASE BINDING | 273 | 1.26e-01 | 5.40e-02 | 5.75e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 234 | 1.56e-01 | 5.40e-02 | 6.19e-01 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 283 | 1.19e-01 | 5.40e-02 | 5.69e-01 |
| GOBP REGULATION OF NEURON MATURATION | 6 | 8.19e-01 | -5.39e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 45 | 5.32e-01 | -5.39e-02 | 8.75e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 25 | 6.41e-01 | 5.39e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 5 | 8.35e-01 | 5.39e-02 | 9.61e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.19e-01 | 5.39e-02 | 9.59e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 88 | 3.83e-01 | 5.38e-02 | 8.09e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 102 | 3.48e-01 | 5.38e-02 | 7.90e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 20 | 6.77e-01 | -5.38e-02 | 9.18e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 16 | 7.09e-01 | 5.38e-02 | 9.27e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 22 | 6.62e-01 | 5.38e-02 | 9.13e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 22 | 6.62e-01 | -5.38e-02 | 9.13e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 4.54e-01 | -5.38e-02 | 8.42e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 215 | 1.75e-01 | -5.37e-02 | 6.39e-01 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 218 | 1.72e-01 | 5.37e-02 | 6.37e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 75 | 4.21e-01 | -5.37e-02 | 8.25e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 110 | 3.31e-01 | 5.37e-02 | 7.78e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 51 | 5.07e-01 | -5.37e-02 | 8.66e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 113 | 3.25e-01 | -5.37e-02 | 7.73e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 84 | 3.96e-01 | 5.37e-02 | 8.14e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 19 | 6.86e-01 | 5.36e-02 | 9.20e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 69 | 4.42e-01 | -5.36e-02 | 8.37e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 23 | 6.56e-01 | -5.36e-02 | 9.10e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 367 | 7.91e-02 | -5.36e-02 | 4.97e-01 |
| GOCC CENTRIOLE | 132 | 2.89e-01 | 5.36e-02 | 7.49e-01 |
| GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 13 | 7.38e-01 | 5.35e-02 | 9.37e-01 |
| GOBP VESICLE LOCALIZATION | 182 | 2.14e-01 | -5.35e-02 | 6.79e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 14 | 7.29e-01 | -5.35e-02 | 9.36e-01 |
| GOBP REGULATION OF HEAT GENERATION | 8 | 7.93e-01 | -5.35e-02 | 9.51e-01 |
| GOBP REGULATION OF JNK CASCADE | 104 | 3.47e-01 | 5.35e-02 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 65 | 4.56e-01 | 5.35e-02 | 8.43e-01 |
| GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 6 | 8.21e-01 | -5.34e-02 | 9.60e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 61 | 4.71e-01 | 5.34e-02 | 8.49e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 31 | 6.07e-01 | 5.34e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 807 | 1.06e-02 | 5.34e-02 | 2.41e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 17 | 7.03e-01 | -5.33e-02 | 9.25e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 12 | 7.49e-01 | -5.33e-02 | 9.41e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 58 | 4.83e-01 | -5.33e-02 | 8.54e-01 |
| GOMF NUCLEAR RECEPTOR ACTIVITY | 32 | 6.02e-01 | 5.33e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 17 | 7.04e-01 | 5.33e-02 | 9.25e-01 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 9 | 7.82e-01 | 5.33e-02 | 9.48e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 30 | 6.14e-01 | 5.33e-02 | 9.01e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 7 | 8.07e-01 | -5.32e-02 | 9.57e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 325 | 1.00e-01 | -5.32e-02 | 5.32e-01 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 7.71e-01 | 5.32e-02 | 9.46e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 104 | 3.49e-01 | -5.32e-02 | 7.90e-01 |
| GOMF GUANYLATE KINASE ACTIVITY | 9 | 7.83e-01 | 5.31e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 90 | 3.84e-01 | 5.31e-02 | 8.09e-01 |
| GOBP REGULATION OF MITOPHAGY | 15 | 7.22e-01 | 5.31e-02 | 9.32e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 59 | 4.81e-01 | 5.31e-02 | 8.53e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 79 | 4.15e-01 | -5.31e-02 | 8.21e-01 |
| GOCC AXON HILLOCK | 5 | 8.37e-01 | 5.31e-02 | 9.61e-01 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 6.89e-01 | -5.31e-02 | 9.20e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 11 | 7.61e-01 | 5.31e-02 | 9.44e-01 |
| GOCC GRANULAR COMPONENT | 6 | 8.22e-01 | -5.31e-02 | 9.60e-01 |
| GOMF PROLINE RICH REGION BINDING | 15 | 7.22e-01 | 5.31e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 20 | 6.81e-01 | -5.30e-02 | 9.19e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 46 | 5.34e-01 | 5.30e-02 | 8.75e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 58 | 4.86e-01 | -5.30e-02 | 8.55e-01 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 21 | 6.75e-01 | -5.29e-02 | 9.17e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 11 | 7.61e-01 | 5.29e-02 | 9.44e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 6.54e-01 | -5.29e-02 | 9.09e-01 |
| GOBP ORGANELLE INHERITANCE | 15 | 7.23e-01 | -5.29e-02 | 9.32e-01 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 8.38e-01 | 5.29e-02 | 9.61e-01 |
| GOBP MITOTIC CELL CYCLE | 756 | 1.41e-02 | 5.29e-02 | 2.66e-01 |
| GOMF RECEPTOR ANTAGONIST ACTIVITY | 6 | 8.23e-01 | -5.28e-02 | 9.60e-01 |
| GOBP INSULIN SECRETION | 116 | 3.26e-01 | 5.28e-02 | 7.74e-01 |
| GOBP RECOMBINATIONAL REPAIR | 163 | 2.46e-01 | 5.28e-02 | 7.10e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 107 | 3.46e-01 | -5.28e-02 | 7.89e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 25 | 6.48e-01 | -5.28e-02 | 9.08e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 45 | 5.40e-01 | 5.28e-02 | 8.76e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 14 | 7.33e-01 | 5.27e-02 | 9.36e-01 |
| GOMF LAMIN BINDING | 14 | 7.33e-01 | 5.27e-02 | 9.36e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 7 | 8.09e-01 | -5.27e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 12 | 7.52e-01 | -5.27e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY | 5 | 8.38e-01 | -5.26e-02 | 9.61e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 11 | 7.62e-01 | 5.26e-02 | 9.44e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 20 | 6.84e-01 | 5.26e-02 | 9.19e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 7.33e-01 | -5.26e-02 | 9.36e-01 |
| GOBP CELLULAR SENESCENCE | 81 | 4.13e-01 | 5.26e-02 | 8.20e-01 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 6 | 8.24e-01 | 5.26e-02 | 9.60e-01 |
| GOBP MEMBRANE ORGANIZATION | 650 | 2.32e-02 | -5.25e-02 | 3.18e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 10 | 7.74e-01 | 5.25e-02 | 9.48e-01 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 18 | 7.00e-01 | -5.25e-02 | 9.25e-01 |
| GOBP MOTOR BEHAVIOR | 16 | 7.16e-01 | -5.25e-02 | 9.30e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 18 | 7.00e-01 | -5.25e-02 | 9.25e-01 |
| GOBP NUCLEAR MIGRATION | 21 | 6.77e-01 | 5.24e-02 | 9.18e-01 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 61 | 4.79e-01 | 5.24e-02 | 8.52e-01 |
| GOCC PLASMA MEMBRANE REGION | 760 | 1.47e-02 | 5.24e-02 | 2.72e-01 |
| GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.39e-01 | 5.24e-02 | 9.61e-01 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 30 | 6.20e-01 | -5.24e-02 | 9.03e-01 |
| GOBP MESODERM MORPHOGENESIS | 35 | 5.92e-01 | 5.24e-02 | 8.94e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 152 | 2.66e-01 | 5.24e-02 | 7.27e-01 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 8.39e-01 | 5.23e-02 | 9.61e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 15 | 7.26e-01 | 5.23e-02 | 9.34e-01 |
| GOBP LIPID OXIDATION | 89 | 3.94e-01 | -5.23e-02 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 12 | 7.54e-01 | 5.23e-02 | 9.42e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 8.11e-01 | -5.23e-02 | 9.57e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 56 | 4.99e-01 | 5.22e-02 | 8.63e-01 |
| GOBP HEART PROCESS | 132 | 3.01e-01 | 5.22e-02 | 7.56e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 8 | 7.98e-01 | 5.22e-02 | 9.54e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 11 | 7.64e-01 | 5.22e-02 | 9.44e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 18 | 7.02e-01 | -5.22e-02 | 9.25e-01 |
| GOBP APOPTOTIC PROCESS | 1369 | 1.44e-03 | -5.21e-02 | 8.63e-02 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 11 | 7.65e-01 | 5.21e-02 | 9.44e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 13 | 7.45e-01 | -5.21e-02 | 9.39e-01 |
| GOCC DENSE CORE GRANULE | 14 | 7.36e-01 | 5.21e-02 | 9.37e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 56 | 5.01e-01 | -5.21e-02 | 8.63e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 149 | 2.74e-01 | 5.20e-02 | 7.36e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 11 | 7.65e-01 | -5.20e-02 | 9.45e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 30 | 6.22e-01 | -5.20e-02 | 9.03e-01 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 72 | 4.46e-01 | 5.20e-02 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 85 | 4.08e-01 | 5.20e-02 | 8.18e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 1064 | 4.62e-03 | 5.20e-02 | 1.61e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 37 | 5.84e-01 | -5.20e-02 | 8.91e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 791 | 1.37e-02 | -5.20e-02 | 2.65e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 6 | 8.26e-01 | -5.20e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 9 | 7.87e-01 | 5.19e-02 | 9.49e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 114 | 3.39e-01 | 5.19e-02 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 10 | 7.76e-01 | 5.19e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 33 | 6.06e-01 | 5.19e-02 | 8.99e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 85 | 4.09e-01 | 5.18e-02 | 8.19e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 71 | 4.50e-01 | -5.18e-02 | 8.42e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 236 | 1.71e-01 | -5.18e-02 | 6.36e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 28 | 6.35e-01 | 5.18e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 29 | 6.29e-01 | -5.18e-02 | 9.04e-01 |
| GOBP TRANSLATIONAL TERMINATION | 16 | 7.20e-01 | 5.18e-02 | 9.32e-01 |
| GOCC ENDOLYSOSOME | 24 | 6.61e-01 | 5.18e-02 | 9.12e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 164 | 2.53e-01 | 5.18e-02 | 7.18e-01 |
| GOBP CELL ADHESION | 876 | 9.95e-03 | 5.18e-02 | 2.33e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 21 | 6.81e-01 | -5.18e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 8.00e-01 | -5.18e-02 | 9.55e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 25 | 6.54e-01 | 5.17e-02 | 9.09e-01 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 18 | 7.04e-01 | -5.17e-02 | 9.25e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 369 | 8.97e-02 | -5.16e-02 | 5.12e-01 |
| GOBP RESPONSE TO CYTOKINE | 648 | 2.59e-02 | -5.16e-02 | 3.28e-01 |
| GOBP EPIBOLY | 28 | 6.37e-01 | -5.16e-02 | 9.04e-01 |
| GOBP REGULATION OF IMMUNE RESPONSE | 663 | 2.44e-02 | -5.16e-02 | 3.22e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 8 | 8.01e-01 | -5.16e-02 | 9.55e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 166 | 2.53e-01 | 5.15e-02 | 7.18e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 8 | 8.01e-01 | -5.15e-02 | 9.55e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 31 | 6.20e-01 | 5.15e-02 | 9.03e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 61 | 4.87e-01 | 5.15e-02 | 8.56e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 182 | 2.32e-01 | 5.15e-02 | 6.96e-01 |
| GOBP MEIOTIC CHROMOSOME SEPARATION | 5 | 8.42e-01 | 5.15e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 38 | 5.84e-01 | 5.14e-02 | 8.90e-01 |
| GOBP L KYNURENINE METABOLIC PROCESS | 6 | 8.27e-01 | -5.14e-02 | 9.61e-01 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 15 | 7.30e-01 | 5.14e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 36 | 5.94e-01 | -5.14e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 148 | 2.81e-01 | -5.14e-02 | 7.42e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 10 | 7.79e-01 | -5.14e-02 | 9.48e-01 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 10 | 7.79e-01 | 5.13e-02 | 9.48e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 162 | 2.61e-01 | 5.13e-02 | 7.23e-01 |
| GOCC ENDOSOME MEMBRANE | 463 | 5.97e-02 | -5.13e-02 | 4.47e-01 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 28 | 6.39e-01 | 5.13e-02 | 9.05e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 22 | 6.77e-01 | -5.13e-02 | 9.18e-01 |
| GOBP REGULATION OF COAGULATION | 45 | 5.52e-01 | -5.13e-02 | 8.79e-01 |
| GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 8 | 8.02e-01 | 5.13e-02 | 9.56e-01 |
| GOCC ZONULA ADHERENS | 7 | 8.14e-01 | 5.12e-02 | 9.59e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 10 | 7.79e-01 | 5.12e-02 | 9.48e-01 |
| GOBP RETINAL METABOLIC PROCESS | 11 | 7.69e-01 | 5.12e-02 | 9.46e-01 |
| GOBP OSTEOCLAST DIFFERENTIATION | 80 | 4.29e-01 | 5.12e-02 | 8.30e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 212 | 2.01e-01 | 5.11e-02 | 6.68e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 49 | 5.36e-01 | 5.11e-02 | 8.76e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 5 | 8.43e-01 | 5.11e-02 | 9.62e-01 |
| GOCC PROTEIN LIPID COMPLEX | 24 | 6.65e-01 | -5.11e-02 | 9.14e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 92 | 3.98e-01 | 5.10e-02 | 8.15e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 5 | 8.43e-01 | 5.10e-02 | 9.62e-01 |
| GOBP DIAPEDESIS | 6 | 8.29e-01 | 5.10e-02 | 9.61e-01 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 12 | 7.60e-01 | 5.10e-02 | 9.44e-01 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 6 | 8.29e-01 | 5.10e-02 | 9.61e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 83 | 4.23e-01 | 5.09e-02 | 8.26e-01 |
| GOBP VESICLE CARGO LOADING | 28 | 6.41e-01 | 5.09e-02 | 9.06e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 137 | 3.05e-01 | 5.09e-02 | 7.60e-01 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 6 | 8.29e-01 | 5.09e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 89 | 4.07e-01 | 5.09e-02 | 8.18e-01 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 5 | 8.44e-01 | 5.08e-02 | 9.62e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 77 | 4.41e-01 | -5.08e-02 | 8.37e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 25 | 6.60e-01 | -5.08e-02 | 9.12e-01 |
| GOBP VACUOLE ORGANIZATION | 208 | 2.08e-01 | -5.08e-02 | 6.75e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 42 | 5.70e-01 | -5.07e-02 | 8.83e-01 |
| GOMF FATTY ACID DERIVATIVE BINDING | 14 | 7.43e-01 | -5.07e-02 | 9.38e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 96 | 3.91e-01 | -5.07e-02 | 8.12e-01 |
| GOBP MEMBRANE BIOGENESIS | 49 | 5.40e-01 | -5.07e-02 | 8.76e-01 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 5 | 8.45e-01 | -5.06e-02 | 9.62e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 8 | 8.04e-01 | -5.06e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 14 | 7.43e-01 | -5.06e-02 | 9.38e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 17 | 7.18e-01 | -5.06e-02 | 9.31e-01 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 30 | 6.32e-01 | 5.06e-02 | 9.04e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 26 | 6.55e-01 | 5.06e-02 | 9.09e-01 |
| GOBP THYMUS DEVELOPMENT | 34 | 6.10e-01 | -5.05e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 13 | 7.52e-01 | -5.05e-02 | 9.42e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 47 | 5.49e-01 | 5.05e-02 | 8.78e-01 |
| GOBP REGULATION OF GLYCOLYTIC PROCESS | 42 | 5.71e-01 | 5.05e-02 | 8.83e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 15 | 7.35e-01 | 5.05e-02 | 9.37e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 32 | 6.21e-01 | -5.05e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 29 | 6.38e-01 | -5.04e-02 | 9.05e-01 |
| GOBP CALCIUM ION HOMEOSTASIS | 201 | 2.19e-01 | -5.04e-02 | 6.82e-01 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 17 | 7.19e-01 | 5.04e-02 | 9.32e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 6.51e-01 | 5.04e-02 | 9.08e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 27 | 6.51e-01 | 5.04e-02 | 9.08e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 35 | 6.07e-01 | -5.03e-02 | 8.99e-01 |
| GOMF DEACETYLASE ACTIVITY | 34 | 6.12e-01 | -5.03e-02 | 9.00e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 108 | 3.67e-01 | 5.03e-02 | 8.00e-01 |
| GOCC MAIN AXON | 40 | 5.82e-01 | 5.03e-02 | 8.90e-01 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 9 | 7.94e-01 | -5.03e-02 | 9.52e-01 |
| GOBP SERINE TRANSPORT | 8 | 8.06e-01 | 5.02e-02 | 9.57e-01 |
| GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 8.06e-01 | 5.02e-02 | 9.57e-01 |
| GOCC SITE OF POLARIZED GROWTH | 130 | 3.24e-01 | 5.02e-02 | 7.72e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 12 | 7.64e-01 | 5.01e-02 | 9.44e-01 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 38 | 5.93e-01 | -5.01e-02 | 8.94e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 7 | 8.19e-01 | -5.00e-02 | 9.59e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 12 | 7.64e-01 | -5.00e-02 | 9.44e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 284 | 1.48e-01 | 5.00e-02 | 6.07e-01 |
| GOBP HEAD DEVELOPMENT | 464 | 6.61e-02 | 5.00e-02 | 4.69e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 59 | 5.07e-01 | 5.00e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 359 | 1.05e-01 | 5.00e-02 | 5.43e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 548 | 4.69e-02 | 4.99e-02 | 4.04e-01 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 8 | 8.07e-01 | 4.99e-02 | 9.57e-01 |
| GOMF PROTEIN KINASE C BINDING | 37 | 6.00e-01 | -4.99e-02 | 8.97e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 25 | 6.66e-01 | 4.99e-02 | 9.14e-01 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 11 | 7.75e-01 | 4.98e-02 | 9.48e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 7.96e-01 | 4.98e-02 | 9.52e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 8 | 8.07e-01 | -4.98e-02 | 9.57e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 8 | 8.07e-01 | -4.98e-02 | 9.57e-01 |
| GOCC U1 SNRNP | 19 | 7.07e-01 | -4.98e-02 | 9.26e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 100 | 3.90e-01 | -4.98e-02 | 8.11e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 6 | 8.33e-01 | 4.97e-02 | 9.61e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 40 | 5.87e-01 | 4.97e-02 | 8.92e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 23 | 6.80e-01 | -4.96e-02 | 9.19e-01 |
| GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 363 | 1.06e-01 | 4.96e-02 | 5.43e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 46 | 5.61e-01 | 4.96e-02 | 8.79e-01 |
| GOCC CELL CORTEX REGION | 23 | 6.80e-01 | 4.96e-02 | 9.19e-01 |
| GOBP COCHLEA DEVELOPMENT | 19 | 7.08e-01 | 4.96e-02 | 9.26e-01 |
| GOCC CHROMOCENTER | 11 | 7.76e-01 | 4.96e-02 | 9.48e-01 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 8.48e-01 | 4.96e-02 | 9.62e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 7.16e-01 | -4.95e-02 | 9.30e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 11 | 7.76e-01 | -4.95e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 6 | 8.34e-01 | 4.95e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 38 | 5.97e-01 | -4.95e-02 | 8.97e-01 |
| GOBP SIALYLATION | 5 | 8.48e-01 | 4.95e-02 | 9.62e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 21 | 6.94e-01 | -4.95e-02 | 9.24e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 98 | 3.97e-01 | 4.95e-02 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 11 | 7.76e-01 | -4.95e-02 | 9.48e-01 |
| GOBP RESPONSE TO UV A | 8 | 8.09e-01 | 4.94e-02 | 9.57e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 7.67e-01 | -4.94e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 77 | 4.54e-01 | -4.94e-02 | 8.42e-01 |
| GOCC OUTER MEMBRANE | 214 | 2.14e-01 | -4.94e-02 | 6.79e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 91 | 4.16e-01 | -4.94e-02 | 8.22e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 303 | 1.41e-01 | -4.94e-02 | 5.98e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 68 | 4.82e-01 | -4.94e-02 | 8.54e-01 |
| GOBP REGULATION OF DNA REPAIR | 197 | 2.33e-01 | 4.94e-02 | 6.97e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 806 | 1.82e-02 | -4.93e-02 | 2.95e-01 |
| GOCC PHAGOLYSOSOME | 5 | 8.49e-01 | 4.93e-02 | 9.62e-01 |
| GOBP RESPONSE TO ACIDIC PH | 15 | 7.41e-01 | 4.93e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 47 | 5.59e-01 | -4.93e-02 | 8.79e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 28 | 6.53e-01 | -4.91e-02 | 9.09e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 83 | 4.40e-01 | -4.91e-02 | 8.36e-01 |
| GOCC BRCA1 A COMPLEX | 8 | 8.10e-01 | 4.91e-02 | 9.57e-01 |
| GOBP VISUAL BEHAVIOR | 32 | 6.32e-01 | -4.90e-02 | 9.04e-01 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 21 | 6.98e-01 | -4.90e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 10 | 7.89e-01 | 4.89e-02 | 9.49e-01 |
| GOMF ALPHA TUBULIN BINDING | 34 | 6.22e-01 | 4.89e-02 | 9.03e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 11 | 7.79e-01 | -4.89e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 5 | 8.50e-01 | -4.89e-02 | 9.62e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 11 | 7.79e-01 | 4.89e-02 | 9.48e-01 |
| GOMF DNA POLYMERASE BINDING | 21 | 6.98e-01 | 4.88e-02 | 9.25e-01 |
| GOMF FOLIC ACID BINDING | 11 | 7.79e-01 | 4.88e-02 | 9.48e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 48 | 5.59e-01 | -4.88e-02 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF GROWTH | 164 | 2.82e-01 | 4.88e-02 | 7.42e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 228 | 2.05e-01 | 4.88e-02 | 6.73e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 23 | 6.86e-01 | 4.88e-02 | 9.20e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 10 | 7.89e-01 | -4.88e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 118 | 3.61e-01 | 4.88e-02 | 7.94e-01 |
| GOBP O GLYCAN PROCESSING | 32 | 6.33e-01 | -4.87e-02 | 9.04e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 28 | 6.56e-01 | 4.87e-02 | 9.09e-01 |
| GOMF GUANYL NUCLEOTIDE BINDING | 309 | 1.42e-01 | -4.87e-02 | 6.00e-01 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 170 | 2.75e-01 | -4.87e-02 | 7.38e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 8 | 8.12e-01 | -4.86e-02 | 9.58e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 23 | 6.86e-01 | -4.86e-02 | 9.20e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 7 | 8.24e-01 | -4.86e-02 | 9.60e-01 |
| GOBP GLAND MORPHOGENESIS | 65 | 4.98e-01 | 4.86e-02 | 8.63e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 86 | 4.36e-01 | 4.86e-02 | 8.34e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 601 | 4.33e-02 | 4.86e-02 | 3.92e-01 |
| GOBP REGULATION OF CELL CYCLE | 861 | 1.66e-02 | 4.85e-02 | 2.87e-01 |
| GOCC DENDRITIC TREE | 367 | 1.12e-01 | 4.85e-02 | 5.57e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 34 | 6.25e-01 | 4.85e-02 | 9.04e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 27 | 6.63e-01 | 4.85e-02 | 9.13e-01 |
| GOBP HISTAMINE SECRETION | 10 | 7.91e-01 | -4.84e-02 | 9.50e-01 |
| GOBP HISTAMINE TRANSPORT | 10 | 7.91e-01 | -4.84e-02 | 9.50e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 138 | 3.27e-01 | 4.84e-02 | 7.75e-01 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 18 | 7.22e-01 | 4.84e-02 | 9.32e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 7 | 8.25e-01 | 4.83e-02 | 9.60e-01 |
| GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE | 5 | 8.52e-01 | 4.83e-02 | 9.62e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 8 | 8.13e-01 | -4.83e-02 | 9.58e-01 |
| GOBP RESPONSE TO VIRUS | 336 | 1.30e-01 | -4.83e-02 | 5.82e-01 |
| GOBP VIRAL PROCESS | 362 | 1.16e-01 | -4.83e-02 | 5.65e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 29 | 6.53e-01 | 4.82e-02 | 9.09e-01 |
| GOBP ENERGY HOMEOSTASIS | 49 | 5.59e-01 | 4.82e-02 | 8.79e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 28 | 6.59e-01 | -4.82e-02 | 9.11e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 467 | 7.60e-02 | 4.82e-02 | 4.91e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 8.52e-01 | -4.81e-02 | 9.63e-01 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 204 | 2.37e-01 | -4.81e-02 | 7.01e-01 |
| GOCC ESC E Z COMPLEX | 10 | 7.92e-01 | -4.81e-02 | 9.51e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 420 | 9.26e-02 | 4.80e-02 | 5.18e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 24 | 6.84e-01 | 4.80e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 6 | 8.39e-01 | -4.80e-02 | 9.61e-01 |
| GOCC LEADING EDGE MEMBRANE | 127 | 3.51e-01 | 4.80e-02 | 7.90e-01 |
| GOBP RESPONSE TO THYROID HORMONE | 21 | 7.04e-01 | 4.80e-02 | 9.25e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 11 | 7.83e-01 | 4.80e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 13 | 7.65e-01 | 4.80e-02 | 9.44e-01 |
| GOBP DNA DEALKYLATION | 29 | 6.55e-01 | -4.79e-02 | 9.09e-01 |
| GOBP NEUTROPHIL CHEMOTAXIS | 68 | 4.95e-01 | -4.79e-02 | 8.61e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 106 | 3.95e-01 | 4.79e-02 | 8.14e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 7 | 8.26e-01 | -4.79e-02 | 9.61e-01 |
| GOBP DENDRITIC CELL MIGRATION | 25 | 6.79e-01 | -4.79e-02 | 9.19e-01 |
| GOCC GEMINI OF COILED BODIES | 12 | 7.74e-01 | 4.79e-02 | 9.48e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 54 | 5.43e-01 | 4.79e-02 | 8.76e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 66 | 5.02e-01 | -4.79e-02 | 8.63e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 55 | 5.40e-01 | -4.78e-02 | 8.76e-01 |
| GOBP B CELL DIFFERENTIATION | 105 | 3.98e-01 | -4.78e-02 | 8.15e-01 |
| GOBP AXONAL TRANSPORT | 52 | 5.52e-01 | -4.78e-02 | 8.79e-01 |
| GOCC CELL PROJECTION MEMBRANE | 230 | 2.13e-01 | 4.77e-02 | 6.79e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 12 | 7.75e-01 | -4.77e-02 | 9.48e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 22 | 6.99e-01 | -4.77e-02 | 9.25e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 22 | 6.99e-01 | -4.77e-02 | 9.25e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 11 | 7.84e-01 | -4.77e-02 | 9.48e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 460 | 8.14e-02 | 4.76e-02 | 4.99e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 15 | 7.50e-01 | 4.76e-02 | 9.41e-01 |
| GOBP REGULATION OF HEART RATE | 49 | 5.65e-01 | 4.75e-02 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 23 | 6.93e-01 | 4.75e-02 | 9.23e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 98 | 4.17e-01 | 4.75e-02 | 8.22e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 35 | 6.27e-01 | -4.75e-02 | 9.04e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 194 | 2.55e-01 | -4.75e-02 | 7.18e-01 |
| GOBP REGULATION OF CELL ADHESION | 538 | 6.12e-02 | 4.75e-02 | 4.50e-01 |
| GOCC SCAR COMPLEX | 11 | 7.85e-01 | -4.74e-02 | 9.48e-01 |
| GOMF PROTEIN SELF ASSOCIATION | 52 | 5.54e-01 | 4.74e-02 | 8.79e-01 |
| GOBP REPRODUCTION | 849 | 2.01e-02 | 4.74e-02 | 3.02e-01 |
| GOCC DENDRITE TERMINUS | 10 | 7.95e-01 | 4.74e-02 | 9.52e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 35 | 6.28e-01 | 4.74e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 41 | 6.00e-01 | -4.74e-02 | 8.97e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 128 | 3.55e-01 | 4.74e-02 | 7.92e-01 |
| GOBP MITOCHONDRION MORPHOGENESIS | 19 | 7.21e-01 | -4.74e-02 | 9.32e-01 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 19 | 7.21e-01 | 4.74e-02 | 9.32e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 26 | 6.76e-01 | -4.73e-02 | 9.17e-01 |
| GOCC HETEROCHROMATIN | 68 | 5.00e-01 | -4.73e-02 | 8.63e-01 |
| GOBP RESPONSE TO FATTY ACID | 36 | 6.23e-01 | 4.73e-02 | 9.04e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 59 | 5.30e-01 | -4.73e-02 | 8.75e-01 |
| GOMF RETROMER COMPLEX BINDING | 9 | 8.06e-01 | 4.73e-02 | 9.57e-01 |
| GOBP VIRAL RNA GENOME REPLICATION | 27 | 6.71e-01 | -4.73e-02 | 9.15e-01 |
| GOMF AMYLOID BETA BINDING | 62 | 5.20e-01 | -4.73e-02 | 8.72e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 49 | 5.67e-01 | 4.72e-02 | 8.82e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 41 | 6.01e-01 | 4.72e-02 | 8.97e-01 |
| GOBP MEIOTIC TELOMERE CLUSTERING | 6 | 8.41e-01 | -4.72e-02 | 9.61e-01 |
| GOBP PROTEIN PROCESSING | 167 | 2.93e-01 | -4.72e-02 | 7.52e-01 |
| GOMF CHROMATIN BINDING | 457 | 8.54e-02 | 4.72e-02 | 5.06e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 17 | 7.36e-01 | -4.72e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 14 | 7.60e-01 | 4.71e-02 | 9.44e-01 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 8.42e-01 | -4.71e-02 | 9.61e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 15 | 7.52e-01 | -4.71e-02 | 9.42e-01 |
| GOMF PEPTIDASE ACTIVITY | 362 | 1.26e-01 | -4.70e-02 | 5.75e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 38 | 6.16e-01 | 4.70e-02 | 9.02e-01 |
| GOCC CELL BODY MEMBRANE | 13 | 7.69e-01 | -4.70e-02 | 9.46e-01 |
| GOBP MRNA METABOLIC PROCESS | 645 | 4.30e-02 | -4.70e-02 | 3.91e-01 |
| GOBP FOREBRAIN DEVELOPMENT | 228 | 2.23e-01 | 4.70e-02 | 6.86e-01 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 34 | 6.36e-01 | -4.69e-02 | 9.04e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 42 | 5.99e-01 | 4.69e-02 | 8.97e-01 |
| GOMF PHOSPHATASE ACTIVITY | 203 | 2.50e-01 | 4.69e-02 | 7.16e-01 |
| GOBP REGULATION OF XENOPHAGY | 9 | 8.08e-01 | -4.69e-02 | 9.57e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 117 | 3.82e-01 | 4.68e-02 | 8.08e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 18 | 7.31e-01 | -4.68e-02 | 9.36e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 209 | 2.45e-01 | 4.68e-02 | 7.09e-01 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.43e-01 | 4.68e-02 | 9.62e-01 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 5 | 8.56e-01 | -4.67e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 7 | 8.31e-01 | 4.67e-02 | 9.61e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 125 | 3.68e-01 | 4.67e-02 | 8.00e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 69 | 5.03e-01 | -4.67e-02 | 8.63e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 438 | 9.60e-02 | 4.66e-02 | 5.26e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 36 | 6.29e-01 | -4.66e-02 | 9.04e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 40 | 6.10e-01 | -4.66e-02 | 8.99e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 281 | 1.81e-01 | 4.65e-02 | 6.48e-01 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 24 | 6.93e-01 | -4.65e-02 | 9.23e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1144 | 8.80e-03 | -4.65e-02 | 2.19e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 29 | 6.65e-01 | -4.65e-02 | 9.14e-01 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 8.32e-01 | 4.64e-02 | 9.61e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 16 | 7.48e-01 | -4.64e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1103 | 1.03e-02 | 4.63e-02 | 2.37e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 9 | 8.10e-01 | -4.63e-02 | 9.57e-01 |
| GOBP NEUTROPHIL EXTRAVASATION | 12 | 7.81e-01 | 4.63e-02 | 9.48e-01 |
| GOBP SNRNA TRANSCRIPTION | 17 | 7.41e-01 | 4.63e-02 | 9.38e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 7 | 8.32e-01 | 4.63e-02 | 9.61e-01 |
| GOMF DNA BINDING BENDING | 9 | 8.10e-01 | -4.63e-02 | 9.57e-01 |
| GOBP ACTIN NUCLEATION | 45 | 5.92e-01 | -4.62e-02 | 8.94e-01 |
| GOBP PEXOPHAGY | 6 | 8.45e-01 | -4.62e-02 | 9.62e-01 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 6 | 8.45e-01 | 4.62e-02 | 9.62e-01 |
| GOBP PROTEIN SUMOYLATION | 61 | 5.33e-01 | 4.62e-02 | 8.75e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 31 | 6.57e-01 | 4.61e-02 | 9.10e-01 |
| GOBP COMPLEMENT ACTIVATION | 32 | 6.52e-01 | -4.61e-02 | 9.09e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 5 | 8.58e-01 | 4.61e-02 | 9.65e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 466 | 8.98e-02 | -4.61e-02 | 5.12e-01 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 7 | 8.33e-01 | 4.59e-02 | 9.61e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 34 | 6.43e-01 | 4.59e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 534 | 7.09e-02 | -4.59e-02 | 4.78e-01 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 9 | 8.12e-01 | 4.59e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 16 | 7.51e-01 | 4.59e-02 | 9.42e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 24 | 6.97e-01 | 4.59e-02 | 9.25e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 7 | 8.34e-01 | 4.58e-02 | 9.61e-01 |
| GOBP VIRAL GENE EXPRESSION | 95 | 4.41e-01 | -4.58e-02 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 341 | 1.47e-01 | 4.58e-02 | 6.07e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 36 | 6.35e-01 | -4.58e-02 | 9.04e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 13 | 7.75e-01 | 4.58e-02 | 9.48e-01 |
| GOMF TITIN BINDING | 8 | 8.23e-01 | -4.58e-02 | 9.60e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 14 | 7.67e-01 | 4.58e-02 | 9.45e-01 |
| GOBP CERAMIDE CATABOLIC PROCESS | 12 | 7.84e-01 | -4.57e-02 | 9.48e-01 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 18 | 7.37e-01 | 4.57e-02 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 7 | 8.34e-01 | 4.57e-02 | 9.61e-01 |
| GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 5 | 8.60e-01 | -4.56e-02 | 9.65e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 174 | 3.00e-01 | -4.56e-02 | 7.56e-01 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 5.66e-01 | -4.56e-02 | 8.81e-01 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 147 | 3.41e-01 | 4.56e-02 | 7.85e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 321 | 1.62e-01 | 4.56e-02 | 6.21e-01 |
| GOBP PHAGOSOME MATURATION | 29 | 6.71e-01 | 4.56e-02 | 9.15e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 8 | 8.23e-01 | 4.55e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 16 | 7.53e-01 | -4.54e-02 | 9.42e-01 |
| GOCC CELL CELL JUNCTION | 306 | 1.74e-01 | 4.54e-02 | 6.38e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 49 | 5.83e-01 | -4.53e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 7 | 8.36e-01 | -4.53e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 60 | 5.45e-01 | 4.53e-02 | 8.77e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 16 | 7.54e-01 | 4.52e-02 | 9.42e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 56 | 5.59e-01 | -4.52e-02 | 8.79e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 38 | 6.30e-01 | 4.52e-02 | 9.04e-01 |
| GOBP RESPONSE TO TYPE II INTERFERON | 104 | 4.26e-01 | -4.52e-02 | 8.29e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 33 | 6.54e-01 | 4.51e-02 | 9.09e-01 |
| GOCC OMEGASOME | 5 | 8.61e-01 | -4.51e-02 | 9.66e-01 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 11 | 7.96e-01 | -4.51e-02 | 9.52e-01 |
| GOBP EXOCYTIC PROCESS | 58 | 5.53e-01 | -4.51e-02 | 8.79e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 117 | 4.01e-01 | 4.50e-02 | 8.15e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 34 | 6.50e-01 | 4.50e-02 | 9.08e-01 |
| GOBP RESPONSE TO BACTERIUM | 400 | 1.24e-01 | -4.50e-02 | 5.72e-01 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 9 | 8.15e-01 | 4.50e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 10 | 8.06e-01 | -4.50e-02 | 9.57e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 9 | 8.15e-01 | -4.50e-02 | 9.59e-01 |
| GOBP RESPONSE TO STEROID HORMONE | 218 | 2.54e-01 | 4.49e-02 | 7.18e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 12 | 7.88e-01 | 4.49e-02 | 9.49e-01 |
| GOBP METHIONINE METABOLIC PROCESS | 13 | 7.79e-01 | -4.49e-02 | 9.48e-01 |
| GOBP MEMORY | 65 | 5.32e-01 | 4.49e-02 | 8.75e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 8.16e-01 | -4.49e-02 | 9.59e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 94 | 4.53e-01 | 4.48e-02 | 8.42e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 60 | 5.48e-01 | -4.48e-02 | 8.78e-01 |
| GOBP CYTOSOLIC TRANSPORT | 168 | 3.17e-01 | 4.48e-02 | 7.67e-01 |
| GOBP MICROGLIA DIFFERENTIATION | 9 | 8.16e-01 | -4.48e-02 | 9.59e-01 |
| GOBP BEHAVIOR | 357 | 1.48e-01 | 4.48e-02 | 6.07e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 28 | 6.82e-01 | 4.47e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 32 | 6.62e-01 | 4.47e-02 | 9.13e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 30 | 6.72e-01 | 4.47e-02 | 9.15e-01 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 17 | 7.50e-01 | 4.46e-02 | 9.41e-01 |
| GOBP ABSCISSION | 6 | 8.50e-01 | -4.46e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 18 | 7.43e-01 | -4.46e-02 | 9.38e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 7.81e-01 | 4.46e-02 | 9.48e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 542 | 7.77e-02 | 4.46e-02 | 4.96e-01 |
| GOBP THIOESTER METABOLIC PROCESS | 74 | 5.08e-01 | -4.45e-02 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF CELL VOLUME | 5 | 8.63e-01 | 4.45e-02 | 9.66e-01 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 6 | 8.50e-01 | 4.45e-02 | 9.62e-01 |
| GOCC NEURON PROJECTION | 779 | 3.63e-02 | 4.45e-02 | 3.71e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 704 | 4.61e-02 | 4.44e-02 | 4.01e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 13 | 7.82e-01 | 4.44e-02 | 9.48e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 80 | 4.93e-01 | 4.43e-02 | 8.59e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 13 | 7.82e-01 | 4.43e-02 | 9.48e-01 |
| GOBP REGULATION OF PIGMENTATION | 10 | 8.08e-01 | -4.43e-02 | 9.57e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 63 | 5.43e-01 | 4.43e-02 | 8.76e-01 |
| GOBP CELL FATE COMMITMENT | 112 | 4.19e-01 | 4.43e-02 | 8.23e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 214 | 2.66e-01 | 4.42e-02 | 7.27e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 7.39e-01 | 4.42e-02 | 9.37e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 22 | 7.20e-01 | -4.42e-02 | 9.32e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 31 | 6.70e-01 | 4.42e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 92 | 4.64e-01 | 4.42e-02 | 8.48e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 29 | 6.81e-01 | 4.42e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 63 | 5.45e-01 | 4.42e-02 | 8.77e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 519 | 8.70e-02 | -4.41e-02 | 5.09e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 33 | 6.61e-01 | 4.41e-02 | 9.13e-01 |
| GOBP RNA METHYLATION | 88 | 4.75e-01 | 4.41e-02 | 8.51e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 38 | 6.38e-01 | -4.41e-02 | 9.05e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 44 | 6.13e-01 | -4.41e-02 | 9.01e-01 |
| GOMF NUCLEOSOME BINDING | 53 | 5.79e-01 | 4.40e-02 | 8.88e-01 |
| GOBP RENAL ABSORPTION | 13 | 7.83e-01 | 4.40e-02 | 9.48e-01 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 15 | 7.68e-01 | -4.40e-02 | 9.46e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 50 | 5.90e-01 | -4.40e-02 | 8.93e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 79 | 4.99e-01 | -4.40e-02 | 8.63e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 28 | 6.87e-01 | -4.40e-02 | 9.20e-01 |
| GOBP ENDOSOMAL TRANSPORT | 223 | 2.59e-01 | -4.40e-02 | 7.21e-01 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 146 | 3.60e-01 | 4.40e-02 | 7.94e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 9 | 8.19e-01 | -4.40e-02 | 9.59e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 214 | 2.69e-01 | 4.39e-02 | 7.31e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 14 | 7.76e-01 | 4.39e-02 | 9.48e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 10 | 8.10e-01 | -4.39e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 117 | 4.13e-01 | -4.39e-02 | 8.20e-01 |
| GOBP RESPONSE TO FORSKOLIN | 7 | 8.41e-01 | 4.39e-02 | 9.61e-01 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 12 | 7.92e-01 | -4.39e-02 | 9.51e-01 |
| GOCC VACUOLAR MEMBRANE | 423 | 1.23e-01 | -4.39e-02 | 5.71e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 13 | 7.84e-01 | 4.38e-02 | 9.48e-01 |
| GOBP MUSCLE CELL MIGRATION | 59 | 5.61e-01 | 4.38e-02 | 8.79e-01 |
| GOCC BBSOME | 8 | 8.30e-01 | -4.38e-02 | 9.61e-01 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 432 | 1.20e-01 | -4.38e-02 | 5.70e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 41 | 6.28e-01 | -4.38e-02 | 9.04e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 141 | 3.70e-01 | -4.38e-02 | 8.02e-01 |
| GOCC FILAMENTOUS ACTIN | 19 | 7.41e-01 | -4.38e-02 | 9.38e-01 |
| GOCC CATALYTIC COMPLEX | 1504 | 5.27e-03 | -4.38e-02 | 1.76e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 349 | 1.62e-01 | 4.38e-02 | 6.21e-01 |
| GOBP B CELL PROLIFERATION | 63 | 5.48e-01 | -4.37e-02 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 30 | 6.79e-01 | 4.37e-02 | 9.19e-01 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 495 | 9.84e-02 | 4.36e-02 | 5.28e-01 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 35 | 6.55e-01 | 4.36e-02 | 9.09e-01 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 293 | 2.01e-01 | 4.36e-02 | 6.68e-01 |
| GOMF GATED CHANNEL ACTIVITY | 126 | 3.99e-01 | 4.36e-02 | 8.15e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 36 | 6.51e-01 | -4.35e-02 | 9.09e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 66 | 5.42e-01 | -4.35e-02 | 8.76e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 272 | 2.19e-01 | 4.34e-02 | 6.82e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 86 | 4.87e-01 | 4.34e-02 | 8.56e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 9 | 8.22e-01 | -4.34e-02 | 9.60e-01 |
| GOBP DOSAGE COMPENSATION | 29 | 6.86e-01 | -4.34e-02 | 9.20e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 13 | 7.86e-01 | -4.34e-02 | 9.49e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 8.54e-01 | -4.34e-02 | 9.63e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 37 | 6.48e-01 | -4.34e-02 | 9.08e-01 |
| GOMF NEUROPEPTIDE ACTIVITY | 10 | 8.12e-01 | 4.34e-02 | 9.58e-01 |
| GOBP CENTROSOME DUPLICATION | 69 | 5.34e-01 | 4.34e-02 | 8.75e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 20 | 7.37e-01 | -4.34e-02 | 9.37e-01 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 42 | 6.27e-01 | -4.34e-02 | 9.04e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 33 | 6.67e-01 | 4.33e-02 | 9.14e-01 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 23 | 7.19e-01 | 4.33e-02 | 9.32e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 725 | 4.86e-02 | 4.33e-02 | 4.09e-01 |
| GOBP CALCIUM ION TRANSPORT | 262 | 2.29e-01 | -4.33e-02 | 6.91e-01 |
| GOCC AP 3 ADAPTOR COMPLEX | 9 | 8.22e-01 | 4.33e-02 | 9.60e-01 |
| GOBP CELL MORPHOGENESIS | 594 | 7.32e-02 | 4.33e-02 | 4.84e-01 |
| GOCC P BODY | 88 | 4.83e-01 | 4.33e-02 | 8.54e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 357 | 1.62e-01 | 4.33e-02 | 6.21e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 164 | 3.40e-01 | 4.33e-02 | 7.84e-01 |
| GOCC NUCLEAR PORE | 87 | 4.86e-01 | 4.32e-02 | 8.56e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 59 | 5.66e-01 | 4.32e-02 | 8.81e-01 |
| GOCC NUCLEAR BODY | 728 | 4.90e-02 | 4.32e-02 | 4.11e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 21 | 7.32e-01 | -4.32e-02 | 9.36e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 289 | 2.08e-01 | 4.32e-02 | 6.75e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 315 | 1.89e-01 | -4.32e-02 | 6.60e-01 |
| GOBP RESPONSE TO HORMONE | 571 | 7.99e-02 | 4.31e-02 | 4.98e-01 |
| GOBP ANATOMICAL STRUCTURE REGRESSION | 5 | 8.67e-01 | -4.31e-02 | 9.68e-01 |
| GOMF TRANSITION METAL ION BINDING | 743 | 4.73e-02 | 4.31e-02 | 4.06e-01 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 13 | 7.88e-01 | 4.31e-02 | 9.49e-01 |
| GOMF COLLAGEN BINDING | 46 | 6.13e-01 | 4.31e-02 | 9.01e-01 |
| GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 14 | 7.80e-01 | -4.31e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 18 | 7.52e-01 | 4.30e-02 | 9.42e-01 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 513 | 9.74e-02 | -4.30e-02 | 5.27e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 129 | 4.00e-01 | 4.30e-02 | 8.15e-01 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 24 | 7.16e-01 | 4.29e-02 | 9.30e-01 |
| GOBP DOPAMINE SECRETION | 15 | 7.73e-01 | -4.29e-02 | 9.48e-01 |
| GOBP CATECHOLAMINE SECRETION | 22 | 7.28e-01 | 4.29e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 292 | 2.09e-01 | -4.29e-02 | 6.75e-01 |
| GOMF UNMETHYLATED CPG BINDING | 9 | 8.24e-01 | 4.29e-02 | 9.60e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 21 | 7.34e-01 | 4.29e-02 | 9.36e-01 |
| GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 6 | 8.56e-01 | -4.28e-02 | 9.64e-01 |
| GOBP WNT PROTEIN SECRETION | 5 | 8.68e-01 | -4.28e-02 | 9.68e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 95 | 4.71e-01 | 4.28e-02 | 8.49e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 8 | 8.34e-01 | -4.28e-02 | 9.61e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 7.89e-01 | -4.28e-02 | 9.49e-01 |
| GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 171 | 3.35e-01 | -4.28e-02 | 7.81e-01 |
| GOMF ANKYRIN BINDING | 11 | 8.06e-01 | 4.28e-02 | 9.57e-01 |
| GOBP JNK CASCADE | 130 | 4.00e-01 | 4.28e-02 | 8.15e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 63 | 5.58e-01 | -4.27e-02 | 8.79e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 8.69e-01 | 4.27e-02 | 9.68e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 14 | 7.82e-01 | 4.27e-02 | 9.48e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1551 | 5.81e-03 | 4.27e-02 | 1.81e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 7 | 8.45e-01 | -4.27e-02 | 9.62e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 13 | 7.90e-01 | -4.26e-02 | 9.50e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 16 | 7.68e-01 | -4.26e-02 | 9.46e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 20 | 7.42e-01 | -4.26e-02 | 9.38e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 108 | 4.45e-01 | 4.26e-02 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 27 | 7.02e-01 | 4.26e-02 | 9.25e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 51 | 5.99e-01 | -4.26e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 62 | 5.62e-01 | -4.26e-02 | 8.80e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 8 | 8.35e-01 | -4.25e-02 | 9.61e-01 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 19 | 7.49e-01 | -4.24e-02 | 9.41e-01 |
| GOCC CAJAL BODY | 57 | 5.80e-01 | 4.24e-02 | 8.88e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 24 | 7.20e-01 | -4.23e-02 | 9.32e-01 |
| GOBP REGULATION OF CELL DIVISION | 127 | 4.11e-01 | 4.23e-02 | 8.19e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 18 | 7.56e-01 | 4.23e-02 | 9.43e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 182 | 3.26e-01 | -4.23e-02 | 7.74e-01 |
| GOCC HOST CELLULAR COMPONENT | 8 | 8.36e-01 | 4.22e-02 | 9.61e-01 |
| GOMF SYNTAXIN 1 BINDING | 12 | 8.00e-01 | -4.22e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 25 | 7.16e-01 | -4.21e-02 | 9.30e-01 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 7 | 8.47e-01 | 4.21e-02 | 9.62e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 8.27e-01 | 4.20e-02 | 9.61e-01 |
| GOMF CHEMOKINE BINDING | 17 | 7.64e-01 | -4.20e-02 | 9.44e-01 |
| GOBP DETECTION OF BACTERIUM | 11 | 8.10e-01 | 4.20e-02 | 9.57e-01 |
| GOBP TISSUE MIGRATION | 207 | 3.00e-01 | 4.19e-02 | 7.56e-01 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 8.28e-01 | 4.19e-02 | 9.61e-01 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 7 | 8.48e-01 | 4.19e-02 | 9.62e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 7.86e-01 | 4.18e-02 | 9.49e-01 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 26 | 7.12e-01 | 4.18e-02 | 9.29e-01 |
| GOBP PROTEIN PHOSPHORYLATION | 942 | 3.14e-02 | 4.18e-02 | 3.52e-01 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 13 | 7.94e-01 | -4.18e-02 | 9.52e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 31 | 6.88e-01 | 4.17e-02 | 9.20e-01 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 68 | 5.52e-01 | 4.17e-02 | 8.79e-01 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 8.48e-01 | 4.17e-02 | 9.62e-01 |
| GOMF MAGNESIUM ION BINDING | 184 | 3.30e-01 | -4.17e-02 | 7.78e-01 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1348 | 1.13e-02 | -4.17e-02 | 2.45e-01 |
| GOCC MANCHETTE | 11 | 8.11e-01 | -4.17e-02 | 9.57e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 121 | 4.29e-01 | 4.17e-02 | 8.30e-01 |
| GOBP L AMINO ACID TRANSPORT | 57 | 5.87e-01 | 4.16e-02 | 8.92e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 11 | 8.11e-01 | 4.16e-02 | 9.58e-01 |
| GOCC NON MOTILE CILIUM | 98 | 4.77e-01 | 4.16e-02 | 8.52e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 254 | 2.55e-01 | -4.16e-02 | 7.18e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 57 | 5.88e-01 | 4.16e-02 | 8.92e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 53 | 6.01e-01 | 4.15e-02 | 8.97e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 71 | 5.46e-01 | -4.15e-02 | 8.77e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 32 | 6.85e-01 | -4.15e-02 | 9.19e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 31 | 6.90e-01 | 4.15e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 29 | 6.99e-01 | -4.14e-02 | 9.25e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 8.04e-01 | -4.14e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 18 | 7.61e-01 | 4.14e-02 | 9.44e-01 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 8.61e-01 | 4.14e-02 | 9.66e-01 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 372 | 1.73e-01 | 4.13e-02 | 6.37e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 16 | 7.75e-01 | 4.13e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 6 | 8.61e-01 | 4.13e-02 | 9.66e-01 |
| GOBP POSITIVE CHEMOTAXIS | 32 | 6.86e-01 | -4.13e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 53 | 6.04e-01 | -4.12e-02 | 8.97e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 213 | 3.01e-01 | 4.12e-02 | 7.56e-01 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 10 | 8.21e-01 | 4.12e-02 | 9.60e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 8 | 8.40e-01 | 4.12e-02 | 9.61e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 8 | 8.40e-01 | 4.12e-02 | 9.61e-01 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 8.22e-01 | 4.12e-02 | 9.60e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 54 | 6.01e-01 | 4.12e-02 | 8.97e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 79 | 5.27e-01 | -4.12e-02 | 8.74e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 33 | 6.83e-01 | -4.11e-02 | 9.19e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 54 | 6.01e-01 | -4.11e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 253 | 2.61e-01 | -4.11e-02 | 7.23e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 31 | 6.92e-01 | 4.11e-02 | 9.22e-01 |
| GOMF HISTONE KINASE ACTIVITY | 18 | 7.63e-01 | -4.11e-02 | 9.44e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 6 | 8.62e-01 | -4.11e-02 | 9.66e-01 |
| GOMF SNRNA BINDING | 45 | 6.34e-01 | -4.10e-02 | 9.04e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 264 | 2.53e-01 | 4.10e-02 | 7.18e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 709 | 6.53e-02 | -4.09e-02 | 4.66e-01 |
| GOMF TELOMERIC DNA BINDING | 37 | 6.67e-01 | 4.09e-02 | 9.14e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 17 | 7.70e-01 | -4.09e-02 | 9.46e-01 |
| GOBP CELLULAR PIGMENTATION | 58 | 5.90e-01 | -4.09e-02 | 8.93e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 282 | 2.39e-01 | 4.09e-02 | 7.04e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1334 | 1.36e-02 | 4.08e-02 | 2.65e-01 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 8.52e-01 | -4.08e-02 | 9.62e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 101 | 4.79e-01 | 4.08e-02 | 8.52e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 8.75e-01 | -4.08e-02 | 9.71e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 384 | 1.72e-01 | 4.08e-02 | 6.36e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 73 | 5.48e-01 | -4.07e-02 | 8.78e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 15 | 7.85e-01 | 4.07e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINESIS | 5 | 8.75e-01 | -4.07e-02 | 9.71e-01 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 10 | 8.24e-01 | 4.07e-02 | 9.60e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 369 | 1.81e-01 | 4.07e-02 | 6.50e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 5 | 8.75e-01 | -4.07e-02 | 9.71e-01 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 185 | 3.41e-01 | 4.06e-02 | 7.85e-01 |
| GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER | 5 | 8.75e-01 | -4.06e-02 | 9.71e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 14 | 7.92e-01 | -4.06e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 13 | 8.00e-01 | -4.06e-02 | 9.55e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 7 | 8.52e-01 | 4.06e-02 | 9.63e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 20 | 7.53e-01 | 4.06e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 11 | 8.16e-01 | 4.06e-02 | 9.59e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 44 | 6.42e-01 | -4.06e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 8 | 8.43e-01 | 4.06e-02 | 9.62e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 11 | 8.16e-01 | -4.06e-02 | 9.59e-01 |
| GOBP PLACENTA DEVELOPMENT | 103 | 4.78e-01 | 4.05e-02 | 8.52e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 93 | 5.00e-01 | -4.05e-02 | 8.63e-01 |
| GOBP SYNAPTIC SIGNALING | 395 | 1.69e-01 | 4.05e-02 | 6.33e-01 |
| GOBP CELL CYCLE PROCESS | 1029 | 2.99e-02 | 4.05e-02 | 3.50e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 331 | 2.07e-01 | 4.04e-02 | 6.74e-01 |
| GOBP NEUTROPHIL MIGRATION | 86 | 5.17e-01 | -4.04e-02 | 8.69e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 19 | 7.60e-01 | 4.04e-02 | 9.44e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 7.61e-01 | 4.04e-02 | 9.44e-01 |
| GOBP THYROID HORMONE GENERATION | 10 | 8.25e-01 | 4.04e-02 | 9.60e-01 |
| GOCC ORGANELLE ENVELOPE LUMEN | 80 | 5.33e-01 | -4.03e-02 | 8.75e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 59 | 5.93e-01 | -4.03e-02 | 8.94e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 11 | 8.17e-01 | -4.03e-02 | 9.59e-01 |
| GOBP RESPONSE TO ACTIVITY | 48 | 6.30e-01 | 4.03e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 531 | 1.15e-01 | 4.02e-02 | 5.64e-01 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 11 | 8.17e-01 | 4.02e-02 | 9.59e-01 |
| GOCC GERM CELL NUCLEUS | 47 | 6.34e-01 | 4.02e-02 | 9.04e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 125 | 4.39e-01 | 4.02e-02 | 8.36e-01 |
| GOMF SNARE BINDING | 77 | 5.43e-01 | 4.01e-02 | 8.76e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 38 | 6.69e-01 | -4.01e-02 | 9.15e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 146 | 4.04e-01 | 4.01e-02 | 8.18e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 39 | 6.65e-01 | -4.00e-02 | 9.14e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 497 | 1.29e-01 | 4.00e-02 | 5.81e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 145 | 4.07e-01 | 4.00e-02 | 8.18e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 24 | 7.35e-01 | -4.00e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 92 | 5.08e-01 | 4.00e-02 | 8.66e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 9 | 8.36e-01 | -4.00e-02 | 9.61e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 11 | 8.19e-01 | 3.99e-02 | 9.59e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 14 | 7.96e-01 | 3.99e-02 | 9.52e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 12 | 8.11e-01 | 3.99e-02 | 9.57e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 9 | 8.36e-01 | 3.99e-02 | 9.61e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 46 | 6.41e-01 | -3.98e-02 | 9.06e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 50 | 6.27e-01 | 3.98e-02 | 9.04e-01 |
| GOMF ACYL COA BINDING | 17 | 7.77e-01 | 3.97e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 11 | 8.20e-01 | -3.97e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 56 | 6.08e-01 | -3.97e-02 | 8.99e-01 |
| GOBP HEART TRABECULA FORMATION | 8 | 8.46e-01 | 3.97e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 56 | 6.08e-01 | -3.96e-02 | 8.99e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 169 | 3.75e-01 | 3.96e-02 | 8.05e-01 |
| GOBP P38MAPK CASCADE | 44 | 6.50e-01 | 3.96e-02 | 9.08e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 17 | 7.78e-01 | -3.96e-02 | 9.48e-01 |
| GOMF CARGO ADAPTOR ACTIVITY | 16 | 7.84e-01 | 3.96e-02 | 9.48e-01 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 6 | 8.67e-01 | -3.96e-02 | 9.67e-01 |
| GOBP PYROPTOSIS | 27 | 7.22e-01 | -3.95e-02 | 9.32e-01 |
| GOBP REGULATION OF BODY FLUID LEVELS | 218 | 3.16e-01 | 3.95e-02 | 7.66e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 451 | 1.53e-01 | 3.95e-02 | 6.13e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 10 | 8.29e-01 | 3.95e-02 | 9.61e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 37 | 6.78e-01 | 3.95e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 13 | 8.05e-01 | 3.95e-02 | 9.57e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 144 | 4.14e-01 | -3.95e-02 | 8.21e-01 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 8.38e-01 | 3.95e-02 | 9.61e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 114 | 4.67e-01 | -3.94e-02 | 8.49e-01 |
| GOBP UBIQUINONE METABOLIC PROCESS | 19 | 7.66e-01 | -3.94e-02 | 9.45e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 142 | 4.18e-01 | 3.94e-02 | 8.22e-01 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 38 | 6.74e-01 | 3.94e-02 | 9.17e-01 |
| GOBP CERAMIDE TRANSPORT | 12 | 8.13e-01 | -3.94e-02 | 9.58e-01 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 23 | 7.44e-01 | -3.94e-02 | 9.38e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 8.47e-01 | -3.94e-02 | 9.62e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 150 | 4.06e-01 | -3.94e-02 | 8.18e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 31 | 7.05e-01 | -3.93e-02 | 9.25e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 103 | 4.91e-01 | -3.93e-02 | 8.58e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 31 | 7.05e-01 | 3.93e-02 | 9.26e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 109 | 4.79e-01 | 3.93e-02 | 8.52e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 176 | 3.70e-01 | -3.92e-02 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 19 | 7.67e-01 | -3.92e-02 | 9.46e-01 |
| GOBP RHYTHMIC BEHAVIOR | 25 | 7.35e-01 | -3.92e-02 | 9.37e-01 |
| GOCC CHROMOSOME | 1320 | 1.86e-02 | 3.92e-02 | 2.95e-01 |
| GOBP SPINDLE ELONGATION | 12 | 8.14e-01 | 3.91e-02 | 9.59e-01 |
| GOCC LIPID DROPLET | 84 | 5.36e-01 | -3.91e-02 | 8.76e-01 |
| GOMF FMN BINDING | 9 | 8.39e-01 | 3.91e-02 | 9.61e-01 |
| GOBP RESPONSE TO VITAMIN A | 6 | 8.68e-01 | -3.91e-02 | 9.68e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 114 | 4.72e-01 | 3.90e-02 | 8.50e-01 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 11 | 8.23e-01 | 3.90e-02 | 9.60e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 5 | 8.80e-01 | -3.90e-02 | 9.72e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 22 | 7.51e-01 | 3.90e-02 | 9.42e-01 |
| GOBP ENTRY INTO HOST | 121 | 4.59e-01 | -3.90e-02 | 8.45e-01 |
| GOBP BONE MINERALIZATION | 69 | 5.76e-01 | 3.90e-02 | 8.86e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 5 | 8.80e-01 | 3.90e-02 | 9.72e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 157 | 4.00e-01 | 3.90e-02 | 8.15e-01 |
| GOBP ACTION POTENTIAL | 74 | 5.63e-01 | 3.89e-02 | 8.80e-01 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 410 | 1.79e-01 | 3.89e-02 | 6.45e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 7 | 8.59e-01 | 3.89e-02 | 9.65e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 11 | 8.24e-01 | 3.88e-02 | 9.60e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 9 | 8.40e-01 | 3.88e-02 | 9.61e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 472 | 1.51e-01 | 3.88e-02 | 6.12e-01 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 7 | 8.59e-01 | 3.88e-02 | 9.65e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 18 | 7.76e-01 | 3.88e-02 | 9.48e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 50 | 6.36e-01 | 3.87e-02 | 9.04e-01 |
| GOBP BRADYKININ CATABOLIC PROCESS | 6 | 8.70e-01 | -3.87e-02 | 9.69e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 369 | 2.04e-01 | -3.87e-02 | 6.72e-01 |
| GOCC TOR COMPLEX | 11 | 8.24e-01 | 3.86e-02 | 9.60e-01 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 24 | 7.43e-01 | 3.86e-02 | 9.38e-01 |
| GOBP KERATINIZATION | 10 | 8.32e-01 | -3.86e-02 | 9.61e-01 |
| GOBP RNA STABILIZATION | 55 | 6.20e-01 | 3.86e-02 | 9.03e-01 |
| GOBP RESPONSE TO OXYGEN RADICAL | 19 | 7.71e-01 | 3.86e-02 | 9.46e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 39 | 6.77e-01 | 3.86e-02 | 9.18e-01 |
| GOBP AMP METABOLIC PROCESS | 17 | 7.83e-01 | 3.86e-02 | 9.48e-01 |
| GOBP SULFUR COMPOUND TRANSPORT | 41 | 6.70e-01 | -3.85e-02 | 9.15e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 29 | 7.20e-01 | 3.85e-02 | 9.32e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 15 | 7.96e-01 | 3.85e-02 | 9.52e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 65 | 5.92e-01 | -3.85e-02 | 8.94e-01 |
| GOMF DIOXYGENASE ACTIVITY | 75 | 5.65e-01 | -3.85e-02 | 8.81e-01 |
| GOMF PROTEIN KINASE A BINDING | 37 | 6.86e-01 | -3.85e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 9 | 8.42e-01 | -3.84e-02 | 9.61e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 294 | 2.59e-01 | 3.84e-02 | 7.21e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 8.71e-01 | 3.84e-02 | 9.70e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 144 | 4.28e-01 | 3.83e-02 | 8.30e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 252 | 2.96e-01 | 3.83e-02 | 7.54e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 19 | 7.73e-01 | 3.83e-02 | 9.48e-01 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 16 | 7.91e-01 | 3.82e-02 | 9.50e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 8.26e-01 | 3.82e-02 | 9.61e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 36 | 6.92e-01 | -3.82e-02 | 9.22e-01 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 10 | 8.34e-01 | 3.82e-02 | 9.61e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 7 | 8.61e-01 | -3.82e-02 | 9.66e-01 |
| GOCC MEIOTIC SPINDLE | 11 | 8.27e-01 | 3.81e-02 | 9.61e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 89 | 5.34e-01 | 3.81e-02 | 8.75e-01 |
| GOCC KINOCILIUM | 6 | 8.72e-01 | -3.81e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 446 | 1.70e-01 | 3.81e-02 | 6.34e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 10 | 8.35e-01 | 3.81e-02 | 9.61e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 8.62e-01 | -3.80e-02 | 9.66e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 28 | 7.28e-01 | -3.80e-02 | 9.35e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 8 | 8.52e-01 | 3.80e-02 | 9.63e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 145 | 4.30e-01 | 3.80e-02 | 8.30e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 101 | 5.10e-01 | -3.80e-02 | 8.67e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 56 | 6.23e-01 | -3.80e-02 | 9.04e-01 |
| GOBP ELASTIC FIBER ASSEMBLY | 6 | 8.72e-01 | 3.80e-02 | 9.70e-01 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 6 | 8.72e-01 | 3.80e-02 | 9.70e-01 |
| GOBP SECRETION | 582 | 1.20e-01 | 3.80e-02 | 5.69e-01 |
| GOCC CLATHRIN COATED PIT | 60 | 6.11e-01 | -3.80e-02 | 9.00e-01 |
| GOMF REGULATORY RNA BINDING | 40 | 6.78e-01 | 3.79e-02 | 9.19e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 123 | 4.68e-01 | 3.79e-02 | 8.49e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 193 | 3.65e-01 | 3.79e-02 | 7.98e-01 |
| GOCC CDC73 PAF1 COMPLEX | 6 | 8.72e-01 | -3.79e-02 | 9.71e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 115 | 4.84e-01 | -3.79e-02 | 8.54e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 1240 | 2.71e-02 | -3.78e-02 | 3.34e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 848 | 6.39e-02 | 3.78e-02 | 4.62e-01 |
| GOMF ACTIN BINDING | 311 | 2.53e-01 | 3.78e-02 | 7.18e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 8.28e-01 | 3.78e-02 | 9.61e-01 |
| GOCC SPERM CONNECTING PIECE | 5 | 8.84e-01 | 3.78e-02 | 9.72e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 25 | 7.44e-01 | 3.77e-02 | 9.38e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 19 | 7.76e-01 | -3.77e-02 | 9.48e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 10 | 8.36e-01 | 3.77e-02 | 9.61e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 22 | 7.60e-01 | 3.77e-02 | 9.44e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 161 | 4.10e-01 | 3.77e-02 | 8.19e-01 |
| GOBP HISTONE H4 K16 ACETYLATION | 7 | 8.63e-01 | 3.76e-02 | 9.66e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 172 | 3.95e-01 | 3.76e-02 | 8.14e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 69 | 5.89e-01 | 3.76e-02 | 8.93e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 9 | 8.45e-01 | -3.76e-02 | 9.62e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 9 | 8.45e-01 | -3.76e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 22 | 7.61e-01 | -3.75e-02 | 9.44e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 54 | 6.34e-01 | -3.75e-02 | 9.04e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 11 | 8.29e-01 | -3.75e-02 | 9.61e-01 |
| GOMF C C CHEMOKINE BINDING | 9 | 8.46e-01 | -3.75e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 403 | 1.99e-01 | -3.75e-02 | 6.68e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 23 | 7.56e-01 | 3.74e-02 | 9.43e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 7 | 8.64e-01 | -3.74e-02 | 9.67e-01 |
| GOBP REGULATION OF BEHAVIOR | 36 | 6.98e-01 | 3.74e-02 | 9.25e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 50 | 6.48e-01 | -3.74e-02 | 9.08e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 60 | 6.17e-01 | 3.73e-02 | 9.02e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 165 | 4.09e-01 | 3.73e-02 | 8.19e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 91 | 5.39e-01 | -3.73e-02 | 8.76e-01 |
| GOBP REGULATION OF LOCOMOTION | 665 | 1.04e-01 | 3.73e-02 | 5.41e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 48 | 6.55e-01 | -3.72e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 11 | 8.31e-01 | 3.72e-02 | 9.61e-01 |
| GOBP REGULATION OF AUTOPHAGY | 310 | 2.62e-01 | -3.72e-02 | 7.24e-01 |
| GOMF ACID THIOL LIGASE ACTIVITY | 21 | 7.68e-01 | 3.72e-02 | 9.46e-01 |
| GOBP DENDRITE MORPHOGENESIS | 90 | 5.43e-01 | 3.72e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 13 | 8.17e-01 | -3.72e-02 | 9.59e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 31 | 7.20e-01 | 3.72e-02 | 9.32e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 127 | 4.71e-01 | -3.71e-02 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 27 | 7.39e-01 | -3.71e-02 | 9.38e-01 |
| GOCC CLEAVAGE FURROW | 46 | 6.64e-01 | -3.71e-02 | 9.14e-01 |
| GOBP RESPONSE TO ALCOHOL | 155 | 4.27e-01 | 3.70e-02 | 8.30e-01 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 7 | 8.66e-01 | -3.70e-02 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 16 | 7.98e-01 | -3.69e-02 | 9.54e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 10 | 8.40e-01 | -3.69e-02 | 9.61e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 194 | 3.77e-01 | 3.69e-02 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 119 | 4.88e-01 | 3.68e-02 | 8.56e-01 |
| GOCC BRISC COMPLEX | 6 | 8.76e-01 | 3.68e-02 | 9.71e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 10 | 8.40e-01 | -3.68e-02 | 9.61e-01 |
| GOBP MAINTENANCE OF LOCATION | 251 | 3.17e-01 | -3.68e-02 | 7.67e-01 |
| GOBP MACROMOLECULE METHYLATION | 185 | 3.89e-01 | 3.68e-02 | 8.11e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 60 | 6.23e-01 | 3.68e-02 | 9.03e-01 |
| GOMF ORGANIC ACID BINDING | 119 | 4.90e-01 | 3.67e-02 | 8.58e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 63 | 6.15e-01 | -3.67e-02 | 9.02e-01 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 9 | 8.49e-01 | 3.67e-02 | 9.62e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 53 | 6.45e-01 | 3.66e-02 | 9.07e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 423 | 1.98e-01 | -3.66e-02 | 6.67e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 57 | 6.32e-01 | -3.66e-02 | 9.04e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 219 | 3.53e-01 | 3.65e-02 | 7.91e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 27 | 7.43e-01 | 3.65e-02 | 9.38e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 69 | 6.00e-01 | 3.65e-02 | 8.97e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE | 44 | 6.76e-01 | 3.65e-02 | 9.17e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 23 | 7.62e-01 | 3.64e-02 | 9.44e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 38 | 6.98e-01 | 3.64e-02 | 9.25e-01 |
| GOCC APICAL JUNCTION COMPLEX | 90 | 5.52e-01 | 3.63e-02 | 8.79e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 9 | 8.50e-01 | -3.63e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 70 | 5.99e-01 | 3.63e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 66 | 6.10e-01 | -3.63e-02 | 8.99e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 34 | 7.14e-01 | -3.63e-02 | 9.30e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 123 | 4.88e-01 | 3.63e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 772 | 8.92e-02 | 3.63e-02 | 5.12e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 11 | 8.35e-01 | 3.62e-02 | 9.61e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 1094 | 4.57e-02 | 3.62e-02 | 3.99e-01 |
| GOBP MAST CELL MEDIATED IMMUNITY | 42 | 6.85e-01 | -3.62e-02 | 9.19e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 346 | 2.50e-01 | 3.61e-02 | 7.16e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 9 | 8.51e-01 | 3.61e-02 | 9.62e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 70 | 6.03e-01 | 3.60e-02 | 8.97e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 41 | 6.90e-01 | 3.60e-02 | 9.21e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 151 | 4.46e-01 | 3.60e-02 | 8.40e-01 |
| GOBP EPITHELIAL CELL MATURATION | 15 | 8.10e-01 | 3.60e-02 | 9.57e-01 |
| GOMF DAMAGED DNA BINDING | 68 | 6.09e-01 | -3.59e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 348 | 2.52e-01 | -3.59e-02 | 7.18e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 6 | 8.79e-01 | -3.59e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 10 | 8.44e-01 | 3.59e-02 | 9.62e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 8.30e-01 | -3.58e-02 | 9.61e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 110 | 5.17e-01 | 3.58e-02 | 8.69e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 119 | 5.00e-01 | -3.58e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 36 | 7.10e-01 | 3.58e-02 | 9.28e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 225 | 3.56e-01 | 3.58e-02 | 7.92e-01 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 8.90e-01 | 3.58e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 6 | 8.80e-01 | -3.57e-02 | 9.72e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 46 | 6.75e-01 | 3.57e-02 | 9.17e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 284 | 3.02e-01 | -3.57e-02 | 7.57e-01 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 6 | 8.80e-01 | -3.57e-02 | 9.72e-01 |
| GOBP FAS SIGNALING PATHWAY | 6 | 8.80e-01 | 3.57e-02 | 9.72e-01 |
| GOBP POLYKETIDE METABOLIC PROCESS | 6 | 8.80e-01 | -3.57e-02 | 9.72e-01 |
| GOBP RESPONSE TO ETHANOL | 70 | 6.06e-01 | 3.56e-02 | 8.99e-01 |
| GOBP SUCKLING BEHAVIOR | 6 | 8.80e-01 | 3.56e-02 | 9.72e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 59 | 6.36e-01 | 3.56e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 9 | 8.53e-01 | -3.56e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 417 | 2.14e-01 | -3.56e-02 | 6.79e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 277 | 3.09e-01 | -3.56e-02 | 7.63e-01 |
| GOBP BONE GROWTH | 16 | 8.05e-01 | 3.56e-02 | 9.57e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 21 | 7.78e-01 | 3.56e-02 | 9.48e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 8 | 8.62e-01 | 3.55e-02 | 9.66e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 14 | 8.18e-01 | -3.55e-02 | 9.59e-01 |
| GOCC ANCHORING JUNCTION | 631 | 1.31e-01 | -3.55e-02 | 5.83e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 962 | 6.51e-02 | 3.55e-02 | 4.66e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 26 | 7.54e-01 | -3.55e-02 | 9.42e-01 |
| GOCC CELL CORTEX | 221 | 3.65e-01 | -3.55e-02 | 7.98e-01 |
| GOBP NCRNA CATABOLIC PROCESS | 50 | 6.65e-01 | -3.54e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 16 | 8.06e-01 | -3.54e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 8 | 8.62e-01 | 3.54e-02 | 9.66e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 16 | 8.07e-01 | -3.54e-02 | 9.57e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 15 | 8.13e-01 | 3.53e-02 | 9.58e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 110 | 5.23e-01 | 3.53e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 8.47e-01 | -3.53e-02 | 9.62e-01 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 6 | 8.81e-01 | -3.53e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 277 | 3.14e-01 | -3.53e-02 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 232 | 3.56e-01 | 3.52e-02 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 14 | 8.20e-01 | -3.52e-02 | 9.59e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 8.40e-01 | 3.52e-02 | 9.61e-01 |
| GOCC G PROTEIN COUPLED RECEPTOR COMPLEX | 6 | 8.82e-01 | -3.51e-02 | 9.72e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 178 | 4.21e-01 | 3.50e-02 | 8.25e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 76 | 5.98e-01 | 3.50e-02 | 8.97e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 62 | 6.34e-01 | -3.49e-02 | 9.04e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 392 | 2.37e-01 | 3.49e-02 | 7.01e-01 |
| GOBP RESPONSE TO STARVATION | 170 | 4.33e-01 | 3.49e-02 | 8.31e-01 |
| GOCC POSTSYNAPTIC ENDOSOME | 11 | 8.41e-01 | -3.49e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 21 | 7.82e-01 | -3.49e-02 | 9.48e-01 |
| GOBP INFLAMMATORY RESPONSE | 545 | 1.66e-01 | -3.49e-02 | 6.28e-01 |
| GOBP MAST CELL ACTIVATION | 51 | 6.67e-01 | -3.49e-02 | 9.14e-01 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 6 | 8.82e-01 | 3.49e-02 | 9.72e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 60 | 6.41e-01 | -3.49e-02 | 9.06e-01 |
| GOMF HEPARIN BINDING | 74 | 6.05e-01 | 3.48e-02 | 8.98e-01 |
| GOBP REGULATION OF CELL SHAPE | 109 | 5.30e-01 | 3.48e-02 | 8.75e-01 |
| GOCC RNA CAP BINDING COMPLEX | 20 | 7.87e-01 | 3.48e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 15 | 8.16e-01 | -3.48e-02 | 9.59e-01 |
| GOCC CONTRACTILE FIBER | 150 | 4.63e-01 | -3.47e-02 | 8.47e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 121 | 5.10e-01 | -3.47e-02 | 8.67e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 15 | 8.16e-01 | 3.47e-02 | 9.59e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 69 | 6.19e-01 | -3.47e-02 | 9.03e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 105 | 5.40e-01 | -3.46e-02 | 8.76e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 59 | 6.46e-01 | 3.46e-02 | 9.07e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 8 | 8.65e-01 | -3.46e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 94 | 5.62e-01 | 3.46e-02 | 8.80e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 21 | 7.84e-01 | 3.46e-02 | 9.48e-01 |
| GOBP SPERM MOTILITY | 56 | 6.55e-01 | -3.46e-02 | 9.09e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 121 | 5.12e-01 | 3.45e-02 | 8.67e-01 |
| GOBP LYSOSOMAL TRANSPORT | 115 | 5.23e-01 | 3.45e-02 | 8.72e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 111 | 5.30e-01 | 3.45e-02 | 8.75e-01 |
| GOBP MACROPHAGE PROLIFERATION | 7 | 8.74e-01 | 3.45e-02 | 9.71e-01 |
| GOCC TRANSPORTER COMPLEX | 227 | 3.72e-01 | -3.45e-02 | 8.04e-01 |
| GOCC AUTOPHAGOSOME | 106 | 5.40e-01 | -3.45e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 74 | 6.09e-01 | -3.45e-02 | 8.99e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 26 | 7.61e-01 | -3.44e-02 | 9.44e-01 |
| GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.94e-01 | 3.44e-02 | 9.77e-01 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 7 | 8.75e-01 | 3.44e-02 | 9.71e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 95 | 5.63e-01 | 3.43e-02 | 8.80e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 394 | 2.44e-01 | -3.43e-02 | 7.08e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 215 | 3.87e-01 | 3.43e-02 | 8.10e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 65 | 6.33e-01 | -3.43e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 12 | 8.37e-01 | 3.43e-02 | 9.61e-01 |
| GOCC CENTRIOLAR SATELLITE | 95 | 5.64e-01 | 3.43e-02 | 8.80e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 194 | 4.12e-01 | 3.42e-02 | 8.19e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 6 | 8.85e-01 | -3.42e-02 | 9.73e-01 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 19 | 7.96e-01 | 3.42e-02 | 9.52e-01 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 61 | 6.44e-01 | 3.42e-02 | 9.07e-01 |
| GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION | 6 | 8.85e-01 | -3.42e-02 | 9.73e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 64 | 6.37e-01 | -3.42e-02 | 9.04e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 6 | 8.85e-01 | 3.41e-02 | 9.73e-01 |
| GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 6 | 8.85e-01 | 3.41e-02 | 9.73e-01 |
| GOBP NUCLEAR TRANSPORT | 288 | 3.21e-01 | 3.41e-02 | 7.69e-01 |
| GOBP DETECTION OF BIOTIC STIMULUS | 26 | 7.64e-01 | -3.41e-02 | 9.44e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 12 | 8.38e-01 | 3.41e-02 | 9.61e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 31 | 7.43e-01 | -3.40e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 17 | 8.09e-01 | -3.39e-02 | 9.57e-01 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 241 | 3.66e-01 | 3.39e-02 | 7.99e-01 |
| GOBP GLAND DEVELOPMENT | 258 | 3.50e-01 | 3.39e-02 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 48 | 6.85e-01 | 3.39e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 7 | 8.77e-01 | -3.39e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 80 | 6.02e-01 | 3.38e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 54 | 6.68e-01 | 3.38e-02 | 9.14e-01 |
| GOBP CHOLESTEROL STORAGE | 21 | 7.89e-01 | 3.38e-02 | 9.49e-01 |
| GOMF HISTONE BINDING | 216 | 3.93e-01 | 3.38e-02 | 8.13e-01 |
| GOBP METHYLATION | 240 | 3.69e-01 | 3.38e-02 | 8.01e-01 |
| GOBP LIPID LOCALIZATION | 308 | 3.10e-01 | 3.38e-02 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 135 | 5.00e-01 | 3.37e-02 | 8.63e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 157 | 4.67e-01 | 3.37e-02 | 8.49e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 64 | 6.42e-01 | -3.37e-02 | 9.06e-01 |
| GOBP PROTEIN DEMETHYLATION | 12 | 8.40e-01 | -3.36e-02 | 9.61e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 110 | 5.43e-01 | 3.36e-02 | 8.76e-01 |
| GOMF FATTY ACID LIGASE ACTIVITY | 12 | 8.41e-01 | -3.35e-02 | 9.61e-01 |
| GOBP CYTIDINE TO URIDINE EDITING | 8 | 8.70e-01 | 3.35e-02 | 9.69e-01 |
| GOBP REGULATION OF GLOMERULAR FILTRATION | 5 | 8.97e-01 | -3.35e-02 | 9.78e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 73 | 6.21e-01 | 3.35e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 14 | 8.28e-01 | -3.34e-02 | 9.61e-01 |
| GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 8.48e-01 | 3.34e-02 | 9.62e-01 |
| GOBP TRANSPORT ALONG MICROTUBULE | 142 | 4.92e-01 | 3.34e-02 | 8.59e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 112 | 5.42e-01 | -3.34e-02 | 8.76e-01 |
| GOMF KINASE BINDING | 596 | 1.67e-01 | 3.34e-02 | 6.28e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 10 | 8.55e-01 | -3.34e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 128 | 5.15e-01 | 3.34e-02 | 8.68e-01 |
| GOBP MALE SEX DIFFERENTIATION | 94 | 5.77e-01 | -3.34e-02 | 8.87e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 71 | 6.27e-01 | 3.33e-02 | 9.04e-01 |
| GOMF TBP CLASS PROTEIN BINDING | 23 | 7.82e-01 | -3.33e-02 | 9.48e-01 |
| GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 109 | 5.48e-01 | 3.33e-02 | 8.78e-01 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 10 | 8.55e-01 | 3.33e-02 | 9.64e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 59 | 6.58e-01 | 3.33e-02 | 9.11e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 29 | 7.56e-01 | 3.33e-02 | 9.43e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 125 | 5.21e-01 | -3.33e-02 | 8.72e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 297 | 3.25e-01 | -3.33e-02 | 7.73e-01 |
| GOBP MONOAMINE TRANSPORT | 35 | 7.33e-01 | -3.33e-02 | 9.36e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 199 | 4.19e-01 | -3.33e-02 | 8.23e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 37 | 7.27e-01 | 3.32e-02 | 9.35e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 23 | 7.83e-01 | 3.32e-02 | 9.48e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 15 | 8.24e-01 | 3.32e-02 | 9.60e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME | 5 | 8.98e-01 | 3.32e-02 | 9.78e-01 |
| GOBP TUBE DEVELOPMENT | 655 | 1.51e-01 | 3.31e-02 | 6.13e-01 |
| GOBP OOGENESIS | 60 | 6.58e-01 | 3.31e-02 | 9.11e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 119 | 5.34e-01 | -3.31e-02 | 8.75e-01 |
| GOMF INTEGRIN BINDING | 93 | 5.82e-01 | 3.31e-02 | 8.89e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 76 | 6.19e-01 | -3.30e-02 | 9.03e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 26 | 7.71e-01 | -3.30e-02 | 9.46e-01 |
| GOCC PRESPLICEOSOME | 16 | 8.19e-01 | 3.30e-02 | 9.59e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 8.50e-01 | 3.29e-02 | 9.62e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 230 | 3.91e-01 | 3.29e-02 | 8.11e-01 |
| GOMF ISOPRENOID BINDING | 13 | 8.37e-01 | -3.29e-02 | 9.61e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 83 | 6.05e-01 | -3.29e-02 | 8.98e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 133 | 5.13e-01 | -3.29e-02 | 8.67e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 24 | 7.80e-01 | -3.29e-02 | 9.48e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 16 | 8.20e-01 | 3.29e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 102 | 5.67e-01 | 3.29e-02 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 5 | 8.99e-01 | -3.29e-02 | 9.78e-01 |
| GOBP DECIDUALIZATION | 18 | 8.09e-01 | -3.29e-02 | 9.57e-01 |
| GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 57 | 6.68e-01 | -3.28e-02 | 9.14e-01 |
| GOBP VASCULATURE DEVELOPMENT | 461 | 2.29e-01 | 3.28e-02 | 6.92e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 8.89e-01 | 3.28e-02 | 9.75e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 7 | 8.80e-01 | 3.28e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 10 | 8.57e-01 | -3.28e-02 | 9.64e-01 |
| GOBP PROTEIN TRIMERIZATION | 12 | 8.44e-01 | 3.28e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 9 | 8.65e-01 | 3.28e-02 | 9.67e-01 |
| GOBP SPROUTING ANGIOGENESIS | 75 | 6.24e-01 | 3.28e-02 | 9.04e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 37 | 7.31e-01 | 3.27e-02 | 9.36e-01 |
| GOCC SPINDLE MICROTUBULE | 72 | 6.32e-01 | 3.27e-02 | 9.04e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 265 | 3.61e-01 | 3.27e-02 | 7.94e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 758 | 1.29e-01 | -3.27e-02 | 5.81e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 126 | 5.27e-01 | 3.27e-02 | 8.74e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 395 | 2.67e-01 | -3.27e-02 | 7.29e-01 |
| GOBP DETOXIFICATION | 99 | 5.75e-01 | -3.26e-02 | 8.86e-01 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 713 | 1.41e-01 | 3.26e-02 | 5.98e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 307 | 3.27e-01 | 3.26e-02 | 7.75e-01 |
| GOMF PHOSPHATASE BINDING | 160 | 4.77e-01 | 3.26e-02 | 8.52e-01 |
| GOMF INTERMEDIATE FILAMENT BINDING | 5 | 9.00e-01 | 3.26e-02 | 9.78e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 24 | 7.82e-01 | -3.26e-02 | 9.48e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 173 | 4.60e-01 | 3.26e-02 | 8.45e-01 |
| GOBP DNA RECOMBINATION | 277 | 3.52e-01 | 3.26e-02 | 7.91e-01 |
| GOMF GDP BINDING | 61 | 6.61e-01 | -3.25e-02 | 9.13e-01 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 6 | 8.90e-01 | 3.25e-02 | 9.76e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 109 | 5.59e-01 | 3.25e-02 | 8.79e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 12 | 8.46e-01 | 3.24e-02 | 9.62e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 21 | 7.97e-01 | -3.24e-02 | 9.53e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 32 | 7.51e-01 | 3.24e-02 | 9.42e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 61 | 6.62e-01 | -3.24e-02 | 9.13e-01 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 9.00e-01 | -3.23e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 24 | 7.84e-01 | -3.23e-02 | 9.48e-01 |
| GOBP RIBOSOME DISASSEMBLY | 13 | 8.40e-01 | 3.23e-02 | 9.61e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 12 | 8.46e-01 | -3.23e-02 | 9.62e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 7.56e-01 | -3.23e-02 | 9.43e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 262 | 3.70e-01 | -3.22e-02 | 8.02e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 120 | 5.43e-01 | 3.22e-02 | 8.76e-01 |
| GOBP MONOCYTE ACTIVATION | 11 | 8.53e-01 | 3.22e-02 | 9.63e-01 |
| GOCC MRNA EDITING COMPLEX | 13 | 8.41e-01 | 3.22e-02 | 9.61e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 49 | 6.97e-01 | -3.22e-02 | 9.25e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 11 | 8.53e-01 | 3.22e-02 | 9.63e-01 |
| GOBP REGULATION OF LIPID STORAGE | 41 | 7.22e-01 | 3.21e-02 | 9.32e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 14 | 8.35e-01 | -3.21e-02 | 9.61e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 20 | 8.04e-01 | 3.21e-02 | 9.56e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 42 | 7.19e-01 | 3.21e-02 | 9.32e-01 |
| GOCC DISTAL AXON | 169 | 4.73e-01 | 3.20e-02 | 8.50e-01 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 11 | 8.54e-01 | 3.20e-02 | 9.63e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 9 | 8.68e-01 | 3.19e-02 | 9.68e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 387 | 2.83e-01 | 3.19e-02 | 7.43e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 30 | 7.63e-01 | 3.19e-02 | 9.44e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 284 | 3.57e-01 | 3.18e-02 | 7.92e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 7 | 8.84e-01 | -3.18e-02 | 9.73e-01 |
| GOBP MITOTIC CYTOKINESIS | 81 | 6.21e-01 | 3.18e-02 | 9.03e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 45 | 7.12e-01 | 3.18e-02 | 9.29e-01 |
| GOBP MITOPHAGY | 36 | 7.42e-01 | 3.18e-02 | 9.38e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 178 | 4.66e-01 | -3.17e-02 | 8.48e-01 |
| GOBP BONE DEVELOPMENT | 126 | 5.39e-01 | 3.17e-02 | 8.76e-01 |
| GOBP CELL GROWTH | 342 | 3.16e-01 | 3.17e-02 | 7.66e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 68 | 6.52e-01 | -3.17e-02 | 9.09e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 36 | 7.42e-01 | 3.17e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 16 | 8.27e-01 | 3.16e-02 | 9.61e-01 |
| GOBP SYNCYTIUM FORMATION | 42 | 7.23e-01 | -3.16e-02 | 9.32e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 19 | 8.12e-01 | 3.16e-02 | 9.58e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 45 | 7.14e-01 | 3.16e-02 | 9.30e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 12 | 8.50e-01 | 3.15e-02 | 9.62e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 16 | 8.27e-01 | -3.15e-02 | 9.61e-01 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 6 | 8.94e-01 | -3.15e-02 | 9.77e-01 |
| GOBP COPPER ION TRANSPORT | 14 | 8.39e-01 | 3.14e-02 | 9.61e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 11 | 8.57e-01 | 3.14e-02 | 9.64e-01 |
| GOCC CILIARY ROOTLET | 11 | 8.57e-01 | -3.14e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 110 | 5.70e-01 | 3.14e-02 | 8.83e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1143 | 7.71e-02 | -3.14e-02 | 4.94e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 155 | 5.01e-01 | -3.14e-02 | 8.63e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 29 | 7.70e-01 | 3.14e-02 | 9.46e-01 |
| GOBP REGULATION OF APPETITE | 8 | 8.78e-01 | -3.14e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 11 | 8.57e-01 | -3.13e-02 | 9.64e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 965 | 1.03e-01 | 3.13e-02 | 5.41e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 13 | 8.45e-01 | 3.13e-02 | 9.62e-01 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 348 | 3.18e-01 | 3.12e-02 | 7.67e-01 |
| GOCC PROTEIN DNA COMPLEX | 863 | 1.23e-01 | 3.12e-02 | 5.71e-01 |
| GOBP ORGANIC ANION TRANSPORT | 258 | 3.89e-01 | 3.12e-02 | 8.11e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 74 | 6.43e-01 | -3.12e-02 | 9.06e-01 |
| GOMF DYSTROGLYCAN BINDING | 8 | 8.79e-01 | -3.12e-02 | 9.72e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 17 | 8.24e-01 | -3.12e-02 | 9.60e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 17 | 8.24e-01 | 3.11e-02 | 9.60e-01 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 8.95e-01 | 3.11e-02 | 9.77e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 7 | 8.87e-01 | -3.11e-02 | 9.74e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 87 | 6.16e-01 | 3.11e-02 | 9.02e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 32 | 7.61e-01 | 3.11e-02 | 9.44e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 389 | 2.94e-01 | -3.11e-02 | 7.53e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 14 | 8.40e-01 | 3.11e-02 | 9.61e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 8.58e-01 | 3.11e-02 | 9.65e-01 |
| GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 17 | 8.24e-01 | -3.11e-02 | 9.60e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 7.92e-01 | 3.11e-02 | 9.51e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 8 | 8.79e-01 | -3.10e-02 | 9.72e-01 |
| GOBP MACROAUTOPHAGY | 309 | 3.50e-01 | -3.10e-02 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 15 | 8.35e-01 | -3.10e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 295 | 3.62e-01 | 3.09e-02 | 7.96e-01 |
| GOBP PHOSPHORYLATION | 1155 | 8.03e-02 | 3.09e-02 | 4.98e-01 |
| GOBP REGULATION OF VESICLE FUSION | 13 | 8.47e-01 | 3.08e-02 | 9.62e-01 |
| GOBP RESPONSE TO FOLIC ACID | 6 | 8.96e-01 | -3.08e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 385 | 3.01e-01 | 3.08e-02 | 7.56e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 143 | 5.26e-01 | 3.08e-02 | 8.73e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 24 | 7.94e-01 | 3.08e-02 | 9.52e-01 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 8 | 8.80e-01 | -3.07e-02 | 9.72e-01 |
| GOBP NCRNA METABOLIC PROCESS | 539 | 2.25e-01 | -3.07e-02 | 6.88e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 118 | 5.65e-01 | -3.07e-02 | 8.81e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 12 | 8.54e-01 | 3.07e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 9 | 8.73e-01 | -3.07e-02 | 9.71e-01 |
| GOCC RISC LOADING COMPLEX | 8 | 8.81e-01 | -3.06e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 80 | 6.36e-01 | 3.06e-02 | 9.04e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 82 | 6.32e-01 | -3.06e-02 | 9.04e-01 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 146 | 5.24e-01 | 3.06e-02 | 8.73e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 23 | 8.00e-01 | 3.06e-02 | 9.55e-01 |
| GOBP MESENCHYME DEVELOPMENT | 167 | 4.96e-01 | 3.06e-02 | 8.62e-01 |
| GOBP CELL MOTILITY | 1041 | 9.96e-02 | 3.05e-02 | 5.31e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 28 | 7.80e-01 | -3.05e-02 | 9.48e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 50 | 7.10e-01 | -3.04e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 19 | 8.18e-01 | 3.04e-02 | 9.59e-01 |
| GOBP FIBROBLAST PROLIFERATION | 76 | 6.47e-01 | 3.04e-02 | 9.08e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 29 | 7.77e-01 | 3.04e-02 | 9.48e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 30 | 7.73e-01 | -3.04e-02 | 9.48e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 14 | 8.44e-01 | 3.04e-02 | 9.62e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 53 | 7.02e-01 | -3.04e-02 | 9.25e-01 |
| GOMF RETINOL BINDING | 5 | 9.07e-01 | 3.03e-02 | 9.81e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 11 | 8.62e-01 | 3.03e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 9.07e-01 | -3.03e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 32 | 7.67e-01 | -3.03e-02 | 9.45e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 15 | 8.39e-01 | -3.03e-02 | 9.61e-01 |
| GOBP RESPONSE TO PEPTIDE | 352 | 3.31e-01 | 3.02e-02 | 7.78e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 314 | 3.59e-01 | -3.02e-02 | 7.93e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 14 | 8.45e-01 | 3.02e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 410 | 2.96e-01 | 3.02e-02 | 7.54e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 12 | 8.56e-01 | -3.02e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 8 | 8.82e-01 | -3.02e-02 | 9.72e-01 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 6 | 8.98e-01 | 3.02e-02 | 9.78e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 247 | 4.16e-01 | 3.01e-02 | 8.22e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 95 | 6.12e-01 | 3.01e-02 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 37 | 7.52e-01 | -3.01e-02 | 9.42e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 24 | 7.99e-01 | -3.01e-02 | 9.54e-01 |
| GOBP KINETOCHORE ASSEMBLY | 17 | 8.30e-01 | 3.01e-02 | 9.61e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 162 | 5.10e-01 | 3.00e-02 | 8.67e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 675 | 1.88e-01 | 2.99e-02 | 6.58e-01 |
| GOCC MRNA CAP BINDING COMPLEX | 12 | 8.58e-01 | 2.99e-02 | 9.64e-01 |
| GOCC FIBRILLAR CENTER | 130 | 5.57e-01 | -2.99e-02 | 8.79e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 40 | 7.44e-01 | -2.99e-02 | 9.38e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 141 | 5.41e-01 | -2.99e-02 | 8.76e-01 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 131 | 5.56e-01 | -2.98e-02 | 8.79e-01 |
| GOBP MYOBLAST FUSION | 28 | 7.85e-01 | -2.98e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 50 | 7.16e-01 | 2.97e-02 | 9.30e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 106 | 5.98e-01 | -2.97e-02 | 8.97e-01 |
| GOCC MICROVILLUS MEMBRANE | 19 | 8.23e-01 | 2.97e-02 | 9.60e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 23 | 8.05e-01 | 2.97e-02 | 9.57e-01 |
| GOBP PLATELET ACTIVATION | 91 | 6.25e-01 | -2.97e-02 | 9.04e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 64 | 6.82e-01 | 2.97e-02 | 9.19e-01 |
| GOBP FATTY ACID TRANSPORT | 63 | 6.84e-01 | 2.96e-02 | 9.19e-01 |
| GOBP MITOTIC SPINDLE ELONGATION | 10 | 8.71e-01 | 2.96e-02 | 9.70e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 71 | 6.67e-01 | -2.96e-02 | 9.14e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 29 | 7.83e-01 | 2.96e-02 | 9.48e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 10 | 8.71e-01 | 2.96e-02 | 9.70e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 203 | 4.69e-01 | 2.95e-02 | 8.49e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 8.85e-01 | -2.95e-02 | 9.73e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 133 | 5.57e-01 | 2.95e-02 | 8.79e-01 |
| GOBP DEFENSE RESPONSE TO SYMBIONT | 262 | 4.12e-01 | -2.95e-02 | 8.19e-01 |
| GOCC POSTSYNAPSE | 388 | 3.20e-01 | 2.95e-02 | 7.69e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 22 | 8.11e-01 | -2.95e-02 | 9.57e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 693 | 1.89e-01 | -2.95e-02 | 6.60e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 6 | 9.01e-01 | -2.95e-02 | 9.79e-01 |
| GOCC ENDOSOME | 816 | 1.56e-01 | -2.95e-02 | 6.19e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 427 | 2.99e-01 | 2.95e-02 | 7.55e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 86 | 6.37e-01 | 2.94e-02 | 9.05e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 26 | 7.95e-01 | -2.94e-02 | 9.52e-01 |
| GOMF CALCIUM ION BINDING | 340 | 3.54e-01 | 2.94e-02 | 7.92e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 31 | 7.78e-01 | -2.93e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 18 | 8.30e-01 | 2.93e-02 | 9.61e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 444 | 2.92e-01 | 2.93e-02 | 7.52e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 557 | 2.40e-01 | -2.93e-02 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 22 | 8.12e-01 | -2.93e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 37 | 7.58e-01 | -2.93e-02 | 9.44e-01 |
| GOMF TETRAPYRROLE BINDING | 75 | 6.62e-01 | 2.92e-02 | 9.13e-01 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 6 | 9.01e-01 | 2.92e-02 | 9.79e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 456 | 2.87e-01 | 2.92e-02 | 7.48e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 20 | 8.21e-01 | 2.92e-02 | 9.60e-01 |
| GOBP RESPONSE TO GRAVITY | 5 | 9.10e-01 | 2.92e-02 | 9.81e-01 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 134 | 5.60e-01 | -2.92e-02 | 8.79e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 257 | 4.22e-01 | 2.92e-02 | 8.25e-01 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 8.73e-01 | -2.91e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 128 | 5.70e-01 | 2.91e-02 | 8.83e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 58 | 7.02e-01 | 2.91e-02 | 9.25e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 136 | 5.59e-01 | 2.91e-02 | 8.79e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 9 | 8.80e-01 | -2.91e-02 | 9.72e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 22 | 8.13e-01 | -2.91e-02 | 9.58e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 27 | 7.94e-01 | -2.91e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 9.10e-01 | -2.90e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 152 | 5.38e-01 | -2.90e-02 | 8.76e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 17 | 8.36e-01 | 2.90e-02 | 9.61e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 21 | 8.18e-01 | 2.89e-02 | 9.59e-01 |
| GOBP PIGMENT ACCUMULATION | 10 | 8.74e-01 | 2.89e-02 | 9.71e-01 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 8.74e-01 | 2.89e-02 | 9.71e-01 |
| GOCC VESICLE MEMBRANE | 924 | 1.40e-01 | -2.89e-02 | 5.98e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 38 | 7.58e-01 | 2.89e-02 | 9.44e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 18 | 8.32e-01 | -2.89e-02 | 9.61e-01 |
| GOMF DIACYLGLYCEROL BINDING | 10 | 8.74e-01 | 2.89e-02 | 9.71e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 267 | 4.18e-01 | 2.89e-02 | 8.22e-01 |
| GOCC CLATHRIN COATED VESICLE | 157 | 5.33e-01 | 2.88e-02 | 8.75e-01 |
| GOMF WNT PROTEIN BINDING | 15 | 8.47e-01 | 2.88e-02 | 9.62e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 82 | 6.53e-01 | -2.87e-02 | 9.09e-01 |
| GOCC CILIUM | 466 | 2.90e-01 | 2.87e-02 | 7.49e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 14 | 8.52e-01 | 2.87e-02 | 9.63e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 53 | 7.18e-01 | -2.87e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 174 | 5.15e-01 | -2.87e-02 | 8.68e-01 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 40 | 7.54e-01 | 2.86e-02 | 9.42e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 92 | 6.36e-01 | -2.86e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 23 | 8.12e-01 | 2.86e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 76 | 6.67e-01 | -2.86e-02 | 9.14e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 178 | 5.11e-01 | 2.86e-02 | 8.67e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 7 | 8.96e-01 | 2.86e-02 | 9.77e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 154 | 5.41e-01 | 2.86e-02 | 8.76e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 665 | 2.12e-01 | -2.86e-02 | 6.77e-01 |
| GOCC WASH COMPLEX | 10 | 8.76e-01 | 2.85e-02 | 9.71e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 749 | 1.87e-01 | -2.85e-02 | 6.56e-01 |
| GOBP REGULATION OF AXONOGENESIS | 98 | 6.27e-01 | 2.84e-02 | 9.04e-01 |
| GOBP CELL ACTIVATION | 773 | 1.82e-01 | -2.84e-02 | 6.51e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 7 | 8.96e-01 | 2.84e-02 | 9.78e-01 |
| GOBP NECROPTOTIC PROCESS | 34 | 7.74e-01 | -2.84e-02 | 9.48e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 69 | 6.83e-01 | 2.84e-02 | 9.19e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 217 | 4.72e-01 | 2.84e-02 | 8.50e-01 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 6 | 9.04e-01 | 2.84e-02 | 9.81e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 77 | 6.67e-01 | 2.84e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 12 | 8.65e-01 | -2.83e-02 | 9.67e-01 |
| GOBP RESPONSE TO YEAST | 6 | 9.04e-01 | 2.83e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 15 | 8.50e-01 | 2.83e-02 | 9.62e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 19 | 8.31e-01 | -2.83e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 23 | 8.14e-01 | -2.83e-02 | 9.59e-01 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 10 | 8.77e-01 | -2.83e-02 | 9.71e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 18 | 8.36e-01 | 2.82e-02 | 9.61e-01 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 9.13e-01 | -2.82e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 588 | 2.46e-01 | 2.82e-02 | 7.10e-01 |
| GOBP PLASMA MEMBRANE FUSION | 9 | 8.84e-01 | -2.82e-02 | 9.72e-01 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 97 | 6.32e-01 | -2.81e-02 | 9.04e-01 |
| GOMF LNCRNA BINDING | 11 | 8.72e-01 | -2.81e-02 | 9.70e-01 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 6 | 9.05e-01 | 2.81e-02 | 9.81e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 17 | 8.41e-01 | -2.81e-02 | 9.61e-01 |
| GOCC GAMMA TUBULIN COMPLEX | 16 | 8.46e-01 | -2.81e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 51 | 7.29e-01 | -2.81e-02 | 9.36e-01 |
| GOCC ATPASE COMPLEX | 133 | 5.77e-01 | -2.81e-02 | 8.87e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 8 | 8.91e-01 | -2.80e-02 | 9.76e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 8.91e-01 | -2.80e-02 | 9.76e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 51 | 7.29e-01 | -2.80e-02 | 9.36e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 18 | 8.37e-01 | 2.80e-02 | 9.61e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 146 | 5.60e-01 | 2.80e-02 | 8.79e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 30 | 7.91e-01 | -2.80e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION | 5 | 9.14e-01 | -2.80e-02 | 9.82e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 65 | 6.97e-01 | 2.79e-02 | 9.25e-01 |
| GOBP L PROLINE BIOSYNTHETIC PROCESS | 5 | 9.14e-01 | -2.79e-02 | 9.82e-01 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 5 | 9.14e-01 | 2.79e-02 | 9.82e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 570 | 2.58e-01 | -2.79e-02 | 7.21e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 348 | 3.73e-01 | -2.79e-02 | 8.04e-01 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.14e-01 | -2.79e-02 | 9.82e-01 |
| GOMF DELTA CATENIN BINDING | 5 | 9.14e-01 | -2.79e-02 | 9.82e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 98 | 6.34e-01 | 2.79e-02 | 9.04e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 101 | 6.29e-01 | -2.78e-02 | 9.04e-01 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 23 | 8.17e-01 | -2.78e-02 | 9.59e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 98 | 6.35e-01 | 2.78e-02 | 9.04e-01 |
| GOBP ORGANIC ACID TRANSPORT | 205 | 4.93e-01 | 2.78e-02 | 8.59e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 11 | 8.73e-01 | -2.78e-02 | 9.71e-01 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 7 | 8.99e-01 | -2.77e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1153 | 1.17e-01 | -2.77e-02 | 5.68e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 54 | 7.25e-01 | 2.77e-02 | 9.33e-01 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 9 | 8.86e-01 | 2.77e-02 | 9.73e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 27 | 8.04e-01 | 2.77e-02 | 9.56e-01 |
| GOBP L GLUTAMATE IMPORT | 26 | 8.08e-01 | 2.76e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 155 | 5.54e-01 | 2.76e-02 | 8.79e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 11 | 8.74e-01 | 2.75e-02 | 9.71e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 235 | 4.69e-01 | -2.75e-02 | 8.49e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1092 | 1.30e-01 | -2.74e-02 | 5.82e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 8 | 8.93e-01 | -2.74e-02 | 9.76e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 844 | 1.80e-01 | -2.74e-02 | 6.47e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 106 | 6.27e-01 | 2.73e-02 | 9.04e-01 |
| GOBP VITAMIN METABOLIC PROCESS | 73 | 6.88e-01 | 2.72e-02 | 9.20e-01 |
| GOBP RECEPTOR INTERNALIZATION | 87 | 6.62e-01 | -2.72e-02 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 57 | 7.23e-01 | 2.72e-02 | 9.32e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 22 | 8.26e-01 | -2.71e-02 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 199 | 5.11e-01 | 2.71e-02 | 8.67e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 13 | 8.66e-01 | 2.71e-02 | 9.67e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 34 | 7.85e-01 | 2.71e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 70 | 6.95e-01 | 2.71e-02 | 9.24e-01 |
| GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 9.16e-01 | -2.71e-02 | 9.82e-01 |
| GOBP ACTIN MYOSIN FILAMENT SLIDING | 5 | 9.17e-01 | 2.71e-02 | 9.82e-01 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 20 | 8.34e-01 | 2.70e-02 | 9.61e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 22 | 8.26e-01 | -2.70e-02 | 9.61e-01 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 8.95e-01 | -2.70e-02 | 9.77e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 21 | 8.30e-01 | 2.70e-02 | 9.61e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 62 | 7.13e-01 | 2.70e-02 | 9.29e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 6 | 9.09e-01 | -2.70e-02 | 9.81e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 7 | 9.02e-01 | 2.69e-02 | 9.79e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 15 | 8.57e-01 | 2.69e-02 | 9.64e-01 |
| GOBP RIG I SIGNALING PATHWAY | 24 | 8.20e-01 | 2.69e-02 | 9.59e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 28 | 8.06e-01 | -2.68e-02 | 9.57e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 903 | 1.76e-01 | 2.68e-02 | 6.40e-01 |
| GOBP GLUTATHIONE TRANSPORT | 6 | 9.10e-01 | -2.68e-02 | 9.81e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 749 | 2.16e-01 | 2.67e-02 | 6.80e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 10 | 8.84e-01 | -2.67e-02 | 9.72e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 8.96e-01 | -2.67e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 130 | 6.00e-01 | -2.67e-02 | 8.97e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 24 | 8.22e-01 | -2.66e-02 | 9.60e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 41 | 7.69e-01 | -2.66e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 310 | 4.24e-01 | 2.65e-02 | 8.26e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 22 | 8.30e-01 | -2.65e-02 | 9.61e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 9 | 8.91e-01 | 2.65e-02 | 9.76e-01 |
| GOBP SOMITE DEVELOPMENT | 38 | 7.78e-01 | -2.65e-02 | 9.48e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 12 | 8.74e-01 | 2.65e-02 | 9.71e-01 |
| GOCC SECONDARY LYSOSOME | 17 | 8.50e-01 | -2.64e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 17 | 8.50e-01 | 2.64e-02 | 9.62e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 493 | 3.19e-01 | -2.64e-02 | 7.67e-01 |
| GOMF HORMONE RECEPTOR BINDING | 10 | 8.85e-01 | 2.64e-02 | 9.73e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 40 | 7.73e-01 | -2.63e-02 | 9.48e-01 |
| GOBP PROTEIN DESTABILIZATION | 45 | 7.60e-01 | -2.63e-02 | 9.44e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 35 | 7.88e-01 | 2.63e-02 | 9.49e-01 |
| GOBP TRNA MODIFICATION | 92 | 6.64e-01 | 2.63e-02 | 9.14e-01 |
| GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 14 | 8.65e-01 | 2.62e-02 | 9.67e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 39 | 7.77e-01 | -2.62e-02 | 9.48e-01 |
| GOBP REGULATION OF PH | 76 | 6.94e-01 | -2.61e-02 | 9.24e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 12 | 8.76e-01 | -2.61e-02 | 9.71e-01 |
| GOBP HEMOSTASIS | 146 | 5.87e-01 | -2.61e-02 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 834 | 2.05e-01 | 2.61e-02 | 6.72e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 22 | 8.32e-01 | 2.61e-02 | 9.61e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 8 | 8.98e-01 | 2.61e-02 | 9.78e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 220 | 5.06e-01 | 2.61e-02 | 8.66e-01 |
| GOBP CELLULAR RESPONSE TO X RAY | 7 | 9.05e-01 | 2.60e-02 | 9.81e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 8.45e-01 | -2.60e-02 | 9.62e-01 |
| GOBP REGULATION OF ACTION POTENTIAL | 31 | 8.02e-01 | -2.60e-02 | 9.56e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 8 | 8.99e-01 | 2.60e-02 | 9.78e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 145 | 5.90e-01 | 2.60e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 77 | 6.94e-01 | -2.60e-02 | 9.24e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 59 | 7.30e-01 | -2.60e-02 | 9.36e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST | 7 | 9.05e-01 | -2.59e-02 | 9.81e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION | 53 | 7.44e-01 | -2.59e-02 | 9.39e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 15 | 8.62e-01 | -2.59e-02 | 9.66e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 22 | 8.33e-01 | 2.59e-02 | 9.61e-01 |
| GOBP MUSCLE HYPERTROPHY | 56 | 7.38e-01 | -2.58e-02 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 142 | 5.96e-01 | 2.58e-02 | 8.96e-01 |
| GOBP RECEPTOR RECYCLING | 39 | 7.80e-01 | 2.58e-02 | 9.48e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 84 | 6.83e-01 | 2.58e-02 | 9.19e-01 |
| GOBP MICROTUBULE BASED PROCESS | 680 | 2.55e-01 | 2.58e-02 | 7.18e-01 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 47 | 7.60e-01 | -2.57e-02 | 9.44e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 41 | 7.76e-01 | 2.57e-02 | 9.48e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 103 | 6.52e-01 | -2.57e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 11 | 8.83e-01 | 2.57e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 9.21e-01 | -2.57e-02 | 9.83e-01 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 74 | 7.03e-01 | -2.57e-02 | 9.25e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 473 | 3.41e-01 | -2.57e-02 | 7.85e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 11 | 8.83e-01 | 2.57e-02 | 9.72e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 236 | 4.98e-01 | 2.57e-02 | 8.63e-01 |
| GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 7 | 9.06e-01 | -2.56e-02 | 9.81e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 87 | 6.80e-01 | 2.56e-02 | 9.19e-01 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 32 | 8.02e-01 | -2.56e-02 | 9.56e-01 |
| GOMF CYTOKINE ACTIVITY | 82 | 6.89e-01 | 2.56e-02 | 9.20e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 20 | 8.43e-01 | 2.55e-02 | 9.62e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 10 | 8.89e-01 | -2.55e-02 | 9.75e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 23 | 8.32e-01 | 2.55e-02 | 9.61e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 9.14e-01 | -2.55e-02 | 9.82e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 9.01e-01 | 2.55e-02 | 9.79e-01 |
| GOBP REGULATION OF MACROPHAGE FUSION | 5 | 9.21e-01 | 2.55e-02 | 9.84e-01 |
| GOMF CYCLIN BINDING | 32 | 8.03e-01 | -2.55e-02 | 9.56e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 306 | 4.47e-01 | -2.54e-02 | 8.40e-01 |
| GOBP INCLUSION BODY ASSEMBLY | 20 | 8.44e-01 | 2.54e-02 | 9.62e-01 |
| GOBP CHITIN METABOLIC PROCESS | 5 | 9.22e-01 | 2.54e-02 | 9.84e-01 |
| GOMF CHITINASE ACTIVITY | 5 | 9.22e-01 | 2.54e-02 | 9.84e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 18 | 8.52e-01 | -2.53e-02 | 9.63e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 87 | 6.83e-01 | 2.53e-02 | 9.19e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 8.95e-01 | 2.53e-02 | 9.77e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 269 | 4.77e-01 | 2.53e-02 | 8.52e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 1057 | 1.70e-01 | -2.52e-02 | 6.35e-01 |
| GOCC MITOTIC SPINDLE | 155 | 5.88e-01 | 2.52e-02 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 98 | 6.67e-01 | -2.52e-02 | 9.14e-01 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 17 | 8.57e-01 | -2.52e-02 | 9.64e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 19 | 8.49e-01 | -2.52e-02 | 9.62e-01 |
| GOCC TRAMP COMPLEX | 5 | 9.22e-01 | 2.51e-02 | 9.84e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 88 | 6.84e-01 | 2.51e-02 | 9.19e-01 |
| GOMF SPHINGOLIPID BINDING | 19 | 8.50e-01 | 2.51e-02 | 9.62e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 19 | 8.50e-01 | -2.51e-02 | 9.62e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 564 | 3.11e-01 | -2.51e-02 | 7.65e-01 |
| GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 43 | 7.76e-01 | 2.51e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 976 | 1.90e-01 | -2.51e-02 | 6.61e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 446 | 3.67e-01 | 2.50e-02 | 8.00e-01 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 9.09e-01 | -2.50e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 12 | 8.81e-01 | -2.50e-02 | 9.72e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 10 | 8.91e-01 | 2.50e-02 | 9.76e-01 |
| GOBP MIRNA PROCESSING | 40 | 7.85e-01 | -2.50e-02 | 9.48e-01 |
| GOBP MYELOID CELL HOMEOSTASIS | 136 | 6.16e-01 | -2.49e-02 | 9.02e-01 |
| GOCC MEMBRANE MICRODOMAIN | 199 | 5.45e-01 | 2.49e-02 | 8.77e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 549 | 3.21e-01 | 2.49e-02 | 7.69e-01 |
| GOBP SPERM DNA CONDENSATION | 7 | 9.09e-01 | 2.49e-02 | 9.81e-01 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 61 | 7.37e-01 | -2.49e-02 | 9.37e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 9 | 8.97e-01 | 2.49e-02 | 9.78e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 39 | 7.89e-01 | 2.48e-02 | 9.49e-01 |
| GOBP VASODILATION | 23 | 8.37e-01 | -2.48e-02 | 9.61e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 60 | 7.40e-01 | -2.48e-02 | 9.38e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 12 | 8.82e-01 | 2.48e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 8 | 9.04e-01 | -2.47e-02 | 9.81e-01 |
| GOBP GRANULOCYTE MIGRATION | 102 | 6.67e-01 | -2.47e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 297 | 4.65e-01 | 2.47e-02 | 8.48e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 482 | 3.56e-01 | 2.47e-02 | 7.92e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 72 | 7.18e-01 | -2.47e-02 | 9.31e-01 |
| GOBP PROLINE TRANSMEMBRANE TRANSPORT | 7 | 9.10e-01 | -2.47e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 88 | 6.90e-01 | -2.47e-02 | 9.20e-01 |
| GOBP ORGANELLE LOCALIZATION | 502 | 3.47e-01 | 2.47e-02 | 7.89e-01 |
| GOBP AXONOGENESIS INVOLVED IN INNERVATION | 5 | 9.24e-01 | 2.46e-02 | 9.84e-01 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 60 | 7.42e-01 | -2.46e-02 | 9.38e-01 |
| GOBP LIPID STORAGE | 69 | 7.24e-01 | -2.46e-02 | 9.33e-01 |
| GOBP RESPONSE TO CORTISOL | 5 | 9.24e-01 | 2.46e-02 | 9.84e-01 |
| GOCC TRANS GOLGI NETWORK | 217 | 5.34e-01 | 2.45e-02 | 8.75e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 34 | 8.05e-01 | -2.45e-02 | 9.57e-01 |
| GOBP CELL CYCLE | 1430 | 1.27e-01 | 2.45e-02 | 5.77e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 1090 | 1.78e-01 | 2.45e-02 | 6.43e-01 |
| GOBP REGULATION OF CELL GROWTH | 291 | 4.74e-01 | 2.45e-02 | 8.50e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 8.61e-01 | -2.45e-02 | 9.66e-01 |
| GOBP HAIR FOLLICLE MATURATION | 10 | 8.94e-01 | 2.44e-02 | 9.77e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 370 | 4.21e-01 | 2.44e-02 | 8.25e-01 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 11 | 8.88e-01 | 2.44e-02 | 9.75e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 56 | 7.52e-01 | -2.44e-02 | 9.42e-01 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 6 | 9.18e-01 | -2.44e-02 | 9.82e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 161 | 5.94e-01 | 2.44e-02 | 8.94e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 74 | 7.17e-01 | 2.44e-02 | 9.31e-01 |
| GOBP BONE MATURATION | 15 | 8.70e-01 | 2.44e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 47 | 7.73e-01 | -2.43e-02 | 9.48e-01 |
| GOBP MRNA MODIFICATION | 30 | 8.18e-01 | -2.43e-02 | 9.59e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 229 | 5.27e-01 | 2.43e-02 | 8.74e-01 |
| GOBP MEMBRANE FUSION | 136 | 6.25e-01 | -2.43e-02 | 9.04e-01 |
| GOBP L ALANINE TRANSPORT | 8 | 9.05e-01 | 2.43e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 63 | 7.39e-01 | -2.43e-02 | 9.38e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 45 | 7.79e-01 | 2.42e-02 | 9.48e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 37 | 7.99e-01 | -2.42e-02 | 9.54e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 21 | 8.48e-01 | 2.42e-02 | 9.62e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 108 | 6.65e-01 | 2.41e-02 | 9.14e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 78 | 7.13e-01 | 2.41e-02 | 9.29e-01 |
| GOBP CHEMOKINE PRODUCTION | 68 | 7.31e-01 | -2.41e-02 | 9.36e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 24 | 8.38e-01 | -2.41e-02 | 9.61e-01 |
| GOBP DNA CATABOLIC PROCESS | 24 | 8.38e-01 | -2.41e-02 | 9.61e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 406 | 4.08e-01 | 2.40e-02 | 8.18e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 13 | 8.81e-01 | -2.40e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 17 | 8.64e-01 | -2.40e-02 | 9.67e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 79 | 7.13e-01 | -2.40e-02 | 9.29e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 15 | 8.72e-01 | -2.40e-02 | 9.71e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 268 | 5.01e-01 | 2.40e-02 | 8.63e-01 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 47 | 7.77e-01 | 2.39e-02 | 9.48e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 7 | 9.13e-01 | -2.39e-02 | 9.82e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 16 | 8.69e-01 | -2.39e-02 | 9.68e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 33 | 8.13e-01 | 2.39e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 366 | 4.35e-01 | 2.39e-02 | 8.33e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 8.54e-01 | -2.39e-02 | 9.63e-01 |
| GOCC MITOTIC SPINDLE POLE | 35 | 8.07e-01 | -2.38e-02 | 9.57e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 75 | 7.22e-01 | -2.38e-02 | 9.32e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 261 | 5.09e-01 | -2.38e-02 | 8.67e-01 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.02e-01 | -2.38e-02 | 9.79e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 52 | 7.67e-01 | -2.37e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 13 | 8.82e-01 | 2.37e-02 | 9.72e-01 |
| GOBP RRNA TRANSCRIPTION | 33 | 8.14e-01 | 2.37e-02 | 9.58e-01 |
| GOBP ADRENAL GLAND DEVELOPMENT | 15 | 8.74e-01 | -2.37e-02 | 9.71e-01 |
| GOBP TRNA METABOLIC PROCESS | 175 | 5.89e-01 | 2.37e-02 | 8.93e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 63 | 7.45e-01 | 2.37e-02 | 9.39e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 102 | 6.79e-01 | -2.37e-02 | 9.19e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 24 | 8.41e-01 | 2.37e-02 | 9.61e-01 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 9.20e-01 | 2.37e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 61 | 7.49e-01 | 2.37e-02 | 9.41e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 134 | 6.37e-01 | -2.36e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 14 | 8.78e-01 | 2.36e-02 | 9.72e-01 |
| GOBP VIRAL TRANSCRIPTION | 47 | 7.80e-01 | -2.36e-02 | 9.48e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 6 | 9.20e-01 | 2.35e-02 | 9.83e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 8 | 9.08e-01 | -2.35e-02 | 9.81e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 26 | 8.36e-01 | -2.35e-02 | 9.61e-01 |
| GOBP DENDRITE ARBORIZATION | 5 | 9.28e-01 | 2.35e-02 | 9.85e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 14 | 8.79e-01 | -2.34e-02 | 9.72e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 338 | 4.61e-01 | -2.34e-02 | 8.45e-01 |
| GOMF DEMETHYLASE ACTIVITY | 36 | 8.08e-01 | 2.34e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 9.21e-01 | 2.34e-02 | 9.83e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 334 | 4.65e-01 | 2.34e-02 | 8.48e-01 |
| GOBP HISTONE MODIFICATION | 110 | 6.72e-01 | 2.34e-02 | 9.15e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 159 | 6.12e-01 | 2.33e-02 | 9.00e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 61 | 7.53e-01 | 2.33e-02 | 9.42e-01 |
| GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR | 5 | 9.28e-01 | 2.33e-02 | 9.86e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 100 | 6.88e-01 | 2.33e-02 | 9.20e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 8.72e-01 | -2.32e-02 | 9.71e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 109 | 6.75e-01 | -2.32e-02 | 9.17e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 67 | 7.43e-01 | -2.31e-02 | 9.38e-01 |
| GOCC KERATIN FILAMENT | 9 | 9.04e-01 | 2.31e-02 | 9.81e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 14 | 8.81e-01 | 2.31e-02 | 9.72e-01 |
| GOBP MEMBRANOUS SEPTUM MORPHOGENESIS | 5 | 9.29e-01 | -2.31e-02 | 9.86e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 463 | 3.98e-01 | 2.31e-02 | 8.15e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 75 | 7.30e-01 | -2.30e-02 | 9.36e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 48 | 7.83e-01 | -2.30e-02 | 9.48e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 19 | 8.62e-01 | 2.30e-02 | 9.66e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 5 | 9.29e-01 | -2.30e-02 | 9.86e-01 |
| GOMF TOLL LIKE RECEPTOR 4 BINDING | 5 | 9.29e-01 | 2.29e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 7 | 9.17e-01 | 2.28e-02 | 9.82e-01 |
| GOCC AXOLEMMA | 9 | 9.06e-01 | -2.28e-02 | 9.81e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 111 | 6.79e-01 | 2.28e-02 | 9.19e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 60 | 7.60e-01 | -2.28e-02 | 9.44e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 11 | 8.96e-01 | -2.28e-02 | 9.77e-01 |
| GOBP DETECTION OF CALCIUM ION | 9 | 9.06e-01 | 2.27e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 6 | 9.23e-01 | -2.27e-02 | 9.84e-01 |
| GOBP ACROSOME ASSEMBLY | 14 | 8.83e-01 | -2.27e-02 | 9.72e-01 |
| GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 49 | 7.84e-01 | -2.27e-02 | 9.48e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 19 | 8.64e-01 | -2.27e-02 | 9.67e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 12 | 8.92e-01 | -2.26e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 172 | 6.09e-01 | -2.26e-02 | 8.99e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 12 | 8.92e-01 | 2.26e-02 | 9.76e-01 |
| GOBP CILIUM MOVEMENT | 90 | 7.12e-01 | -2.26e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 234 | 5.54e-01 | 2.25e-02 | 8.79e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 41 | 8.03e-01 | 2.25e-02 | 9.56e-01 |
| GOCC SITE OF DNA DAMAGE | 107 | 6.88e-01 | 2.25e-02 | 9.20e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 37 | 8.13e-01 | -2.25e-02 | 9.58e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 19 | 8.65e-01 | 2.25e-02 | 9.67e-01 |
| GOMF TOLL LIKE RECEPTOR BINDING | 14 | 8.84e-01 | -2.25e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 24 | 8.49e-01 | 2.24e-02 | 9.62e-01 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 23 | 8.52e-01 | -2.24e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 31 | 8.29e-01 | 2.24e-02 | 9.61e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 332 | 4.85e-01 | -2.24e-02 | 8.55e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 570 | 3.64e-01 | 2.24e-02 | 7.97e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 16 | 8.77e-01 | 2.23e-02 | 9.71e-01 |
| GOBP MRNA TRANSCRIPTION | 48 | 7.89e-01 | -2.23e-02 | 9.49e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 234 | 5.58e-01 | -2.23e-02 | 8.79e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 145 | 6.44e-01 | 2.23e-02 | 9.07e-01 |
| GOCC CENTROSOME | 549 | 3.75e-01 | 2.23e-02 | 8.05e-01 |
| GOBP ADENINE TRANSPORT | 6 | 9.25e-01 | -2.23e-02 | 9.85e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 99 | 7.02e-01 | 2.22e-02 | 9.25e-01 |
| GOCC RNA POLYMERASE COMPLEX | 96 | 7.07e-01 | 2.22e-02 | 9.26e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 23 | 8.54e-01 | 2.22e-02 | 9.63e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 13 | 8.90e-01 | 2.22e-02 | 9.75e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 62 | 7.63e-01 | 2.22e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 9 | 9.08e-01 | 2.22e-02 | 9.81e-01 |
| GOBP MELANIN METABOLIC PROCESS | 16 | 8.78e-01 | -2.21e-02 | 9.72e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 84 | 7.27e-01 | -2.21e-02 | 9.34e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 31 | 8.32e-01 | 2.21e-02 | 9.61e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 222 | 5.72e-01 | -2.20e-02 | 8.83e-01 |
| GOBP RESPONSE TO AMINE | 24 | 8.52e-01 | -2.20e-02 | 9.62e-01 |
| GOBP REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY | 7 | 9.20e-01 | 2.20e-02 | 9.83e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 36 | 8.19e-01 | 2.20e-02 | 9.59e-01 |
| GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 5 | 9.32e-01 | 2.20e-02 | 9.87e-01 |
| GOBP POSITIVE T CELL SELECTION | 25 | 8.49e-01 | -2.20e-02 | 9.62e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 47 | 7.95e-01 | -2.20e-02 | 9.52e-01 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 8 | 9.14e-01 | -2.19e-02 | 9.82e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 20 | 8.66e-01 | -2.19e-02 | 9.67e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 68 | 7.56e-01 | -2.18e-02 | 9.43e-01 |
| GOBP LIPID METABOLIC PROCESS | 932 | 2.63e-01 | -2.18e-02 | 7.24e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 59 | 7.72e-01 | -2.18e-02 | 9.47e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 14 | 8.88e-01 | 2.18e-02 | 9.74e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 42 | 8.07e-01 | -2.18e-02 | 9.57e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 9 | 9.10e-01 | -2.18e-02 | 9.81e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 13 | 8.92e-01 | 2.18e-02 | 9.76e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 5 | 9.33e-01 | -2.17e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 53 | 7.84e-01 | 2.17e-02 | 9.48e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 30 | 8.37e-01 | -2.17e-02 | 9.61e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 12 | 8.96e-01 | 2.17e-02 | 9.78e-01 |
| GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY | 6 | 9.27e-01 | -2.17e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 24 | 8.54e-01 | 2.17e-02 | 9.63e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 13 | 8.93e-01 | -2.16e-02 | 9.76e-01 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 8.97e-01 | -2.16e-02 | 9.78e-01 |
| GOBP AMINO ACID TRANSPORT | 89 | 7.27e-01 | -2.15e-02 | 9.34e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 54 | 7.85e-01 | -2.15e-02 | 9.48e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 220 | 5.84e-01 | 2.14e-02 | 8.91e-01 |
| GOMF CHEMOATTRACTANT ACTIVITY | 16 | 8.82e-01 | -2.14e-02 | 9.72e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 8 | 9.17e-01 | 2.14e-02 | 9.82e-01 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 9 | 9.12e-01 | 2.14e-02 | 9.82e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 15 | 8.86e-01 | 2.14e-02 | 9.73e-01 |
| GOMF VITAMIN BINDING | 93 | 7.22e-01 | -2.14e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 12 | 8.98e-01 | 2.13e-02 | 9.78e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 85 | 7.34e-01 | 2.13e-02 | 9.36e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 109 | 7.02e-01 | -2.13e-02 | 9.25e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 17 | 8.80e-01 | 2.12e-02 | 9.72e-01 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 6 | 9.28e-01 | -2.12e-02 | 9.86e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 74 | 7.53e-01 | 2.12e-02 | 9.42e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 725 | 3.35e-01 | 2.12e-02 | 7.81e-01 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 18 | 8.76e-01 | -2.12e-02 | 9.71e-01 |
| GOCC CLATHRIN SCULPTED VESICLE | 6 | 9.28e-01 | -2.12e-02 | 9.86e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 21 | 8.67e-01 | 2.12e-02 | 9.67e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 9 | 9.13e-01 | 2.12e-02 | 9.82e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 204 | 6.03e-01 | 2.12e-02 | 8.97e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 40 | 8.17e-01 | -2.11e-02 | 9.59e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 323 | 5.15e-01 | 2.11e-02 | 8.68e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 18 | 8.77e-01 | 2.11e-02 | 9.71e-01 |
| GOBP CELLULAR RESPONSE TO IRON ION | 6 | 9.29e-01 | 2.11e-02 | 9.86e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 327 | 5.13e-01 | -2.11e-02 | 8.67e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE | 7 | 9.23e-01 | 2.11e-02 | 9.84e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 15 | 8.88e-01 | -2.10e-02 | 9.74e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 408 | 4.69e-01 | 2.10e-02 | 8.49e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 787 | 3.21e-01 | 2.10e-02 | 7.69e-01 |
| GOMF NADP BINDING | 43 | 8.12e-01 | 2.09e-02 | 9.58e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 84 | 7.41e-01 | 2.09e-02 | 9.38e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 49 | 8.00e-01 | -2.09e-02 | 9.55e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 25 | 8.57e-01 | 2.09e-02 | 9.64e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 143 | 6.68e-01 | -2.08e-02 | 9.14e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 545 | 4.09e-01 | 2.08e-02 | 8.19e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 115 | 7.00e-01 | -2.08e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 15 | 8.89e-01 | 2.08e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 19 | 8.76e-01 | -2.07e-02 | 9.71e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 672 | 3.63e-01 | 2.07e-02 | 7.97e-01 |
| GOBP MYELOID CELL DEVELOPMENT | 60 | 7.81e-01 | -2.07e-02 | 9.48e-01 |
| GOBP ORGANELLE FUSION | 135 | 6.78e-01 | -2.07e-02 | 9.19e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 76 | 7.56e-01 | -2.07e-02 | 9.43e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 368 | 4.98e-01 | -2.07e-02 | 8.63e-01 |
| GOBP MRNA CATABOLIC PROCESS | 212 | 6.06e-01 | 2.06e-02 | 8.99e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 15 | 8.90e-01 | 2.05e-02 | 9.76e-01 |
| GOMF ENZYME INHIBITOR ACTIVITY | 239 | 5.86e-01 | -2.05e-02 | 8.91e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 51 | 8.00e-01 | -2.05e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 535 | 4.22e-01 | 2.04e-02 | 8.25e-01 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 15 | 8.91e-01 | 2.04e-02 | 9.76e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 23 | 8.66e-01 | -2.04e-02 | 9.67e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 7 | 9.26e-01 | 2.03e-02 | 9.85e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 76 | 7.60e-01 | -2.03e-02 | 9.44e-01 |
| GOBP CILIUM ORGANIZATION | 315 | 5.37e-01 | 2.03e-02 | 8.76e-01 |
| GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 7 | 9.26e-01 | 2.03e-02 | 9.85e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 51 | 8.02e-01 | 2.03e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 6 | 9.32e-01 | 2.02e-02 | 9.87e-01 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 9.16e-01 | -2.02e-02 | 9.82e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 38 | 8.29e-01 | -2.02e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 116 | 7.07e-01 | -2.02e-02 | 9.26e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 46 | 8.13e-01 | -2.02e-02 | 9.58e-01 |
| GOBP GMP METABOLIC PROCESS | 26 | 8.59e-01 | 2.02e-02 | 9.65e-01 |
| GOBP INHIBITORY SYNAPSE ASSEMBLY | 6 | 9.32e-01 | 2.02e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 682 | 3.73e-01 | -2.01e-02 | 8.04e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 31 | 8.46e-01 | 2.01e-02 | 9.62e-01 |
| GOBP DNA REPAIR | 534 | 4.30e-01 | 2.01e-02 | 8.30e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 106 | 7.21e-01 | 2.01e-02 | 9.32e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 9.13e-01 | 2.01e-02 | 9.82e-01 |
| GOBP CHOLESTEROL EFFLUX | 37 | 8.33e-01 | -2.00e-02 | 9.61e-01 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 11 | 9.09e-01 | -2.00e-02 | 9.81e-01 |
| GOCC GOLGI CISTERNA | 77 | 7.62e-01 | -1.99e-02 | 9.44e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 79 | 7.60e-01 | 1.99e-02 | 9.44e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 9 | 9.18e-01 | 1.99e-02 | 9.82e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1096 | 2.72e-01 | -1.99e-02 | 7.36e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 34 | 8.41e-01 | -1.98e-02 | 9.61e-01 |
| GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 5 | 9.39e-01 | 1.98e-02 | 9.87e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 108 | 7.22e-01 | -1.98e-02 | 9.32e-01 |
| GOCC NUCLEAR SPECK | 366 | 5.17e-01 | 1.98e-02 | 8.69e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 11 | 9.10e-01 | -1.98e-02 | 9.81e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 14 | 8.98e-01 | 1.98e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 9 | 9.18e-01 | -1.98e-02 | 9.82e-01 |
| GOMF HSP70 PROTEIN BINDING | 40 | 8.29e-01 | -1.98e-02 | 9.61e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 83 | 7.56e-01 | 1.97e-02 | 9.43e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 15 | 8.95e-01 | -1.97e-02 | 9.77e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 162 | 6.66e-01 | 1.97e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 95 | 7.41e-01 | 1.97e-02 | 9.38e-01 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 7 | 9.28e-01 | 1.96e-02 | 9.86e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 38 | 8.35e-01 | 1.96e-02 | 9.61e-01 |
| GOBP LOCOMOTION | 770 | 3.60e-01 | 1.96e-02 | 7.94e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 10 | 9.15e-01 | -1.95e-02 | 9.82e-01 |
| GOBP DISTAL TUBULE DEVELOPMENT | 6 | 9.34e-01 | 1.95e-02 | 9.87e-01 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 15 | 8.96e-01 | 1.95e-02 | 9.77e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 9.19e-01 | 1.95e-02 | 9.83e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 11 | 9.11e-01 | 1.94e-02 | 9.82e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 57 | 8.00e-01 | 1.94e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 10 | 9.15e-01 | -1.94e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 11 | 9.11e-01 | -1.94e-02 | 9.82e-01 |
| GOBP RESPONSE TO IRON ION | 22 | 8.75e-01 | -1.94e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 88 | 7.54e-01 | 1.94e-02 | 9.42e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 13 | 9.04e-01 | 1.94e-02 | 9.81e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 168 | 6.66e-01 | -1.93e-02 | 9.14e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 10 | 9.16e-01 | 1.93e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 18 | 8.87e-01 | -1.93e-02 | 9.74e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 12 | 9.08e-01 | -1.93e-02 | 9.81e-01 |
| GOBP REGULATION OF WOUND HEALING | 77 | 7.70e-01 | -1.93e-02 | 9.46e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1359 | 2.41e-01 | -1.92e-02 | 7.06e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 5 | 9.41e-01 | 1.92e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 41 | 8.31e-01 | -1.92e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 9 | 9.21e-01 | 1.92e-02 | 9.83e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 10 | 9.16e-01 | -1.92e-02 | 9.82e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 963 | 3.19e-01 | 1.92e-02 | 7.67e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 256 | 5.99e-01 | -1.92e-02 | 8.97e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 16 | 8.95e-01 | -1.91e-02 | 9.77e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 229 | 6.19e-01 | -1.91e-02 | 9.03e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 34 | 8.47e-01 | -1.91e-02 | 9.62e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 9.41e-01 | 1.91e-02 | 9.88e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 40 | 8.35e-01 | 1.90e-02 | 9.61e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 23 | 8.74e-01 | -1.90e-02 | 9.71e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 56 | 8.05e-01 | -1.90e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 168 | 6.71e-01 | 1.90e-02 | 9.15e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 7 | 9.31e-01 | 1.90e-02 | 9.86e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 383 | 5.25e-01 | 1.90e-02 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 254 | 6.04e-01 | 1.90e-02 | 8.97e-01 |
| GOMF RNA POLYMERASE II ACTIVITY | 11 | 9.13e-01 | -1.89e-02 | 9.82e-01 |
| GOCC EARLY ENDOSOME | 340 | 5.50e-01 | -1.89e-02 | 8.78e-01 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 6 | 9.36e-01 | 1.89e-02 | 9.87e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 45 | 8.27e-01 | -1.88e-02 | 9.61e-01 |
| GOBP EXPORT FROM CELL | 553 | 4.52e-01 | 1.88e-02 | 8.42e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 38 | 8.41e-01 | -1.88e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 85 | 7.65e-01 | 1.88e-02 | 9.44e-01 |
| GOBP RESPONSE TO UV B | 16 | 8.97e-01 | 1.88e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 99 | 7.47e-01 | 1.87e-02 | 9.41e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 446 | 5.00e-01 | 1.87e-02 | 8.63e-01 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 9 | 9.23e-01 | -1.87e-02 | 9.84e-01 |
| GOBP MITOCHONDRIAL FUSION | 32 | 8.55e-01 | -1.87e-02 | 9.63e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 59 | 8.04e-01 | 1.87e-02 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 9.15e-01 | -1.87e-02 | 9.82e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 156 | 6.88e-01 | 1.87e-02 | 9.20e-01 |
| GOMF CARBOHYDRATE BINDING | 157 | 6.87e-01 | -1.86e-02 | 9.20e-01 |
| GOCC HOPS COMPLEX | 9 | 9.23e-01 | -1.86e-02 | 9.84e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 147 | 6.98e-01 | -1.86e-02 | 9.25e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 88 | 7.64e-01 | -1.86e-02 | 9.44e-01 |
| GOBP CYTOSKELETON ORGANIZATION | 1051 | 3.16e-01 | 1.85e-02 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION | 7 | 9.32e-01 | 1.85e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 435 | 5.10e-01 | -1.85e-02 | 8.67e-01 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 9 | 9.24e-01 | 1.85e-02 | 9.84e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 61 | 8.03e-01 | -1.85e-02 | 9.56e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 74 | 7.84e-01 | 1.84e-02 | 9.48e-01 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 9 | 9.24e-01 | 1.84e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 67 | 7.95e-01 | 1.84e-02 | 9.52e-01 |
| GOCC CELL TRAILING EDGE | 13 | 9.09e-01 | -1.83e-02 | 9.81e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 273 | 6.03e-01 | 1.83e-02 | 8.97e-01 |
| GOMF CHANNEL REGULATOR ACTIVITY | 74 | 7.85e-01 | -1.83e-02 | 9.48e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 23 | 8.79e-01 | 1.83e-02 | 9.72e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 51 | 8.21e-01 | 1.83e-02 | 9.60e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 6 | 9.38e-01 | -1.83e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 13 | 9.09e-01 | -1.83e-02 | 9.81e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 22 | 8.82e-01 | 1.83e-02 | 9.72e-01 |
| GOMF PROTEIN KINASE C ACTIVITY | 12 | 9.13e-01 | 1.82e-02 | 9.82e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 11 | 9.17e-01 | 1.82e-02 | 9.82e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 127 | 7.23e-01 | -1.82e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 331 | 5.70e-01 | -1.82e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 9.25e-01 | -1.82e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 170 | 6.83e-01 | 1.82e-02 | 9.19e-01 |
| GOBP COCHLEA MORPHOGENESIS | 7 | 9.34e-01 | -1.82e-02 | 9.87e-01 |
| GOBP EAR DEVELOPMENT | 105 | 7.48e-01 | 1.82e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 12 | 9.13e-01 | -1.82e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 67 | 7.97e-01 | 1.81e-02 | 9.53e-01 |
| GOMF FAD BINDING | 32 | 8.59e-01 | -1.81e-02 | 9.65e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 44 | 8.35e-01 | -1.81e-02 | 9.61e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 149 | 7.03e-01 | -1.81e-02 | 9.25e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 38 | 8.47e-01 | 1.81e-02 | 9.62e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 17 | 8.97e-01 | 1.81e-02 | 9.78e-01 |
| GOCC MIDBODY | 187 | 6.70e-01 | -1.81e-02 | 9.15e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 213 | 6.50e-01 | -1.81e-02 | 9.08e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 15 | 9.04e-01 | -1.81e-02 | 9.81e-01 |
| GOBP REGULATION OF MYELINATION | 32 | 8.60e-01 | -1.80e-02 | 9.65e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 566 | 4.67e-01 | 1.80e-02 | 8.48e-01 |
| GOMF HISTONE H3K4ME H3K4ME2 H3K4ME3 DEMETHYLASE ACTIVITY | 5 | 9.44e-01 | 1.80e-02 | 9.88e-01 |
| GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT | 6 | 9.39e-01 | -1.80e-02 | 9.87e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 44 | 8.37e-01 | -1.79e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 9.39e-01 | 1.79e-02 | 9.87e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 14 | 9.08e-01 | -1.79e-02 | 9.81e-01 |
| GOCC MEMBRANE COAT | 86 | 7.74e-01 | 1.79e-02 | 9.48e-01 |
| GOBP RNA 3 END PROCESSING | 89 | 7.71e-01 | 1.79e-02 | 9.46e-01 |
| GOBP SEX DIFFERENTIATION | 152 | 7.05e-01 | 1.78e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 62 | 8.09e-01 | -1.78e-02 | 9.57e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 55 | 8.19e-01 | -1.78e-02 | 9.59e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 141 | 7.16e-01 | 1.78e-02 | 9.30e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 12 | 9.15e-01 | -1.78e-02 | 9.82e-01 |
| GOBP DNA METABOLIC PROCESS | 868 | 3.79e-01 | 1.77e-02 | 8.06e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 185 | 6.79e-01 | -1.77e-02 | 9.19e-01 |
| GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 9.45e-01 | 1.77e-02 | 9.88e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 75 | 7.92e-01 | -1.76e-02 | 9.50e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 31 | 8.65e-01 | 1.76e-02 | 9.67e-01 |
| GOBP GERM CELL DEVELOPMENT | 187 | 6.79e-01 | 1.76e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 9.46e-01 | 1.76e-02 | 9.88e-01 |
| GOBP CYTOKINE PRODUCTION | 561 | 4.79e-01 | -1.76e-02 | 8.52e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 11 | 9.20e-01 | 1.75e-02 | 9.83e-01 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 163 | 7.00e-01 | 1.75e-02 | 9.25e-01 |
| GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT | 5 | 9.46e-01 | -1.75e-02 | 9.88e-01 |
| GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY | 5 | 9.46e-01 | -1.75e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 157 | 7.06e-01 | 1.75e-02 | 9.26e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 43 | 8.43e-01 | -1.75e-02 | 9.62e-01 |
| GOBP TUBE MORPHOGENESIS | 521 | 4.97e-01 | 1.75e-02 | 8.62e-01 |
| GOCC TRANSFERASE COMPLEX | 756 | 4.18e-01 | 1.74e-02 | 8.22e-01 |
| GOBP TISSUE HOMEOSTASIS | 162 | 7.02e-01 | -1.74e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 136 | 7.26e-01 | -1.74e-02 | 9.34e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 13 | 9.13e-01 | -1.74e-02 | 9.82e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 26 | 8.78e-01 | -1.74e-02 | 9.72e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 22 | 8.88e-01 | 1.74e-02 | 9.74e-01 |
| GOCC CILIARY TIP | 37 | 8.55e-01 | 1.74e-02 | 9.63e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 13 | 9.14e-01 | -1.74e-02 | 9.82e-01 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 8 | 9.32e-01 | 1.74e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 39 | 8.52e-01 | 1.73e-02 | 9.62e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 33 | 8.64e-01 | -1.73e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 8.68e-01 | -1.73e-02 | 9.68e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 140 | 7.25e-01 | -1.73e-02 | 9.33e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 11 | 9.21e-01 | 1.72e-02 | 9.83e-01 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 12 | 9.18e-01 | -1.72e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 96 | 7.71e-01 | 1.72e-02 | 9.46e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 37 | 8.57e-01 | 1.72e-02 | 9.64e-01 |
| GOBP RETINA LAYER FORMATION | 13 | 9.15e-01 | -1.72e-02 | 9.82e-01 |
| GOCC MICROVILLUS | 56 | 8.25e-01 | -1.71e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 16 | 9.06e-01 | 1.71e-02 | 9.81e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 84 | 7.87e-01 | 1.70e-02 | 9.49e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 33 | 8.66e-01 | 1.70e-02 | 9.67e-01 |
| GOBP TESTOSTERONE BIOSYNTHETIC PROCESS | 6 | 9.43e-01 | -1.69e-02 | 9.88e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 101 | 7.69e-01 | 1.69e-02 | 9.46e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 83 | 7.90e-01 | -1.69e-02 | 9.50e-01 |
| GOMF SYNTAXIN BINDING | 46 | 8.43e-01 | -1.69e-02 | 9.62e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 70 | 8.08e-01 | -1.68e-02 | 9.57e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 17 | 9.04e-01 | 1.68e-02 | 9.81e-01 |
| GOBP MATING BEHAVIOR | 16 | 9.07e-01 | 1.68e-02 | 9.81e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 11 | 9.23e-01 | 1.68e-02 | 9.84e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 13 | 9.17e-01 | 1.68e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1069 | 3.60e-01 | 1.68e-02 | 7.94e-01 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 12 | 9.20e-01 | -1.68e-02 | 9.83e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 106 | 7.67e-01 | 1.67e-02 | 9.45e-01 |
| GOBP DESMOSOME ORGANIZATION | 6 | 9.44e-01 | 1.67e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 65 | 8.16e-01 | 1.67e-02 | 9.59e-01 |
| GOBP DEFENSE RESPONSE | 1147 | 3.46e-01 | -1.67e-02 | 7.89e-01 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 30 | 8.74e-01 | 1.67e-02 | 9.71e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 513 | 5.22e-01 | 1.66e-02 | 8.72e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 113 | 7.61e-01 | 1.66e-02 | 9.44e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 8 | 9.35e-01 | 1.66e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 57 | 8.29e-01 | -1.66e-02 | 9.61e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 792 | 4.33e-01 | -1.65e-02 | 8.31e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 46 | 8.47e-01 | 1.65e-02 | 9.62e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 395 | 5.77e-01 | -1.64e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 57 | 8.31e-01 | 1.64e-02 | 9.61e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 49 | 8.43e-01 | -1.64e-02 | 9.62e-01 |
| GOMF HISTONE DEACETYLASE BINDING | 93 | 7.85e-01 | 1.64e-02 | 9.48e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 133 | 7.45e-01 | 1.64e-02 | 9.39e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 10 | 9.29e-01 | -1.63e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 20 | 8.99e-01 | 1.63e-02 | 9.78e-01 |
| GOBP RESPONSE TO CALCIUM ION | 96 | 7.83e-01 | -1.63e-02 | 9.48e-01 |
| GOBP SPINDLE ORGANIZATION | 180 | 7.06e-01 | -1.63e-02 | 9.26e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 8.69e-01 | -1.63e-02 | 9.69e-01 |
| GOBP RNA CATABOLIC PROCESS | 262 | 6.51e-01 | 1.63e-02 | 9.08e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 77 | 8.05e-01 | 1.63e-02 | 9.57e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 59 | 8.29e-01 | 1.63e-02 | 9.61e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 209 | 6.87e-01 | 1.62e-02 | 9.20e-01 |
| GOMF CARDIOLIPIN BINDING | 8 | 9.37e-01 | 1.62e-02 | 9.87e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 91 | 7.90e-01 | -1.62e-02 | 9.50e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 757 | 4.53e-01 | 1.61e-02 | 8.42e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 343 | 6.09e-01 | 1.61e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 21 | 8.98e-01 | 1.61e-02 | 9.78e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 58 | 8.32e-01 | -1.61e-02 | 9.61e-01 |
| GOBP MUCUS SECRETION | 10 | 9.30e-01 | 1.61e-02 | 9.86e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 147 | 7.36e-01 | 1.61e-02 | 9.37e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 97 | 7.84e-01 | 1.61e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 16 | 9.11e-01 | -1.61e-02 | 9.82e-01 |
| GOBP SEGMENTATION | 50 | 8.44e-01 | 1.61e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 17 | 9.09e-01 | -1.61e-02 | 9.81e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 33 | 8.74e-01 | 1.60e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 116 | 7.67e-01 | -1.60e-02 | 9.45e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 45 | 8.53e-01 | 1.59e-02 | 9.63e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 24 | 8.92e-01 | 1.59e-02 | 9.76e-01 |
| GOCC PERICHROMATIN FIBRILS | 5 | 9.51e-01 | -1.59e-02 | 9.90e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 80 | 8.06e-01 | 1.59e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 43 | 8.57e-01 | -1.59e-02 | 9.64e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 96 | 7.88e-01 | -1.59e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 6 | 9.46e-01 | -1.59e-02 | 9.88e-01 |
| GOBP ADULT BEHAVIOR | 77 | 8.10e-01 | -1.58e-02 | 9.57e-01 |
| GOBP PEROXISOMAL TRANSPORT | 22 | 8.98e-01 | 1.58e-02 | 9.78e-01 |
| GOCC MICROTUBULE | 344 | 6.16e-01 | 1.58e-02 | 9.02e-01 |
| GOMF ATPASE BINDING | 64 | 8.27e-01 | 1.58e-02 | 9.61e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 15 | 9.16e-01 | 1.58e-02 | 9.82e-01 |
| GOCC COATED VESICLE MEMBRANE | 160 | 7.31e-01 | -1.58e-02 | 9.36e-01 |
| GOBP MIRNA METABOLIC PROCESS | 77 | 8.11e-01 | 1.57e-02 | 9.58e-01 |
| GOMF ADP BINDING | 33 | 8.76e-01 | 1.57e-02 | 9.71e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 9.47e-01 | 1.57e-02 | 9.88e-01 |
| GOBP TRNA PROCESSING | 129 | 7.58e-01 | 1.57e-02 | 9.44e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 9 | 9.35e-01 | -1.57e-02 | 9.87e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 45 | 8.55e-01 | -1.57e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 381 | 6.01e-01 | 1.57e-02 | 8.97e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 40 | 8.65e-01 | -1.56e-02 | 9.67e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 9.43e-01 | 1.56e-02 | 9.88e-01 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 9.52e-01 | -1.55e-02 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 123 | 7.66e-01 | -1.55e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 7 | 9.43e-01 | 1.55e-02 | 9.88e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 12 | 9.26e-01 | -1.55e-02 | 9.85e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 26 | 8.91e-01 | 1.55e-02 | 9.76e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 122 | 7.68e-01 | -1.55e-02 | 9.46e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 478 | 5.65e-01 | -1.54e-02 | 8.81e-01 |
| GOBP METHYLGUANOSINE CAP DECAPPING | 16 | 9.15e-01 | -1.54e-02 | 9.82e-01 |
| GOBP VASCULAR WOUND HEALING | 10 | 9.33e-01 | 1.54e-02 | 9.87e-01 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 9 | 9.36e-01 | 1.54e-02 | 9.87e-01 |
| GOBP INNATE IMMUNE RESPONSE | 650 | 5.08e-01 | -1.53e-02 | 8.66e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 13 | 9.24e-01 | 1.53e-02 | 9.84e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE | 5 | 9.53e-01 | -1.53e-02 | 9.90e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 67 | 8.29e-01 | 1.53e-02 | 9.61e-01 |
| GOBP CLATHRIN COAT ASSEMBLY | 12 | 9.27e-01 | 1.53e-02 | 9.85e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 8 | 9.40e-01 | 1.53e-02 | 9.88e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 43 | 8.63e-01 | 1.52e-02 | 9.66e-01 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 5 | 9.53e-01 | 1.52e-02 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 55 | 8.46e-01 | 1.52e-02 | 9.62e-01 |
| GOBP VESICLE TETHERING | 32 | 8.82e-01 | -1.52e-02 | 9.72e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 28 | 8.90e-01 | 1.52e-02 | 9.75e-01 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 5 | 9.53e-01 | 1.51e-02 | 9.90e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 7 | 9.45e-01 | -1.51e-02 | 9.88e-01 |
| GOBP WOUND HEALING | 266 | 6.72e-01 | -1.51e-02 | 9.15e-01 |
| GOCC PHOSPHATASE COMPLEX | 47 | 8.58e-01 | 1.50e-02 | 9.65e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 153 | 7.48e-01 | -1.50e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 24 | 8.99e-01 | -1.50e-02 | 9.78e-01 |
| GOBP DIET INDUCED THERMOGENESIS | 6 | 9.49e-01 | -1.50e-02 | 9.89e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 15 | 9.20e-01 | -1.50e-02 | 9.83e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 6 | 9.49e-01 | 1.50e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 599 | 5.33e-01 | 1.50e-02 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 9.49e-01 | 1.50e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 78 | 8.19e-01 | -1.50e-02 | 9.59e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 117 | 7.80e-01 | -1.49e-02 | 9.48e-01 |
| GOBP REGULATED EXOCYTOSIS | 146 | 7.56e-01 | 1.49e-02 | 9.43e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 37 | 8.75e-01 | -1.49e-02 | 9.71e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 9.35e-01 | -1.49e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 66 | 8.34e-01 | -1.49e-02 | 9.61e-01 |
| GOCC CELL LEADING EDGE | 330 | 6.43e-01 | 1.49e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 486 | 5.77e-01 | 1.49e-02 | 8.87e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 5 | 9.54e-01 | 1.49e-02 | 9.90e-01 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 17 | 9.16e-01 | -1.49e-02 | 9.82e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 45 | 8.63e-01 | 1.48e-02 | 9.66e-01 |
| GOBP EXOCYTOSIS | 237 | 6.95e-01 | -1.48e-02 | 9.24e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 10 | 9.35e-01 | 1.48e-02 | 9.87e-01 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 534 | 5.61e-01 | -1.48e-02 | 8.80e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 638 | 5.27e-01 | 1.48e-02 | 8.74e-01 |
| GOBP MELANOSOME ASSEMBLY | 19 | 9.11e-01 | -1.48e-02 | 9.82e-01 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 6 | 9.50e-01 | 1.47e-02 | 9.90e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 36 | 8.79e-01 | 1.47e-02 | 9.72e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 18 | 9.14e-01 | 1.47e-02 | 9.82e-01 |
| GOBP ETHER METABOLIC PROCESS | 19 | 9.12e-01 | -1.47e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 25 | 8.99e-01 | 1.47e-02 | 9.78e-01 |
| GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS | 5 | 9.55e-01 | 1.47e-02 | 9.91e-01 |
| GOBP RESPONSE TO FRUCTOSE | 6 | 9.51e-01 | -1.46e-02 | 9.90e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 17 | 9.17e-01 | -1.46e-02 | 9.82e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 7 | 9.47e-01 | -1.46e-02 | 9.88e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 148 | 7.60e-01 | 1.46e-02 | 9.44e-01 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 9.04e-01 | 1.46e-02 | 9.81e-01 |
| GOMF CORECEPTOR ACTIVITY | 29 | 8.92e-01 | -1.45e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 60 | 8.46e-01 | 1.45e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 137 | 7.69e-01 | 1.45e-02 | 9.46e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 85 | 8.18e-01 | -1.45e-02 | 9.59e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 917 | 4.62e-01 | 1.45e-02 | 8.45e-01 |
| GOBP DNA CYTOSINE DEAMINATION | 8 | 9.44e-01 | -1.45e-02 | 9.88e-01 |
| GOBP RESPONSE TO AMPHETAMINE | 14 | 9.25e-01 | -1.45e-02 | 9.85e-01 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 29 | 8.93e-01 | 1.44e-02 | 9.76e-01 |
| GOMF SULFUR COMPOUND BINDING | 145 | 7.65e-01 | -1.44e-02 | 9.45e-01 |
| GOCC INTERCELLULAR CANALICULUS | 6 | 9.51e-01 | -1.43e-02 | 9.90e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 9.44e-01 | 1.43e-02 | 9.88e-01 |
| GOBP HORMONE METABOLIC PROCESS | 125 | 7.82e-01 | 1.43e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 32 | 8.89e-01 | 1.43e-02 | 9.75e-01 |
| GOBP AMINE TRANSPORT | 46 | 8.67e-01 | 1.43e-02 | 9.68e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 58 | 8.51e-01 | 1.42e-02 | 9.62e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 24 | 9.04e-01 | -1.42e-02 | 9.81e-01 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 10 | 9.38e-01 | 1.42e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 293 | 6.76e-01 | -1.42e-02 | 9.17e-01 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 9.56e-01 | -1.42e-02 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 6 | 9.52e-01 | 1.42e-02 | 9.90e-01 |
| GOBP SPLEEN DEVELOPMENT | 26 | 9.00e-01 | -1.42e-02 | 9.79e-01 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 9 | 9.41e-01 | 1.42e-02 | 9.88e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 12 | 9.32e-01 | 1.42e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 31 | 8.92e-01 | 1.41e-02 | 9.76e-01 |
| GOMF PROFILIN BINDING | 10 | 9.39e-01 | 1.41e-02 | 9.87e-01 |
| GOBP RESPONSE TO COCAINE | 27 | 9.00e-01 | -1.40e-02 | 9.78e-01 |
| GOBP PINOCYTOSIS | 18 | 9.18e-01 | -1.40e-02 | 9.82e-01 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 35 | 8.86e-01 | -1.40e-02 | 9.73e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 753 | 5.17e-01 | -1.40e-02 | 8.69e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 37 | 8.84e-01 | -1.39e-02 | 9.72e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 29 | 8.97e-01 | 1.39e-02 | 9.78e-01 |
| GOMF SINGLE STRANDED RNA BINDING | 69 | 8.43e-01 | 1.38e-02 | 9.62e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 180 | 7.50e-01 | -1.38e-02 | 9.41e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 91 | 8.21e-01 | 1.37e-02 | 9.60e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 145 | 7.76e-01 | -1.37e-02 | 9.48e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 66 | 8.47e-01 | 1.37e-02 | 9.62e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 63 | 8.51e-01 | -1.37e-02 | 9.62e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 215 | 7.30e-01 | -1.37e-02 | 9.36e-01 |
| GOBP RESPONSE TO CATECHOLAMINE | 41 | 8.80e-01 | -1.37e-02 | 9.72e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 17 | 9.22e-01 | 1.37e-02 | 9.84e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 9 | 9.44e-01 | 1.36e-02 | 9.88e-01 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 25 | 9.06e-01 | -1.36e-02 | 9.81e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 50 | 8.68e-01 | -1.36e-02 | 9.68e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 8 | 9.47e-01 | 1.36e-02 | 9.88e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 7 | 9.50e-01 | 1.36e-02 | 9.90e-01 |
| GOBP HEMOPOIESIS | 681 | 5.50e-01 | 1.35e-02 | 8.78e-01 |
| GOBP RESPONSE TO PH | 21 | 9.15e-01 | 1.35e-02 | 9.82e-01 |
| GOBP RESPONSE TO MAGNESIUM ION | 12 | 9.36e-01 | 1.34e-02 | 9.87e-01 |
| GOBP LIPID HOMEOSTASIS | 107 | 8.11e-01 | -1.34e-02 | 9.57e-01 |
| GOCC CYTOPLASMIC REGION | 185 | 7.54e-01 | 1.34e-02 | 9.42e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 112 | 8.07e-01 | 1.34e-02 | 9.57e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 306 | 6.89e-01 | 1.33e-02 | 9.20e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 61 | 8.57e-01 | 1.33e-02 | 9.64e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 26 | 9.06e-01 | -1.33e-02 | 9.81e-01 |
| GOBP SKIN DEVELOPMENT | 148 | 7.80e-01 | 1.33e-02 | 9.48e-01 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 212 | 7.39e-01 | 1.33e-02 | 9.38e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 13 | 9.34e-01 | 1.33e-02 | 9.87e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 913 | 5.01e-01 | 1.33e-02 | 8.63e-01 |
| GOBP POSTREPLICATION REPAIR | 33 | 8.95e-01 | -1.32e-02 | 9.77e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 104 | 8.16e-01 | -1.32e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 107 | 8.13e-01 | -1.32e-02 | 9.58e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 18 | 9.23e-01 | -1.32e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 689 | 5.60e-01 | -1.31e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 81 | 8.38e-01 | 1.31e-02 | 9.61e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 17 | 9.25e-01 | 1.31e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 547 | 6.04e-01 | -1.30e-02 | 8.97e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 13 | 9.35e-01 | -1.30e-02 | 9.87e-01 |
| GOBP DEPHOSPHORYLATION | 239 | 7.29e-01 | 1.30e-02 | 9.36e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1069 | 4.77e-01 | -1.30e-02 | 8.52e-01 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 17 | 9.26e-01 | 1.30e-02 | 9.85e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 89 | 8.32e-01 | -1.30e-02 | 9.61e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 85 | 8.37e-01 | 1.29e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 910 | 5.13e-01 | -1.29e-02 | 8.67e-01 |
| GOCC COATED VESICLE | 245 | 7.29e-01 | -1.29e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 7 | 9.53e-01 | 1.29e-02 | 9.90e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 423 | 6.52e-01 | -1.28e-02 | 9.09e-01 |
| GOBP MECHANOSENSORY BEHAVIOR | 7 | 9.53e-01 | -1.28e-02 | 9.90e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 39 | 8.90e-01 | 1.28e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 30 | 9.03e-01 | 1.28e-02 | 9.81e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 84 | 8.39e-01 | -1.28e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 119 | 8.10e-01 | -1.28e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 196 | 7.59e-01 | 1.28e-02 | 9.44e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 88 | 8.37e-01 | -1.27e-02 | 9.61e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 246 | 7.32e-01 | -1.27e-02 | 9.36e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING | 5 | 9.61e-01 | -1.27e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 5 | 9.61e-01 | -1.26e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 18 | 9.26e-01 | 1.26e-02 | 9.85e-01 |
| GOBP PROLINE METABOLIC PROCESS | 6 | 9.57e-01 | 1.26e-02 | 9.92e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 178 | 7.73e-01 | 1.26e-02 | 9.48e-01 |
| GOBP ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING | 6 | 9.58e-01 | -1.25e-02 | 9.92e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 10 | 9.46e-01 | -1.25e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 65 | 8.62e-01 | -1.25e-02 | 9.66e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 359 | 6.86e-01 | 1.24e-02 | 9.20e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 12 | 9.41e-01 | 1.24e-02 | 9.88e-01 |
| GOMF MRNA BINDING | 268 | 7.28e-01 | 1.24e-02 | 9.35e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 190 | 7.69e-01 | 1.24e-02 | 9.46e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 14 | 9.36e-01 | 1.23e-02 | 9.87e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 17 | 9.30e-01 | -1.23e-02 | 9.86e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 68 | 8.62e-01 | 1.22e-02 | 9.66e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 132 | 8.09e-01 | -1.22e-02 | 9.57e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 107 | 8.28e-01 | -1.22e-02 | 9.61e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 51 | 8.80e-01 | 1.22e-02 | 9.72e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 93 | 8.39e-01 | 1.22e-02 | 9.61e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 43 | 8.90e-01 | 1.22e-02 | 9.76e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 99 | 8.35e-01 | -1.21e-02 | 9.61e-01 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 9.59e-01 | -1.21e-02 | 9.92e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 11 | 9.45e-01 | 1.21e-02 | 9.88e-01 |
| GOCC GOLGI APPARATUS | 1204 | 4.88e-01 | 1.20e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 6 | 9.59e-01 | 1.20e-02 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 254 | 7.42e-01 | 1.20e-02 | 9.38e-01 |
| GOBP LEUKOCYTE MIGRATION | 260 | 7.40e-01 | -1.20e-02 | 9.38e-01 |
| GOBP COMPARTMENT PATTERN SPECIFICATION | 5 | 9.63e-01 | 1.20e-02 | 9.93e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 15 | 9.36e-01 | -1.20e-02 | 9.87e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 33 | 9.05e-01 | -1.20e-02 | 9.81e-01 |
| GOBP CELL RECOGNITION | 78 | 8.55e-01 | -1.19e-02 | 9.64e-01 |
| GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS | 5 | 9.63e-01 | 1.19e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 19 | 9.29e-01 | -1.19e-02 | 9.86e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 127 | 8.18e-01 | 1.19e-02 | 9.59e-01 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 73 | 8.61e-01 | 1.19e-02 | 9.66e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 87 | 8.49e-01 | 1.19e-02 | 9.62e-01 |
| GOBP SPERMATID DIFFERENTIATION | 102 | 8.37e-01 | 1.18e-02 | 9.61e-01 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 6 | 9.60e-01 | 1.18e-02 | 9.93e-01 |
| GOBP ORGANELLE ASSEMBLY | 796 | 5.75e-01 | -1.18e-02 | 8.86e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 9.17e-01 | 1.18e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 21 | 9.26e-01 | 1.18e-02 | 9.85e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 30 | 9.11e-01 | 1.18e-02 | 9.82e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 167 | 7.94e-01 | 1.18e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 17 | 9.33e-01 | 1.17e-02 | 9.87e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 525 | 6.48e-01 | 1.17e-02 | 9.08e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 838 | 5.70e-01 | 1.16e-02 | 8.83e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 17 | 9.34e-01 | -1.16e-02 | 9.87e-01 |
| GOBP RESPONSE TO METAL ION | 241 | 7.58e-01 | 1.15e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 33 | 9.09e-01 | 1.15e-02 | 9.81e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1175 | 5.13e-01 | -1.15e-02 | 8.67e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 11 | 9.48e-01 | -1.14e-02 | 9.89e-01 |
| GOCC PHAGOCYTIC VESICLE | 131 | 8.21e-01 | 1.14e-02 | 9.60e-01 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 15 | 9.39e-01 | -1.14e-02 | 9.87e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 13 | 9.43e-01 | -1.14e-02 | 9.88e-01 |
| GOBP CELL CELL ADHESION | 538 | 6.52e-01 | 1.14e-02 | 9.09e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 9.50e-01 | -1.14e-02 | 9.90e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 9 | 9.53e-01 | -1.14e-02 | 9.90e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 73 | 8.66e-01 | -1.14e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 18 | 9.33e-01 | -1.14e-02 | 9.87e-01 |
| GOCC NUCLEAR PERIPHERY | 135 | 8.20e-01 | -1.14e-02 | 9.59e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 9.65e-01 | -1.14e-02 | 9.93e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 7 | 9.58e-01 | 1.14e-02 | 9.92e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 45 | 8.95e-01 | -1.13e-02 | 9.77e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 147 | 8.13e-01 | -1.13e-02 | 9.58e-01 |
| GOBP RRNA TRANSPORT | 5 | 9.65e-01 | 1.13e-02 | 9.93e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 333 | 7.24e-01 | 1.13e-02 | 9.33e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 318 | 7.30e-01 | -1.13e-02 | 9.36e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 119 | 8.32e-01 | -1.13e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 15 | 9.40e-01 | -1.12e-02 | 9.88e-01 |
| GOMF SODIUM CHANNEL INHIBITOR ACTIVITY | 5 | 9.66e-01 | 1.12e-02 | 9.93e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 270 | 7.53e-01 | -1.11e-02 | 9.42e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 41 | 9.02e-01 | 1.11e-02 | 9.79e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 289 | 7.46e-01 | 1.11e-02 | 9.39e-01 |
| GOCC GOLGI MEMBRANE | 537 | 6.65e-01 | -1.10e-02 | 9.14e-01 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 6 | 9.63e-01 | -1.09e-02 | 9.93e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 9.44e-01 | -1.09e-02 | 9.88e-01 |
| GOBP T CELL ACTIVATION | 399 | 7.09e-01 | -1.09e-02 | 9.27e-01 |
| GOBP OBSERVATIONAL LEARNING | 5 | 9.66e-01 | -1.09e-02 | 9.93e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 95 | 8.55e-01 | 1.09e-02 | 9.63e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 14 | 9.44e-01 | 1.09e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 5 | 9.66e-01 | 1.09e-02 | 9.93e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 9 | 9.55e-01 | 1.08e-02 | 9.91e-01 |
| GOBP PROTEIN ACYLATION | 123 | 8.36e-01 | -1.08e-02 | 9.61e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 478 | 6.87e-01 | 1.08e-02 | 9.20e-01 |
| GOBP NCRNA TRANSCRIPTION | 103 | 8.50e-01 | -1.08e-02 | 9.62e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 20 | 9.33e-01 | -1.08e-02 | 9.87e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 44 | 9.01e-01 | -1.08e-02 | 9.79e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 65 | 8.81e-01 | 1.08e-02 | 9.72e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 874 | 5.92e-01 | 1.08e-02 | 8.94e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 9.49e-01 | -1.07e-02 | 9.89e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 107 | 8.49e-01 | 1.07e-02 | 9.62e-01 |
| GOBP CARDIAC CONDUCTION | 48 | 8.98e-01 | -1.07e-02 | 9.78e-01 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 9.64e-01 | 1.06e-02 | 9.93e-01 |
| GOBP DNA DAMAGE RESPONSE | 780 | 6.17e-01 | 1.06e-02 | 9.02e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 25 | 9.27e-01 | 1.06e-02 | 9.85e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 42 | 9.06e-01 | 1.06e-02 | 9.81e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 43 | 9.05e-01 | -1.06e-02 | 9.81e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 15 | 9.44e-01 | 1.05e-02 | 9.88e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 92 | 8.62e-01 | 1.05e-02 | 9.66e-01 |
| GOMF RIBOSOME BINDING | 103 | 8.54e-01 | 1.05e-02 | 9.63e-01 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 62 | 8.86e-01 | 1.05e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 191 | 8.03e-01 | 1.05e-02 | 9.56e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 40 | 9.09e-01 | 1.05e-02 | 9.81e-01 |
| GOBP GLYCOLYTIC PROCESS | 72 | 8.78e-01 | 1.05e-02 | 9.72e-01 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 13 | 9.48e-01 | 1.05e-02 | 9.89e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 113 | 8.48e-01 | -1.04e-02 | 9.62e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 9 | 9.57e-01 | -1.04e-02 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 953 | 5.90e-01 | -1.04e-02 | 8.93e-01 |
| GOCC ZYMOGEN GRANULE | 7 | 9.62e-01 | -1.04e-02 | 9.93e-01 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 5 | 9.68e-01 | -1.04e-02 | 9.94e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 156 | 8.23e-01 | 1.04e-02 | 9.60e-01 |
| GOBP REGULATION OF METAL ION TRANSPORT | 221 | 7.91e-01 | 1.04e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 36 | 9.14e-01 | 1.04e-02 | 9.82e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 124 | 8.43e-01 | -1.03e-02 | 9.62e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 202 | 8.01e-01 | -1.03e-02 | 9.55e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 26 | 9.28e-01 | 1.03e-02 | 9.85e-01 |
| GOBP DNA MODIFICATION | 82 | 8.73e-01 | -1.02e-02 | 9.71e-01 |
| GOBP RESPONSE TO RADIATION | 318 | 7.55e-01 | -1.02e-02 | 9.42e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 15 | 9.45e-01 | -1.02e-02 | 9.88e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 15 | 9.46e-01 | 1.01e-02 | 9.88e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 48 | 9.04e-01 | -1.01e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 81 | 8.75e-01 | -1.01e-02 | 9.71e-01 |
| GOBP LUTEOLYSIS | 5 | 9.69e-01 | 1.01e-02 | 9.95e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 9.56e-01 | 1.01e-02 | 9.91e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 30 | 9.24e-01 | -1.01e-02 | 9.84e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 41 | 9.11e-01 | 1.01e-02 | 9.82e-01 |
| GOBP VASCULAR TRANSPORT | 52 | 9.00e-01 | 1.01e-02 | 9.78e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 7 | 9.63e-01 | 1.00e-02 | 9.93e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 9.66e-01 | -1.00e-02 | 9.93e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 374 | 7.40e-01 | 1.00e-02 | 9.38e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 65 | 8.89e-01 | -9.99e-03 | 9.75e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 24 | 9.33e-01 | 9.95e-03 | 9.87e-01 |
| GOBP RNA MODIFICATION | 166 | 8.25e-01 | 9.95e-03 | 9.60e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 5 | 9.69e-01 | -9.89e-03 | 9.95e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 111 | 8.58e-01 | -9.84e-03 | 9.65e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 8 | 9.62e-01 | 9.82e-03 | 9.93e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 9.70e-01 | 9.81e-03 | 9.95e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1311 | 5.57e-01 | 9.80e-03 | 8.79e-01 |
| GOCC ENDOCYTIC VESICLE | 264 | 7.85e-01 | 9.77e-03 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 34 | 9.21e-01 | -9.77e-03 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 665 | 6.70e-01 | -9.76e-03 | 9.15e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 9 | 9.60e-01 | 9.71e-03 | 9.92e-01 |
| GOBP GLYCOSYLATION | 170 | 8.28e-01 | -9.69e-03 | 9.61e-01 |
| GOCC CELL BODY | 331 | 7.63e-01 | -9.68e-03 | 9.44e-01 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 6 | 9.67e-01 | 9.64e-03 | 9.94e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 13 | 9.52e-01 | 9.64e-03 | 9.90e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 26 | 9.32e-01 | -9.61e-03 | 9.87e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 542 | 7.04e-01 | 9.58e-03 | 9.25e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 76 | 8.85e-01 | 9.57e-03 | 9.73e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 20 | 9.41e-01 | 9.52e-03 | 9.88e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 813 | 6.48e-01 | 9.50e-03 | 9.08e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 23 | 9.37e-01 | -9.45e-03 | 9.87e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 548 | 7.08e-01 | -9.41e-03 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 27 | 9.33e-01 | -9.36e-03 | 9.87e-01 |
| GOBP PHOSPHOLIPID EFFLUX | 8 | 9.63e-01 | 9.36e-03 | 9.93e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 113 | 8.64e-01 | 9.34e-03 | 9.67e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 27 | 9.33e-01 | 9.34e-03 | 9.87e-01 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 9.64e-01 | 9.31e-03 | 9.93e-01 |
| GOCC TRANSPORT VESICLE | 306 | 7.80e-01 | -9.30e-03 | 9.48e-01 |
| GOBP AMINO ACID METABOLIC PROCESS | 194 | 8.24e-01 | -9.30e-03 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 99 | 8.73e-01 | 9.27e-03 | 9.71e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 50 | 9.10e-01 | 9.22e-03 | 9.82e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 565 | 7.11e-01 | 9.19e-03 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 690 | 6.83e-01 | -9.18e-03 | 9.19e-01 |
| GOBP L SERINE BIOSYNTHETIC PROCESS | 5 | 9.72e-01 | 9.15e-03 | 9.96e-01 |
| GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 83 | 8.86e-01 | 9.14e-03 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 6 | 9.69e-01 | 9.13e-03 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 965 | 6.37e-01 | 9.08e-03 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 43 | 9.18e-01 | 9.08e-03 | 9.82e-01 |
| GOBP RENAL SYSTEM PROCESS | 55 | 9.08e-01 | -9.04e-03 | 9.81e-01 |
| GOCC PLASMA MEMBRANE RAFT | 71 | 8.95e-01 | 9.03e-03 | 9.77e-01 |
| GOMF TRANSPORTER ACTIVITY | 735 | 6.80e-01 | 9.00e-03 | 9.19e-01 |
| GOBP REGULATION OF TRANSPORT | 1108 | 6.18e-01 | -8.98e-03 | 9.02e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 34 | 9.28e-01 | -8.98e-03 | 9.85e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 122 | 8.64e-01 | -8.96e-03 | 9.67e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 420 | 7.54e-01 | 8.94e-03 | 9.42e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 44 | 9.19e-01 | -8.91e-03 | 9.83e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 77 | 8.93e-01 | 8.88e-03 | 9.76e-01 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 5 | 9.73e-01 | 8.86e-03 | 9.96e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 60 | 9.06e-01 | -8.80e-03 | 9.81e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 41 | 9.23e-01 | -8.77e-03 | 9.84e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 11 | 9.60e-01 | -8.77e-03 | 9.92e-01 |
| GOCC CMG COMPLEX | 10 | 9.62e-01 | 8.76e-03 | 9.93e-01 |
| GOBP GANGLION DEVELOPMENT | 9 | 9.64e-01 | -8.69e-03 | 9.93e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 191 | 8.36e-01 | -8.69e-03 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 142 | 8.58e-01 | -8.69e-03 | 9.65e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 171 | 8.45e-01 | 8.66e-03 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 80 | 8.94e-01 | 8.62e-03 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 9 | 9.64e-01 | 8.59e-03 | 9.93e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 9 | 9.64e-01 | 8.59e-03 | 9.93e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 192 | 8.38e-01 | -8.56e-03 | 9.61e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 22 | 9.45e-01 | 8.51e-03 | 9.88e-01 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 36 | 9.30e-01 | -8.50e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 21 | 9.46e-01 | -8.47e-03 | 9.88e-01 |
| GOBP ENDOCYTOSIS | 520 | 7.42e-01 | -8.47e-03 | 9.38e-01 |
| GOBP CHROMATIN REMODELING | 494 | 7.49e-01 | 8.44e-03 | 9.41e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 25 | 9.42e-01 | 8.42e-03 | 9.88e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 28 | 9.39e-01 | -8.40e-03 | 9.87e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 691 | 7.09e-01 | 8.40e-03 | 9.27e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 16 | 9.54e-01 | 8.39e-03 | 9.90e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 559 | 7.36e-01 | 8.39e-03 | 9.37e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 126 | 8.71e-01 | -8.38e-03 | 9.70e-01 |
| GOBP TELOMERE ORGANIZATION | 152 | 8.59e-01 | -8.36e-03 | 9.65e-01 |
| GOBP RESPONSE TO WOUNDING | 351 | 7.89e-01 | 8.36e-03 | 9.49e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 60 | 9.11e-01 | 8.34e-03 | 9.82e-01 |
| GOBP MEMBRANE DOCKING | 79 | 8.99e-01 | -8.30e-03 | 9.78e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 22 | 9.46e-01 | 8.29e-03 | 9.88e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 10 | 9.64e-01 | 8.28e-03 | 9.93e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 21 | 9.48e-01 | 8.27e-03 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 30 | 9.38e-01 | -8.27e-03 | 9.87e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 156 | 8.59e-01 | -8.23e-03 | 9.65e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 24 | 9.44e-01 | 8.22e-03 | 9.88e-01 |
| GOBP FAT CELL DIFFERENTIATION | 157 | 8.59e-01 | -8.22e-03 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 18 | 9.52e-01 | 8.19e-03 | 9.90e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 31 | 9.37e-01 | -8.18e-03 | 9.87e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 393 | 7.82e-01 | -8.16e-03 | 9.48e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 31 | 9.38e-01 | -8.12e-03 | 9.87e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 523 | 7.53e-01 | -8.10e-03 | 9.42e-01 |
| GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY | 5 | 9.75e-01 | 8.09e-03 | 9.97e-01 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 11 | 9.63e-01 | 8.05e-03 | 9.93e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 824 | 6.97e-01 | 8.04e-03 | 9.25e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 127 | 8.77e-01 | -7.98e-03 | 9.71e-01 |
| GOBP RESPONSE TO DOPAMINE | 31 | 9.39e-01 | 7.95e-03 | 9.87e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 463 | 7.71e-01 | -7.93e-03 | 9.46e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 13 | 9.61e-01 | -7.89e-03 | 9.93e-01 |
| GOBP REGULATION OF IRON ION TRANSPORT | 5 | 9.76e-01 | 7.88e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 46 | 9.27e-01 | 7.83e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 31 | 9.40e-01 | -7.83e-03 | 9.88e-01 |
| GOBP MAPK CASCADE | 496 | 7.67e-01 | 7.81e-03 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 65 | 9.13e-01 | -7.80e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 7 | 9.72e-01 | -7.71e-03 | 9.96e-01 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 55 | 9.21e-01 | -7.70e-03 | 9.84e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 18 | 9.55e-01 | 7.69e-03 | 9.91e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 11 | 9.65e-01 | 7.67e-03 | 9.93e-01 |
| GOBP CELLULAR HOMEOSTASIS | 538 | 7.62e-01 | -7.66e-03 | 9.44e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 23 | 9.50e-01 | -7.63e-03 | 9.89e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 276 | 8.28e-01 | 7.63e-03 | 9.61e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 31 | 9.41e-01 | -7.63e-03 | 9.88e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 149 | 8.73e-01 | -7.63e-03 | 9.71e-01 |
| GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 125 | 8.84e-01 | -7.60e-03 | 9.72e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 11 | 9.65e-01 | 7.60e-03 | 9.93e-01 |
| GOBP LIPID MODIFICATION | 144 | 8.75e-01 | -7.59e-03 | 9.71e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 76 | 9.09e-01 | -7.58e-03 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 39 | 9.35e-01 | 7.58e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 22 | 9.51e-01 | -7.55e-03 | 9.90e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 30 | 9.43e-01 | -7.54e-03 | 9.88e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 575 | 7.59e-01 | 7.54e-03 | 9.44e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 22 | 9.51e-01 | 7.53e-03 | 9.90e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 24 | 9.49e-01 | -7.52e-03 | 9.89e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 17 | 9.57e-01 | 7.51e-03 | 9.92e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 55 | 9.24e-01 | -7.49e-03 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 249 | 8.40e-01 | 7.46e-03 | 9.61e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 81 | 9.08e-01 | -7.46e-03 | 9.81e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 9.66e-01 | -7.37e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 18 | 9.57e-01 | -7.36e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 6 | 9.75e-01 | -7.35e-03 | 9.97e-01 |
| GOCC VESICLE TETHERING COMPLEX | 52 | 9.27e-01 | 7.35e-03 | 9.85e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 32 | 9.43e-01 | 7.30e-03 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 36 | 9.40e-01 | -7.29e-03 | 9.88e-01 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 46 | 9.32e-01 | 7.27e-03 | 9.87e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 21 | 9.54e-01 | -7.26e-03 | 9.90e-01 |
| GOBP NEURON PROJECTION ORGANIZATION | 65 | 9.20e-01 | 7.25e-03 | 9.83e-01 |
| GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 9.72e-01 | -7.23e-03 | 9.96e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 797 | 7.33e-01 | -7.18e-03 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 280 | 8.37e-01 | -7.16e-03 | 9.61e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 27 | 9.49e-01 | -7.09e-03 | 9.89e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 53 | 9.29e-01 | 7.06e-03 | 9.86e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 52 | 9.30e-01 | 7.02e-03 | 9.86e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 253 | 8.48e-01 | 7.02e-03 | 9.62e-01 |
| GOMF RNA CAP BINDING | 19 | 9.58e-01 | -7.01e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 24 | 9.53e-01 | -7.00e-03 | 9.90e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 220 | 8.59e-01 | -6.98e-03 | 9.65e-01 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 9.79e-01 | 6.96e-03 | 9.97e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 15 | 9.63e-01 | 6.87e-03 | 9.93e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 33 | 9.46e-01 | 6.86e-03 | 9.88e-01 |
| GOCC CATION CHANNEL COMPLEX | 86 | 9.13e-01 | -6.86e-03 | 9.82e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 719 | 7.56e-01 | -6.86e-03 | 9.43e-01 |
| GOBP PEROXISOME ORGANIZATION | 34 | 9.45e-01 | -6.85e-03 | 9.88e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 16 | 9.62e-01 | -6.85e-03 | 9.93e-01 |
| GOBP NK T CELL DIFFERENTIATION | 7 | 9.75e-01 | 6.84e-03 | 9.97e-01 |
| GOBP BONE CELL DEVELOPMENT | 15 | 9.63e-01 | 6.83e-03 | 9.93e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 37 | 9.43e-01 | 6.83e-03 | 9.88e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 20 | 9.58e-01 | 6.83e-03 | 9.92e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 50 | 9.34e-01 | 6.82e-03 | 9.87e-01 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 13 | 9.66e-01 | 6.81e-03 | 9.93e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 15 | 9.64e-01 | 6.76e-03 | 9.93e-01 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 11 | 9.69e-01 | 6.74e-03 | 9.95e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 8 | 9.74e-01 | 6.69e-03 | 9.96e-01 |
| GOCC TORC2 COMPLEX | 9 | 9.72e-01 | -6.64e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 17 | 9.62e-01 | 6.63e-03 | 9.93e-01 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 78 | 9.19e-01 | 6.63e-03 | 9.83e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 82 | 9.18e-01 | -6.61e-03 | 9.82e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 274 | 8.51e-01 | -6.60e-03 | 9.62e-01 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.73e-01 | -6.60e-03 | 9.96e-01 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 10 | 9.71e-01 | 6.59e-03 | 9.96e-01 |
| GOCC RECYCLING ENDOSOME | 159 | 8.87e-01 | 6.56e-03 | 9.74e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 15 | 9.65e-01 | 6.53e-03 | 9.93e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 80 | 9.20e-01 | 6.53e-03 | 9.83e-01 |
| GOBP DEMETHYLATION | 39 | 9.44e-01 | -6.52e-03 | 9.88e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 19 | 9.61e-01 | 6.52e-03 | 9.93e-01 |
| GOCC CALCIUM CHANNEL COMPLEX | 45 | 9.40e-01 | 6.52e-03 | 9.88e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 59 | 9.32e-01 | 6.42e-03 | 9.87e-01 |
| GOCC MLL1 2 COMPLEX | 32 | 9.50e-01 | -6.42e-03 | 9.90e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 25 | 9.56e-01 | -6.40e-03 | 9.91e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 10 | 9.72e-01 | 6.38e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 25 | 9.56e-01 | -6.36e-03 | 9.91e-01 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 55 | 9.35e-01 | 6.35e-03 | 9.87e-01 |
| GOBP SELECTIVE AUTOPHAGY | 91 | 9.17e-01 | 6.34e-03 | 9.82e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 9.77e-01 | -6.27e-03 | 9.97e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 9 | 9.74e-01 | 6.26e-03 | 9.96e-01 |
| GOCC CELL SURFACE | 480 | 8.16e-01 | 6.25e-03 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 138 | 9.00e-01 | 6.23e-03 | 9.78e-01 |
| GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 109 | 9.11e-01 | -6.22e-03 | 9.82e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 189 | 8.83e-01 | 6.21e-03 | 9.72e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 6 | 9.79e-01 | -6.21e-03 | 9.98e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 74 | 9.27e-01 | -6.19e-03 | 9.85e-01 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1162 | 7.26e-01 | 6.18e-03 | 9.34e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 9.73e-01 | 6.16e-03 | 9.96e-01 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 68 | 9.30e-01 | 6.15e-03 | 9.86e-01 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 119 | 9.08e-01 | -6.12e-03 | 9.81e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 11 | 9.72e-01 | -6.12e-03 | 9.96e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 33 | 9.52e-01 | 6.09e-03 | 9.90e-01 |
| GOBP HEMIDESMOSOME ASSEMBLY | 5 | 9.81e-01 | 6.09e-03 | 9.98e-01 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 9.79e-01 | -6.07e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 357 | 8.44e-01 | -6.07e-03 | 9.62e-01 |
| GOCC SPERM HEAD | 5 | 9.81e-01 | 6.06e-03 | 9.98e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 696 | 7.88e-01 | 6.04e-03 | 9.49e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 391 | 8.39e-01 | 6.02e-03 | 9.61e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 61 | 9.36e-01 | -5.99e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 68 | 9.32e-01 | 5.99e-03 | 9.87e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 8 | 9.77e-01 | 5.98e-03 | 9.97e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1362 | 7.16e-01 | -5.96e-03 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 21 | 9.62e-01 | 5.95e-03 | 9.93e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 9.62e-01 | -5.93e-03 | 9.93e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 61 | 9.36e-01 | -5.91e-03 | 9.87e-01 |
| GOCC ACTOMYOSIN | 57 | 9.39e-01 | 5.88e-03 | 9.87e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 8 | 9.77e-01 | 5.88e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 18 | 9.66e-01 | 5.86e-03 | 9.93e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 110 | 9.16e-01 | -5.86e-03 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 6 | 9.80e-01 | 5.83e-03 | 9.98e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 284 | 8.67e-01 | 5.77e-03 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 12 | 9.72e-01 | 5.77e-03 | 9.96e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 6 | 9.80e-01 | 5.77e-03 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 251 | 8.75e-01 | -5.77e-03 | 9.71e-01 |
| GOBP REGULATION OF MICROVILLUS ASSEMBLY | 6 | 9.81e-01 | -5.68e-03 | 9.98e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 73 | 9.33e-01 | -5.66e-03 | 9.87e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 9 | 9.77e-01 | -5.66e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 54 | 9.43e-01 | -5.64e-03 | 9.88e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 20 | 9.65e-01 | 5.60e-03 | 9.93e-01 |
| GOCC BRUSH BORDER | 64 | 9.38e-01 | 5.60e-03 | 9.87e-01 |
| GOBP NUCLEAR EXPORT | 154 | 9.05e-01 | 5.60e-03 | 9.81e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 18 | 9.67e-01 | 5.59e-03 | 9.94e-01 |
| GOBP STEROL HOMEOSTASIS | 52 | 9.45e-01 | 5.57e-03 | 9.88e-01 |
| GOBP TELOMERE MAINTENANCE | 147 | 9.08e-01 | 5.56e-03 | 9.81e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 703 | 8.03e-01 | 5.55e-03 | 9.56e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.77e-01 | -5.54e-03 | 9.97e-01 |
| GOCC CAVEOLA | 54 | 9.44e-01 | 5.52e-03 | 9.88e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 8 | 9.78e-01 | 5.51e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 5 | 9.83e-01 | -5.51e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 5 | 9.83e-01 | 5.45e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 5 | 9.83e-01 | 5.45e-03 | 9.98e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 9.80e-01 | -5.40e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 32 | 9.58e-01 | 5.40e-03 | 9.92e-01 |
| GOCC SYNAPSE | 888 | 7.87e-01 | -5.39e-03 | 9.49e-01 |
| GOBP MESENCHYMAL CELL MIGRATION | 32 | 9.58e-01 | 5.39e-03 | 9.92e-01 |
| GOBP TAXIS | 278 | 8.78e-01 | -5.35e-03 | 9.72e-01 |
| GOBP CELLULAR RESPONSE TO UV | 75 | 9.37e-01 | -5.30e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 799 | 8.01e-01 | -5.29e-03 | 9.55e-01 |
| GOBP RNA LOCALIZATION | 180 | 9.03e-01 | 5.29e-03 | 9.80e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 376 | 8.61e-01 | -5.29e-03 | 9.66e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 90 | 9.31e-01 | -5.28e-03 | 9.87e-01 |
| GOBP T CELL DIFFERENTIATION | 224 | 8.92e-01 | 5.27e-03 | 9.76e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 298 | 8.76e-01 | -5.27e-03 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 17 | 9.70e-01 | 5.26e-03 | 9.95e-01 |
| GOCC NUCLEAR MEMBRANE | 266 | 8.83e-01 | 5.26e-03 | 9.72e-01 |
| GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 19 | 9.68e-01 | -5.24e-03 | 9.94e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 51 | 9.49e-01 | -5.23e-03 | 9.89e-01 |
| GOCC CHROMATOID BODY | 6 | 9.82e-01 | 5.19e-03 | 9.98e-01 |
| GOBP TOOTH MINERALIZATION | 14 | 9.73e-01 | 5.17e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 27 | 9.63e-01 | -5.17e-03 | 9.93e-01 |
| GOMF BH3 DOMAIN BINDING | 6 | 9.83e-01 | -5.04e-03 | 9.98e-01 |
| GOBP RESPONSE TO LIPID | 584 | 8.37e-01 | -5.03e-03 | 9.61e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 9 | 9.79e-01 | 5.01e-03 | 9.98e-01 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 7 | 9.82e-01 | -4.99e-03 | 9.98e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1282 | 7.68e-01 | -4.97e-03 | 9.46e-01 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 27 | 9.65e-01 | 4.91e-03 | 9.93e-01 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 7 | 9.82e-01 | 4.86e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 167 | 9.14e-01 | 4.85e-03 | 9.82e-01 |
| GOBP UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 5 | 9.85e-01 | 4.85e-03 | 9.98e-01 |
| GOBP B CELL HOMEOSTASIS | 28 | 9.65e-01 | 4.77e-03 | 9.93e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 82 | 9.41e-01 | 4.75e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 12 | 9.77e-01 | 4.74e-03 | 9.97e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 41 | 9.58e-01 | 4.74e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 204 | 9.07e-01 | 4.73e-03 | 9.81e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 96 | 9.37e-01 | 4.71e-03 | 9.87e-01 |
| GOBP VASCULOGENESIS | 44 | 9.57e-01 | 4.67e-03 | 9.92e-01 |
| GOCC CILIARY PLASM | 94 | 9.38e-01 | -4.64e-03 | 9.87e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 9.82e-01 | -4.64e-03 | 9.98e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 17 | 9.74e-01 | 4.59e-03 | 9.96e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 7 | 9.83e-01 | 4.57e-03 | 9.98e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 143 | 9.26e-01 | -4.53e-03 | 9.85e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 18 | 9.74e-01 | 4.50e-03 | 9.96e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 39 | 9.61e-01 | -4.49e-03 | 9.93e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 40 | 9.61e-01 | 4.47e-03 | 9.93e-01 |
| GOBP INTERFERON BETA PRODUCTION | 53 | 9.55e-01 | -4.44e-03 | 9.91e-01 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 70 | 9.49e-01 | 4.44e-03 | 9.89e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 52 | 9.56e-01 | 4.40e-03 | 9.91e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 103 | 9.39e-01 | 4.39e-03 | 9.87e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 87 | 9.44e-01 | 4.38e-03 | 9.88e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 9.76e-01 | 4.36e-03 | 9.97e-01 |
| GOMF APOLIPOPROTEIN BINDING | 10 | 9.81e-01 | -4.36e-03 | 9.98e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 22 | 9.72e-01 | 4.30e-03 | 9.96e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 6 | 9.85e-01 | 4.29e-03 | 9.98e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 145 | 9.29e-01 | -4.29e-03 | 9.86e-01 |
| GOMF VITAMIN B6 BINDING | 35 | 9.65e-01 | -4.27e-03 | 9.93e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 76 | 9.49e-01 | 4.22e-03 | 9.89e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 54 | 9.57e-01 | -4.21e-03 | 9.92e-01 |
| GOCC ACTIN CYTOSKELETON | 351 | 8.93e-01 | -4.19e-03 | 9.76e-01 |
| GOBP FAT CELL PROLIFERATION | 9 | 9.83e-01 | -4.19e-03 | 9.98e-01 |
| GOBP RESPONSE TO ETHER | 10 | 9.82e-01 | 4.16e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 102 | 9.43e-01 | 4.09e-03 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 9.84e-01 | -4.06e-03 | 9.98e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 8 | 9.84e-01 | -4.04e-03 | 9.98e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 597 | 8.67e-01 | -4.03e-03 | 9.68e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 20 | 9.75e-01 | -4.01e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1182 | 8.22e-01 | 3.94e-03 | 9.60e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 91 | 9.48e-01 | 3.92e-03 | 9.89e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 21 | 9.75e-01 | -3.89e-03 | 9.97e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 5 | 9.88e-01 | 3.87e-03 | 9.98e-01 |
| GOBP POLYOL METABOLIC PROCESS | 76 | 9.54e-01 | -3.87e-03 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 8 | 9.85e-01 | 3.85e-03 | 9.98e-01 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 7 | 9.86e-01 | 3.78e-03 | 9.98e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 94 | 9.50e-01 | -3.75e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 18 | 9.78e-01 | -3.74e-03 | 9.97e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 8 | 9.85e-01 | -3.73e-03 | 9.98e-01 |
| GOBP BONE RESORPTION | 47 | 9.65e-01 | 3.71e-03 | 9.93e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 288 | 9.14e-01 | 3.70e-03 | 9.82e-01 |
| GOBP RESPONSE TO MANGANESE ION | 15 | 9.80e-01 | -3.66e-03 | 9.98e-01 |
| GOMF GLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 5 | 9.89e-01 | -3.66e-03 | 9.98e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 161 | 9.37e-01 | -3.64e-03 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 23 | 9.76e-01 | -3.61e-03 | 9.97e-01 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 8 | 9.86e-01 | -3.60e-03 | 9.98e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 49 | 9.66e-01 | 3.48e-03 | 9.93e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 185 | 9.35e-01 | -3.47e-03 | 9.87e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 46 | 9.68e-01 | -3.45e-03 | 9.94e-01 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 8 | 9.87e-01 | -3.43e-03 | 9.98e-01 |
| GOBP CYTOKINESIS | 156 | 9.41e-01 | -3.41e-03 | 9.88e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 9.86e-01 | 3.41e-03 | 9.98e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 50 | 9.67e-01 | -3.41e-03 | 9.93e-01 |
| GOMF PHOSPHOLIPID BINDING | 352 | 9.13e-01 | 3.39e-03 | 9.82e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 16 | 9.81e-01 | 3.39e-03 | 9.98e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 26 | 9.76e-01 | 3.38e-03 | 9.97e-01 |
| GOCC COPI COATED VESICLE | 24 | 9.77e-01 | 3.37e-03 | 9.97e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 9.88e-01 | -3.33e-03 | 9.98e-01 |
| GOMF CENTROMERIC DNA BINDING | 5 | 9.90e-01 | 3.31e-03 | 9.98e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 162 | 9.43e-01 | 3.27e-03 | 9.88e-01 |
| GOBP VIRAL GENOME REPLICATION | 114 | 9.52e-01 | 3.26e-03 | 9.90e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 15 | 9.83e-01 | 3.25e-03 | 9.98e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 7 | 9.88e-01 | -3.25e-03 | 9.98e-01 |
| GOBP CELL CHEMOTAXIS | 196 | 9.38e-01 | 3.25e-03 | 9.87e-01 |
| GOBP NEUTROPHIL DIFFERENTIATION | 9 | 9.87e-01 | 3.24e-03 | 9.98e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 17 | 9.82e-01 | 3.15e-03 | 9.98e-01 |
| GOBP DETECTION OF STIMULUS | 119 | 9.53e-01 | 3.14e-03 | 9.90e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 495 | 9.06e-01 | -3.13e-03 | 9.81e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 79 | 9.62e-01 | -3.12e-03 | 9.93e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 220 | 9.37e-01 | -3.10e-03 | 9.87e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 11 | 9.86e-01 | -3.08e-03 | 9.98e-01 |
| GOBP NADH OXIDATION | 5 | 9.90e-01 | -3.08e-03 | 9.98e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 16 | 9.83e-01 | -3.07e-03 | 9.98e-01 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 38 | 9.74e-01 | 3.04e-03 | 9.96e-01 |
| GOMF LIPID TRANSFER ACTIVITY | 38 | 9.74e-01 | 3.04e-03 | 9.96e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 7 | 9.89e-01 | -3.03e-03 | 9.98e-01 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 47 | 9.72e-01 | 3.00e-03 | 9.96e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 37 | 9.75e-01 | 2.98e-03 | 9.97e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 8 | 9.88e-01 | -2.97e-03 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 13 | 9.85e-01 | 2.96e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 6 | 9.90e-01 | -2.93e-03 | 9.98e-01 |
| GOMF MONOSACCHARIDE BINDING | 55 | 9.71e-01 | -2.86e-03 | 9.96e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 13 | 9.86e-01 | 2.85e-03 | 9.98e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 393 | 9.23e-01 | -2.84e-03 | 9.84e-01 |
| GOBP COLLATERAL SPROUTING | 17 | 9.84e-01 | -2.82e-03 | 9.98e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 376 | 9.28e-01 | 2.74e-03 | 9.85e-01 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 5 | 9.92e-01 | 2.71e-03 | 9.98e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 554 | 9.14e-01 | -2.70e-03 | 9.82e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 630 | 9.09e-01 | 2.69e-03 | 9.81e-01 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 9.90e-01 | 2.69e-03 | 9.98e-01 |
| GOBP RESPONSE TO SALT | 228 | 9.45e-01 | 2.67e-03 | 9.88e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 12 | 9.87e-01 | 2.63e-03 | 9.98e-01 |
| GOMF BILE ACID BINDING | 5 | 9.92e-01 | 2.63e-03 | 9.98e-01 |
| GOMF POLY A BINDING | 20 | 9.84e-01 | -2.62e-03 | 9.98e-01 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 9.85e-01 | 2.60e-03 | 9.98e-01 |
| GOCC EXOCYTIC VESICLE | 151 | 9.57e-01 | 2.56e-03 | 9.92e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 58 | 9.73e-01 | -2.55e-03 | 9.96e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 182 | 9.53e-01 | -2.55e-03 | 9.90e-01 |
| GOBP REGULATION OF SECRETION | 368 | 9.33e-01 | -2.55e-03 | 9.87e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 39 | 9.78e-01 | 2.51e-03 | 9.97e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 100 | 9.66e-01 | 2.50e-03 | 9.93e-01 |
| GOCC DYNEIN COMPLEX | 35 | 9.80e-01 | 2.48e-03 | 9.98e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 142 | 9.60e-01 | 2.46e-03 | 9.92e-01 |
| GOBP POTASSIUM ION TRANSPORT | 105 | 9.66e-01 | 2.43e-03 | 9.93e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 219 | 9.51e-01 | 2.42e-03 | 9.90e-01 |
| GOBP TELOMERE CAPPING | 37 | 9.80e-01 | 2.41e-03 | 9.98e-01 |
| GOBP NEURON MATURATION | 28 | 9.82e-01 | -2.40e-03 | 9.98e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 52 | 9.76e-01 | 2.39e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 284 | 9.45e-01 | 2.38e-03 | 9.88e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 198 | 9.54e-01 | -2.36e-03 | 9.91e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 697 | 9.18e-01 | 2.31e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 6 | 9.92e-01 | 2.31e-03 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 47 | 9.78e-01 | -2.27e-03 | 9.97e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 30 | 9.83e-01 | 2.27e-03 | 9.98e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 47 | 9.79e-01 | 2.26e-03 | 9.97e-01 |
| GOBP HETEROCYCLE CATABOLIC PROCESS | 399 | 9.39e-01 | -2.25e-03 | 9.87e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 411 | 9.39e-01 | 2.20e-03 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 9.92e-01 | 2.20e-03 | 9.98e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 227 | 9.55e-01 | 2.20e-03 | 9.91e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 184 | 9.60e-01 | 2.16e-03 | 9.92e-01 |
| GOCC MYOSIN COMPLEX | 29 | 9.84e-01 | -2.15e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 12 | 9.90e-01 | -2.15e-03 | 9.98e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 19 | 9.87e-01 | -2.15e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 9 | 9.91e-01 | 2.14e-03 | 9.98e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 6 | 9.93e-01 | 2.13e-03 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1600 | 8.89e-01 | -2.13e-03 | 9.75e-01 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 38 | 9.82e-01 | -2.08e-03 | 9.98e-01 |
| GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 80 | 9.75e-01 | 2.07e-03 | 9.97e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 605 | 9.31e-01 | -2.06e-03 | 9.87e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 294 | 9.52e-01 | 2.05e-03 | 9.90e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 9.93e-01 | 2.05e-03 | 9.98e-01 |
| GOCC I BAND | 87 | 9.74e-01 | 2.04e-03 | 9.96e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 120 | 9.70e-01 | -1.98e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 97 | 9.73e-01 | 1.97e-03 | 9.96e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 229 | 9.60e-01 | -1.94e-03 | 9.92e-01 |
| GOBP AGGRESOME ASSEMBLY | 5 | 9.94e-01 | 1.94e-03 | 9.99e-01 |
| GOBP SENSORY PERCEPTION | 252 | 9.58e-01 | -1.94e-03 | 9.92e-01 |
| GOMF ACTIN FILAMENT BINDING | 147 | 9.68e-01 | 1.90e-03 | 9.94e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 54 | 9.81e-01 | -1.88e-03 | 9.98e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 60 | 9.81e-01 | -1.81e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 35 | 9.85e-01 | 1.80e-03 | 9.98e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 70 | 9.80e-01 | -1.78e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 42 | 9.84e-01 | -1.77e-03 | 9.98e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 20 | 9.89e-01 | 1.76e-03 | 9.98e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 29 | 9.87e-01 | -1.75e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 22 | 9.89e-01 | 1.75e-03 | 9.98e-01 |
| GOCC SPERM PRINCIPAL PIECE | 16 | 9.90e-01 | -1.73e-03 | 9.98e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 555 | 9.45e-01 | 1.72e-03 | 9.88e-01 |
| GOMF LIPID BINDING | 574 | 9.45e-01 | -1.70e-03 | 9.88e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 17 | 9.90e-01 | 1.70e-03 | 9.98e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 33 | 9.87e-01 | 1.69e-03 | 9.98e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 111 | 9.76e-01 | 1.65e-03 | 9.97e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 9.95e-01 | -1.61e-03 | 9.99e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 19 | 9.91e-01 | 1.58e-03 | 9.98e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 29 | 9.88e-01 | -1.55e-03 | 9.98e-01 |
| GOCC CILIARY MEMBRANE | 47 | 9.86e-01 | 1.47e-03 | 9.98e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 170 | 9.74e-01 | 1.44e-03 | 9.96e-01 |
| GOBP REGULATION OF RNA BINDING | 9 | 9.94e-01 | -1.40e-03 | 9.99e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 43 | 9.88e-01 | -1.38e-03 | 9.98e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 333 | 9.66e-01 | -1.38e-03 | 9.93e-01 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 24 | 9.91e-01 | 1.34e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 40 | 9.88e-01 | 1.33e-03 | 9.98e-01 |
| GOBP HOMEOSTATIC PROCESS | 1109 | 9.42e-01 | 1.31e-03 | 9.88e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 148 | 9.78e-01 | 1.30e-03 | 9.97e-01 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 28 | 9.91e-01 | -1.30e-03 | 9.98e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 190 | 9.76e-01 | 1.29e-03 | 9.97e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 43 | 9.89e-01 | -1.25e-03 | 9.98e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 130 | 9.81e-01 | -1.24e-03 | 9.98e-01 |
| GOBP RESPONSE TO UV | 126 | 9.81e-01 | 1.21e-03 | 9.98e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 56 | 9.87e-01 | -1.21e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 115 | 9.82e-01 | -1.20e-03 | 9.98e-01 |
| GOCC AXON CYTOPLASM | 50 | 9.88e-01 | -1.18e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 8 | 9.95e-01 | 1.17e-03 | 9.99e-01 |
| GOMF PEPTIDE BINDING | 200 | 9.78e-01 | 1.13e-03 | 9.97e-01 |
| GOBP VACUOLAR TRANSPORT | 149 | 9.81e-01 | -1.11e-03 | 9.98e-01 |
| GOMF TOXIC SUBSTANCE BINDING | 6 | 9.96e-01 | 1.10e-03 | 9.99e-01 |
| GOBP PROTEIN ACETYLATION | 89 | 9.86e-01 | 1.08e-03 | 9.98e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 16 | 9.94e-01 | -1.08e-03 | 9.99e-01 |
| GOBP RELAXATION OF MUSCLE | 24 | 9.93e-01 | -1.06e-03 | 9.98e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 25 | 9.93e-01 | -1.06e-03 | 9.98e-01 |
| GOBP EXPLORATION BEHAVIOR | 13 | 9.95e-01 | -1.05e-03 | 9.99e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 479 | 9.69e-01 | 1.03e-03 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 8 | 9.96e-01 | -1.02e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 42 | 9.91e-01 | 9.93e-04 | 9.98e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 68 | 9.89e-01 | -9.87e-04 | 9.98e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 50 | 9.90e-01 | 9.80e-04 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 46 | 9.91e-01 | 9.27e-04 | 9.98e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 8 | 9.96e-01 | 9.24e-04 | 9.99e-01 |
| GOBP NUCLEUS ORGANIZATION | 127 | 9.86e-01 | -9.20e-04 | 9.98e-01 |
| GOMF AMIDE BINDING | 265 | 9.80e-01 | 9.17e-04 | 9.98e-01 |
| GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.97e-01 | 8.85e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 9.94e-01 | -8.77e-04 | 9.99e-01 |
| GOCC LAMELLIPODIUM | 169 | 9.84e-01 | 8.74e-04 | 9.98e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 10 | 9.96e-01 | 8.45e-04 | 9.99e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 289 | 9.81e-01 | -8.06e-04 | 9.98e-01 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 25 | 9.95e-01 | -7.91e-04 | 9.99e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 196 | 9.85e-01 | 7.76e-04 | 9.98e-01 |
| GOCC NEURON PROJECTION TERMINUS | 62 | 9.92e-01 | -7.57e-04 | 9.98e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 73 | 9.91e-01 | 7.46e-04 | 9.98e-01 |
| GOBP IMPORT INTO CELL | 632 | 9.75e-01 | 7.38e-04 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 105 | 9.90e-01 | 7.37e-04 | 9.98e-01 |
| GOBP PIGMENTATION | 84 | 9.91e-01 | 7.30e-04 | 9.98e-01 |
| GOBP XENOPHAGY | 14 | 9.96e-01 | -7.08e-04 | 9.99e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 81 | 9.91e-01 | 6.91e-04 | 9.98e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 112 | 9.90e-01 | 6.66e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 11 | 9.97e-01 | 6.42e-04 | 9.99e-01 |
| GOBP DNA INTEGRATION | 6 | 9.98e-01 | 6.38e-04 | 1.00e+00 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 64 | 9.93e-01 | 6.05e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 276 | 9.87e-01 | 5.86e-04 | 9.98e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 20 | 9.96e-01 | 5.82e-04 | 9.99e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 45 | 9.95e-01 | -5.16e-04 | 9.99e-01 |
| GOBP PROTEIN DESUMOYLATION | 8 | 9.98e-01 | -4.62e-04 | 1.00e+00 |
| GOCC PRESYNAPSE | 342 | 9.88e-01 | 4.59e-04 | 9.98e-01 |
| GOCC NUCLEOSOME | 33 | 9.96e-01 | 4.47e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 51 | 9.96e-01 | -4.25e-04 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 43 | 9.96e-01 | -4.02e-04 | 9.99e-01 |
| GOCC SYNAPTIC CLEFT | 7 | 9.99e-01 | -3.68e-04 | 1.00e+00 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 25 | 9.97e-01 | -3.62e-04 | 1.00e+00 |
| GOBP ENDOCYTIC RECYCLING | 75 | 9.96e-01 | -3.40e-04 | 9.99e-01 |
| GOCC NUCLEAR ENVELOPE | 415 | 9.91e-01 | 3.29e-04 | 9.98e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 553 | 9.90e-01 | -3.29e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 766 | 9.88e-01 | 3.16e-04 | 9.98e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 52 | 9.97e-01 | 3.11e-04 | 9.99e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 113 | 9.95e-01 | 3.10e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 814 | 9.88e-01 | -3.04e-04 | 9.98e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 10 | 9.99e-01 | -3.04e-04 | 1.00e+00 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 186 | 9.95e-01 | 2.73e-04 | 9.99e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 21 | 9.99e-01 | -2.36e-04 | 1.00e+00 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 9.99e-01 | -2.27e-04 | 1.00e+00 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 319 | 9.95e-01 | 2.22e-04 | 9.99e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 161 | 9.96e-01 | -2.10e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 7 | 9.99e-01 | 1.98e-04 | 1.00e+00 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 37 | 9.98e-01 | -1.95e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 44 | 9.98e-01 | 1.90e-04 | 1.00e+00 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 9 | 9.99e-01 | -1.83e-04 | 1.00e+00 |
| GOBP FILOPODIUM ASSEMBLY | 51 | 9.98e-01 | 1.78e-04 | 1.00e+00 |
| GOMF SERINE HYDROLASE ACTIVITY | 91 | 9.98e-01 | -1.63e-04 | 1.00e+00 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 1.00e+00 | 1.23e-04 | 1.00e+00 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 31 | 9.99e-01 | -1.22e-04 | 1.00e+00 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 123 | 9.98e-01 | -1.05e-04 | 1.00e+00 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 1.00e+00 | 9.44e-05 | 1.00e+00 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 71 | 9.99e-01 | 9.25e-05 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 29 | 1.00e+00 | -6.61e-05 | 1.00e+00 |
| GOBP CLEAVAGE FURROW FORMATION | 7 | 1.00e+00 | -2.83e-05 | 1.00e+00 |
Detailed Gene set reports
GOBP TRANS SYNAPTIC SIGNALING BY LIPID
| set | GOBP TRANS SYNAPTIC SIGNALING BY LIPID |
| setSize | 5 |
| pANOVA | 0.000919 |
| s.dist | -0.856 |
| p.adjustANOVA | 0.0657 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PLCB1 | -7954 |
| FABP5 | -7730 |
| ABHD6 | -7530 |
| F2R | -7106 |
| DAGLA | -4018 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PLCB1 | -7954 |
| FABP5 | -7730 |
| ABHD6 | -7530 |
| F2R | -7106 |
| DAGLA | -4018 |
GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY
| set | GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00169 |
| s.dist | -0.811 |
| p.adjustANOVA | 0.0919 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AKR1C3 | -7960 |
| HSD17B8 | -7456 |
| DHRS9 | -7341 |
| HSD17B10 | -5983 |
| HSD17B1 | -3902 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AKR1C3 | -7960 |
| HSD17B8 | -7456 |
| DHRS9 | -7341 |
| HSD17B10 | -5983 |
| HSD17B1 | -3902 |
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX
| set | GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX |
| setSize | 7 |
| pANOVA | 0.000534 |
| s.dist | -0.756 |
| p.adjustANOVA | 0.0432 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMA6 | -7250 |
| PSMA2 | -7166 |
| PSMA1 | -6742 |
| PSMA5 | -5813 |
| PSMA4 | -5665 |
| PSMA7 | -5497 |
| PSMA3 | -4633 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PSMA6 | -7250 |
| PSMA2 | -7166 |
| PSMA1 | -6742 |
| PSMA5 | -5813 |
| PSMA4 | -5665 |
| PSMA7 | -5497 |
| PSMA3 | -4633 |
GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS
| set | GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS |
| setSize | 5 |
| pANOVA | 0.00356 |
| s.dist | -0.753 |
| p.adjustANOVA | 0.144 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TKT | -7695 |
| TKFC | -7209 |
| TALDO1 | -6419 |
| TPI1 | -4950 |
| GLYCTK | -4159 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TKT | -7695 |
| TKFC | -7209 |
| TALDO1 | -6419 |
| TPI1 | -4950 |
| GLYCTK | -4159 |
GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY
| set | GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00392 |
| s.dist | -0.745 |
| p.adjustANOVA | 0.151 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GNAI3 | -7569 |
| ADGRV1 | -7248 |
| AKAP5 | -5969 |
| GNAI2 | -5783 |
| GABBR2 | -3568 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GNAI3 | -7569 |
| ADGRV1 | -7248 |
| AKAP5 | -5969 |
| GNAI2 | -5783 |
| GABBR2 | -3568 |
GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX
| set | GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX |
| setSize | 7 |
| pANOVA | 0.00105 |
| s.dist | -0.715 |
| p.adjustANOVA | 0.0728 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ADRM1 | -7896 |
| PSMD3 | -7833 |
| PSMD8 | -6248 |
| PSMD13 | -6048 |
| PSMD12 | -5771 |
| PSMD14 | -4336 |
| PSMD11 | -2480 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ADRM1 | -7896 |
| PSMD3 | -7833 |
| PSMD8 | -6248 |
| PSMD13 | -6048 |
| PSMD12 | -5771 |
| PSMD14 | -4336 |
| PSMD11 | -2480 |
GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION
| set | GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION |
| setSize | 5 |
| pANOVA | 0.00671 |
| s.dist | 0.7 |
| p.adjustANOVA | 0.194 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ATP8A2 | 6774 |
| ATP8A1 | 5960 |
| TMEM30A | 5441 |
| ABCB4 | 3401 |
| PRKCD | 3000 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ATP8A2 | 6774 |
| ATP8A1 | 5960 |
| TMEM30A | 5441 |
| ABCB4 | 3401 |
| PRKCD | 3000 |
GOCC LAMIN FILAMENT
| set | GOCC LAMIN FILAMENT |
| setSize | 5 |
| pANOVA | 0.00675 |
| s.dist | -0.699 |
| p.adjustANOVA | 0.194 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LMNTD2 | -7651 |
| EIF6 | -6979 |
| LMNB1 | -6571 |
| NARF | -4920 |
| LMNA | -2299 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| LMNTD2 | -7651 |
| EIF6 | -6979 |
| LMNB1 | -6571 |
| NARF | -4920 |
| LMNA | -2299 |
GOCC WEIBEL PALADE BODY
| set | GOCC WEIBEL PALADE BODY |
| setSize | 5 |
| pANOVA | 0.00825 |
| s.dist | 0.682 |
| p.adjustANOVA | 0.214 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| UNC13D | 6336 |
| EDN1 | 6237 |
| VWF | 5394 |
| ECE1 | 4289 |
| RAB27A | 1642 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| UNC13D | 6336 |
| EDN1 | 6237 |
| VWF | 5394 |
| ECE1 | 4289 |
| RAB27A | 1642 |
GOBP GALACTOSE CATABOLIC PROCESS
| set | GOBP GALACTOSE CATABOLIC PROCESS |
| setSize | 5 |
| pANOVA | 0.00894 |
| s.dist | -0.675 |
| p.adjustANOVA | 0.22 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GALK1 | -7925 |
| GALT | -7508 |
| GLB1 | -6383 |
| GALE | -4035 |
| GALM | -1646 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GALK1 | -7925 |
| GALT | -7508 |
| GLB1 | -6383 |
| GALE | -4035 |
| GALM | -1646 |
GOBP POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS
| set | GOBP POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS |
| setSize | 5 |
| pANOVA | 0.00993 |
| s.dist | -0.666 |
| p.adjustANOVA | 0.233 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PTGS2 | -7098 |
| ANXA1 | -6829 |
| AVP | -6659 |
| IL1B | -3553 |
| CD74 | -3007 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PTGS2 | -7098 |
| ANXA1 | -6829 |
| AVP | -6659 |
| IL1B | -3553 |
| CD74 | -3007 |
GOBP SKELETAL MUSCLE TISSUE GROWTH
| set | GOBP SKELETAL MUSCLE TISSUE GROWTH |
| setSize | 5 |
| pANOVA | 0.0102 |
| s.dist | 0.663 |
| p.adjustANOVA | 0.236 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS6KB1 | 6055 |
| MTM1 | 5470 |
| CHRNA1 | 5005 |
| DLL1 | 3362 |
| VPS54 | 3288 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RPS6KB1 | 6055 |
| MTM1 | 5470 |
| CHRNA1 | 5005 |
| DLL1 | 3362 |
| VPS54 | 3288 |
GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS
| set | GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS |
| setSize | 7 |
| pANOVA | 0.00272 |
| s.dist | 0.654 |
| p.adjustANOVA | 0.122 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ADAR | 6739 |
| STK4 | 6619 |
| RB1 | 6435 |
| IGF1R | 6173 |
| PPARA | 4543 |
| PRKAA1 | 2166 |
| CFLAR | -704 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ADAR | 6739 |
| STK4 | 6619 |
| RB1 | 6435 |
| IGF1R | 6173 |
| PPARA | 4543 |
| PRKAA1 | 2166 |
| CFLAR | -704 |
GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS
| set | GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS |
| setSize | 7 |
| pANOVA | 0.00295 |
| s.dist | -0.649 |
| p.adjustANOVA | 0.129 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SRRD | -7495 |
| TMEM14A | -6572 |
| TMEM14B | -5759 |
| ABCB7 | -5302 |
| TMEM14C | -4269 |
| ABCB10 | -4054 |
| CLYBL | -3647 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SRRD | -7495 |
| TMEM14A | -6572 |
| TMEM14B | -5759 |
| ABCB7 | -5302 |
| TMEM14C | -4269 |
| ABCB10 | -4054 |
| CLYBL | -3647 |
GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY
| set | GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0123 |
| s.dist | 0.647 |
| p.adjustANOVA | 0.253 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ATP8A2 | 6774 |
| ATP11C | 6487 |
| ABCB1 | 3776 |
| ATP11B | 3756 |
| ATP11A | 1762 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ATP8A2 | 6774 |
| ATP11C | 6487 |
| ABCB1 | 3776 |
| ATP11B | 3756 |
| ATP11A | 1762 |
GOCC PROTEASOME CORE COMPLEX
| set | GOCC PROTEASOME CORE COMPLEX |
| setSize | 18 |
| pANOVA | 2.35e-06 |
| s.dist | -0.643 |
| p.adjustANOVA | 0.000706 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB1 | -7711 |
| PSMB10 | -7591 |
| PSMA6 | -7250 |
| PSMA2 | -7166 |
| PSMB3 | -7163 |
| PSMB8 | -6793 |
| PSMA1 | -6742 |
| PSMB7 | -6444 |
| PSMB9 | -6062 |
| PSMA5 | -5813 |
| PSMA4 | -5665 |
| PSMA7 | -5497 |
| PSMA3 | -4633 |
| PSMB6 | -3955 |
| PSMB2 | -3842 |
| PSMB5 | -2248 |
| PSMB4 | -687 |
| PSMF1 | 774 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PSMB1 | -7711 |
| PSMB10 | -7591 |
| PSMA6 | -7250 |
| PSMA2 | -7166 |
| PSMB3 | -7163 |
| PSMB8 | -6793 |
| PSMA1 | -6742 |
| PSMB7 | -6444 |
| PSMB9 | -6062 |
| PSMA5 | -5813 |
| PSMA4 | -5665 |
| PSMA7 | -5497 |
| PSMA3 | -4633 |
| PSMB6 | -3955 |
| PSMB2 | -3842 |
| PSMB5 | -2248 |
| PSMB4 | -687 |
| PSMF1 | 774 |
GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX
| set | GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX |
| setSize | 10 |
| pANOVA | 0.000436 |
| s.dist | -0.642 |
| p.adjustANOVA | 0.0388 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB1 | -7711 |
| PSMB10 | -7591 |
| PSMB3 | -7163 |
| PSMB8 | -6793 |
| PSMB7 | -6444 |
| PSMB9 | -6062 |
| PSMB6 | -3955 |
| PSMB2 | -3842 |
| PSMB5 | -2248 |
| PSMB4 | -687 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PSMB1 | -7711 |
| PSMB10 | -7591 |
| PSMB3 | -7163 |
| PSMB8 | -6793 |
| PSMB7 | -6444 |
| PSMB9 | -6062 |
| PSMB6 | -3955 |
| PSMB2 | -3842 |
| PSMB5 | -2248 |
| PSMB4 | -687 |
GOBP PHOSPHATE ION HOMEOSTASIS
| set | GOBP PHOSPHATE ION HOMEOSTASIS |
| setSize | 6 |
| pANOVA | 0.00658 |
| s.dist | 0.641 |
| p.adjustANOVA | 0.192 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ANKH | 6859 |
| ENPP3 | 5815 |
| SFRP4 | 4965 |
| XPR1 | 4734 |
| SLC17A7 | 4575 |
| ABCC6 | -157 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ANKH | 6859 |
| ENPP3 | 5815 |
| SFRP4 | 4965 |
| XPR1 | 4734 |
| SLC17A7 | 4575 |
| ABCC6 | -157 |
GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE
| set | GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE |
| setSize | 5 |
| pANOVA | 0.0134 |
| s.dist | -0.639 |
| p.adjustANOVA | 0.262 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HSPA5 | -7899 |
| DDRGK1 | -7201 |
| DNAJB9 | -4794 |
| BFAR | -4719 |
| UFL1 | -1501 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HSPA5 | -7899 |
| DDRGK1 | -7201 |
| DNAJB9 | -4794 |
| BFAR | -4719 |
| UFL1 | -1501 |
GOMF CASPASE BINDING
| set | GOMF CASPASE BINDING |
| setSize | 8 |
| pANOVA | 0.00206 |
| s.dist | -0.629 |
| p.adjustANOVA | 0.104 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NOL3 | -6938 |
| CASP1 | -6326 |
| RIPK2 | -6029 |
| CARD16 | -6024 |
| FADD | -5890 |
| RIOK3 | -4734 |
| BFAR | -4719 |
| NLRC4 | -537 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NOL3 | -6938 |
| CASP1 | -6326 |
| RIPK2 | -6029 |
| CARD16 | -6024 |
| FADD | -5890 |
| RIOK3 | -4734 |
| BFAR | -4719 |
| NLRC4 | -537 |
GOCC MEIOTIC COHESIN COMPLEX
| set | GOCC MEIOTIC COHESIN COMPLEX |
| setSize | 5 |
| pANOVA | 0.0153 |
| s.dist | 0.626 |
| p.adjustANOVA | 0.277 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| STAG3 | 7054 |
| REC8 | 5453 |
| RAD21 | 5048 |
| SMC3 | 3492 |
| SMC1A | 740 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| STAG3 | 7054 |
| REC8 | 5453 |
| RAD21 | 5048 |
| SMC3 | 3492 |
| SMC1A | 740 |
GOBP PROTEIN UNFOLDING
| set | GOBP PROTEIN UNFOLDING |
| setSize | 5 |
| pANOVA | 0.016 |
| s.dist | -0.622 |
| p.adjustANOVA | 0.282 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ERP29 | -7399 |
| HSP90AA1 | -7319 |
| ANGPTL4 | -6918 |
| PEX6 | -3756 |
| PEX1 | -107 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ERP29 | -7399 |
| HSP90AA1 | -7319 |
| ANGPTL4 | -6918 |
| PEX6 | -3756 |
| PEX1 | -107 |
GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS
| set | GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS |
| setSize | 5 |
| pANOVA | 0.0161 |
| s.dist | 0.621 |
| p.adjustANOVA | 0.282 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CCL4 | 6854 |
| CCL2 | 5786 |
| CCL5 | 5608 |
| CCL3 | 3837 |
| CCL7 | -489 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CCL4 | 6854 |
| CCL2 | 5786 |
| CCL5 | 5608 |
| CCL3 | 3837 |
| CCL7 | -489 |
GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY
| set | GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY |
| setSize | 6 |
| pANOVA | 0.00881 |
| s.dist | -0.618 |
| p.adjustANOVA | 0.219 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TGFB2 | -7690 |
| IL10 | -7532 |
| CR1L | -5076 |
| CD59 | -4064 |
| CD55 | -3720 |
| CR1 | -2295 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TGFB2 | -7690 |
| IL10 | -7532 |
| CR1L | -5076 |
| CD59 | -4064 |
| CD55 | -3720 |
| CR1 | -2295 |
GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS
| set | GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS |
| setSize | 6 |
| pANOVA | 0.00979 |
| s.dist | 0.609 |
| p.adjustANOVA | 0.232 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ADAR | 6739 |
| RB1 | 6435 |
| IGF1R | 6173 |
| PPARA | 4543 |
| PRKAA1 | 2166 |
| CFLAR | -704 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ADAR | 6739 |
| RB1 | 6435 |
| IGF1R | 6173 |
| PPARA | 4543 |
| PRKAA1 | 2166 |
| CFLAR | -704 |
GOBP URETER DEVELOPMENT
| set | GOBP URETER DEVELOPMENT |
| setSize | 5 |
| pANOVA | 0.0186 |
| s.dist | 0.608 |
| p.adjustANOVA | 0.295 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ALDH1A2 | 5557 |
| NFIA | 5401 |
| LZTS2 | 3777 |
| RET | 3773 |
| NPHP3 | 2583 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ALDH1A2 | 5557 |
| NFIA | 5401 |
| LZTS2 | 3777 |
| RET | 3773 |
| NPHP3 | 2583 |
GOCC TRANSCRIPTION EXPORT COMPLEX 2
| set | GOCC TRANSCRIPTION EXPORT COMPLEX 2 |
| setSize | 5 |
| pANOVA | 0.0194 |
| s.dist | -0.604 |
| p.adjustANOVA | 0.299 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PCID2 | -7610 |
| MCM3AP | -6559 |
| CETN3 | -5542 |
| ENY2 | -5240 |
| CETN2 | 161 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PCID2 | -7610 |
| MCM3AP | -6559 |
| CETN3 | -5542 |
| ENY2 | -5240 |
| CETN2 | 161 |
GOBP TYPE II HYPERSENSITIVITY
| set | GOBP TYPE II HYPERSENSITIVITY |
| setSize | 5 |
| pANOVA | 0.0195 |
| s.dist | -0.603 |
| p.adjustANOVA | 0.299 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| C3 | -7044 |
| HLA-E | -5205 |
| FCGR2B | -5155 |
| FCGR1A | -3848 |
| FCGR3A | -3528 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| C3 | -7044 |
| HLA-E | -5205 |
| FCGR2B | -5155 |
| FCGR1A | -3848 |
| FCGR3A | -3528 |
GOBP INTERLEUKIN 1 ALPHA PRODUCTION
| set | GOBP INTERLEUKIN 1 ALPHA PRODUCTION |
| setSize | 5 |
| pANOVA | 0.0208 |
| s.dist | 0.597 |
| p.adjustANOVA | 0.306 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IL16 | 6838 |
| S100A13 | 6502 |
| IL1R2 | 6111 |
| PANX1 | 3833 |
| P2RX7 | -2606 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IL16 | 6838 |
| S100A13 | 6502 |
| IL1R2 | 6111 |
| PANX1 | 3833 |
| P2RX7 | -2606 |
GOBP PLASMA CELL DIFFERENTIATION
| set | GOBP PLASMA CELL DIFFERENTIATION |
| setSize | 6 |
| pANOVA | 0.0119 |
| s.dist | -0.593 |
| p.adjustANOVA | 0.252 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IL10 | -7532 |
| XBP1 | -7219 |
| BCL6 | -6193 |
| LGALS1 | -5112 |
| CR1 | -2295 |
| NFKBIZ | -913 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IL10 | -7532 |
| XBP1 | -7219 |
| BCL6 | -6193 |
| LGALS1 | -5112 |
| CR1 | -2295 |
| NFKBIZ | -913 |
GOBP CELLULAR DETOXIFICATION OF ALDEHYDE
| set | GOBP CELLULAR DETOXIFICATION OF ALDEHYDE |
| setSize | 7 |
| pANOVA | 0.00664 |
| s.dist | -0.592 |
| p.adjustANOVA | 0.193 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AKR1A1 | -7442 |
| ADH5 | -7415 |
| ESD | -6382 |
| ALDH1A1 | -4431 |
| RDH12 | -3772 |
| PARK7 | -2894 |
| RDH11 | -1772 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AKR1A1 | -7442 |
| ADH5 | -7415 |
| ESD | -6382 |
| ALDH1A1 | -4431 |
| RDH12 | -3772 |
| PARK7 | -2894 |
| RDH11 | -1772 |
GOCC GROWTH FACTOR COMPLEX
| set | GOCC GROWTH FACTOR COMPLEX |
| setSize | 5 |
| pANOVA | 0.022 |
| s.dist | 0.592 |
| p.adjustANOVA | 0.312 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IGFBP6 | 6981 |
| VEGFA | 6518 |
| IGF1 | 6396 |
| PDGFB | 2691 |
| PDGFA | -2113 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IGFBP6 | 6981 |
| VEGFA | 6518 |
| IGF1 | 6396 |
| PDGFB | 2691 |
| PDGFA | -2113 |
GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX
| set | GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX |
| setSize | 5 |
| pANOVA | 0.0228 |
| s.dist | 0.588 |
| p.adjustANOVA | 0.317 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| POLA2 | 6999 |
| MCM3 | 6419 |
| PRIM2 | 5159 |
| POLA1 | 5093 |
| PRIM1 | -3331 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| POLA2 | 6999 |
| MCM3 | 6419 |
| PRIM2 | 5159 |
| POLA1 | 5093 |
| PRIM1 | -3331 |
GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION
| set | GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION |
| setSize | 6 |
| pANOVA | 0.0126 |
| s.dist | 0.588 |
| p.adjustANOVA | 0.253 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SRF | 7145 |
| NOTCH1 | 6453 |
| GREM1 | 5799 |
| REST | 3297 |
| RBPJ | 1314 |
| ITGB1 | 397 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SRF | 7145 |
| NOTCH1 | 6453 |
| GREM1 | 5799 |
| REST | 3297 |
| RBPJ | 1314 |
| ITGB1 | 397 |
GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT
| set | GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT |
| setSize | 7 |
| pANOVA | 0.00709 |
| s.dist | 0.588 |
| p.adjustANOVA | 0.198 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| KIF14 | 5481 |
| OPHN1 | 5349 |
| MDK | 5179 |
| TTBK2 | 4121 |
| MTPN | 3180 |
| FAIM2 | 3040 |
| SERPINE2 | 2098 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| KIF14 | 5481 |
| OPHN1 | 5349 |
| MDK | 5179 |
| TTBK2 | 4121 |
| MTPN | 3180 |
| FAIM2 | 3040 |
| SERPINE2 | 2098 |
GOCC SPECTRIN ASSOCIATED CYTOSKELETON
| set | GOCC SPECTRIN ASSOCIATED CYTOSKELETON |
| setSize | 5 |
| pANOVA | 0.0232 |
| s.dist | 0.586 |
| p.adjustANOVA | 0.318 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ANK3 | 6468 |
| SPTBN2 | 5882 |
| ANK1 | 5486 |
| EPB41 | 1514 |
| SPTBN1 | 919 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ANK3 | 6468 |
| SPTBN2 | 5882 |
| ANK1 | 5486 |
| EPB41 | 1514 |
| SPTBN1 | 919 |
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION
| set | GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
| setSize | 9 |
| pANOVA | 0.00234 |
| s.dist | 0.586 |
| p.adjustANOVA | 0.114 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ZFPM2 | 6763 |
| CDK1 | 6472 |
| NOTCH1 | 6453 |
| MEF2C | 6231 |
| MAPK14 | 5537 |
| PIM1 | 2940 |
| BMPR1A | 1864 |
| RBPJ | 1314 |
| TGFBR3 | -1133 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ZFPM2 | 6763 |
| CDK1 | 6472 |
| NOTCH1 | 6453 |
| MEF2C | 6231 |
| MAPK14 | 5537 |
| PIM1 | 2940 |
| BMPR1A | 1864 |
| RBPJ | 1314 |
| TGFBR3 | -1133 |
GOCC PARANODE REGION OF AXON
| set | GOCC PARANODE REGION OF AXON |
| setSize | 5 |
| pANOVA | 0.0236 |
| s.dist | -0.585 |
| p.adjustANOVA | 0.319 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SPTBN4 | -7918 |
| CNTNAP2 | -6680 |
| SIRT2 | -5971 |
| NCMAP | -3910 |
| EPB41L3 | 408 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SPTBN4 | -7918 |
| CNTNAP2 | -6680 |
| SIRT2 | -5971 |
| NCMAP | -3910 |
| EPB41L3 | 408 |
GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS
| set | GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS |
| setSize | 7 |
| pANOVA | 0.0074 |
| s.dist | 0.585 |
| p.adjustANOVA | 0.204 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SETD2 | 6061 |
| SUPT6H | 5100 |
| AKAP8L | 4932 |
| WNK1 | 4490 |
| IWS1 | 4156 |
| TPR | 3010 |
| NSUN2 | 532 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SETD2 | 6061 |
| SUPT6H | 5100 |
| AKAP8L | 4932 |
| WNK1 | 4490 |
| IWS1 | 4156 |
| TPR | 3010 |
| NSUN2 | 532 |
GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY
| set | GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY |
| setSize | 5 |
| pANOVA | 0.0236 |
| s.dist | 0.584 |
| p.adjustANOVA | 0.319 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DDR2 | 6952 |
| COL4A2 | 6664 |
| COL4A1 | 6095 |
| UBASH3B | 3813 |
| SYK | -3325 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DDR2 | 6952 |
| COL4A2 | 6664 |
| COL4A1 | 6095 |
| UBASH3B | 3813 |
| SYK | -3325 |
GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION
| set | GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION |
| setSize | 5 |
| pANOVA | 0.024 |
| s.dist | -0.583 |
| p.adjustANOVA | 0.32 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LGALS9 | -6630 |
| HLA-DRA | -5732 |
| IL2RG | -4685 |
| HLA-DRB1 | -3892 |
| KLHL25 | -3069 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| LGALS9 | -6630 |
| HLA-DRA | -5732 |
| IL2RG | -4685 |
| HLA-DRB1 | -3892 |
| KLHL25 | -3069 |
GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS
| set | GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS |
| setSize | 6 |
| pANOVA | 0.0135 |
| s.dist | 0.582 |
| p.adjustANOVA | 0.264 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| C12orf29 | 6910 |
| RTCA | 5000 |
| LIG3 | 3959 |
| LIG1 | 3324 |
| LIG4 | 2543 |
| RTCB | 2396 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| C12orf29 | 6910 |
| RTCA | 5000 |
| LIG3 | 3959 |
| LIG1 | 3324 |
| LIG4 | 2543 |
| RTCB | 2396 |
GOBP SEQUESTERING OF IRON ION
| set | GOBP SEQUESTERING OF IRON ION |
| setSize | 5 |
| pANOVA | 0.0242 |
| s.dist | -0.582 |
| p.adjustANOVA | 0.322 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SRI | -7764 |
| NAGLU | -7440 |
| BDH2 | -4303 |
| FTL | -2401 |
| FTH1 | -2063 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SRI | -7764 |
| NAGLU | -7440 |
| BDH2 | -4303 |
| FTL | -2401 |
| FTH1 | -2063 |
GOBP IRON IMPORT INTO CELL
| set | GOBP IRON IMPORT INTO CELL |
| setSize | 5 |
| pANOVA | 0.0243 |
| s.dist | 0.582 |
| p.adjustANOVA | 0.322 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC39A14 | 6577 |
| SLC11A2 | 5391 |
| SLC39A8 | 4344 |
| CYBRD1 | 3080 |
| ISCU | 704 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SLC39A14 | 6577 |
| SLC11A2 | 5391 |
| SLC39A8 | 4344 |
| CYBRD1 | 3080 |
| ISCU | 704 |
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY
| set | GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY |
| setSize | 6 |
| pANOVA | 0.0139 |
| s.dist | 0.58 |
| p.adjustANOVA | 0.265 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PIK3CA | 6471 |
| PIK3C2B | 6107 |
| PIK3C2A | 5240 |
| PIK3CB | 3633 |
| PIK3CG | 3243 |
| PIK3CD | -654 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PIK3CA | 6471 |
| PIK3C2B | 6107 |
| PIK3C2A | 5240 |
| PIK3CB | 3633 |
| PIK3CG | 3243 |
| PIK3CD | -654 |
GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION
| set | GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION |
| setSize | 5 |
| pANOVA | 0.025 |
| s.dist | 0.579 |
| p.adjustANOVA | 0.323 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DBF4B | 6617 |
| WIZ | 5850 |
| DBF4 | 5697 |
| INO80 | 1080 |
| ATRX | 749 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DBF4B | 6617 |
| WIZ | 5850 |
| DBF4 | 5697 |
| INO80 | 1080 |
| ATRX | 749 |
GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY
| set | GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0251 |
| s.dist | 0.578 |
| p.adjustANOVA | 0.323 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PARP10 | 6632 |
| PARP11 | 5445 |
| PARP16 | 3702 |
| PARP3 | 3245 |
| SIRT6 | 949 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PARP10 | 6632 |
| PARP11 | 5445 |
| PARP16 | 3702 |
| PARP3 | 3245 |
| SIRT6 | 949 |
GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS
| set | GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
| setSize | 7 |
| pANOVA | 0.00843 |
| s.dist | 0.575 |
| p.adjustANOVA | 0.216 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HOXB7 | 6537 |
| VEGFA | 6518 |
| LGR4 | 6101 |
| GREM1 | 5799 |
| MAGED1 | 3407 |
| PAX8 | -4 |
| WNT2B | -586 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HOXB7 | 6537 |
| VEGFA | 6518 |
| LGR4 | 6101 |
| GREM1 | 5799 |
| MAGED1 | 3407 |
| PAX8 | -4 |
| WNT2B | -586 |
GOBP B 1 B CELL DIFFERENTIATION
| set | GOBP B 1 B CELL DIFFERENTIATION |
| setSize | 5 |
| pANOVA | 0.0262 |
| s.dist | -0.574 |
| p.adjustANOVA | 0.329 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CMTM7 | -7135 |
| MALT1 | -5179 |
| CD19 | -4634 |
| SLAMF8 | -3446 |
| PLCL2 | -3277 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CMTM7 | -7135 |
| MALT1 | -5179 |
| CD19 | -4634 |
| SLAMF8 | -3446 |
| PLCL2 | -3277 |
GOBP MEIOTIC CHROMOSOME CONDENSATION
| set | GOBP MEIOTIC CHROMOSOME CONDENSATION |
| setSize | 6 |
| pANOVA | 0.0149 |
| s.dist | 0.574 |
| p.adjustANOVA | 0.274 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCAPD3 | 6100 |
| NCAPD2 | 5178 |
| SMC2 | 5086 |
| SMC4 | 3394 |
| NCAPH | 2791 |
| NCAPH2 | 1211 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NCAPD3 | 6100 |
| NCAPD2 | 5178 |
| SMC2 | 5086 |
| SMC4 | 3394 |
| NCAPH | 2791 |
| NCAPH2 | 1211 |
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.4.1 (2024-06-14)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.4.0 GGally_2.2.1
## [3] reshape2_1.4.4 gplots_3.1.3.1
## [5] gtools_3.9.5 tibble_3.2.1
## [7] dplyr_1.1.4 echarts4r_0.4.5
## [9] limma_3.60.0 SingleR_2.6.0
## [11] celldex_1.14.0 harmony_1.2.0
## [13] Rcpp_1.0.12 mitch_1.16.0
## [15] DESeq2_1.44.0 muscat_1.18.0
## [17] beeswarm_0.4.0 stringi_1.8.4
## [19] SingleCellExperiment_1.26.0 SummarizedExperiment_1.34.0
## [21] Biobase_2.64.0 GenomicRanges_1.56.0
## [23] GenomeInfoDb_1.40.0 IRanges_2.38.0
## [25] S4Vectors_0.42.0 BiocGenerics_0.50.0
## [27] MatrixGenerics_1.16.0 matrixStats_1.3.0
## [29] hdf5r_1.3.11 Seurat_5.1.0
## [31] SeuratObject_5.0.2 sp_2.1-4
## [33] plyr_1.8.9 ggplot2_3.5.1
## [35] kableExtra_1.4.0
##
## loaded via a namespace (and not attached):
## [1] progress_1.2.3 goftest_1.2-3
## [3] Biostrings_2.72.0 HDF5Array_1.32.0
## [5] vctrs_0.6.5 spatstat.random_3.2-3
## [7] digest_0.6.36 png_0.1-8
## [9] corpcor_1.6.10 shape_1.4.6.1
## [11] gypsum_1.0.1 ggrepel_0.9.5
## [13] deldir_2.0-4 parallelly_1.37.1
## [15] MASS_7.3-61 httpuv_1.6.15
## [17] foreach_1.5.2 withr_3.0.0
## [19] xfun_0.45 survival_3.7-0
## [21] memoise_2.0.1.9000 ggbeeswarm_0.7.2
## [23] systemfonts_1.1.0 zoo_1.8-12
## [25] GlobalOptions_0.1.2 pbapply_1.7-2
## [27] prettyunits_1.2.0 KEGGREST_1.44.0
## [29] promises_1.3.0 httr_1.4.7
## [31] globals_0.16.3 fitdistrplus_1.1-11
## [33] rhdf5filters_1.16.0 rhdf5_2.48.0
## [35] rstudioapi_0.16.0 UCSC.utils_1.0.0
## [37] miniUI_0.1.1.1 generics_0.1.3
## [39] curl_5.2.1 zlibbioc_1.50.0
## [41] ScaledMatrix_1.12.0 polyclip_1.10-6
## [43] GenomeInfoDbData_1.2.12 ExperimentHub_2.12.0
## [45] SparseArray_1.4.3 xtable_1.8-4
## [47] stringr_1.5.1 doParallel_1.0.17
## [49] evaluate_0.24.0 S4Arrays_1.4.0
## [51] BiocFileCache_2.12.0 hms_1.1.3
## [53] irlba_2.3.5.1 colorspace_2.1-0
## [55] filelock_1.0.3 ROCR_1.0-11
## [57] reticulate_1.38.0 spatstat.data_3.1-2
## [59] magrittr_2.0.3 lmtest_0.9-40
## [61] later_1.3.2 viridis_0.6.5
## [63] lattice_0.22-6 spatstat.geom_3.2-9
## [65] future.apply_1.11.2 scattermore_1.2
## [67] scuttle_1.14.0 cowplot_1.1.3
## [69] RcppAnnoy_0.0.22 pillar_1.9.0
## [71] nlme_3.1-165 iterators_1.0.14
## [73] caTools_1.18.2 compiler_4.4.1
## [75] beachmat_2.20.0 RSpectra_0.16-1
## [77] tensor_1.5 minqa_1.2.7
## [79] crayon_1.5.3 abind_1.4-5
## [81] scater_1.32.0 blme_1.0-5
## [83] locfit_1.5-9.10 bit_4.0.5
## [85] codetools_0.2-20 BiocSingular_1.20.0
## [87] bslib_0.7.0 alabaster.ranges_1.4.0
## [89] GetoptLong_1.0.5 plotly_4.10.4
## [91] remaCor_0.0.18 mime_0.12
## [93] splines_4.4.1 circlize_0.4.16
## [95] fastDummies_1.7.3 dbplyr_2.5.0
## [97] sparseMatrixStats_1.16.0 knitr_1.48
## [99] blob_1.2.4 utf8_1.2.4
## [101] clue_0.3-65 BiocVersion_3.19.1
## [103] lme4_1.1-35.3 listenv_0.9.1
## [105] DelayedMatrixStats_1.26.0 Rdpack_2.6
## [107] Matrix_1.7-0 statmod_1.5.0
## [109] svglite_2.1.3 fANCOVA_0.6-1
## [111] pkgconfig_2.0.3 tools_4.4.1
## [113] cachem_1.1.0 RhpcBLASctl_0.23-42
## [115] rbibutils_2.2.16 RSQLite_2.3.7
## [117] viridisLite_0.4.2 DBI_1.2.3
## [119] numDeriv_2016.8-1.1 fastmap_1.2.0
## [121] rmarkdown_2.27 scales_1.3.0
## [123] grid_4.4.1 ica_1.0-3
## [125] broom_1.0.6 AnnotationHub_3.12.0
## [127] sass_0.4.9 patchwork_1.2.0
## [129] BiocManager_1.30.23 ggstats_0.6.0
## [131] dotCall64_1.1-1 RANN_2.6.1
## [133] alabaster.schemas_1.4.0 farver_2.1.2
## [135] aod_1.3.3 mgcv_1.9-1
## [137] yaml_2.3.9 cli_3.6.3
## [139] purrr_1.0.2 leiden_0.4.3.1
## [141] lifecycle_1.0.4 uwot_0.2.2
## [143] glmmTMB_1.1.9 mvtnorm_1.2-5
## [145] backports_1.5.0 BiocParallel_1.38.0
## [147] gtable_0.3.5 rjson_0.2.21
## [149] ggridges_0.5.6 progressr_0.14.0
## [151] jsonlite_1.8.8 edgeR_4.2.0
## [153] RcppHNSW_0.6.0 bitops_1.0-7
## [155] bit64_4.0.5 Rtsne_0.17
## [157] alabaster.matrix_1.4.0 spatstat.utils_3.0-5
## [159] BiocNeighbors_1.22.0 highr_0.11
## [161] jquerylib_0.1.4 alabaster.se_1.4.0
## [163] pbkrtest_0.5.3 lazyeval_0.2.2
## [165] alabaster.base_1.4.1 shiny_1.8.1.1
## [167] htmltools_0.5.8.1 sctransform_0.4.1
## [169] rappdirs_0.3.3 glue_1.7.0
## [171] spam_2.10-0 httr2_1.0.1
## [173] XVector_0.44.0 gridExtra_2.3
## [175] EnvStats_2.8.1 boot_1.3-30
## [177] igraph_2.0.3 variancePartition_1.34.0
## [179] TMB_1.9.11 R6_2.5.1
## [181] tidyr_1.3.1 labeling_0.4.3
## [183] cluster_2.1.6 Rhdf5lib_1.26.0
## [185] nloptr_2.1.1 DelayedArray_0.30.1
## [187] tidyselect_1.2.1 vipor_0.4.7
## [189] xml2_1.3.6 AnnotationDbi_1.66.0
## [191] future_1.33.2 rsvd_1.0.5
## [193] munsell_0.5.1 KernSmooth_2.23-24
## [195] data.table_1.15.4 htmlwidgets_1.6.4
## [197] ComplexHeatmap_2.20.0 RColorBrewer_1.1-3
## [199] rlang_1.1.4 spatstat.sparse_3.1-0
## [201] spatstat.explore_3.2-7 lmerTest_3.1-3
## [203] fansi_1.0.6END of report